data_2n8k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n8k _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.878 0.37 . . . . 63.11 111.127 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.5 m -136.02 109.59 7.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.121 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.8 m -127.54 143.89 51.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.88 43.11 70.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.99 24.51 58.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.49 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -145.09 136.26 24.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.694 0.283 . . . . 75.44 110.938 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.8 139.35 50.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.932 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.1 m -122.09 164.07 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 52.42 110.915 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -66.1 161.1 59.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.564 0.697 . . . . 70.44 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 167.49 24.3 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.68 2.253 . . . . 75.41 112.335 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 63.62 27.55 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.87 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -141.99 116.64 9.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.31 110.883 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.88 168.13 13.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.898 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 m -90.51 131.72 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.44 110.909 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.68 133.68 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 74.32 111.109 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -78.83 123.08 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.902 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.907 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.688 0.756 . . . . 72.52 110.861 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.03 28.93 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.697 2.265 . . . . 72.34 112.358 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -123.63 162.32 23.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.871 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.4 m -91.89 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.906 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 148.42 40.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.566 0.698 . . . . 71.22 110.888 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 152.18 69.24 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 74.41 112.375 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.52 150.59 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 61.23 110.892 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.25 152.84 49.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.503 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -108.73 -172.96 2.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 73.44 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.6 tp -74.82 151.79 39.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.873 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.14 22.29 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.21 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.66 159.33 46.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 73.54 110.895 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 132.14 22.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 75.32 112.385 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.0 159.1 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 54.23 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -122.2 143.35 49.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 72.32 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -52.01 -65.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.33 111.129 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -137.66 156.99 74.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 75.44 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 72.45 112.343 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.41 -169.35 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 71.21 110.868 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -68.54 -14.89 63.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -95.61 -28.29 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.13 110.863 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 32.12 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.37 147.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 73.1 111.134 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -99.76 -175.95 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.911 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -77.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 73.42 110.819 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -123.01 -58.57 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -75.59 169.93 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.817 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.5 m -118.09 160.0 40.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 74.32 110.853 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 166.55 27.22 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 74.34 112.324 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.5 m -66.81 124.55 23.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.89 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.96 16.03 1.18 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 74.14 112.463 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 75.21 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.01 23.57 29.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 52.44 112.509 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.9 176.07 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 72.43 110.942 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 119.77 5.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.13 110.866 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.99 108.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.858 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.51 137.8 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.138 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.34 120.87 18.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.886 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.69 -19.36 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 73.3 111.118 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.37 -157.25 7.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 73.11 112.503 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -138.0 159.55 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 60.22 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.8 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.663 -1.807 . . . . 73.04 112.339 0.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -130.12 49.7 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -72.93 78.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mp -79.73 129.25 34.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 73.52 110.905 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.26 157.78 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.43 129.23 36.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.55 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -140.64 124.3 17.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 63.24 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -51.78 116.94 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.918 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.96 147.59 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.32 110.887 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.816 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.876 0.37 . . . . 63.11 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -128.96 109.99 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.51 111.167 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.59 142.86 50.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.872 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.98 41.55 59.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 72.44 112.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.14 20.18 57.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 75.23 112.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -135.75 140.45 44.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 75.44 110.932 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -84.01 135.41 34.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.3 110.95 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 m -123.65 167.7 13.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 52.42 110.825 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -67.78 160.67 72.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 70.44 110.879 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 174.55 9.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.718 2.279 . . . . 75.41 112.321 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 62.54 26.14 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.1 p -141.45 119.53 12.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.816 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.97 168.23 12.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 72.13 110.845 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.7 m -92.92 128.62 38.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.83 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -117.9 141.57 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.43 136.36 53.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 71.52 110.861 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.954 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.618 0.723 . . . . 72.52 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.8 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.764 2.31 . . . . 72.34 112.276 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -132.32 164.78 25.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.01 110.86 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -96.34 119.04 34.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 149.27 47.88 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 71.22 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 148.11 64.02 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.723 2.282 . . . . 74.41 112.379 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 mt -57.25 149.33 20.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 61.23 110.931 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.75 145.6 49.91 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 72.22 112.506 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -100.87 -172.83 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 73.44 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.94 151.12 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 70.23 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 m120 58.21 22.34 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.93 159.47 40.74 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 73.54 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 141.59 45.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 75.32 112.254 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -150.79 165.37 33.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 54.23 110.959 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 72.32 110.835 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.8 t -51.65 -61.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 73.33 111.139 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -142.27 156.74 64.19 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.678 0.751 . . . . 75.44 110.817 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -168.43 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.538 2.158 . . . . 72.45 112.381 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -169.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 71.21 110.895 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -65.98 -19.76 65.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 74.04 110.824 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -97.06 -28.24 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.13 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.33 3.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 63.51 112.463 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.25 155.99 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 73.1 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -112.91 -176.03 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.926 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.36 -78.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.42 110.782 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -122.94 -59.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.971 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -76.01 157.87 32.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.836 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.77 159.81 29.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 74.32 110.953 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.05 36.06 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 74.34 112.324 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.1 m -66.55 127.82 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.839 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.39 17.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 74.14 112.516 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.91 27.59 5.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 75.21 110.895 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.64 19.17 28.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.533 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -108.54 164.68 12.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 72.43 110.944 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -142.61 125.61 16.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 73.13 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -55.46 101.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.936 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -118.57 140.27 50.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.45 111.091 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -70.5 125.84 27.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.43 110.892 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.05 12.86 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.3 111.093 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.11 -165.49 30.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 73.11 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -142.5 159.83 56.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 60.22 110.856 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.1 Cg_endo -69.64 -48.74 0.26 Allowed 'Cis proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.721 -1.783 . . . . 73.04 112.369 -0.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -125.2 75.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.898 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -101.47 78.03 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 74.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.8 136.93 36.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.916 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -144.78 154.18 42.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 74.42 110.859 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.08 134.11 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.55 110.96 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -141.62 136.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -51.11 116.68 2.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.889 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 158.51 29.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.822 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 75.13 110.897 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 63.11 111.117 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m -146.86 110.27 4.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 73.51 111.099 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.2 m -146.63 135.24 22.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.477 . . . . 73.21 110.886 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.78 73.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.764 . . . . 72.44 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.5 70.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.504 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 136.24 27.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.711 0.291 . . . . 75.44 110.903 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -93.36 142.81 26.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.3 110.913 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -130.97 169.61 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 52.42 110.897 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -57.41 160.73 6.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.582 0.705 . . . . 70.44 110.834 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 175.5 7.95 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.727 2.285 . . . . 75.41 112.354 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 58.63 37.34 25.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.47 . . . . 75.25 110.905 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -140.96 127.57 20.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 72.31 110.866 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 p -90.36 168.11 12.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.839 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 m -90.49 126.58 35.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.44 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 m -122.46 155.19 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.124 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.13 131.73 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.52 110.902 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 75.54 110.896 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.1 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.653 0.739 . . . . 72.52 110.795 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 165.96 29.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 72.34 112.307 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -131.57 170.19 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.01 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.9 130.26 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.42 110.855 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 149.52 58.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.587 0.708 . . . . 71.22 110.871 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.73 51.84 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.622 2.215 . . . . 74.41 112.379 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.4 mt -54.33 151.26 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 61.23 110.887 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.48 158.72 48.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.525 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -111.12 -175.08 2.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 73.44 110.943 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.1 tp -70.09 144.19 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 70.23 110.916 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 58.51 38.92 25.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.21 110.951 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 159.67 67.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.64 0.733 . . . . 73.54 110.866 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 123.39 10.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.629 2.219 . . . . 75.32 112.308 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 p -142.07 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 54.23 110.933 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -128.52 146.84 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -52.24 -64.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.118 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -139.78 157.05 70.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 75.44 110.831 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.06 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.759 2.306 . . . . 72.45 112.298 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.95 -169.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.892 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -67.88 -16.25 63.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.844 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.62 -28.42 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.39 32.07 4.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 63.51 112.432 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mt -122.04 148.5 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 73.1 111.158 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -104.9 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.918 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.35 -76.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.828 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -122.64 -59.65 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.905 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -75.33 163.57 27.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.804 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 m -115.13 159.61 37.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 74.32 110.935 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 168.28 22.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.22 . . . . 74.34 112.34 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.45 130.97 44.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.44 19.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 74.14 112.483 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -128.02 26.24 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 75.21 110.842 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.47 21.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 52.44 112.478 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -108.4 175.67 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.43 110.904 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.1 116.26 7.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 73.13 110.797 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 106.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 73.14 110.887 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -119.24 139.43 51.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.45 111.115 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -68.75 122.28 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.872 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.79 -18.88 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.3 111.069 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.95 -157.45 7.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -144.17 159.6 51.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 60.22 110.917 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.79 -48.41 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 -1.79 . . . . 73.04 112.312 0.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -123.06 52.7 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 62.02 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -88.64 77.98 7.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.69 156.2 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -147.84 157.92 43.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 74.42 110.868 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.6 140.45 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.862 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -149.36 125.74 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 63.24 110.92 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -52.04 117.59 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -66.52 158.76 28.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.818 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.937 0.398 . . . . 63.11 111.139 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 m -138.67 107.84 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 73.51 111.165 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 m -135.19 147.93 49.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.864 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.29 37.57 87.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 72.44 112.455 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.63 23.14 64.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 75.23 112.499 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -142.36 143.53 32.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 75.44 110.914 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -95.92 148.18 22.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.3 110.971 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.2 m -137.93 168.87 18.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 52.42 110.904 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -54.43 160.94 2.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 70.44 110.843 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.26 8.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.714 2.276 . . . . 75.41 112.308 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.17 39.07 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.905 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -140.61 131.26 25.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 72.31 110.861 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -94.01 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 72.13 110.875 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 m -90.25 123.59 34.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.852 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.22 144.47 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.087 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -90.56 124.82 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 71.52 110.951 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 m120 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.948 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.731 0.777 . . . . 72.52 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 165.88 29.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.72 2.28 . . . . 72.34 112.342 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -134.48 173.91 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 72.01 110.872 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.45 130.95 46.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 149.39 59.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 71.22 110.912 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 146.28 59.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 74.41 112.328 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.73 150.04 13.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 61.23 110.911 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.77 157.19 52.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 72.22 112.492 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -109.51 -171.69 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.858 0.361 . . . . 73.44 110.899 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 tp -72.13 146.1 47.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.938 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 58.09 34.6 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.911 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.44 159.74 56.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.54 110.907 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 119.41 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 75.32 112.279 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -136.58 168.31 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 54.23 110.851 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -129.96 144.27 51.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 72.32 110.94 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.08 -63.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -138.98 156.99 72.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.695 0.759 . . . . 75.44 110.851 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.83 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 72.45 112.402 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.07 -169.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.21 110.878 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.47 -16.32 64.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -96.97 -28.34 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.947 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.17 31.99 4.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.9 149.64 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 73.1 111.111 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -104.13 -176.27 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.892 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -77.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 73.42 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -122.76 -59.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 74.41 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -74.77 161.09 29.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.795 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.1 159.9 31.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 74.32 110.949 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.07 22.55 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 74.34 112.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.57 129.93 41.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 70.41 110.906 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.67 19.41 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 74.14 112.476 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.34 25.83 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 75.21 110.892 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.0 22.8 16.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 52.44 112.466 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.84 178.47 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 72.43 110.966 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.33 114.39 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.13 110.882 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.3 106.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.875 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -119.14 139.26 52.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.45 111.105 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -69.27 123.4 21.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 m -116.45 -21.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 73.3 111.126 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.92 -164.55 10.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.468 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -133.34 160.14 69.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 60.22 110.906 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.73 -48.55 0.26 Allowed 'Cis proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.714 -1.786 . . . . 73.04 112.364 -0.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -125.53 50.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.02 110.932 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -83.99 77.92 9.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -86.8 154.46 20.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.915 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -146.31 149.7 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.883 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.1 137.52 56.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.55 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -146.84 126.29 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.92 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.03 117.43 2.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.87 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.06 158.11 32.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 75.13 110.867 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.9 0.381 . . . . 63.11 111.074 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 m -148.93 114.49 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.51 111.131 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.18 152.62 40.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.27 25.81 67.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 72.44 112.458 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.42 78.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 75.23 112.488 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -143.89 153.95 42.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 75.44 110.863 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -93.11 138.97 31.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 74.3 110.921 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 m -117.76 175.15 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 52.42 110.802 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -76.29 160.52 77.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.6 0.714 . . . . 70.44 110.881 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.41 112.311 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.52 32.89 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -142.07 132.11 24.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 72.31 110.851 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -97.74 168.27 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 m -95.98 124.25 39.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.883 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 131.7 70.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 74.32 111.127 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.39 124.67 30.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.929 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 75.54 110.862 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.634 0.73 . . . . 72.52 110.798 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 166.45 27.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 72.34 112.366 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -127.26 172.21 10.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 72.01 110.841 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.9 m -103.3 118.11 36.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.952 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 148.82 64.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.594 0.711 . . . . 71.22 110.812 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 149.99 67.96 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.626 2.217 . . . . 74.41 112.392 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.21 157.86 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 61.23 110.891 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 157.07 51.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 72.22 112.501 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -108.29 -173.47 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 73.44 110.878 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.7 tp -71.62 148.29 46.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 70.23 110.936 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 55.02 35.4 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.879 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.32 159.53 56.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.61 0.719 . . . . 73.54 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 117.97 5.4 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 75.32 112.333 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -133.89 171.06 14.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 54.23 110.847 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -126.98 147.82 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.32 110.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.64 -63.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 73.33 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 154.14 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 75.44 110.897 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -169.64 0.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.675 2.25 . . . . 72.45 112.382 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.66 -169.34 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 71.21 110.907 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -65.2 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -93.69 -25.66 17.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 64.13 110.895 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.25 5.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.431 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 mm -108.74 156.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 73.1 111.129 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.75 -176.73 2.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.962 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -79.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.805 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -123.32 -58.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.41 110.951 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -77.22 158.68 30.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.898 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.6 m -107.57 159.4 30.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 74.32 110.873 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 168.22 22.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 74.34 112.355 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.7 m -69.45 132.84 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 70.41 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.67 19.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.708 -0.758 . . . . 74.14 112.466 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.61 27.0 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 75.21 110.946 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.49 23.09 19.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 52.44 112.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.77 177.04 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 72.43 110.908 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.34 122.36 7.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.878 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.12 111.8 0.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 73.14 110.871 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -131.25 136.56 48.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 74.45 111.121 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -65.99 127.23 31.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.79 -23.59 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 73.3 111.131 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.5 -167.46 12.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 73.11 112.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.1 pt-20 -119.09 159.69 44.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.692 0.758 . . . . 60.22 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.76 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 -1.796 . . . . 73.04 112.346 -0.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -131.25 43.58 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 62.02 110.835 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -66.5 89.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.41 136.38 33.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.886 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -135.35 145.99 47.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.936 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.29 136.66 55.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 74.55 110.882 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -144.99 126.04 14.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 63.24 110.878 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -51.85 116.92 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.953 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.71 155.67 38.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 75.32 110.928 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.864 -179.773 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.833 0.349 . . . . 63.11 111.118 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -132.05 110.06 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 73.51 111.152 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.13 137.97 52.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.88 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.22 18.58 69.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.09 -19.62 48.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.509 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -108.41 152.88 24.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.722 0.296 . . . . 75.44 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -80.73 144.19 32.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 74.3 110.974 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.81 159.84 24.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 52.42 110.894 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -56.6 160.99 4.78 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.526 0.679 . . . . 70.44 110.944 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 166.87 26.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.716 2.277 . . . . 75.41 112.332 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 59.23 33.96 22.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.91 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -141.97 123.8 15.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 72.31 110.901 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -88.78 168.12 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 72.13 110.897 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -88.62 120.38 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.44 110.979 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.64 141.04 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.32 111.12 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 122.84 47.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.52 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.54 110.916 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.6 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.687 0.756 . . . . 72.52 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 166.56 27.33 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 72.34 112.261 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -135.23 173.81 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.01 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 m -96.67 129.83 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.861 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.07 148.32 68.84 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.549 0.69 . . . . 71.22 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 155.69 65.4 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 74.41 112.338 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.2 mt -63.68 162.07 13.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 61.23 110.913 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.68 150.21 41.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.741 . . . . 72.22 112.459 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -99.47 -174.29 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.44 110.957 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 tp -71.14 144.01 50.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.924 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 57.38 26.86 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.869 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.04 159.55 31.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 73.54 110.863 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 119.27 6.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.646 2.231 . . . . 75.32 112.383 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -136.59 166.07 24.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 54.23 110.814 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -125.64 142.58 51.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 72.32 110.883 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -51.67 -63.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.33 111.078 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -138.52 157.11 72.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.693 0.759 . . . . 75.44 110.841 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 72.45 112.3 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -72.98 -169.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.21 110.858 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.63 -14.15 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.04 110.883 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -97.63 -28.34 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.13 110.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.07 32.12 4.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 63.51 112.527 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mt -125.26 148.84 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.844 0.355 . . . . 73.1 111.101 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -99.78 -176.26 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.908 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.13 -77.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 73.42 110.929 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.01 -59.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -74.88 162.42 28.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.9 m -113.36 158.73 37.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.542 0.686 . . . . 74.32 110.918 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 168.11 22.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.636 2.224 . . . . 74.34 112.34 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -67.74 125.64 26.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.911 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.54 15.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.733 . . . . 74.14 112.469 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.9 37.21 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 75.21 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.4 24.6 39.18 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 52.44 112.501 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.37 174.85 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 72.43 110.848 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.5 118.77 6.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 73.13 110.791 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 110.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.14 110.862 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -130.7 140.99 50.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.117 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -67.83 119.68 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.855 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.85 -20.4 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.147 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.34 -157.47 7.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 73.11 112.464 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -144.1 159.73 51.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.717 . . . . 60.22 110.886 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.3 Cg_endo -69.7 -48.41 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.156 0 C-N-CA 122.69 -1.796 . . . . 73.04 112.372 -0.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -124.69 58.33 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 62.02 110.845 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -90.21 82.36 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.935 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.28 149.24 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.94 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -151.13 146.51 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.42 110.834 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.41 141.28 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.891 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -150.9 127.06 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 63.24 110.941 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -51.9 116.94 2.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.58 157.67 37.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.788 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.976 0.417 . . . . 63.11 111.108 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -147.88 123.55 10.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 73.51 111.131 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.2 m -150.2 150.44 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.877 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.82 37.14 89.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.79 20.83 62.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 75.23 112.505 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -140.22 154.46 46.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 75.44 110.876 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -93.99 138.27 32.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.961 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.58 174.99 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 52.42 110.856 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -81.75 160.88 62.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 70.44 110.899 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.78 33.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.737 2.292 . . . . 75.41 112.322 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.04 25.26 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.92 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -142.05 119.99 12.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.811 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.96 168.0 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.0 m -88.2 133.25 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 75.44 110.959 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.53 124.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.32 111.121 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -82.61 125.65 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 71.52 110.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m120 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.921 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.701 0.762 . . . . 72.52 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 166.67 26.74 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.716 2.277 . . . . 72.34 112.398 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -127.03 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.01 110.85 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.8 m -103.45 111.73 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.886 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.51 148.64 42.24 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.603 0.716 . . . . 71.22 110.808 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.54 69.27 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.663 2.242 . . . . 74.41 112.344 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.31 148.51 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 61.23 110.912 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.81 152.87 38.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.752 . . . . 72.22 112.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -103.94 -170.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 73.44 110.883 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.03 142.1 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.65 34.64 22.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.851 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.62 49.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.651 0.739 . . . . 73.54 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 75.32 112.381 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.51 161.96 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 54.23 110.857 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.67 146.65 47.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.855 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.94 -64.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.164 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -138.29 156.98 73.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 75.44 110.907 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.632 2.222 . . . . 72.45 112.344 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.23 -169.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 71.21 110.959 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.48 -15.58 63.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -95.46 -28.32 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.13 110.89 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.03 32.06 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.502 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.3 mt -125.64 149.54 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 73.1 111.123 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -102.19 -176.09 3.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.71 -77.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.42 110.916 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -122.85 -59.46 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.946 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -75.93 160.9 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -112.79 160.07 32.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.649 0.738 . . . . 74.32 110.889 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 168.04 22.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.227 . . . . 74.34 112.423 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -68.87 126.31 29.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 70.41 110.887 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.9 19.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 74.14 112.481 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -127.85 27.48 5.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 75.21 110.887 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.55 19.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.729 -0.748 . . . . 52.44 112.498 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -109.74 169.5 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 72.43 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.52 117.79 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 73.13 110.872 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.66 103.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.908 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -115.77 136.58 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.45 111.065 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -68.91 124.67 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.89 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.07 13.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.108 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.13 -167.52 33.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 73.11 112.513 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -127.48 159.58 64.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.6 0.714 . . . . 60.22 110.942 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.77 -48.23 0.28 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 73.04 112.355 -0.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.13 43.72 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 62.02 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.06 102.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 74.0 110.991 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.88 138.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 73.52 110.939 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -135.86 150.24 49.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.42 110.829 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.47 140.28 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.55 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -151.56 129.14 11.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 63.24 110.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.77 116.95 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.896 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -66.94 149.5 50.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.94 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.847 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.956 0.408 . . . . 63.11 111.096 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -128.73 115.58 18.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 73.51 111.136 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 m -137.48 125.51 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.44 17.76 79.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 72.44 112.477 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.25 -16.72 58.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 75.23 112.482 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.53 152.33 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 75.44 110.848 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -97.17 154.7 17.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 74.3 110.878 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.49 172.04 14.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 52.42 110.9 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -64.08 160.83 44.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.719 . . . . 70.44 110.898 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 175.75 7.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.236 . . . . 75.41 112.321 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 56.5 37.81 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.941 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.33 122.32 14.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 72.31 110.807 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -87.72 168.1 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.88 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -90.56 134.63 34.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 75.44 110.87 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.34 144.83 36.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 74.32 111.156 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -89.34 124.09 34.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 71.52 110.972 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.6 m120 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.905 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.716 0.77 . . . . 72.52 110.868 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 166.2 28.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.669 2.246 . . . . 72.34 112.339 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -136.11 174.05 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 72.01 110.832 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.57 130.29 46.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.924 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 149.4 53.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 71.22 110.861 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 144.67 54.66 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.26 . . . . 74.41 112.307 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.2 mt -54.29 149.11 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.23 110.942 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 153.04 51.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 72.22 112.509 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -106.34 -172.33 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.44 110.875 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.77 151.15 39.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 70.23 110.939 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 60.5 21.87 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.22 159.52 44.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.627 0.727 . . . . 73.54 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 145.93 58.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 75.32 112.361 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.9 p -153.96 167.3 30.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 54.23 110.881 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -126.54 145.43 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.897 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -53.13 -65.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.33 111.172 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -140.01 156.8 70.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.641 0.734 . . . . 75.44 110.927 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -170.5 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.238 . . . . 72.45 112.308 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.21 110.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.72 -16.58 64.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 74.04 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -96.36 -28.37 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.86 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 63.51 112.505 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.71 146.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 73.1 111.111 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -100.15 -176.3 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.51 -77.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 73.42 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -122.81 -58.85 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 74.41 110.985 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -76.31 167.74 21.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.908 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -117.8 160.19 39.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.548 0.689 . . . . 74.32 110.913 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 168.11 22.47 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 74.34 112.332 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 91.9 m -69.1 127.97 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.841 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.11 19.36 0.73 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.68 -0.772 . . . . 74.14 112.465 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.57 27.64 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 75.21 110.813 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.04 20.44 23.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 52.44 112.507 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.34 177.48 4.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 72.43 110.939 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 122.18 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 73.13 110.861 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.09 108.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -123.92 148.45 46.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.45 111.173 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -82.47 122.75 28.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.909 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.94 13.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.3 111.082 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.05 -167.98 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.466 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -140.26 160.04 61.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 60.22 110.872 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.2 Cg_endo -69.68 -44.91 0.46 Allowed 'Cis proline' 0 C--N 1.341 0.151 0 C-N-CA 122.753 -1.769 . . . . 73.04 112.325 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -130.73 69.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 62.02 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -94.26 78.2 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.17 137.9 33.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.52 110.888 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -144.15 170.81 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.38 135.44 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.55 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -146.7 130.93 17.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.24 110.872 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.77 117.24 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.851 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.87 149.21 49.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.901 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.85 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.893 0.377 . . . . 63.11 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.4 m -136.47 109.17 7.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.51 111.159 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.3 m -136.97 137.58 39.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.897 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 39.96 97.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.701 -0.761 . . . . 72.44 112.446 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.98 29.07 64.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.442 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -144.94 139.59 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 75.44 110.831 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -89.64 148.58 23.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 74.3 110.939 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -139.09 170.4 16.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 52.42 110.881 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -60.35 161.07 14.66 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.544 0.687 . . . . 70.44 110.876 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 173.42 10.95 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.666 2.244 . . . . 75.41 112.334 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 58.19 37.58 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.21 122.54 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.31 110.86 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.55 168.1 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.861 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -89.82 129.89 36.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.828 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.1 152.64 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 74.32 111.165 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -112.07 136.72 51.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.52 110.898 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 75.54 110.894 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.711 0.767 . . . . 72.52 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 166.46 27.48 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 72.34 112.389 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.0 mtp85 -140.24 173.98 10.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.859 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.26 129.97 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 71.42 110.858 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.12 149.64 54.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 71.22 110.838 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.29 62.35 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.655 2.237 . . . . 74.41 112.318 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.2 mt -56.6 148.8 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 61.23 110.863 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.68 154.48 45.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 72.22 112.518 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -107.34 -174.42 2.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.856 0.36 . . . . 73.44 110.837 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.7 145.47 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 70.23 110.9 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 58.37 38.33 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.946 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.03 159.74 68.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.585 0.707 . . . . 73.54 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 130.96 20.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.683 2.255 . . . . 75.32 112.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -144.38 170.44 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 54.23 110.894 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -129.53 147.78 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.32 -67.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 73.33 111.123 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -138.51 156.78 73.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 75.44 110.881 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 72.45 112.358 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -169.51 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.904 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -66.79 -16.54 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.885 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -97.49 -28.25 14.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 64.13 110.865 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.98 4.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 63.51 112.491 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.7 146.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 73.1 111.153 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -103.1 -176.09 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.885 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.06 -77.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.868 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -123.02 -59.88 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.932 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -75.72 158.29 32.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.885 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.53 160.17 30.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 74.32 110.844 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 168.08 22.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.673 2.249 . . . . 74.34 112.432 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.58 128.77 37.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 70.41 110.86 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.99 20.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 74.14 112.495 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.8 28.26 5.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.923 0.392 . . . . 75.21 110.919 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.95 23.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 52.44 112.516 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -109.06 176.11 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 72.43 110.996 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.65 119.6 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.893 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.21 108.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 137.12 55.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 74.45 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -71.92 124.06 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.908 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.89 -20.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.3 111.154 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.05 -174.06 16.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 73.11 112.504 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -116.7 159.41 40.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.571 0.701 . . . . 60.22 110.837 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -48.25 0.28 Allowed 'Cis proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.708 -1.788 . . . . 73.04 112.403 -0.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -130.98 46.55 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 62.02 110.865 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -70.12 83.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 74.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.17 145.8 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.941 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -143.33 154.96 44.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.846 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.92 139.28 48.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.55 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.98 128.59 12.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 63.24 110.874 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.04 117.05 2.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.16 153.92 42.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.906 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.13 110.862 -179.809 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.936 0.398 . . . . 63.11 111.095 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 m -129.7 122.22 28.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 73.51 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 m -139.68 130.35 25.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.878 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.24 22.84 59.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.07 68.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.73 . . . . 75.23 112.455 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 139.05 31.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 75.44 110.866 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.12 142.97 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 74.3 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -139.45 174.63 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 52.42 110.905 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -72.41 160.73 82.01 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 70.44 110.877 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 177.77 5.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.626 2.217 . . . . 75.41 112.313 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 62.81 27.09 15.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 75.25 110.955 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.0 m -142.03 117.41 10.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.855 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.19 168.26 16.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -91.57 131.0 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 75.44 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.19 147.04 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.153 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.94 136.54 54.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 71.52 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.848 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.708 0.766 . . . . 72.52 110.851 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 165.64 30.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.75 2.3 . . . . 72.34 112.329 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -130.51 163.39 27.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.86 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -90.72 121.04 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.934 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.56 148.57 50.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 71.22 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 154.8 67.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.725 2.283 . . . . 74.41 112.327 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -65.35 158.18 27.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 61.23 110.928 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.32 158.59 50.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 72.22 112.511 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -110.37 -173.08 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 73.44 110.895 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.37 145.0 51.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.958 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 57.24 39.45 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.21 110.869 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 159.45 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.68 0.752 . . . . 73.54 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.767 2.311 . . . . 75.32 112.289 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -142.16 160.21 40.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 54.23 110.841 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.9 142.44 47.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.6 -60.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.15 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -139.03 157.08 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.702 0.763 . . . . 75.44 110.868 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -170.41 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.637 2.225 . . . . 72.45 112.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.21 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.92 -15.75 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.815 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -96.52 -28.44 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 64.13 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.11 32.14 4.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 63.51 112.554 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.3 mt -125.54 150.51 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.1 111.123 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -102.04 -176.1 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.868 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.54 -77.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 73.42 110.854 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -123.04 -58.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.981 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -75.2 169.72 17.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 24.0 m -119.17 158.35 48.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.621 0.724 . . . . 74.32 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 168.27 22.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.637 2.225 . . . . 74.34 112.355 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -64.69 125.18 23.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 70.41 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.94 17.88 1.08 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 74.14 112.479 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.07 28.99 5.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 75.21 110.831 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.67 22.52 23.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 52.44 112.454 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mt -109.81 179.36 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 72.43 110.923 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.74 116.59 5.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.833 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 110.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 73.14 110.847 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -126.21 136.77 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.145 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -65.41 123.92 20.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.896 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.76 -19.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.43 . . . . 73.3 111.096 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.91 -164.5 11.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.438 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -131.39 159.7 70.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.621 0.724 . . . . 60.22 110.918 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.4 Cg_endo -69.74 -48.37 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.146 0 C-N-CA 122.67 -1.804 . . . . 73.04 112.326 -0.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -126.21 47.91 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.02 110.903 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -79.61 77.99 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.867 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.54 152.55 25.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.936 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -145.61 145.53 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.88 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.63 136.11 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.851 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -143.76 125.04 14.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.24 110.912 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -51.8 116.93 2.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.86 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.91 156.97 38.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.929 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.876 -179.784 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.949 0.404 . . . . 63.11 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -137.32 110.48 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 73.51 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 m -125.94 130.99 52.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.824 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 20.89 63.82 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 72.44 112.471 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.31 -20.38 44.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.77 -0.728 . . . . 75.23 112.541 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -100.12 145.56 27.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 75.44 110.864 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.903 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.99 171.53 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 52.42 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -65.4 160.69 57.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.702 . . . . 70.44 110.893 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 174.97 8.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.244 . . . . 75.41 112.341 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 58.47 30.0 19.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.887 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 m -142.06 120.75 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.826 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.2 p -90.31 168.1 12.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.881 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 m -90.14 126.36 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.78 136.97 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 74.32 111.186 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -104.62 128.09 52.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 71.52 110.877 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.54 110.908 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.608 0.718 . . . . 72.52 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 165.64 30.28 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.704 2.269 . . . . 72.34 112.31 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -129.19 171.52 12.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 72.01 110.83 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.2 m -102.3 112.99 25.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.81 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 148.96 40.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 71.22 110.889 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 150.39 68.52 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 74.41 112.391 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.0 mt -59.0 147.99 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 61.23 110.932 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.9 156.7 36.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 72.22 112.503 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -108.32 -170.78 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 73.44 110.868 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.9 tp -73.75 146.4 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 70.23 110.868 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.47 32.52 20.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.849 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.88 159.67 45.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 73.54 110.941 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.92 5.97 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 75.32 112.295 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -135.04 169.33 17.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 54.23 110.893 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -130.21 144.64 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.857 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -52.62 -63.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.113 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -138.98 156.75 72.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 75.44 110.863 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -169.99 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.752 2.301 . . . . 72.45 112.323 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -168.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 71.21 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.1 -24.14 67.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.812 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -89.94 -28.37 19.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.13 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.54 32.25 4.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 63.51 112.566 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.9 mt -120.66 150.73 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 73.1 111.088 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -104.18 -176.09 2.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.22 110.955 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.55 -76.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.864 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -122.66 -60.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 74.41 110.923 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -74.9 158.85 32.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 74.31 110.792 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.1 m -109.93 160.05 29.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 74.32 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 167.93 23.04 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.698 2.266 . . . . 74.34 112.293 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.73 124.74 24.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 70.41 110.883 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.04 17.61 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.14 112.478 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.82 27.44 6.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 75.21 110.951 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.46 21.58 24.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.646 -0.788 . . . . 52.44 112.523 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -107.8 170.94 7.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 72.43 110.841 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.935 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.23 109.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.14 110.909 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -127.75 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.45 111.129 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -66.87 127.97 34.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.941 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.31 13.21 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.3 111.11 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.56 -157.95 18.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 73.11 112.484 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -140.25 159.39 63.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 60.22 110.913 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.74 -41.75 0.86 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.664 -1.807 . . . . 73.04 112.351 -0.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.56 63.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.912 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -81.95 79.81 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -82.15 133.04 35.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.954 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.94 147.77 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 74.42 110.896 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.85 129.42 39.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 74.55 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.72 128.1 30.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 63.24 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 119.98 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.842 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -64.12 154.53 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 75.32 110.831 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 75.13 110.885 -179.814 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.879 0.371 . . . . 63.11 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -128.87 115.29 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.51 111.1 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -138.16 123.14 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.887 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 19.4 79.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.44 112.482 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.57 -13.96 64.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 75.23 112.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.95 139.31 31.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 75.44 110.906 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.1 138.1 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.3 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.79 171.91 12.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 52.42 110.907 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.35 160.74 30.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 70.44 110.815 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 177.8 5.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.668 2.245 . . . . 75.41 112.397 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.98 36.32 27.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 75.25 110.921 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m -141.95 124.51 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.889 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -87.78 168.2 13.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.866 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 m -90.72 128.01 36.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 75.44 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -120.59 166.49 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 74.32 111.09 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -117.93 137.63 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 71.52 110.93 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.856 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.679 0.752 . . . . 72.52 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 164.95 32.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 72.34 112.348 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -133.6 173.8 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.01 110.919 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.14 131.88 50.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 149.34 62.78 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.606 0.717 . . . . 71.22 110.806 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 145.7 57.65 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.654 2.236 . . . . 74.41 112.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 mt -54.14 149.42 9.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 61.23 110.873 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.6 157.06 52.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.732 . . . . 72.22 112.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -105.62 -169.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.324 . . . . 73.44 110.898 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.96 149.04 43.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 70.23 110.927 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 53.03 33.34 14.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.899 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.13 159.66 42.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.641 0.734 . . . . 73.54 110.842 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.81 5.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.68 2.254 . . . . 75.32 112.309 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.5 p -132.19 170.87 14.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 54.23 110.872 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -131.09 146.36 52.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.88 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -52.2 -66.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 73.33 111.155 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -140.64 156.74 69.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 75.44 110.84 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -170.42 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 72.45 112.375 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -169.39 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.856 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.15 -16.03 64.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 74.04 110.908 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -98.38 -28.18 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.882 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 31.99 4.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 63.51 112.449 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.08 145.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.387 . . . . 73.1 111.102 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -102.82 -176.19 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 74.22 110.879 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.82 -77.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 73.42 110.843 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -123.06 -59.39 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 74.41 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -76.23 159.23 30.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.888 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.8 m -112.02 160.06 31.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.605 0.717 . . . . 74.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.99 22.85 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.698 2.265 . . . . 74.34 112.334 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.22 124.17 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.41 110.848 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.98 17.83 1.07 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.6 29.21 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 75.21 110.91 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.74 26.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 52.44 112.446 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mt -109.01 179.56 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 72.43 110.857 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 120.27 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 73.13 110.844 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -54.94 108.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 73.14 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -125.69 136.63 53.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.45 111.209 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.87 125.59 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.924 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -116.68 -21.22 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 73.3 111.122 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.19 -162.26 9.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.688 -0.768 . . . . 73.11 112.486 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -130.09 159.69 68.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.57 0.7 . . . . 60.22 110.92 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.83 -48.48 0.27 Allowed 'Cis proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.676 -1.801 . . . . 73.04 112.291 0.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -127.29 46.55 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 62.02 110.82 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -72.98 77.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.923 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.1 141.96 35.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 73.52 110.928 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -139.39 145.68 39.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.839 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.48 136.73 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 74.55 110.859 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.51 126.94 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.24 110.906 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.856 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.49 152.48 41.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.32 110.857 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.807 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.836 0.35 . . . . 63.11 111.165 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.6 m -137.28 113.7 10.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.221 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.8 m -139.48 157.1 46.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.855 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.81 16.51 51.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 72.44 112.491 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.18 -15.21 60.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 75.23 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.83 163.46 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 75.44 110.893 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -94.63 155.39 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 74.3 110.963 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -132.63 177.19 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.42 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -80.24 160.65 67.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.545 0.688 . . . . 70.44 110.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 168.33 21.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.67 2.246 . . . . 75.41 112.429 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 63.33 27.56 15.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.96 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.0 p -142.02 119.2 11.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.31 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -88.07 168.13 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 72.13 110.924 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 m -91.18 125.48 35.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.44 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.15 156.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 74.32 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -118.2 129.21 55.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 71.52 110.896 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.961 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.611 0.72 . . . . 72.52 110.821 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.0 32.51 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.699 2.266 . . . . 72.34 112.347 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -133.84 173.95 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.01 110.911 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.61 130.85 51.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 71.42 110.848 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 149.35 73.2 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.646 0.736 . . . . 71.22 110.871 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 146.75 61.38 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.725 2.283 . . . . 74.41 112.387 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.09 149.85 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 61.23 110.946 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.81 151.89 36.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.688 . . . . 72.22 112.415 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -177.48 3.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 73.44 110.898 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.73 143.22 53.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 70.23 110.863 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 60.53 39.45 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 73.21 110.904 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.04 159.46 72.56 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.586 0.708 . . . . 73.54 110.921 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 133.18 24.81 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 75.32 112.327 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 p -148.03 167.78 24.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 54.23 110.965 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -126.31 148.07 49.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -52.74 -64.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.15 156.74 64.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.647 0.736 . . . . 75.44 110.851 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.675 2.25 . . . . 72.45 112.303 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.58 -169.53 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.875 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.99 -16.78 64.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -97.36 -28.08 14.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.829 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 32.01 4.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.683 -0.77 . . . . 63.51 112.493 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.98 145.6 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 73.1 111.192 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -104.49 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.58 -78.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 73.42 110.842 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.19 -58.32 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.935 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -77.42 169.06 18.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.901 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.8 m -117.77 160.67 37.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.563 0.696 . . . . 74.32 110.89 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.07 22.59 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.675 2.25 . . . . 74.34 112.334 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 89.0 m -70.67 126.01 28.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 70.41 110.852 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.24 18.58 0.81 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.76 . . . . 74.14 112.402 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.51 30.7 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 75.21 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.15 22.23 27.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.489 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.77 176.42 5.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.365 . . . . 72.43 110.933 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.5 116.8 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 73.13 110.883 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 103.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.853 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -118.21 136.98 53.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.45 111.159 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -76.17 122.71 24.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.946 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.73 -19.29 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 73.3 111.079 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.72 -159.82 9.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 73.11 112.518 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.1 pt-20 -139.78 159.47 64.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.691 0.758 . . . . 60.22 110.864 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.8 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 -1.802 . . . . 73.04 112.342 0.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.76 53.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.02 110.867 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -79.67 78.1 6.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.91 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.09 141.17 34.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 73.52 110.933 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -139.16 153.11 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 74.42 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.0 140.97 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.55 110.875 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -151.86 129.43 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 63.24 110.888 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.93 117.02 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -64.05 149.53 47.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 75.13 110.877 -179.828 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.893 0.377 . . . . 63.11 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.9 m -143.12 107.55 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.51 111.107 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.6 m -146.4 149.29 33.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.855 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.0 75.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 72.44 112.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.67 24.97 75.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 75.23 112.475 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -148.87 137.79 21.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 75.44 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -78.01 133.29 38.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 74.3 110.9 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.98 176.7 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 52.42 110.923 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -77.87 160.73 73.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.625 0.726 . . . . 70.44 110.85 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.88 15.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.755 2.304 . . . . 75.41 112.333 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 63.19 27.78 15.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 75.25 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.75 117.42 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.31 110.891 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 p -88.48 168.09 12.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.877 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 m -91.69 131.11 37.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 75.44 110.888 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.98 124.0 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.32 111.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -78.88 125.65 29.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 71.52 110.902 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m120 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 75.54 110.9 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.66 0.743 . . . . 72.52 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 166.48 27.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 72.34 112.381 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.53 171.36 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 72.01 110.884 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.9 m -107.57 107.37 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.23 149.25 43.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.561 0.696 . . . . 71.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 152.46 69.57 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 74.41 112.35 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.16 149.43 41.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 61.23 110.882 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.57 149.68 39.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.22 112.476 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -172.82 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.754 0.311 . . . . 73.44 110.894 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.0 tp -72.29 146.37 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 70.23 110.925 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.31 35.51 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.861 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.67 159.74 68.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.68 0.752 . . . . 73.54 110.802 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 138.4 37.84 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.601 2.201 . . . . 75.32 112.357 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -147.6 170.77 16.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 54.23 110.918 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -129.22 146.04 51.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.32 110.88 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.76 -67.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 73.33 111.124 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -139.64 156.69 71.08 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.734 . . . . 75.44 110.923 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.719 2.279 . . . . 72.45 112.332 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 -169.47 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.955 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.69 -17.75 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.04 110.901 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -96.28 -28.35 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 64.13 110.926 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.28 31.95 4.47 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.668 -0.777 . . . . 63.51 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.16 146.95 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.1 111.127 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -101.93 -176.19 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 74.22 110.899 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -77.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 73.42 110.858 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -122.78 -59.55 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.942 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -76.95 156.02 32.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.896 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.3 m -106.74 160.41 26.39 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 74.32 110.797 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 167.92 23.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 74.34 112.275 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.7 m -72.92 125.62 28.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 70.41 110.831 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.83 17.62 0.84 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 74.14 112.482 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.68 31.47 5.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 75.21 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.25 21.65 31.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.741 . . . . 52.44 112.539 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -108.04 176.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -148.78 119.16 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 73.13 110.826 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.36 103.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.833 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.39 145.68 47.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.184 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -82.89 123.46 29.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 74.43 110.899 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -125.97 13.13 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.3 111.104 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -158.6 9.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 73.11 112.397 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.0 pt-20 -158.52 159.43 29.81 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.683 0.754 . . . . 60.22 110.809 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -43.09 0.65 Allowed 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 122.727 -1.781 . . . . 73.04 112.309 0.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -126.97 75.1 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 62.02 110.851 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -108.36 78.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 tp -81.2 136.6 35.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 73.52 110.875 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -140.11 156.93 46.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.857 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.61 141.6 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.884 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.04 127.41 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.964 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -52.02 117.06 2.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.866 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.75 157.79 29.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 75.13 110.874 -179.771 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.915 0.388 . . . . 63.11 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.1 m -137.1 107.43 6.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 73.51 111.19 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -125.87 143.25 51.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 73.21 110.87 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.37 43.63 57.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.474 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.14 19.52 46.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.471 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -134.75 140.69 46.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 75.44 110.846 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.25 148.95 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 74.3 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.18 178.76 6.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 52.42 110.939 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -73.7 160.61 81.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.543 0.687 . . . . 70.44 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 172.92 11.76 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 75.41 112.369 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 63.11 26.74 15.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 75.25 110.94 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -142.08 118.26 10.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.31 110.888 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.95 168.24 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 72.13 110.852 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.0 m -93.11 133.64 36.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 75.44 110.873 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -131.04 137.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.32 111.149 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -92.71 131.22 37.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 71.52 110.93 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.875 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.614 0.721 . . . . 72.52 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 164.86 33.04 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.65 2.233 . . . . 72.34 112.314 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.8 173.78 7.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.01 110.934 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 m -97.06 130.03 44.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 71.42 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.28 148.83 71.72 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.626 0.727 . . . . 71.22 110.839 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 155.11 66.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 74.41 112.279 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.49 154.13 39.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 61.23 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.91 159.68 43.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 72.22 112.495 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -115.44 -176.25 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 73.44 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.6 142.35 51.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 70.23 110.919 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 60.57 39.5 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 73.21 110.882 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 159.52 71.45 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.596 0.713 . . . . 73.54 110.937 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 129.03 16.89 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 75.32 112.396 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.1 p -147.44 167.79 23.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 54.23 110.893 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.04 150.54 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.909 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -55.9 -65.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.52 157.02 72.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.686 0.755 . . . . 75.44 110.893 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -170.13 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.645 2.23 . . . . 72.45 112.348 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.83 -169.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 71.21 110.908 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.93 -15.56 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.825 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -96.58 -28.21 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 64.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.16 4.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 63.51 112.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.9 mt -123.95 146.69 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 73.1 111.129 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -101.53 -176.11 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 74.22 110.927 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -77.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -122.89 -58.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 74.41 110.958 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -77.15 161.36 28.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.922 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -111.55 159.98 31.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 74.32 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 168.11 22.55 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.71 2.273 . . . . 74.34 112.403 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.8 m -68.67 126.1 28.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 70.41 110.925 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.39 19.51 0.92 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 74.14 112.402 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -127.31 27.77 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 75.21 110.847 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.3 22.87 21.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 52.44 112.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mt -109.65 175.13 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 72.43 110.979 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.66 116.8 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.912 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.09 105.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.927 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -119.8 137.13 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.17 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -71.63 123.98 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.988 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.47 -20.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 73.3 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.64 -156.82 7.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 73.11 112.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.8 pt-20 -140.6 159.63 62.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.696 0.76 . . . . 60.22 110.78 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.75 -48.37 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.206 0 C-N-CA 122.677 -1.801 . . . . 73.04 112.347 -0.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -125.38 50.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 62.02 110.915 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -77.93 77.96 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.77 148.85 28.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 73.52 110.892 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -145.9 152.75 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.873 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -70.76 137.59 49.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.55 110.883 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -147.38 127.86 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 118.8 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.899 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.1 156.35 28.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.892 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.867 -179.773 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.023 0.44 . . . . 63.11 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 m -142.63 115.45 8.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 73.51 111.082 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -132.49 132.62 42.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.21 110.903 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.77 66.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.781 -0.723 . . . . 72.44 112.478 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.83 -20.85 42.65 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.46 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -99.82 149.16 23.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 75.44 110.931 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -93.48 147.46 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.897 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.22 169.06 16.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 52.42 110.852 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -63.91 160.79 43.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.62 0.724 . . . . 70.44 110.896 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.73 176.44 6.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.75 2.3 . . . . 75.41 112.323 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 62.6 25.27 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.25 110.857 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.844 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.05 168.13 13.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 72.13 110.925 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.89 134.78 34.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.73 135.26 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 74.32 111.203 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.7 123.3 39.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 71.52 110.956 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 75.54 110.886 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.625 0.726 . . . . 72.52 110.837 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 166.6 27.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.703 2.269 . . . . 72.34 112.312 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 161.48 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.865 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 m -95.69 109.05 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.939 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 148.99 39.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 71.22 110.887 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.17 64.79 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.669 2.246 . . . . 74.41 112.316 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.6 mt -56.65 150.35 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 61.23 110.858 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.39 148.44 51.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 72.22 112.476 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -171.73 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.321 . . . . 73.44 110.898 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.12 146.89 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.79 24.08 13.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 159.72 36.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.604 0.716 . . . . 73.54 110.856 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 125.75 12.54 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 75.32 112.323 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.54 164.61 29.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 54.23 110.857 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.84 156.12 43.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.857 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -61.12 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.136 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -140.61 156.9 69.02 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.637 0.732 . . . . 75.44 110.884 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 72.45 112.335 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.08 -169.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.21 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.34 -15.2 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.905 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.81 -28.31 14.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.937 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.13 32.14 4.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 63.51 112.456 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt -124.66 150.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 73.1 111.144 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.1 -176.2 3.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.77 -76.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 73.42 110.84 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -122.65 -59.54 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.949 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -75.9 160.04 30.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 74.31 110.87 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 m -111.48 160.29 29.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.653 0.74 . . . . 74.32 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 168.0 22.86 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.657 2.238 . . . . 74.34 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.92 126.35 29.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 70.41 110.88 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.2 18.27 0.92 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 74.14 112.478 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -127.27 26.47 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 75.21 110.944 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.01 22.82 16.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.726 -0.75 . . . . 52.44 112.475 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -109.73 171.94 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.43 110.933 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 120.0 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.865 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.66 102.48 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.864 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -115.42 140.93 48.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.45 111.117 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.75 125.74 29.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.847 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 m -117.06 -21.24 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.112 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.6 -176.54 15.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 73.11 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -118.0 159.54 42.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.579 0.704 . . . . 60.22 110.897 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.78 -48.68 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.679 -1.8 . . . . 73.04 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -131.11 65.9 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 62.02 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.44 77.79 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.1 140.93 30.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 73.52 110.863 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -140.44 157.39 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.863 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.12 132.04 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.913 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -143.21 129.06 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.9 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -52.05 117.33 2.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.877 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.92 147.5 53.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.32 110.845 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.13 110.843 -179.818 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.946 0.403 . . . . 63.11 111.073 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -146.11 107.83 4.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 73.51 111.2 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -147.03 144.59 29.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 73.21 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.07 20.08 78.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.523 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.87 23.79 73.83 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.728 -0.749 . . . . 75.23 112.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -144.95 155.28 43.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 75.44 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -101.4 155.26 18.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.3 110.856 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.91 173.13 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 52.42 110.923 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -69.06 160.58 77.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.71 . . . . 70.44 110.849 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 175.11 8.51 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.603 2.202 . . . . 75.41 112.389 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 59.98 27.56 16.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 75.25 110.928 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 p -142.02 119.23 11.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.31 110.848 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -89.13 168.14 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.13 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -89.75 132.65 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.44 110.869 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.05 123.98 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.139 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.92 122.94 25.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 71.52 110.896 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.835 -179.912 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.712 0.768 . . . . 72.52 110.845 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.97 25.81 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.656 2.237 . . . . 72.34 112.434 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.66 174.01 10.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.01 110.877 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 120.42 40.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.42 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.64 149.02 47.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 71.22 110.839 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 149.71 67.25 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 74.41 112.337 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -59.34 148.67 31.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 155.42 34.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.819 -0.705 . . . . 72.22 112.448 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -108.72 -172.89 2.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 73.44 110.902 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.15 145.6 46.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.23 110.981 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 58.27 38.68 26.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 73.21 110.836 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.41 159.59 69.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.688 0.756 . . . . 73.54 110.876 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 124.37 11.01 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.715 2.277 . . . . 75.32 112.33 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 p -136.31 168.26 19.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 54.23 110.798 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.16 144.39 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 72.32 110.947 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.94 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.33 111.07 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -140.01 156.8 70.28 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 75.44 110.935 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -169.87 0.36 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.638 2.225 . . . . 72.45 112.33 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -168.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.846 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.86 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.852 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -88.21 -28.44 21.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 64.13 110.826 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.86 32.07 4.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 63.51 112.514 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.46 147.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.353 . . . . 73.1 111.117 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -100.43 -175.99 3.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.21 -77.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -123.06 -58.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.41 110.9 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -77.06 168.65 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.852 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -116.1 160.34 35.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 74.32 110.946 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 168.13 22.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.659 2.24 . . . . 74.34 112.35 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 93.1 m -70.07 125.47 26.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.936 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.88 19.23 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 74.14 112.501 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -125.75 28.1 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 75.21 110.87 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.94 22.65 22.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.7 -0.762 . . . . 52.44 112.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mt -108.64 177.4 4.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 72.43 110.875 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.41 118.6 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.13 110.809 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.1 m -55.41 106.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.901 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.59 136.88 54.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 74.45 111.178 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.43 126.1 29.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.889 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.03 13.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 73.3 111.101 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.87 -160.18 13.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 73.11 112.473 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -138.3 159.99 65.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.686 0.755 . . . . 60.22 110.858 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.84 -42.82 0.69 Allowed 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.288 0.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.42 49.47 2.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 62.02 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.55 97.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 74.0 110.88 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.88 136.87 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.93 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -139.64 150.14 44.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.828 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.72 138.57 55.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 74.55 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -147.01 127.17 13.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.926 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.39 117.02 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -67.17 155.03 39.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.907 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.854 -179.798 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.8 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.893 0.378 . . . . 63.11 111.124 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.9 m -137.49 111.15 8.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 73.51 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 m -130.61 129.16 42.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.965 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.58 39.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.44 112.442 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.04 20.58 64.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.516 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.07 143.86 46.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 75.44 110.875 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -90.88 136.44 33.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.882 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -124.41 169.11 12.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 52.42 110.868 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -63.83 160.6 44.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 70.44 110.964 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 175.95 7.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 75.41 112.3 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 61.05 28.51 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 p -142.06 122.81 14.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.31 110.842 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 p -89.97 168.14 12.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.842 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.28 122.07 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.44 110.854 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -119.95 131.39 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.131 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.36 124.88 31.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 71.52 110.958 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.54 110.881 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.758 0.79 . . . . 72.52 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 166.56 27.17 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.739 2.293 . . . . 72.34 112.384 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -137.08 174.03 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.809 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.6 m -96.86 128.47 43.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.931 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 148.96 69.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 71.22 110.87 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 152.16 69.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.227 . . . . 74.41 112.409 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.48 154.67 23.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 61.23 110.951 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.36 154.46 53.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 72.22 112.446 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.22 -171.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 73.44 110.926 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.99 147.59 46.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 70.23 110.977 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 55.05 32.35 18.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.21 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.66 159.7 45.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.68 0.753 . . . . 73.54 110.827 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.701 2.267 . . . . 75.32 112.27 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 p -134.47 169.81 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 54.23 110.883 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -129.66 148.31 51.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.854 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.51 -63.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 73.33 111.098 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -141.7 154.31 65.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 75.44 110.899 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.641 2.227 . . . . 72.45 112.367 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -74.09 -169.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 71.21 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.2 -17.54 64.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.863 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -95.6 -28.39 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.06 4.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 63.51 112.528 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mt -119.1 148.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.812 0.339 . . . . 73.1 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -104.63 -175.95 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.899 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.7 -77.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.875 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.71 -60.06 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.93 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -75.53 158.52 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.31 110.82 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 m -109.41 159.7 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 74.32 110.869 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.08 22.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.34 112.355 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.3 128.49 36.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.842 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 17.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.679 -0.772 . . . . 74.14 112.488 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.66 27.14 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 75.21 110.876 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.93 19.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 52.44 112.548 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mt -108.86 173.15 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.829 0.347 . . . . 72.43 110.887 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 120.88 8.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.817 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.24 111.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.14 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -128.7 136.75 51.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 74.45 111.167 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -68.0 125.75 27.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 74.43 110.891 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 13.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.092 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.92 -156.57 10.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 73.11 112.536 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -152.56 159.51 32.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 60.22 110.898 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.8 -48.14 0.28 Allowed 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 -1.803 . . . . 73.04 112.34 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -122.77 75.01 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 62.02 110.899 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.7 93.11 4.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 74.0 110.904 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.98 142.41 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 73.52 110.875 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -142.44 145.71 34.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.839 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.39 133.11 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.55 110.858 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -141.64 128.74 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 63.24 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -51.94 117.13 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.888 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.59 155.14 40.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 75.32 110.89 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 75.13 110.831 -179.734 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.882 0.372 . . . . 63.11 111.138 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -140.28 111.25 6.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 73.51 111.075 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.8 m -139.21 146.19 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.879 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.91 20.38 72.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 72.44 112.54 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.69 28.99 56.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 75.23 112.507 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -154.77 151.47 28.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.297 . . . . 75.44 110.89 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.53 136.24 33.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.3 110.942 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.88 156.54 24.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 52.42 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.61 160.91 3.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.592 0.71 . . . . 70.44 110.85 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 164.52 34.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 75.41 112.362 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 63.4 30.48 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 75.25 110.941 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -142.0 116.67 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.9 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.53 168.3 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 72.13 110.867 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.21 127.81 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 75.44 110.861 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.77 135.02 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.32 111.064 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -92.0 126.57 37.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 71.52 110.943 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.54 110.904 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.693 0.759 . . . . 72.52 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.9 26.05 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.652 2.235 . . . . 72.34 112.335 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 161.63 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.876 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 m -90.18 117.85 29.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.868 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 148.72 46.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.528 0.68 . . . . 71.22 110.91 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 154.81 67.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.647 2.231 . . . . 74.41 112.373 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.5 mt -62.44 149.76 41.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 61.23 110.872 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.52 154.77 48.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 72.22 112.474 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -108.51 -173.37 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 73.44 110.892 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.0 tp -73.36 147.09 44.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.893 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.91 22.54 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.892 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.59 159.58 36.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.581 0.705 . . . . 73.54 110.881 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 123.9 10.58 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.723 2.282 . . . . 75.32 112.339 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.2 p -136.91 170.34 16.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 54.23 110.936 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -133.93 146.81 50.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.927 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.89 -66.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -139.29 156.87 71.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.629 0.728 . . . . 75.44 110.888 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -169.62 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 72.45 112.304 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.89 -168.6 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.21 110.914 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.18 67.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -88.7 -28.31 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 64.13 110.905 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.76 32.01 4.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 63.51 112.515 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.39 149.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 73.1 111.159 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.34 -176.12 3.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 74.22 110.927 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.22 -77.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.814 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -123.0 -59.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.934 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -77.05 158.48 30.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.802 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.6 m -108.77 160.29 27.82 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.71 . . . . 74.32 110.922 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 168.03 22.75 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.716 2.277 . . . . 74.34 112.305 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.5 m -68.69 127.1 31.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 70.41 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.67 17.42 0.97 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 74.14 112.499 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.56 27.24 5.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 75.21 110.841 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.63 23.95 19.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.457 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mt -108.74 171.43 7.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.9 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 127.72 17.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.81 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.92 106.23 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.881 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.24 144.47 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.182 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -81.4 123.75 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.873 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.18 -24.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 73.3 111.154 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.16 -161.64 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 73.11 112.51 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.7 pt-20 -127.97 159.44 66.66 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.699 0.762 . . . . 60.22 110.882 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.79 -42.2 0.79 Allowed 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.368 0.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.34 63.53 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.894 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 79.32 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.0 110.937 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.25 147.05 32.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -152.89 159.03 42.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -72.76 128.6 36.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.55 110.884 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.82 126.46 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.948 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.33 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -65.66 152.03 45.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.13 110.886 -179.873 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.921 0.391 . . . . 63.11 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -153.34 110.52 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.51 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 m -148.52 133.64 18.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.21 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.83 76.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 72.44 112.464 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.39 28.66 65.41 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.687 -0.768 . . . . 75.23 112.529 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.96 134.99 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.674 0.273 . . . . 75.44 110.953 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.51 152.01 21.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 74.3 110.919 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.48 171.14 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 52.42 110.877 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -63.28 160.76 38.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.589 0.709 . . . . 70.44 110.856 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.05 8.57 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.756 2.304 . . . . 75.41 112.328 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.18 38.44 26.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 75.25 110.828 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -141.32 123.55 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 72.31 110.907 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -88.92 168.16 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.948 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -88.32 134.44 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.882 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.35 130.53 65.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.113 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.87 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 71.52 110.917 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.875 -179.903 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.655 0.74 . . . . 72.52 110.852 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 166.46 27.47 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.627 2.218 . . . . 72.34 112.327 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -138.14 173.99 11.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.01 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -99.24 130.18 45.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.932 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 149.71 56.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.702 . . . . 71.22 110.815 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 147.32 62.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 74.41 112.376 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.73 149.89 21.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 61.23 110.948 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.44 160.5 32.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 72.22 112.481 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -114.38 -171.87 2.0 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.44 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.7 tp -73.18 144.57 46.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.879 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 58.19 37.09 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.932 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.95 159.72 65.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.638 0.732 . . . . 73.54 110.938 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 124.28 10.91 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.701 2.268 . . . . 75.32 112.344 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -135.0 165.43 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 54.23 110.926 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.17 145.54 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 72.32 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.86 -67.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.33 111.096 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -139.07 156.81 72.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.643 0.735 . . . . 75.44 110.877 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -169.73 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.264 . . . . 72.45 112.34 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -168.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.21 110.878 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.14 67.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.04 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.03 -28.42 21.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 64.13 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.72 32.15 4.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.51 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 mt -122.26 150.54 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.1 111.131 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.47 -176.02 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.976 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.75 -77.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.836 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -122.82 -59.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.71 159.95 30.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 74.31 110.861 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.8 m -111.54 160.13 30.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.561 0.696 . . . . 74.32 110.943 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.99 22.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.658 2.239 . . . . 74.34 112.373 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.5 m -70.23 124.54 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 70.41 110.916 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.63 19.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.494 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.76 28.45 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 75.21 110.903 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.19 22.73 24.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 52.44 112.523 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.34 172.39 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 72.43 110.923 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -144.81 118.32 9.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.852 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.43 102.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.838 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -118.55 147.55 43.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.45 111.149 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -88.96 124.84 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.927 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.55 13.17 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.3 111.136 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.36 -161.5 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 73.11 112.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.2 pt-20 -151.12 159.47 33.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 60.22 110.862 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.78 -48.39 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.748 -1.772 . . . . 73.04 112.331 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -123.82 72.53 1.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 62.02 110.832 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -99.9 78.15 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.68 141.69 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 73.52 110.887 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -149.75 160.67 43.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.59 140.34 41.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.957 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.76 127.3 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.911 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.01 120.35 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.833 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -64.39 150.31 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.878 -179.782 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.902 0.382 . . . . 73.41 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.46 142.21 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 63.11 111.127 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.5 m -136.02 109.59 7.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.121 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.8 m -127.54 143.89 51.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.88 43.11 70.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.99 24.51 58.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.49 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -145.09 136.26 24.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.694 0.283 . . . . 75.44 110.938 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.8 139.35 50.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 74.3 110.932 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.1 m -122.09 164.07 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 52.42 110.915 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -66.1 161.1 59.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.564 0.697 . . . . 70.44 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 167.49 24.3 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.68 2.253 . . . . 75.41 112.335 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 63.62 27.55 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.87 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -141.99 116.64 9.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.31 110.883 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.88 168.13 13.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.898 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 m -90.51 131.72 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.44 110.909 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.68 133.68 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 74.32 111.109 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -78.83 123.08 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.902 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.03 34.97 4.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.907 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -93.32 137.79 32.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 75.21 110.812 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.08 25.91 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 71.42 110.832 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 32.18 22.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 73.44 112.493 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -75.38 -24.36 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 74.54 110.915 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.98 -5.53 34.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 75.3 112.524 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -123.76 94.76 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.344 . . . . 75.43 110.915 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -52.36 103.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 51.33 110.846 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -126.41 84.91 61.18 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 72.52 110.861 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.03 28.93 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.697 2.265 . . . . 72.34 112.358 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -123.63 162.32 23.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.871 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.4 m -91.89 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.906 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 148.42 40.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.566 0.698 . . . . 71.22 110.888 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 152.18 69.24 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 74.41 112.375 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.52 150.59 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 61.23 110.892 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.25 152.84 49.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.503 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -108.73 -172.96 2.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 73.44 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.6 tp -74.82 151.79 39.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.873 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.14 22.29 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.21 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.66 159.33 46.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 73.54 110.895 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 132.14 22.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 75.32 112.385 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.0 159.1 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 54.23 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -122.2 143.35 49.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 72.32 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -52.01 -65.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.33 111.129 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -137.66 156.99 74.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 75.44 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 72.45 112.343 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.41 -169.35 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 71.21 110.868 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -68.54 -14.89 63.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -95.61 -28.29 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.13 110.863 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 32.12 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.37 147.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 73.1 111.134 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -99.76 -175.95 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.911 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -77.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 73.42 110.819 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -123.01 -58.57 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -75.59 169.93 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.817 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.5 m -118.09 160.0 40.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 74.32 110.853 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 166.55 27.22 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 74.34 112.324 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.5 m -66.81 124.55 23.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.89 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.96 16.03 1.18 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 74.14 112.463 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 75.21 110.892 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.01 23.57 29.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 52.44 112.509 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 mt -109.9 176.07 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 72.43 110.942 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 119.77 5.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.13 110.866 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.99 108.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.858 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.51 137.8 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.138 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.34 120.87 18.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.886 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.69 -19.36 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 73.3 111.118 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.37 -157.25 7.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 73.11 112.503 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -138.0 159.55 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 60.22 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.8 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.663 -1.807 . . . . 73.04 112.339 0.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -130.12 49.7 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -72.93 78.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mp -79.73 129.25 34.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 73.52 110.905 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.26 157.78 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.43 129.23 36.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.55 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -140.64 124.3 17.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 63.24 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -51.78 116.94 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.918 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.96 147.59 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.32 110.887 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.816 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.865 0.364 . . . . 73.41 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.58 135.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.11 111.125 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -128.96 109.99 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.51 111.167 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.59 142.86 50.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.872 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.98 41.55 59.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 72.44 112.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.14 20.18 57.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 75.23 112.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -135.75 140.45 44.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 75.44 110.932 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -84.01 135.41 34.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.3 110.95 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 m -123.65 167.7 13.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 52.42 110.825 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -67.78 160.67 72.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 70.44 110.879 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 174.55 9.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.718 2.279 . . . . 75.41 112.321 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 62.54 26.14 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.1 p -141.45 119.53 12.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.816 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.97 168.23 12.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 72.13 110.845 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.7 m -92.92 128.62 38.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.83 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -117.9 141.57 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.43 136.36 53.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 71.52 110.861 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -132.4 27.79 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.954 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -55.28 129.37 38.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 75.21 110.876 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -101.35 26.11 7.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 71.42 110.883 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 22.88 62.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 73.44 112.518 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.01 -25.8 43.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.365 . . . . 74.54 110.934 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.82 15.03 35.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.707 -0.758 . . . . 75.3 112.504 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -127.01 87.13 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.837 0.351 . . . . 75.43 110.885 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.86 94.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 51.33 110.868 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -122.28 85.02 46.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 72.52 110.89 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.8 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.764 2.31 . . . . 72.34 112.276 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -132.32 164.78 25.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.01 110.86 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -96.34 119.04 34.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 149.27 47.88 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 71.22 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 148.11 64.02 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.723 2.282 . . . . 74.41 112.379 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 mt -57.25 149.33 20.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 61.23 110.931 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.75 145.6 49.91 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 72.22 112.506 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -100.87 -172.83 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 73.44 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.94 151.12 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 70.23 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 m120 58.21 22.34 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.93 159.47 40.74 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 73.54 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 141.59 45.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 75.32 112.254 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -150.79 165.37 33.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 54.23 110.959 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 72.32 110.835 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.8 t -51.65 -61.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 73.33 111.139 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -142.27 156.74 64.19 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.678 0.751 . . . . 75.44 110.817 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -168.43 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.538 2.158 . . . . 72.45 112.381 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -169.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 71.21 110.895 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -65.98 -19.76 65.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 74.04 110.824 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -97.06 -28.24 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.13 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.33 3.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 63.51 112.463 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.25 155.99 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 73.1 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -112.91 -176.03 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.926 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.36 -78.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 73.42 110.782 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -122.94 -59.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.971 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -76.01 157.87 32.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.836 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.77 159.81 29.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 74.32 110.953 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.05 36.06 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 74.34 112.324 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.1 m -66.55 127.82 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.839 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.39 17.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 74.14 112.516 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.91 27.59 5.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 75.21 110.895 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.64 19.17 28.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.533 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -108.54 164.68 12.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 72.43 110.944 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -142.61 125.61 16.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 73.13 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -55.46 101.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.936 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -118.57 140.27 50.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.45 111.091 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -70.5 125.84 27.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.43 110.892 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.05 12.86 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.3 111.093 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.11 -165.49 30.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 73.11 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -142.5 159.83 56.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 60.22 110.856 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.1 Cg_endo -69.64 -48.74 0.26 Allowed 'Cis proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.721 -1.783 . . . . 73.04 112.369 -0.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -125.2 75.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.898 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -101.47 78.03 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 74.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.8 136.93 36.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.916 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -144.78 154.18 42.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 74.42 110.859 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.08 134.11 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.55 110.96 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -141.62 136.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -51.11 116.68 2.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.889 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 158.51 29.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.822 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 75.13 110.897 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.948 0.404 . . . . 73.41 110.865 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.07 134.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.11 111.117 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.1 m -146.86 110.27 4.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 73.51 111.099 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.2 m -146.63 135.24 22.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.477 . . . . 73.21 110.886 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.78 73.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.764 . . . . 72.44 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.5 70.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.504 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 136.24 27.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.711 0.291 . . . . 75.44 110.903 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -93.36 142.81 26.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.3 110.913 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -130.97 169.61 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 52.42 110.897 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -57.41 160.73 6.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.582 0.705 . . . . 70.44 110.834 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 175.5 7.95 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.727 2.285 . . . . 75.41 112.354 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 58.63 37.34 25.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.47 . . . . 75.25 110.905 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.4 m -140.96 127.57 20.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 72.31 110.866 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 p -90.36 168.11 12.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.839 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 m -90.49 126.58 35.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.44 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 m -122.46 155.19 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.124 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.13 131.73 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.52 110.902 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -110.37 -26.21 9.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 75.54 110.896 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -52.46 119.87 4.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.85 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -101.49 28.48 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 71.42 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.06 22.69 10.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.685 -0.769 . . . . 73.44 112.44 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.67 -25.96 64.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 74.54 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.98 -5.94 34.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 75.3 112.563 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -122.34 90.5 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 75.43 110.883 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -59.06 101.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 51.33 110.877 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.1 p -134.22 85.12 39.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.739 . . . . 72.52 110.795 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 165.96 29.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 72.34 112.307 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -131.57 170.19 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.01 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.9 130.26 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.42 110.855 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 149.52 58.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.587 0.708 . . . . 71.22 110.871 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.73 51.84 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.622 2.215 . . . . 74.41 112.379 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.4 mt -54.33 151.26 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 61.23 110.887 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.48 158.72 48.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.525 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -111.12 -175.08 2.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 73.44 110.943 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.1 tp -70.09 144.19 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 70.23 110.916 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 58.51 38.92 25.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.21 110.951 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 159.67 67.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.64 0.733 . . . . 73.54 110.866 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 123.39 10.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.629 2.219 . . . . 75.32 112.308 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 p -142.07 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 54.23 110.933 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -128.52 146.84 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -52.24 -64.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.118 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -139.78 157.05 70.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 75.44 110.831 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.06 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.759 2.306 . . . . 72.45 112.298 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.95 -169.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.892 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -67.88 -16.25 63.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.844 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.62 -28.42 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.39 32.07 4.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 63.51 112.432 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mt -122.04 148.5 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 73.1 111.158 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -104.9 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.918 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.35 -76.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 73.42 110.828 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -122.64 -59.65 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.905 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -75.33 163.57 27.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.804 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 m -115.13 159.61 37.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 74.32 110.935 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 168.28 22.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.22 . . . . 74.34 112.34 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.45 130.97 44.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.44 19.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 74.14 112.483 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -128.02 26.24 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 75.21 110.842 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.47 21.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 52.44 112.478 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -108.4 175.67 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.43 110.904 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.1 116.26 7.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 73.13 110.797 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 106.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 73.14 110.887 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -119.24 139.43 51.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.45 111.115 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -68.75 122.28 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.872 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.79 -18.88 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.3 111.069 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.95 -157.45 7.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 73.11 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -144.17 159.6 51.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 60.22 110.917 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.79 -48.41 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 -1.79 . . . . 73.04 112.312 0.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -123.06 52.7 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 62.02 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -88.64 77.98 7.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.69 156.2 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -147.84 157.92 43.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 74.42 110.868 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.6 140.45 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.862 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -149.36 125.74 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 63.24 110.92 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -52.04 117.59 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -66.52 158.76 28.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.818 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.9 0.381 . . . . 73.41 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 84.5 t -75.61 133.9 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 63.11 111.139 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 m -138.67 107.84 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 73.51 111.165 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 m -135.19 147.93 49.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.864 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.29 37.57 87.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 72.44 112.455 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.63 23.14 64.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 75.23 112.499 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -142.36 143.53 32.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 75.44 110.914 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -95.92 148.18 22.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.3 110.971 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.2 m -137.93 168.87 18.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 52.42 110.904 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -54.43 160.94 2.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 70.44 110.843 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.26 8.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.714 2.276 . . . . 75.41 112.308 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.17 39.07 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.905 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.2 p -140.61 131.26 25.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 72.31 110.861 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -94.01 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 72.13 110.875 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 m -90.25 123.59 34.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 75.44 110.852 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.22 144.47 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.087 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -90.56 124.82 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 71.52 110.951 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -131.12 37.77 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.948 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.6 p -76.26 140.5 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 75.21 110.829 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -76.69 -23.06 53.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 71.42 110.898 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.99 34.73 4.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.704 -0.76 . . . . 73.44 112.505 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -107.11 25.19 11.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 74.54 110.986 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.28 -5.63 79.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.776 . . . . 75.3 112.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -118.94 101.16 7.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 75.43 110.883 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -80.28 123.07 27.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 51.33 110.807 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.6 t -134.93 85.02 36.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.731 0.777 . . . . 72.52 110.865 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 165.88 29.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.72 2.28 . . . . 72.34 112.342 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -134.48 173.91 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 72.01 110.872 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.45 130.95 46.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 149.39 59.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 71.22 110.912 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 146.28 59.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 74.41 112.328 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 mt -55.73 150.04 13.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 61.23 110.911 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.77 157.19 52.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 72.22 112.492 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -109.51 -171.69 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.858 0.361 . . . . 73.44 110.899 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 tp -72.13 146.1 47.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.938 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 58.09 34.6 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.911 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.44 159.74 56.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.54 110.907 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 119.41 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 75.32 112.279 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -136.58 168.31 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 54.23 110.851 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -129.96 144.27 51.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 72.32 110.94 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.08 -63.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -138.98 156.99 72.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.695 0.759 . . . . 75.44 110.851 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.83 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 72.45 112.402 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.07 -169.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.21 110.878 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.47 -16.32 64.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -96.97 -28.34 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.947 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.17 31.99 4.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.9 149.64 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 73.1 111.111 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -104.13 -176.27 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.892 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -77.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 73.42 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -122.76 -59.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 74.41 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -74.77 161.09 29.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.795 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.1 159.9 31.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 74.32 110.949 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.07 22.55 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 74.34 112.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.57 129.93 41.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 70.41 110.906 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.67 19.41 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 74.14 112.476 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.34 25.83 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 75.21 110.892 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.0 22.8 16.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 52.44 112.466 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.84 178.47 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 72.43 110.966 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.33 114.39 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.13 110.882 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.3 106.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.875 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -119.14 139.26 52.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.45 111.105 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -69.27 123.4 21.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 m -116.45 -21.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 73.3 111.126 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.92 -164.55 10.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.468 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -133.34 160.14 69.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 60.22 110.906 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.73 -48.55 0.26 Allowed 'Cis proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.714 -1.786 . . . . 73.04 112.364 -0.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -125.53 50.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.02 110.932 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -83.99 77.92 9.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -86.8 154.46 20.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.915 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -146.31 149.7 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.883 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.1 137.52 56.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.55 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -146.84 126.29 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.92 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.03 117.43 2.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.87 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.06 158.11 32.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 75.13 110.867 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.991 0.424 . . . . 73.41 110.879 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.31 140.66 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 63.11 111.074 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 m -148.93 114.49 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.51 111.131 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.18 152.62 40.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.27 25.81 67.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 72.44 112.458 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.42 78.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 75.23 112.488 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -143.89 153.95 42.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 75.44 110.863 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -93.11 138.97 31.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 74.3 110.921 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 m -117.76 175.15 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 52.42 110.802 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -76.29 160.52 77.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.6 0.714 . . . . 70.44 110.881 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.41 112.311 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.52 32.89 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -142.07 132.11 24.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 72.31 110.851 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -97.74 168.27 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 m -95.98 124.25 39.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.883 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 131.7 70.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 74.32 111.127 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.39 124.67 30.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.929 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -135.33 47.31 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 75.54 110.862 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -64.15 163.12 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.21 110.885 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -117.54 25.52 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.82 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.79 50.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.768 -0.729 . . . . 73.44 112.401 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -94.56 -34.98 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.816 0.341 . . . . 74.54 110.905 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.53 15.03 16.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 75.3 112.428 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.28 102.81 7.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 75.43 110.844 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -52.7 107.32 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 51.33 110.895 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -129.37 84.97 60.49 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 72.52 110.798 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 166.45 27.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 72.34 112.366 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -127.26 172.21 10.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 72.01 110.841 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.9 m -103.3 118.11 36.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.952 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 148.82 64.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.594 0.711 . . . . 71.22 110.812 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 149.99 67.96 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.626 2.217 . . . . 74.41 112.392 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.21 157.86 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 61.23 110.891 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 157.07 51.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 72.22 112.501 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -108.29 -173.47 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 73.44 110.878 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.7 tp -71.62 148.29 46.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 70.23 110.936 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 55.02 35.4 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.879 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.32 159.53 56.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.61 0.719 . . . . 73.54 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 117.97 5.4 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 75.32 112.333 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -133.89 171.06 14.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 54.23 110.847 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -126.98 147.82 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.32 110.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.64 -63.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 73.33 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 154.14 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 75.44 110.897 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -169.64 0.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.675 2.25 . . . . 72.45 112.382 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.66 -169.34 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 71.21 110.907 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -65.2 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -93.69 -25.66 17.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 64.13 110.895 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.25 5.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.431 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.6 mm -108.74 156.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 73.1 111.129 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.75 -176.73 2.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.962 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -79.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.805 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -123.32 -58.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.41 110.951 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -77.22 158.68 30.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.898 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.6 m -107.57 159.4 30.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 74.32 110.873 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 168.22 22.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 74.34 112.355 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.7 m -69.45 132.84 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 70.41 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.67 19.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.708 -0.758 . . . . 74.14 112.466 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.61 27.0 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 75.21 110.946 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.49 23.09 19.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 52.44 112.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.77 177.04 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 72.43 110.908 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.34 122.36 7.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.878 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.12 111.8 0.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 73.14 110.871 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -131.25 136.56 48.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 74.45 111.121 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -65.99 127.23 31.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.79 -23.59 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 73.3 111.131 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.5 -167.46 12.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 73.11 112.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.1 pt-20 -119.09 159.69 44.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.692 0.758 . . . . 60.22 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.76 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 -1.796 . . . . 73.04 112.346 -0.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -131.25 43.58 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 62.02 110.835 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -66.5 89.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.41 136.38 33.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.886 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -135.35 145.99 47.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.936 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.29 136.66 55.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 74.55 110.882 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -144.99 126.04 14.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 63.24 110.878 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -51.85 116.92 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.953 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.71 155.67 38.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 75.32 110.928 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.864 -179.773 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.929 0.395 . . . . 73.41 110.857 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.0 t -88.0 134.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 63.11 111.118 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -132.05 110.06 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 73.51 111.152 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.13 137.97 52.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.88 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.22 18.58 69.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.09 -19.62 48.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.509 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -108.41 152.88 24.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.722 0.296 . . . . 75.44 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -80.73 144.19 32.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 74.3 110.974 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.81 159.84 24.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 52.42 110.894 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -56.6 160.99 4.78 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.526 0.679 . . . . 70.44 110.944 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 166.87 26.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.716 2.277 . . . . 75.41 112.332 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 59.23 33.96 22.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.91 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -141.97 123.8 15.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 72.31 110.901 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -88.78 168.12 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 72.13 110.897 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -88.62 120.38 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 75.44 110.979 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.64 141.04 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 74.32 111.12 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 122.84 47.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 71.52 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -128.8 91.19 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.54 110.916 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -107.09 153.78 22.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 75.21 110.909 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -111.3 27.92 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.941 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 24.41 76.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.797 -0.716 . . . . 73.44 112.457 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -87.62 -28.12 22.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 74.54 110.95 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.14 32.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 75.3 112.436 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -120.1 90.6 3.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 75.43 110.937 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.47 102.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 51.33 110.843 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.6 p -129.77 85.07 59.19 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.687 0.756 . . . . 72.52 110.878 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 166.56 27.33 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 72.34 112.261 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -135.23 173.81 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.01 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 m -96.67 129.83 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.861 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.07 148.32 68.84 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.549 0.69 . . . . 71.22 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 155.69 65.4 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 74.41 112.338 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.2 mt -63.68 162.07 13.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 61.23 110.913 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.68 150.21 41.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.741 . . . . 72.22 112.459 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -99.47 -174.29 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.44 110.957 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 tp -71.14 144.01 50.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.924 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 57.38 26.86 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.869 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.04 159.55 31.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 73.54 110.863 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 119.27 6.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.646 2.231 . . . . 75.32 112.383 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -136.59 166.07 24.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 54.23 110.814 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -125.64 142.58 51.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 72.32 110.883 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -51.67 -63.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.33 111.078 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -138.52 157.11 72.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.693 0.759 . . . . 75.44 110.841 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 72.45 112.3 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -72.98 -169.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.21 110.858 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.63 -14.15 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.04 110.883 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -97.63 -28.34 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.13 110.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.07 32.12 4.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 63.51 112.527 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mt -125.26 148.84 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.844 0.355 . . . . 73.1 111.101 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -99.78 -176.26 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.908 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.13 -77.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 73.42 110.929 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.01 -59.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -74.88 162.42 28.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.9 m -113.36 158.73 37.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.542 0.686 . . . . 74.32 110.918 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 168.11 22.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.636 2.224 . . . . 74.34 112.34 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -67.74 125.64 26.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.911 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.54 15.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.733 . . . . 74.14 112.469 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.9 37.21 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 75.21 110.878 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.4 24.6 39.18 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 52.44 112.501 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.37 174.85 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 72.43 110.848 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.5 118.77 6.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 73.13 110.791 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 110.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.14 110.862 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -130.7 140.99 50.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.117 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -67.83 119.68 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.855 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.85 -20.4 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.147 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.34 -157.47 7.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 73.11 112.464 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -144.1 159.73 51.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.717 . . . . 60.22 110.886 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.3 Cg_endo -69.7 -48.41 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.156 0 C-N-CA 122.69 -1.796 . . . . 73.04 112.372 -0.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -124.69 58.33 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 62.02 110.845 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -90.21 82.36 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.935 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.28 149.24 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.94 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -151.13 146.51 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.42 110.834 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.41 141.28 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.891 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -150.9 127.06 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 63.24 110.941 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -51.9 116.94 2.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.58 157.67 37.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 75.13 110.788 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.959 0.409 . . . . 73.41 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.45 144.02 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.502 . . . . 63.11 111.108 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -147.88 123.55 10.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 73.51 111.131 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.2 m -150.2 150.44 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.877 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.82 37.14 89.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.79 20.83 62.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 75.23 112.505 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -140.22 154.46 46.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 75.44 110.876 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -93.99 138.27 32.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.3 110.961 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.4 m -113.58 174.99 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 52.42 110.856 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -81.75 160.88 62.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 70.44 110.899 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.78 33.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.737 2.292 . . . . 75.41 112.322 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.04 25.26 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.92 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -142.05 119.99 12.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.31 110.811 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.96 168.0 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.0 m -88.2 133.25 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 75.44 110.959 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.53 124.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.32 111.121 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -82.61 125.65 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 71.52 110.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -126.65 47.65 2.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.921 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 158.13 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 75.21 110.842 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -122.07 28.5 7.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.792 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 21.67 67.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.716 -0.754 . . . . 73.44 112.535 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -80.63 -29.47 36.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 74.54 110.93 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.08 15.07 27.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 75.3 112.428 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -124.29 103.21 8.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.311 . . . . 75.43 110.873 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.87 100.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 51.33 110.855 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.2 t -128.54 85.03 61.43 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.701 0.762 . . . . 72.52 110.875 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 166.67 26.74 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.716 2.277 . . . . 72.34 112.398 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -127.03 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.01 110.85 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.8 m -103.45 111.73 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.886 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.51 148.64 42.24 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.603 0.716 . . . . 71.22 110.808 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.54 69.27 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.663 2.242 . . . . 74.41 112.344 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.31 148.51 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 61.23 110.912 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.81 152.87 38.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.752 . . . . 72.22 112.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -103.94 -170.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 73.44 110.883 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.03 142.1 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.65 34.64 22.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.851 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.62 49.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.651 0.739 . . . . 73.54 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 75.32 112.381 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.51 161.96 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 54.23 110.857 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.67 146.65 47.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.855 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.94 -64.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.164 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -138.29 156.98 73.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 75.44 110.907 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.632 2.222 . . . . 72.45 112.344 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.23 -169.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 71.21 110.959 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.48 -15.58 63.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -95.46 -28.32 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.13 110.89 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.03 32.06 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.502 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.3 mt -125.64 149.54 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 73.1 111.123 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -102.19 -176.09 3.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.71 -77.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 73.42 110.916 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -122.85 -59.46 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.946 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -75.93 160.9 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -112.79 160.07 32.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.649 0.738 . . . . 74.32 110.889 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 168.04 22.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.227 . . . . 74.34 112.423 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -68.87 126.31 29.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 70.41 110.887 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.9 19.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 74.14 112.481 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -127.85 27.48 5.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 75.21 110.887 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.55 19.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.729 -0.748 . . . . 52.44 112.498 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -109.74 169.5 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 72.43 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.52 117.79 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 73.13 110.872 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.66 103.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.908 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -115.77 136.58 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.45 111.065 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -68.91 124.67 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.89 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.07 13.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.108 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.13 -167.52 33.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 73.11 112.513 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -127.48 159.58 64.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.6 0.714 . . . . 60.22 110.942 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.77 -48.23 0.28 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 73.04 112.355 -0.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.13 43.72 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 62.02 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.06 102.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 74.0 110.991 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.88 138.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 73.52 110.939 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -135.86 150.24 49.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.42 110.829 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.47 140.28 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.55 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -151.56 129.14 11.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 63.24 110.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.77 116.95 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.896 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -66.94 149.5 50.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.94 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.847 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.949 0.404 . . . . 73.41 110.849 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.85 143.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 63.11 111.096 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -128.73 115.58 18.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 73.51 111.136 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 m -137.48 125.51 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.44 17.76 79.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 72.44 112.477 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.25 -16.72 58.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 75.23 112.482 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.53 152.33 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 75.44 110.848 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -97.17 154.7 17.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 74.3 110.878 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.49 172.04 14.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 52.42 110.9 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -64.08 160.83 44.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.719 . . . . 70.44 110.898 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 175.75 7.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.236 . . . . 75.41 112.321 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 56.5 37.81 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.941 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.33 122.32 14.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 72.31 110.807 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -87.72 168.1 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.88 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -90.56 134.63 34.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 75.44 110.87 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.34 144.83 36.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 74.32 111.156 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -89.34 124.09 34.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 71.52 110.972 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -120.47 86.38 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.905 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -139.75 125.55 19.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 75.21 110.927 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -103.38 28.47 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.857 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.39 26.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.811 -0.709 . . . . 73.44 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -79.4 -32.18 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.795 0.331 . . . . 74.54 110.904 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.33 -5.75 41.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 75.3 112.48 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -113.61 89.41 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 75.43 110.888 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.62 104.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 51.33 110.913 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -135.08 84.94 35.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.716 0.77 . . . . 72.52 110.868 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 166.2 28.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.669 2.246 . . . . 72.34 112.339 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -136.11 174.05 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 72.01 110.832 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.57 130.29 46.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.924 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 149.4 53.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 71.22 110.861 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 144.67 54.66 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.26 . . . . 74.41 112.307 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.2 mt -54.29 149.11 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.23 110.942 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 153.04 51.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 72.22 112.509 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -106.34 -172.33 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.44 110.875 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.77 151.15 39.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 70.23 110.939 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 60.5 21.87 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.22 159.52 44.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.627 0.727 . . . . 73.54 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 145.93 58.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 75.32 112.361 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.9 p -153.96 167.3 30.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 54.23 110.881 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -126.54 145.43 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.897 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -53.13 -65.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.33 111.172 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -140.01 156.8 70.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.641 0.734 . . . . 75.44 110.927 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -170.5 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.238 . . . . 72.45 112.308 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.21 110.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.72 -16.58 64.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 74.04 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -96.36 -28.37 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.86 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 63.51 112.505 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.71 146.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 73.1 111.111 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -100.15 -176.3 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.51 -77.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 73.42 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -122.81 -58.85 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 74.41 110.985 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -76.31 167.74 21.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.908 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -117.8 160.19 39.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.548 0.689 . . . . 74.32 110.913 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 168.11 22.47 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 74.34 112.332 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 91.9 m -69.1 127.97 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.841 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.11 19.36 0.73 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.68 -0.772 . . . . 74.14 112.465 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.57 27.64 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 75.21 110.813 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.04 20.44 23.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 52.44 112.507 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.34 177.48 4.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 72.43 110.939 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 122.18 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 73.13 110.861 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.09 108.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -123.92 148.45 46.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.45 111.173 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -82.47 122.75 28.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.909 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.94 13.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.3 111.082 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.05 -167.98 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.466 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -140.26 160.04 61.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 60.22 110.872 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.2 Cg_endo -69.68 -44.91 0.46 Allowed 'Cis proline' 0 C--N 1.341 0.151 0 C-N-CA 122.753 -1.769 . . . . 73.04 112.325 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -130.73 69.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 62.02 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -94.26 78.2 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.17 137.9 33.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.52 110.888 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -144.15 170.81 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.38 135.44 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.55 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -146.7 130.93 17.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.24 110.872 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.77 117.24 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.851 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.87 149.21 49.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.901 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.85 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.901 0.381 . . . . 73.41 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.06 132.34 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 63.11 111.163 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.4 m -136.47 109.17 7.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.51 111.159 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.3 m -136.97 137.58 39.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.897 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 39.96 97.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.701 -0.761 . . . . 72.44 112.446 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.98 29.07 64.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.442 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -144.94 139.59 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 75.44 110.831 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -89.64 148.58 23.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 74.3 110.939 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -139.09 170.4 16.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 52.42 110.881 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -60.35 161.07 14.66 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.544 0.687 . . . . 70.44 110.876 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 173.42 10.95 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.666 2.244 . . . . 75.41 112.334 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 58.19 37.58 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.21 122.54 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.31 110.86 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.55 168.1 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.861 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -89.82 129.89 36.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.828 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.1 152.64 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 74.32 111.165 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -112.07 136.72 51.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.52 110.898 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -150.31 114.38 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 75.54 110.894 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.25 162.43 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.83 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -104.28 -15.33 15.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.841 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.16 35.91 3.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.705 -0.76 . . . . 73.44 112.503 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.94 -20.54 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 74.54 110.925 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.23 15.0 15.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.704 -0.76 . . . . 75.3 112.492 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -118.18 99.47 6.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 75.43 110.896 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -76.78 113.79 14.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 51.33 110.85 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m -137.08 85.03 23.28 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.711 0.767 . . . . 72.52 110.875 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 166.46 27.48 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 72.34 112.389 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.0 mtp85 -140.24 173.98 10.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.859 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.26 129.97 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 71.42 110.858 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.12 149.64 54.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 71.22 110.838 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.29 62.35 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.655 2.237 . . . . 74.41 112.318 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 36.2 mt -56.6 148.8 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 61.23 110.863 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.68 154.48 45.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 72.22 112.518 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -107.34 -174.42 2.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.856 0.36 . . . . 73.44 110.837 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.7 145.47 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 70.23 110.9 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 58.37 38.33 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.946 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.03 159.74 68.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.585 0.707 . . . . 73.54 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 130.96 20.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.683 2.255 . . . . 75.32 112.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -144.38 170.44 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 54.23 110.894 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -129.53 147.78 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.32 -67.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 73.33 111.123 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -138.51 156.78 73.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 75.44 110.881 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 72.45 112.358 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -169.51 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.904 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -66.79 -16.54 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.885 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -97.49 -28.25 14.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 64.13 110.865 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.98 4.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 63.51 112.491 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.7 mt -119.7 146.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 73.1 111.153 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -103.1 -176.09 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.885 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.06 -77.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 73.42 110.868 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -123.02 -59.88 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.932 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -75.72 158.29 32.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.885 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.53 160.17 30.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 74.32 110.844 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 168.08 22.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.673 2.249 . . . . 74.34 112.432 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.58 128.77 37.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 70.41 110.86 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.99 20.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 74.14 112.495 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.8 28.26 5.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.923 0.392 . . . . 75.21 110.919 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.95 23.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 52.44 112.516 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -109.06 176.11 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 72.43 110.996 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.65 119.6 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.893 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.21 108.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 137.12 55.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 74.45 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -71.92 124.06 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.908 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.89 -20.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.3 111.154 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.05 -174.06 16.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 73.11 112.504 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -116.7 159.41 40.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.571 0.701 . . . . 60.22 110.837 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -48.25 0.28 Allowed 'Cis proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.708 -1.788 . . . . 73.04 112.403 -0.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -130.98 46.55 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 62.02 110.865 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -70.12 83.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 74.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.17 145.8 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.941 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -143.33 154.96 44.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.846 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.92 139.28 48.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.55 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.98 128.59 12.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 63.24 110.874 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.04 117.05 2.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.16 153.92 42.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.906 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.13 110.862 -179.809 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.902 0.382 . . . . 73.41 110.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.89 144.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 63.11 111.095 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 m -129.7 122.22 28.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 73.51 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 m -139.68 130.35 25.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.878 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.24 22.84 59.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.07 68.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.73 . . . . 75.23 112.455 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 139.05 31.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 75.44 110.866 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.12 142.97 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 74.3 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -139.45 174.63 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 52.42 110.905 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -72.41 160.73 82.01 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 70.44 110.877 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 177.77 5.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.626 2.217 . . . . 75.41 112.313 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 62.81 27.09 15.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 75.25 110.955 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.0 m -142.03 117.41 10.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.855 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.19 168.26 16.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -91.57 131.0 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 75.44 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.19 147.04 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.153 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.94 136.54 54.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 71.52 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.64 28.71 4.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.848 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 81.1 p -59.06 159.37 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 75.21 110.789 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -124.65 26.69 7.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 71.42 110.827 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.59 33.24 67.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 73.44 112.467 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -93.61 -24.41 17.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 74.54 110.832 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.02 15.02 15.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.796 -0.716 . . . . 75.3 112.447 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -127.06 96.48 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 75.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -79.21 95.69 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 51.33 110.899 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -123.02 85.0 50.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.708 0.766 . . . . 72.52 110.851 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 165.64 30.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.75 2.3 . . . . 72.34 112.329 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -130.51 163.39 27.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.86 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -90.72 121.04 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.934 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.56 148.57 50.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 71.22 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 154.8 67.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.725 2.283 . . . . 74.41 112.327 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -65.35 158.18 27.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 61.23 110.928 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.32 158.59 50.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 72.22 112.511 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -110.37 -173.08 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 73.44 110.895 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.3 tp -70.37 145.0 51.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.958 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 57.24 39.45 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.21 110.869 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 159.45 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.68 0.752 . . . . 73.54 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.767 2.311 . . . . 75.32 112.289 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -142.16 160.21 40.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 54.23 110.841 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.9 142.44 47.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 72.32 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.6 -60.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.15 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -139.03 157.08 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.702 0.763 . . . . 75.44 110.868 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -170.41 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.637 2.225 . . . . 72.45 112.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.21 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.92 -15.75 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.815 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -96.52 -28.44 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 64.13 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.11 32.14 4.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 63.51 112.554 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.3 mt -125.54 150.51 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.1 111.123 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -102.04 -176.1 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.868 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.54 -77.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 73.42 110.854 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -123.04 -58.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.981 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -75.2 169.72 17.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 24.0 m -119.17 158.35 48.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.621 0.724 . . . . 74.32 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 168.27 22.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.637 2.225 . . . . 74.34 112.355 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -64.69 125.18 23.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 70.41 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.94 17.88 1.08 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 74.14 112.479 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.07 28.99 5.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 75.21 110.831 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.67 22.52 23.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 52.44 112.454 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mt -109.81 179.36 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 72.43 110.923 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.74 116.59 5.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.833 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 110.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 73.14 110.847 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -126.21 136.77 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.145 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -65.41 123.92 20.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.896 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.76 -19.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.43 . . . . 73.3 111.096 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.91 -164.5 11.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 73.11 112.438 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -131.39 159.7 70.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.621 0.724 . . . . 60.22 110.918 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.4 Cg_endo -69.74 -48.37 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.146 0 C-N-CA 122.67 -1.804 . . . . 73.04 112.326 -0.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -126.21 47.91 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.02 110.903 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -79.61 77.99 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.867 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.54 152.55 25.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.936 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -145.61 145.53 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.88 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.63 136.11 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.55 110.851 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -143.76 125.04 14.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.24 110.912 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -51.8 116.93 2.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.86 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.91 156.97 38.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.929 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.876 -179.784 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.94 0.4 . . . . 73.41 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.15 141.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 63.11 111.164 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -137.32 110.48 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 73.51 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 m -125.94 130.99 52.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.824 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 20.89 63.82 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 72.44 112.471 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.31 -20.38 44.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.77 -0.728 . . . . 75.23 112.541 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -100.12 145.56 27.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 75.44 110.864 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 74.3 110.903 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.99 171.53 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 52.42 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -65.4 160.69 57.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.702 . . . . 70.44 110.893 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 174.97 8.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.244 . . . . 75.41 112.341 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 58.47 30.0 19.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.887 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 m -142.06 120.75 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.31 110.826 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.2 p -90.31 168.1 12.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.881 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 m -90.14 126.36 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.78 136.97 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 74.32 111.186 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -104.62 128.09 52.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 71.52 110.877 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.68 32.11 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.54 110.908 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -68.36 152.13 45.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 75.21 110.837 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -124.99 26.16 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 71.42 110.844 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.18 30.0 35.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.771 . . . . 73.44 112.48 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -85.16 -28.67 25.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 74.54 110.861 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 9.44 35.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 75.3 112.507 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -127.01 88.74 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 75.43 110.96 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.8 94.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 51.33 110.86 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -118.32 84.95 24.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 72.52 110.935 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 165.64 30.28 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.704 2.269 . . . . 72.34 112.31 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -129.19 171.52 12.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 72.01 110.83 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.2 m -102.3 112.99 25.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.81 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 148.96 40.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 71.22 110.889 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 150.39 68.52 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 74.41 112.391 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.0 mt -59.0 147.99 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 61.23 110.932 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.9 156.7 36.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 72.22 112.503 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -108.32 -170.78 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 73.44 110.868 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.9 tp -73.75 146.4 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 70.23 110.868 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 56.47 32.52 20.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.849 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.88 159.67 45.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 73.54 110.941 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.92 5.97 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 75.32 112.295 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -135.04 169.33 17.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 54.23 110.893 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -130.21 144.64 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.857 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -52.62 -63.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.113 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -138.98 156.75 72.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 75.44 110.863 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -169.99 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.752 2.301 . . . . 72.45 112.323 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -168.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 71.21 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.1 -24.14 67.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.812 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -89.94 -28.37 19.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.13 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.54 32.25 4.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 63.51 112.566 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.9 mt -120.66 150.73 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 73.1 111.088 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -104.18 -176.09 2.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.22 110.955 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.55 -76.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.864 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -122.66 -60.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 74.41 110.923 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -74.9 158.85 32.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 74.31 110.792 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.1 m -109.93 160.05 29.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 74.32 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 167.93 23.04 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.698 2.266 . . . . 74.34 112.293 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.73 124.74 24.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 70.41 110.883 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.04 17.61 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.14 112.478 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.82 27.44 6.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 75.21 110.951 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.46 21.58 24.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.646 -0.788 . . . . 52.44 112.523 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -107.8 170.94 7.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 72.43 110.841 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.13 110.935 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.23 109.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.14 110.909 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -127.75 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.45 111.129 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -66.87 127.97 34.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.941 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.31 13.21 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.3 111.11 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.56 -157.95 18.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 73.11 112.484 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -140.25 159.39 63.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 60.22 110.913 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.74 -41.75 0.86 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.664 -1.807 . . . . 73.04 112.351 -0.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.56 63.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.912 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -81.95 79.81 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -82.15 133.04 35.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.954 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.94 147.77 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 74.42 110.896 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.85 129.42 39.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 74.55 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.72 128.1 30.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 63.24 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 119.98 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.842 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -64.12 154.53 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 75.32 110.831 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 75.13 110.885 -179.814 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.9 0.381 . . . . 73.41 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -71.26 143.13 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 63.11 111.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -128.87 115.29 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.51 111.1 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -138.16 123.14 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.887 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 19.4 79.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.44 112.482 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.57 -13.96 64.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 75.23 112.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.95 139.31 31.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 75.44 110.906 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.1 138.1 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.3 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.79 171.91 12.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 52.42 110.907 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.35 160.74 30.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 70.44 110.815 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 177.8 5.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.668 2.245 . . . . 75.41 112.397 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.98 36.32 27.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 75.25 110.921 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m -141.95 124.51 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.889 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -87.78 168.2 13.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.866 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 m -90.72 128.01 36.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 75.44 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -120.59 166.49 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 74.32 111.09 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -117.93 137.63 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 71.52 110.93 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.74 29.78 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.856 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.8 p -63.15 144.61 56.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.862 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -127.05 26.07 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 71.42 110.828 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.77 60.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 73.44 112.483 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -88.9 -25.96 21.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 74.54 110.905 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.99 -6.21 34.78 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.743 -0.742 . . . . 75.3 112.505 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -124.73 92.66 3.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 75.43 110.892 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.57 117.86 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 51.33 110.856 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 p -137.16 85.0 23.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.679 0.752 . . . . 72.52 110.893 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 164.95 32.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 72.34 112.348 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -133.6 173.8 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.01 110.919 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.14 131.88 50.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 149.34 62.78 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.606 0.717 . . . . 71.22 110.806 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 145.7 57.65 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.654 2.236 . . . . 74.41 112.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 mt -54.14 149.42 9.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 61.23 110.873 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.6 157.06 52.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.732 . . . . 72.22 112.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -105.62 -169.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.324 . . . . 73.44 110.898 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.96 149.04 43.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 70.23 110.927 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 53.03 33.34 14.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.899 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.13 159.66 42.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.641 0.734 . . . . 73.54 110.842 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.81 5.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.68 2.254 . . . . 75.32 112.309 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.5 p -132.19 170.87 14.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 54.23 110.872 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -131.09 146.36 52.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.88 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.5 t -52.2 -66.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 73.33 111.155 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -140.64 156.74 69.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 75.44 110.84 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -170.42 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 72.45 112.375 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -169.39 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.856 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.15 -16.03 64.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 74.04 110.908 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -98.38 -28.18 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.882 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 31.99 4.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 63.51 112.449 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 68.4 mt -119.08 145.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.387 . . . . 73.1 111.102 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -102.82 -176.19 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 74.22 110.879 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.82 -77.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 73.42 110.843 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -123.06 -59.39 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 74.41 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -76.23 159.23 30.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.888 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.8 m -112.02 160.06 31.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.605 0.717 . . . . 74.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.99 22.85 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.698 2.265 . . . . 74.34 112.334 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.22 124.17 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.41 110.848 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.98 17.83 1.07 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.6 29.21 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 75.21 110.91 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.74 26.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 52.44 112.446 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mt -109.01 179.56 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 72.43 110.857 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 120.27 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 73.13 110.844 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -54.94 108.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 73.14 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -125.69 136.63 53.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.45 111.209 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.87 125.59 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.924 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -116.68 -21.22 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 73.3 111.122 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.19 -162.26 9.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.688 -0.768 . . . . 73.11 112.486 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -130.09 159.69 68.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.57 0.7 . . . . 60.22 110.92 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.83 -48.48 0.27 Allowed 'Cis proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.676 -1.801 . . . . 73.04 112.291 0.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -127.29 46.55 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 62.02 110.82 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -72.98 77.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.923 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.1 141.96 35.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 73.52 110.928 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -139.39 145.68 39.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.839 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.48 136.73 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 74.55 110.859 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.51 126.94 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.24 110.906 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.856 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.49 152.48 41.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.32 110.857 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.807 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.941 0.4 . . . . 73.41 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.2 130.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 63.11 111.165 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.6 m -137.28 113.7 10.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.221 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.8 m -139.48 157.1 46.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.855 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.81 16.51 51.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 72.44 112.491 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.18 -15.21 60.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 75.23 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.83 163.46 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 75.44 110.893 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -94.63 155.39 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 74.3 110.963 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -132.63 177.19 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.42 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -80.24 160.65 67.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.545 0.688 . . . . 70.44 110.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 168.33 21.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.67 2.246 . . . . 75.41 112.429 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 63.33 27.56 15.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.96 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.0 p -142.02 119.2 11.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.31 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -88.07 168.13 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 72.13 110.924 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 m -91.18 125.48 35.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.44 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.15 156.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 74.32 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -118.2 129.21 55.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 71.52 110.896 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -152.57 95.97 2.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.961 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 163.25 16.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 75.21 110.845 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -98.63 26.35 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 71.42 110.85 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.9 22.59 72.22 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 73.44 112.49 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -79.98 -27.94 39.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 74.54 110.884 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.5 15.02 18.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 75.3 112.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -118.76 93.75 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 75.43 110.914 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.58 108.57 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 51.33 110.879 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.9 m -135.84 85.01 30.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.611 0.72 . . . . 72.52 110.821 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.0 32.51 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.699 2.266 . . . . 72.34 112.347 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -133.84 173.95 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.01 110.911 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.61 130.85 51.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 71.42 110.848 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 149.35 73.2 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.646 0.736 . . . . 71.22 110.871 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 146.75 61.38 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.725 2.283 . . . . 74.41 112.387 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.09 149.85 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 61.23 110.946 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.81 151.89 36.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.688 . . . . 72.22 112.415 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -177.48 3.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 73.44 110.898 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -69.73 143.22 53.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 70.23 110.863 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 60.53 39.45 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 73.21 110.904 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.04 159.46 72.56 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.586 0.708 . . . . 73.54 110.921 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 133.18 24.81 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 75.32 112.327 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 p -148.03 167.78 24.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 54.23 110.965 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -126.31 148.07 49.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -52.74 -64.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.15 156.74 64.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.647 0.736 . . . . 75.44 110.851 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.675 2.25 . . . . 72.45 112.303 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.58 -169.53 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.875 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.99 -16.78 64.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -97.36 -28.08 14.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.829 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 32.01 4.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.683 -0.77 . . . . 63.51 112.493 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -117.98 145.6 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 73.1 111.192 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -104.49 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.58 -78.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 73.42 110.842 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.19 -58.32 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.935 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -77.42 169.06 18.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.901 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.8 m -117.77 160.67 37.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.563 0.696 . . . . 74.32 110.89 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.07 22.59 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.675 2.25 . . . . 74.34 112.334 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 89.0 m -70.67 126.01 28.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 70.41 110.852 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.24 18.58 0.81 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.76 . . . . 74.14 112.402 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.51 30.7 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 75.21 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.15 22.23 27.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.489 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 mt -108.77 176.42 5.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.365 . . . . 72.43 110.933 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.5 116.8 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 73.13 110.883 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 103.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.853 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -118.21 136.98 53.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.45 111.159 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -76.17 122.71 24.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.946 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.73 -19.29 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 73.3 111.079 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.72 -159.82 9.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 73.11 112.518 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.1 pt-20 -139.78 159.47 64.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.691 0.758 . . . . 60.22 110.864 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.8 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 -1.802 . . . . 73.04 112.342 0.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.76 53.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.02 110.867 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -79.67 78.1 6.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.91 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.09 141.17 34.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 73.52 110.933 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -139.16 153.11 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 74.42 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.0 140.97 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.55 110.875 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -151.86 129.43 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 63.24 110.888 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.93 117.02 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -64.05 149.53 47.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 75.13 110.877 -179.828 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.953 0.406 . . . . 73.41 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.98 139.42 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 63.11 111.123 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.9 m -143.12 107.55 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.51 111.107 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.6 m -146.4 149.29 33.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.855 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.0 75.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 72.44 112.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.67 24.97 75.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 75.23 112.475 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -148.87 137.79 21.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 75.44 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -78.01 133.29 38.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 74.3 110.9 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.98 176.7 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 52.42 110.923 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -77.87 160.73 73.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.625 0.726 . . . . 70.44 110.85 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.88 15.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.755 2.304 . . . . 75.41 112.333 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 63.19 27.78 15.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 75.25 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.75 117.42 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.31 110.891 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 p -88.48 168.09 12.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.877 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 m -91.69 131.11 37.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 75.44 110.888 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.98 124.0 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 74.32 111.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -78.88 125.65 29.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 71.52 110.902 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -126.02 26.44 6.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 75.54 110.9 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -68.59 158.6 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.852 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -111.36 27.38 9.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 71.42 110.881 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.93 26.47 71.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.79 -0.719 . . . . 73.44 112.447 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -82.66 -25.49 33.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 74.54 110.907 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.95 15.11 15.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.837 -0.697 . . . . 75.3 112.428 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -121.49 102.45 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -69.11 100.02 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 51.33 110.842 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.5 p -130.95 84.91 56.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 72.52 110.848 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 166.48 27.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 72.34 112.381 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.53 171.36 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 72.01 110.884 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.9 m -107.57 107.37 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.23 149.25 43.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.561 0.696 . . . . 71.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 152.46 69.57 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 74.41 112.35 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.0 mt -62.16 149.43 41.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 61.23 110.882 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.57 149.68 39.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.22 112.476 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -172.82 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.754 0.311 . . . . 73.44 110.894 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.0 tp -72.29 146.37 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 70.23 110.925 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 58.31 35.51 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.861 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.67 159.74 68.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.68 0.752 . . . . 73.54 110.802 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 138.4 37.84 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.601 2.201 . . . . 75.32 112.357 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -147.6 170.77 16.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 54.23 110.918 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -129.22 146.04 51.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.32 110.88 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.76 -67.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 73.33 111.124 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -139.64 156.69 71.08 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.734 . . . . 75.44 110.923 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.719 2.279 . . . . 72.45 112.332 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 -169.47 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.955 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.69 -17.75 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.04 110.901 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -96.28 -28.35 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 64.13 110.926 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.28 31.95 4.47 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.668 -0.777 . . . . 63.51 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.16 146.95 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.1 111.127 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -101.93 -176.19 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 74.22 110.899 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -77.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 73.42 110.858 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -122.78 -59.55 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.942 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -76.95 156.02 32.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.896 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.3 m -106.74 160.41 26.39 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 74.32 110.797 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 167.92 23.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 74.34 112.275 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.7 m -72.92 125.62 28.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 70.41 110.831 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.83 17.62 0.84 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 74.14 112.482 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.68 31.47 5.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 75.21 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.25 21.65 31.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.741 . . . . 52.44 112.539 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -108.04 176.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -148.78 119.16 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 73.13 110.826 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.36 103.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.833 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.39 145.68 47.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.184 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -82.89 123.46 29.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 74.43 110.899 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -125.97 13.13 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.3 111.104 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -158.6 9.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 73.11 112.397 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.0 pt-20 -158.52 159.43 29.81 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.683 0.754 . . . . 60.22 110.809 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -43.09 0.65 Allowed 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 122.727 -1.781 . . . . 73.04 112.309 0.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -126.97 75.1 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 62.02 110.851 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -108.36 78.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 tp -81.2 136.6 35.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 73.52 110.875 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -140.11 156.93 46.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.857 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.61 141.6 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.55 110.884 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.04 127.41 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.964 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -52.02 117.06 2.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.866 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.75 157.79 29.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 75.13 110.874 -179.771 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.896 0.379 . . . . 73.41 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.36 140.31 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 63.11 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.1 m -137.1 107.43 6.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 73.51 111.19 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -125.87 143.25 51.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 73.21 110.87 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.37 43.63 57.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.474 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.14 19.52 46.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.471 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -134.75 140.69 46.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 75.44 110.846 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.25 148.95 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 74.3 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.18 178.76 6.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 52.42 110.939 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -73.7 160.61 81.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.543 0.687 . . . . 70.44 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 172.92 11.76 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 75.41 112.369 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 63.11 26.74 15.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 75.25 110.94 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -142.08 118.26 10.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.31 110.888 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.95 168.24 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 72.13 110.852 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.0 m -93.11 133.64 36.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 75.44 110.873 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -131.04 137.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.32 111.149 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -92.71 131.22 37.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 71.52 110.93 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -129.06 51.96 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.875 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 t -82.4 136.4 34.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.805 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -101.64 26.04 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 71.42 110.861 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.94 24.45 64.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.544 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -84.67 -28.77 26.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 74.54 110.911 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.96 23.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.687 -0.768 . . . . 75.3 112.574 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.97 94.68 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 75.43 110.893 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.28 94.94 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 51.33 110.849 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.3 p -131.87 84.89 52.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 72.52 110.863 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 164.86 33.04 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.65 2.233 . . . . 72.34 112.314 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.8 173.78 7.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.01 110.934 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 m -97.06 130.03 44.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 71.42 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.28 148.83 71.72 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.626 0.727 . . . . 71.22 110.839 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 155.11 66.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 74.41 112.279 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.49 154.13 39.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 61.23 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.91 159.68 43.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 72.22 112.495 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -115.44 -176.25 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 73.44 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.9 tp -70.6 142.35 51.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 70.23 110.919 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 60.57 39.5 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 73.21 110.882 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 159.52 71.45 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.596 0.713 . . . . 73.54 110.937 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 129.03 16.89 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 75.32 112.396 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.1 p -147.44 167.79 23.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 54.23 110.893 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.04 150.54 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.909 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -55.9 -65.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.52 157.02 72.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.686 0.755 . . . . 75.44 110.893 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -170.13 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.645 2.23 . . . . 72.45 112.348 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.83 -169.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 71.21 110.908 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.93 -15.56 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.825 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -96.58 -28.21 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 64.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.16 4.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 63.51 112.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.9 mt -123.95 146.69 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 73.1 111.129 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -101.53 -176.11 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 74.22 110.927 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -77.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.42 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -122.89 -58.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 74.41 110.958 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -77.15 161.36 28.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.922 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -111.55 159.98 31.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 74.32 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 168.11 22.55 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.71 2.273 . . . . 74.34 112.403 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.8 m -68.67 126.1 28.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 70.41 110.925 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.39 19.51 0.92 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 74.14 112.402 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -127.31 27.77 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 75.21 110.847 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.3 22.87 21.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 52.44 112.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.2 mt -109.65 175.13 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 72.43 110.979 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.66 116.8 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 73.13 110.912 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.09 105.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.927 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -119.8 137.13 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.17 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -71.63 123.98 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.988 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.47 -20.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 73.3 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.64 -156.82 7.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 73.11 112.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.8 pt-20 -140.6 159.63 62.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.696 0.76 . . . . 60.22 110.78 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.75 -48.37 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.206 0 C-N-CA 122.677 -1.801 . . . . 73.04 112.347 -0.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -125.38 50.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 62.02 110.915 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -77.93 77.96 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.77 148.85 28.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 73.52 110.892 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -145.9 152.75 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.873 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -70.76 137.59 49.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.55 110.883 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -147.38 127.86 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 118.8 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.899 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.1 156.35 28.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.892 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 75.13 110.867 -179.773 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.913 0.387 . . . . 73.41 110.854 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.85 143.33 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 63.11 111.034 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 m -142.63 115.45 8.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 73.51 111.082 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -132.49 132.62 42.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.21 110.903 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.77 66.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.781 -0.723 . . . . 72.44 112.478 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.83 -20.85 42.65 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.46 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -99.82 149.16 23.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 75.44 110.931 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -93.48 147.46 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.897 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.22 169.06 16.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 52.42 110.852 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -63.91 160.79 43.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.62 0.724 . . . . 70.44 110.896 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.73 176.44 6.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.75 2.3 . . . . 75.41 112.323 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 62.6 25.27 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.25 110.857 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.844 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.05 168.13 13.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 72.13 110.925 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.89 134.78 34.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.73 135.26 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 74.32 111.203 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.7 123.3 39.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 71.52 110.956 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -129.59 42.72 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 75.54 110.886 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -71.33 154.62 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 75.21 110.846 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -109.19 26.44 10.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 71.42 110.875 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.4 27.16 66.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 73.44 112.452 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.2 -31.08 23.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 74.54 110.846 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.81 15.09 15.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 75.3 112.473 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -119.87 98.95 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 75.43 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.07 94.5 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 51.33 110.902 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 t -126.91 84.92 62.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 72.52 110.837 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 166.6 27.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.703 2.269 . . . . 72.34 112.312 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 161.48 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.865 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 m -95.69 109.05 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.939 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 148.99 39.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 71.22 110.887 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.17 64.79 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.669 2.246 . . . . 74.41 112.316 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.6 mt -56.65 150.35 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 61.23 110.858 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.39 148.44 51.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 72.22 112.476 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -171.73 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.321 . . . . 73.44 110.898 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.4 tp -73.12 146.89 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.79 24.08 13.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 159.72 36.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.604 0.716 . . . . 73.54 110.856 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 125.75 12.54 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 75.32 112.323 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.54 164.61 29.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 54.23 110.857 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.84 156.12 43.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.857 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -61.12 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.136 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -140.61 156.9 69.02 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.637 0.732 . . . . 75.44 110.884 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 72.45 112.335 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.08 -169.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.21 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.34 -15.2 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.905 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.81 -28.31 14.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.937 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.13 32.14 4.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 63.51 112.456 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt -124.66 150.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 73.1 111.144 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.1 -176.2 3.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.77 -76.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 73.42 110.84 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -122.65 -59.54 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.949 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -75.9 160.04 30.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 74.31 110.87 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 m -111.48 160.29 29.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.653 0.74 . . . . 74.32 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 168.0 22.86 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.657 2.238 . . . . 74.34 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.92 126.35 29.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 70.41 110.88 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.2 18.27 0.92 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 74.14 112.478 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -127.27 26.47 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 75.21 110.944 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.01 22.82 16.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.726 -0.75 . . . . 52.44 112.475 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -109.73 171.94 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.43 110.933 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 120.0 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.865 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.66 102.48 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.864 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -115.42 140.93 48.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.45 111.117 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.75 125.74 29.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.847 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.9 m -117.06 -21.24 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.112 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.6 -176.54 15.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 73.11 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -118.0 159.54 42.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.579 0.704 . . . . 60.22 110.897 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.78 -48.68 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.679 -1.8 . . . . 73.04 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -131.11 65.9 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 62.02 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.44 77.79 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.862 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.1 140.93 30.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 73.52 110.863 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -140.44 157.39 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.863 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.12 132.04 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.913 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -143.21 129.06 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.9 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -52.05 117.33 2.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.877 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.92 147.5 53.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.32 110.845 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 75.13 110.843 -179.818 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.852 0.358 . . . . 73.41 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.3 136.02 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.123 -0.49 . . . . 63.11 111.073 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -146.11 107.83 4.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 73.51 111.2 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -147.03 144.59 29.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 73.21 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.07 20.08 78.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.523 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.87 23.79 73.83 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.728 -0.749 . . . . 75.23 112.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -144.95 155.28 43.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 75.44 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -101.4 155.26 18.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 74.3 110.856 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.91 173.13 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 52.42 110.923 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -69.06 160.58 77.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.71 . . . . 70.44 110.849 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 175.11 8.51 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.603 2.202 . . . . 75.41 112.389 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 59.98 27.56 16.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 75.25 110.928 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 p -142.02 119.23 11.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.31 110.848 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -89.13 168.14 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.13 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -89.75 132.65 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 75.44 110.869 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.05 123.98 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.139 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.92 122.94 25.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 71.52 110.896 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -130.01 84.81 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.835 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -96.83 164.97 12.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 75.21 110.867 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -127.66 26.01 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 71.42 110.817 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.19 27.28 66.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 73.44 112.465 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -91.9 -36.0 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.305 . . . . 74.54 110.866 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.6 15.02 16.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 75.3 112.528 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -125.32 95.25 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 75.43 110.836 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -54.44 107.25 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 51.33 110.857 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -133.68 84.98 43.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.712 0.768 . . . . 72.52 110.845 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.97 25.81 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.656 2.237 . . . . 72.34 112.434 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.66 174.01 10.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.01 110.877 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 120.42 40.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.42 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.64 149.02 47.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 71.22 110.839 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 149.71 67.25 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 74.41 112.337 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.7 mt -59.34 148.67 31.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.23 110.894 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 155.42 34.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.819 -0.705 . . . . 72.22 112.448 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -108.72 -172.89 2.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 73.44 110.902 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 23.6 tp -73.15 145.6 46.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.23 110.981 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 58.27 38.68 26.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 73.21 110.836 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.41 159.59 69.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.688 0.756 . . . . 73.54 110.876 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 124.37 11.01 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.715 2.277 . . . . 75.32 112.33 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 p -136.31 168.26 19.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 54.23 110.798 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.16 144.39 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 72.32 110.947 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.94 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.33 111.07 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -140.01 156.8 70.28 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 75.44 110.935 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -169.87 0.36 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.638 2.225 . . . . 72.45 112.33 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -168.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.846 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.86 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.852 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -88.21 -28.44 21.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 64.13 110.826 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.86 32.07 4.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 63.51 112.514 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.46 147.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.353 . . . . 73.1 111.117 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -100.43 -175.99 3.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.21 -77.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.883 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -123.06 -58.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.41 110.9 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -77.06 168.65 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.852 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -116.1 160.34 35.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 74.32 110.946 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 168.13 22.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.659 2.24 . . . . 74.34 112.35 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 93.1 m -70.07 125.47 26.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.936 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.88 19.23 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 74.14 112.501 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -125.75 28.1 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 75.21 110.87 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.94 22.65 22.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.7 -0.762 . . . . 52.44 112.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mt -108.64 177.4 4.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 72.43 110.875 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.41 118.6 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.13 110.809 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.1 m -55.41 106.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.901 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.59 136.88 54.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 74.45 111.178 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.43 126.1 29.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.889 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.03 13.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 73.3 111.101 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.87 -160.18 13.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 73.11 112.473 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -138.3 159.99 65.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.686 0.755 . . . . 60.22 110.858 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.84 -42.82 0.69 Allowed 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.288 0.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.42 49.47 2.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 62.02 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.55 97.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 74.0 110.88 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.88 136.87 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.93 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -139.64 150.14 44.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.828 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.72 138.57 55.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 74.55 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -147.01 127.17 13.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.926 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.39 117.02 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -67.17 155.03 39.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.907 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 75.13 110.854 -179.798 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.859 0.361 . . . . 73.41 110.917 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.8 t -81.31 142.62 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 63.11 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.9 m -137.49 111.15 8.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 73.51 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 m -130.61 129.16 42.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.965 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.58 39.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.44 112.442 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.04 20.58 64.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.516 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.07 143.86 46.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 75.44 110.875 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -90.88 136.44 33.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.882 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -124.41 169.11 12.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 52.42 110.868 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -63.83 160.6 44.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 70.44 110.964 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 175.95 7.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 75.41 112.3 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 61.05 28.51 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 p -142.06 122.81 14.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.31 110.842 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 p -89.97 168.14 12.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.842 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.28 122.07 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 75.44 110.854 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -119.95 131.39 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.131 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.36 124.88 31.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 71.52 110.958 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -150.09 107.54 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.54 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 m -117.11 169.75 9.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 75.21 110.819 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -102.96 27.02 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 71.42 110.929 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.1 20.14 70.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 73.44 112.497 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.86 -26.62 34.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 74.54 110.916 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.0 15.0 15.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.85 -0.691 . . . . 75.3 112.521 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -125.94 102.62 7.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 75.43 110.902 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.61 103.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 51.33 110.896 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.7 t -124.88 84.95 57.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.758 0.79 . . . . 72.52 110.9 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 166.56 27.17 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.739 2.293 . . . . 72.34 112.384 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -137.08 174.03 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.809 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.6 m -96.86 128.47 43.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.931 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 148.96 69.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 71.22 110.87 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 152.16 69.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.227 . . . . 74.41 112.409 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.48 154.67 23.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 61.23 110.951 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.36 154.46 53.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 72.22 112.446 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.22 -171.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 73.44 110.926 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.99 147.59 46.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 70.23 110.977 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 55.05 32.35 18.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.21 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.66 159.7 45.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.68 0.753 . . . . 73.54 110.827 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.701 2.267 . . . . 75.32 112.27 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 p -134.47 169.81 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 54.23 110.883 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -129.66 148.31 51.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.854 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.51 -63.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 73.33 111.098 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -141.7 154.31 65.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 75.44 110.899 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.641 2.227 . . . . 72.45 112.367 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -74.09 -169.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 71.21 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.2 -17.54 64.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.863 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -95.6 -28.39 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.06 4.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 63.51 112.528 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mt -119.1 148.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.812 0.339 . . . . 73.1 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -104.63 -175.95 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.899 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.7 -77.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.875 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.71 -60.06 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.93 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -75.53 158.52 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.31 110.82 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 m -109.41 159.7 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 74.32 110.869 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.08 22.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 74.34 112.355 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.3 128.49 36.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.842 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.12 17.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.679 -0.772 . . . . 74.14 112.488 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.66 27.14 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 75.21 110.876 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.93 19.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 52.44 112.548 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mt -108.86 173.15 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.829 0.347 . . . . 72.43 110.887 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 120.88 8.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.817 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.24 111.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.14 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -128.7 136.75 51.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 74.45 111.167 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -68.0 125.75 27.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 74.43 110.891 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 13.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.092 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.92 -156.57 10.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 73.11 112.536 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.496 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -152.56 159.51 32.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 60.22 110.898 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.8 -48.14 0.28 Allowed 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 -1.803 . . . . 73.04 112.34 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -122.77 75.01 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 62.02 110.899 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.7 93.11 4.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 74.0 110.904 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.98 142.41 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 73.52 110.875 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -142.44 145.71 34.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.839 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.39 133.11 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.55 110.858 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -141.64 128.74 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 63.24 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -51.94 117.13 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.888 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.59 155.14 40.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 75.32 110.89 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 75.13 110.831 -179.734 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.927 0.394 . . . . 73.41 110.859 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.97 131.28 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 63.11 111.138 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -140.28 111.25 6.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 73.51 111.075 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.8 m -139.21 146.19 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.879 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.91 20.38 72.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 72.44 112.54 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.69 28.99 56.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 75.23 112.507 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -154.77 151.47 28.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.297 . . . . 75.44 110.89 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.53 136.24 33.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 74.3 110.942 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.88 156.54 24.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 52.42 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.61 160.91 3.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.592 0.71 . . . . 70.44 110.85 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 164.52 34.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 75.41 112.362 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 63.4 30.48 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 75.25 110.941 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -142.0 116.67 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.9 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.53 168.3 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 72.13 110.867 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.21 127.81 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 75.44 110.861 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.77 135.02 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.32 111.064 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -92.0 126.57 37.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 71.52 110.943 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -154.01 107.37 2.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.54 110.904 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 p -116.18 172.6 7.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 75.21 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -114.62 26.97 9.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.902 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.45 75.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.769 -0.729 . . . . 73.44 112.459 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -88.18 -30.75 19.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 74.54 110.89 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.05 15.17 20.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.776 -0.726 . . . . 75.3 112.467 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.51 103.12 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.306 . . . . 75.43 110.904 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.27 109.01 0.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 51.33 110.858 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -131.59 84.98 53.71 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.759 . . . . 72.52 110.848 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.9 26.05 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.652 2.235 . . . . 72.34 112.335 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 161.63 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.876 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 m -90.18 117.85 29.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.868 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 148.72 46.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.528 0.68 . . . . 71.22 110.91 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 154.81 67.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.647 2.231 . . . . 74.41 112.373 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.5 mt -62.44 149.76 41.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 61.23 110.872 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.52 154.77 48.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 72.22 112.474 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -108.51 -173.37 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 73.44 110.892 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.0 tp -73.36 147.09 44.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.893 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.91 22.54 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.892 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.59 159.58 36.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.581 0.705 . . . . 73.54 110.881 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 123.9 10.58 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.723 2.282 . . . . 75.32 112.339 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.2 p -136.91 170.34 16.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 54.23 110.936 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -133.93 146.81 50.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.927 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.89 -66.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -139.29 156.87 71.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.629 0.728 . . . . 75.44 110.888 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -169.62 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 72.45 112.304 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.89 -168.6 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.21 110.914 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.18 67.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -88.7 -28.31 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 64.13 110.905 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.76 32.01 4.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 63.51 112.515 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.39 149.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 73.1 111.159 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.34 -176.12 3.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 74.22 110.927 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.22 -77.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.814 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -123.0 -59.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.934 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -77.05 158.48 30.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.802 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.6 m -108.77 160.29 27.82 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.71 . . . . 74.32 110.922 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 168.03 22.75 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.716 2.277 . . . . 74.34 112.305 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.5 m -68.69 127.1 31.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 70.41 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.67 17.42 0.97 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 74.14 112.499 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.56 27.24 5.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 75.21 110.841 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.63 23.95 19.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.457 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mt -108.74 171.43 7.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.9 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 127.72 17.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 73.13 110.81 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.92 106.23 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.881 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.24 144.47 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.182 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -81.4 123.75 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.873 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.18 -24.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 73.3 111.154 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.16 -161.64 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 73.11 112.51 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.493 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.7 pt-20 -127.97 159.44 66.66 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.699 0.762 . . . . 60.22 110.882 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.79 -42.2 0.79 Allowed 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.368 0.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.34 63.53 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.894 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 79.32 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.0 110.937 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.25 147.05 32.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -152.89 159.03 42.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -72.76 128.6 36.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.55 110.884 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.82 126.46 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.948 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.33 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -65.66 152.03 45.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 75.13 110.886 -179.873 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.842 0.353 . . . . 73.41 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.29 144.49 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 63.11 111.09 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -153.34 110.52 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.51 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 m -148.52 133.64 18.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.21 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.83 76.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 72.44 112.464 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.39 28.66 65.41 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.687 -0.768 . . . . 75.23 112.529 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.96 134.99 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.674 0.273 . . . . 75.44 110.953 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.51 152.01 21.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 74.3 110.919 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.48 171.14 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 52.42 110.877 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -63.28 160.76 38.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.589 0.709 . . . . 70.44 110.856 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.05 8.57 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.756 2.304 . . . . 75.41 112.328 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.18 38.44 26.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 75.25 110.828 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -141.32 123.55 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 72.31 110.907 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -88.92 168.16 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.948 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -88.32 134.44 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.882 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.35 130.53 65.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.113 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.87 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 71.52 110.917 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -149.7 120.13 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.875 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 179.88 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.853 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -126.35 28.8 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 71.42 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.97 65.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 73.44 112.415 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -92.05 -31.02 15.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 74.54 110.888 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.03 -5.38 34.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 75.3 112.458 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -117.19 93.0 4.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 75.43 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.06 117.9 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 51.33 110.931 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -135.19 84.94 34.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.74 . . . . 72.52 110.852 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 166.46 27.47 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.627 2.218 . . . . 72.34 112.327 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -138.14 173.99 11.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.01 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -99.24 130.18 45.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.932 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 149.71 56.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.702 . . . . 71.22 110.815 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 147.32 62.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 74.41 112.376 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.73 149.89 21.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 61.23 110.948 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.44 160.5 32.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 72.22 112.481 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -114.38 -171.87 2.0 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.44 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.7 tp -73.18 144.57 46.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.879 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 58.19 37.09 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.932 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.95 159.72 65.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.638 0.732 . . . . 73.54 110.938 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 124.28 10.91 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.701 2.268 . . . . 75.32 112.344 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -135.0 165.43 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 54.23 110.926 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.17 145.54 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 72.32 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.86 -67.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.33 111.096 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -139.07 156.81 72.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.643 0.735 . . . . 75.44 110.877 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -169.73 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.264 . . . . 72.45 112.34 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -168.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.21 110.878 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.14 67.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.04 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.03 -28.42 21.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 64.13 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.72 32.15 4.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.51 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 mt -122.26 150.54 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.1 111.131 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.47 -176.02 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.976 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.75 -77.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.836 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -122.82 -59.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.71 159.95 30.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 74.31 110.861 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.8 m -111.54 160.13 30.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.561 0.696 . . . . 74.32 110.943 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.99 22.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.658 2.239 . . . . 74.34 112.373 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.5 m -70.23 124.54 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 70.41 110.916 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.63 19.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.494 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.76 28.45 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 75.21 110.903 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.19 22.73 24.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 52.44 112.523 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.34 172.39 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 72.43 110.923 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -144.81 118.32 9.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.852 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.43 102.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.838 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -118.55 147.55 43.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.45 111.149 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -88.96 124.84 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.927 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.55 13.17 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.3 111.136 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.36 -161.5 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 73.11 112.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.2 pt-20 -151.12 159.47 33.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 60.22 110.862 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.78 -48.39 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.748 -1.772 . . . . 73.04 112.331 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -123.82 72.53 1.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 62.02 110.832 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -99.9 78.15 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.68 141.69 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 73.52 110.887 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -149.75 160.67 43.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.59 140.34 41.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.957 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.76 127.3 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.911 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.01 120.35 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.833 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -64.39 150.31 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.878 -179.782 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.878 0.37 . . . . 63.109999999999999 111.127 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.5 m -136.02 109.59 7.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 111.121 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.8 m -127.54 143.89 51.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 110.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.88 43.11 70.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 72.439999999999998 112.489 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.99 24.51 58.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 75.230000000000004 112.49 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -145.09 136.26 24.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.694 0.283 . . . . 75.439999999999998 110.938 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.8 139.35 50.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 73.239999999999995 110.932 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.1 m -122.09 164.07 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 52.420000000000002 110.915 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -66.1 161.1 59.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.564 0.697 . . . . 50.119999999999997 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 167.49 24.3 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.68 2.253 . . . . 75.409999999999997 112.335 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 63.62 27.55 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.87 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -141.99 116.64 9.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.299999999999997 110.883 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.88 168.13 13.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 72.129999999999995 110.898 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 m -90.51 131.72 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 62.119999999999997 110.909 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.68 133.68 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 44.549999999999997 111.109 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -78.83 123.08 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.230000000000004 110.902 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 75.540000000000006 110.907 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.688 0.756 . . . . 72.519999999999996 110.861 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.03 28.93 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.697 2.265 . . . . 72.0 112.358 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -123.63 162.32 23.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.871 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.4 m -91.89 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 71.420000000000002 110.906 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 148.42 40.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.566 0.698 . . . . 71.219999999999999 110.888 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 152.18 69.24 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 71.299999999999997 112.375 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.614 HD13 ' HA3' ' A' ' 56' ' ' GLY . 22.5 mt -60.52 150.59 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 61.149999999999999 110.892 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.25 152.84 49.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.219999999999999 112.503 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -108.73 -172.96 2.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 73.439999999999998 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.6 tp -74.82 151.79 39.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 70.230000000000004 110.873 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.14 22.29 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.66 159.33 46.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 73.540000000000006 110.895 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 132.14 22.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 52.43 112.385 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.0 159.1 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 51.409999999999997 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -122.2 143.35 49.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 72.030000000000001 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -52.01 -65.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 111.129 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -137.66 156.99 74.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 63.049999999999997 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 54.310000000000002 112.343 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.41 -169.35 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 71.209999999999994 110.868 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -68.54 -14.89 63.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -95.61 -28.29 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.129999999999995 110.863 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 32.12 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 63.509999999999998 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.37 147.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 73.099999999999994 111.134 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -99.76 -175.95 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.911 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -77.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 72.5 110.819 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -123.01 -58.57 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 74.409999999999997 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -75.59 169.93 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.310000000000002 110.817 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.5 m -118.09 160.0 40.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 61.549999999999997 110.853 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 166.55 27.22 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 71.329999999999998 112.324 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.5 m -66.81 124.55 23.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 70.409999999999997 110.89 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -148.96 16.03 1.18 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 74.140000000000001 112.463 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.2 pt-20 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 72.540000000000006 110.892 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.01 23.57 29.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 52.439999999999998 112.509 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 74' ' ' GLU . 10.3 mt -109.9 176.07 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 72.430000000000007 110.942 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 119.77 5.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 64.409999999999997 110.866 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.99 108.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 110.858 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.51 137.8 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.138 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.34 120.87 18.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.886 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.69 -19.36 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 73.299999999999997 111.118 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.37 -157.25 7.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 62.549999999999997 112.503 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -138.0 159.55 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 54.310000000000002 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.8 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.663 -1.807 . . . . 73.040000000000006 112.339 0.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -130.12 49.7 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.020000000000003 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -72.93 78.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mp -79.73 129.25 34.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 73.519999999999996 110.905 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.26 157.78 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.43 129.23 36.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -140.64 124.3 17.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 63.240000000000002 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HG2' HD23 ' A' ' 59' ' ' LEU . 25.8 mm-40 -51.78 116.94 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 110.918 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.96 147.59 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.319999999999993 110.887 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 51.100000000000001 110.816 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.876 0.37 . . . . 63.109999999999999 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -128.96 109.99 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.510000000000005 111.167 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.59 142.86 50.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 73.209999999999994 110.872 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.98 41.55 59.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 72.439999999999998 112.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.14 20.18 57.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 75.230000000000004 112.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -135.75 140.45 44.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 75.439999999999998 110.932 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -84.01 135.41 34.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 73.239999999999995 110.95 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 m -123.65 167.7 13.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 52.420000000000002 110.825 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -67.78 160.67 72.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 50.119999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 174.55 9.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.718 2.279 . . . . 75.409999999999997 112.321 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 62.54 26.14 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.1 p -141.45 119.53 12.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.299999999999997 110.816 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.97 168.23 12.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 72.129999999999995 110.845 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.7 m -92.92 128.62 38.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 110.83 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -117.9 141.57 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.549999999999997 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.43 136.36 53.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 64.230000000000004 110.861 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.954 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.618 0.723 . . . . 72.519999999999996 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.8 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.764 2.31 . . . . 72.0 112.276 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -132.32 164.78 25.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.010000000000005 110.86 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -96.34 119.04 34.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 149.27 47.88 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 71.219999999999999 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 148.11 64.02 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.723 2.282 . . . . 71.299999999999997 112.379 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.618 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.3 mt -57.25 149.33 20.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 61.149999999999999 110.931 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.75 145.6 49.91 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 72.219999999999999 112.506 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -100.87 -172.83 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 73.439999999999998 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.94 151.12 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 m120 58.21 22.34 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.209999999999994 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.93 159.47 40.74 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 73.540000000000006 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 141.59 45.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 52.43 112.254 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -150.79 165.37 33.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 51.409999999999997 110.959 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 72.030000000000001 110.835 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.8 t -51.65 -61.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.139 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -142.27 156.74 64.19 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.678 0.751 . . . . 63.049999999999997 110.817 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -168.43 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.538 2.158 . . . . 54.310000000000002 112.381 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -169.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 71.209999999999994 110.895 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -65.98 -19.76 65.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 110.824 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -97.06 -28.24 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.129999999999995 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.33 3.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 63.509999999999998 112.463 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.25 155.99 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 73.099999999999994 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -112.91 -176.03 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.926 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.36 -78.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.782 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -122.94 -59.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.409999999999997 110.971 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -76.01 157.87 32.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.836 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.77 159.81 29.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 61.549999999999997 110.953 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.05 36.06 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 71.329999999999998 112.324 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.1 m -66.55 127.82 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 70.409999999999997 110.839 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.618 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.39 17.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 74.140000000000001 112.516 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.91 27.59 5.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 72.540000000000006 110.895 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.64 19.17 28.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.706 -0.759 . . . . 52.439999999999998 112.533 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -108.54 164.68 12.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 110.944 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -142.61 125.61 16.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 64.409999999999997 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -55.46 101.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.140000000000001 110.936 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -118.57 140.27 50.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 111.091 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -70.5 125.84 27.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.430000000000007 110.892 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.46 HG21 ' HG3' ' A' ' 71' ' ' ARG . 28.1 m -126.05 12.86 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.299999999999997 111.093 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.11 -165.49 30.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 62.549999999999997 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -142.5 159.83 56.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.310000000000002 110.856 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.1 Cg_endo -69.64 -48.74 0.26 Allowed 'Cis proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.721 -1.783 . . . . 73.040000000000006 112.369 -0.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -125.2 75.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 62.020000000000003 110.898 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -101.47 78.03 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 74.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.8 136.93 36.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 73.519999999999996 110.916 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' HG21 ' A' ' 64' ' ' VAL . 13.2 mmt180 -144.78 154.18 42.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 74.420000000000002 110.859 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.08 134.11 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.96 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -141.62 136.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -51.11 116.68 2.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.889 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 158.51 29.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 75.319999999999993 110.822 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 51.100000000000001 110.897 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 13' ' ' SER . 57.3 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 63.109999999999999 111.117 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 8' ' ' GLN . 10.1 m -146.86 110.27 4.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 73.510000000000005 111.099 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.2 m -146.63 135.24 22.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.477 . . . . 73.209999999999994 110.886 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.78 73.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.764 . . . . 72.439999999999998 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.5 70.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 75.230000000000004 112.504 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 136.24 27.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.711 0.291 . . . . 75.439999999999998 110.903 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 3' ' ' THR . 10.7 mt-30 -93.36 142.81 26.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.239999999999995 110.913 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -130.97 169.61 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 52.420000000000002 110.897 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -57.41 160.73 6.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.582 0.705 . . . . 50.119999999999997 110.834 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 175.5 7.95 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.727 2.285 . . . . 75.409999999999997 112.354 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 58.63 37.34 25.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.47 . . . . 75.25 110.905 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 2' ' ' VAL . 58.4 m -140.96 127.57 20.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 72.299999999999997 110.866 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 p -90.36 168.11 12.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 72.129999999999995 110.839 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 m -90.49 126.58 35.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 62.119999999999997 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 m -122.46 155.19 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 44.549999999999997 111.124 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.13 131.73 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.230000000000004 110.902 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 75.540000000000006 110.896 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.1 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.653 0.739 . . . . 72.519999999999996 110.795 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 165.96 29.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 72.0 112.307 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -131.57 170.19 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.010000000000005 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.9 130.26 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.420000000000002 110.855 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 149.52 58.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.587 0.708 . . . . 71.219999999999999 110.871 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.73 51.84 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.622 2.215 . . . . 71.299999999999997 112.379 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.4 mt -54.33 151.26 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 61.149999999999999 110.887 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.48 158.72 48.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 72.219999999999999 112.525 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -111.12 -175.08 2.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 73.439999999999998 110.943 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 36' ' ' ASN . 28.1 tp -70.09 144.19 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 70.230000000000004 110.916 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.596 ' H ' HD12 ' A' ' 35' ' ' LEU . 59.4 m-20 58.51 38.92 25.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.209999999999994 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 159.67 67.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.64 0.733 . . . . 73.540000000000006 110.866 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 123.39 10.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.629 2.219 . . . . 52.43 112.308 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 p -142.07 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 51.409999999999997 110.933 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -128.52 146.84 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 72.030000000000001 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -52.24 -64.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 111.118 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -139.78 157.05 70.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 63.049999999999997 110.831 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.06 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.759 2.306 . . . . 54.310000000000002 112.298 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.95 -169.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 110.892 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -67.88 -16.25 63.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.844 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.62 -28.42 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 64.129999999999995 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.39 32.07 4.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 63.509999999999998 112.432 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mt -122.04 148.5 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 73.099999999999994 111.158 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -104.9 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.918 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.35 -76.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 72.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -122.64 -59.65 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.409999999999997 110.905 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -75.33 163.57 27.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.804 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 m -115.13 159.61 37.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 61.549999999999997 110.935 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 168.28 22.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.22 . . . . 71.329999999999998 112.34 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.45 130.97 44.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.409999999999997 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.44 19.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 74.140000000000001 112.483 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -128.02 26.24 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 72.540000000000006 110.842 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.47 21.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 52.439999999999998 112.478 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.7 mt -108.4 175.67 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.430000000000007 110.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.1 116.26 7.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 64.409999999999997 110.797 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 106.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 73.140000000000001 110.887 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -119.24 139.43 51.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.450000000000003 111.115 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -68.75 122.28 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 110.872 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.7 HG21 ' HD3' ' A' ' 71' ' ' ARG . 30.1 m -116.79 -18.88 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.299999999999997 111.069 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.95 -157.45 7.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 62.549999999999997 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -144.17 159.6 51.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 54.310000000000002 110.917 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.79 -48.41 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 -1.79 . . . . 73.040000000000006 112.312 0.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -123.06 52.7 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 62.020000000000003 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -88.64 77.98 7.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.69 156.2 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 73.519999999999996 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.7 ' HD3' HG21 ' A' ' 64' ' ' VAL . 45.5 mtp180 -147.84 157.92 43.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.868 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.6 140.45 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.862 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -149.36 125.74 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 63.240000000000002 110.92 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -52.04 117.59 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 74.329999999999998 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -66.52 158.76 28.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.100000000000001 110.818 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 13' ' ' SER . 84.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.937 0.398 . . . . 63.109999999999999 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 8' ' ' GLN . 8.1 m -138.67 107.84 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 111.165 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 m -135.19 147.93 49.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.864 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.29 37.57 87.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 72.439999999999998 112.455 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.63 23.14 64.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 75.230000000000004 112.499 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -142.36 143.53 32.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 75.439999999999998 110.914 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 3' ' ' THR . 34.0 mt-30 -95.92 148.18 22.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 110.971 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.2 m -137.93 168.87 18.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 52.420000000000002 110.904 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -54.43 160.94 2.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 50.119999999999997 110.843 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.26 8.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.714 2.276 . . . . 75.409999999999997 112.308 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.17 39.07 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.905 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 2' ' ' VAL . 93.2 p -140.61 131.26 25.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 72.299999999999997 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -94.01 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 72.129999999999995 110.875 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 m -90.25 123.59 34.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 62.119999999999997 110.852 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.22 144.47 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 44.549999999999997 111.087 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -90.56 124.82 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 64.230000000000004 110.951 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 m120 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.948 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.731 0.777 . . . . 72.519999999999996 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 165.88 29.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.72 2.28 . . . . 72.0 112.342 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -134.48 173.91 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 72.010000000000005 110.872 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.45 130.95 46.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 149.39 59.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 71.219999999999999 110.912 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 146.28 59.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 71.299999999999997 112.328 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.9 mt -55.73 150.04 13.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 61.149999999999999 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.77 157.19 52.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 72.219999999999999 112.492 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -109.51 -171.69 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.899 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.7 tp -72.13 146.1 47.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.230000000000004 110.938 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.507 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.4 m-20 58.09 34.6 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.44 159.74 56.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.540000000000006 110.907 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 119.41 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 52.43 112.279 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -136.58 168.31 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.409999999999997 110.851 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -129.96 144.27 51.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 72.030000000000001 110.94 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.08 -63.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 111.127 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -138.98 156.99 72.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.695 0.759 . . . . 63.049999999999997 110.851 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.83 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 54.310000000000002 112.402 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.07 -169.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.209999999999994 110.878 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.47 -16.32 64.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 74.040000000000006 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -96.97 -28.34 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 64.129999999999995 110.947 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.17 31.99 4.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 63.509999999999998 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.9 149.64 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 73.099999999999994 111.111 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -104.13 -176.27 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 110.892 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -77.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 72.5 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -122.76 -59.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 74.409999999999997 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -74.77 161.09 29.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.795 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.1 159.9 31.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 61.549999999999997 110.949 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.07 22.55 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 71.329999999999998 112.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.57 129.93 41.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 70.409999999999997 110.906 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -154.67 19.41 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 74.140000000000001 112.476 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.5 pt-20 -127.34 25.83 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 72.540000000000006 110.892 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.0 22.8 16.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 52.439999999999998 112.466 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -108.84 178.47 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 72.430000000000007 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.33 114.39 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 64.409999999999997 110.882 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.3 106.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.875 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -119.14 139.26 52.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.105 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -69.27 123.4 21.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 110.905 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 m -116.45 -21.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 73.299999999999997 111.126 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.92 -164.55 10.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 62.549999999999997 112.468 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -133.34 160.14 69.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 54.310000000000002 110.906 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.73 -48.55 0.26 Allowed 'Cis proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.714 -1.786 . . . . 73.040000000000006 112.364 -0.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -125.53 50.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.020000000000003 110.932 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -83.99 77.92 9.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -86.8 154.46 20.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.519999999999996 110.915 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -146.31 149.7 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 110.883 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.1 137.52 56.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.439999999999998 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -146.84 126.29 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 63.240000000000002 110.92 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.03 117.43 2.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.87 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.06 158.11 32.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 51.100000000000001 110.867 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.9 0.381 . . . . 63.109999999999999 111.074 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 m -148.93 114.49 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.510000000000005 111.131 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.18 152.62 40.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.27 25.81 67.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 72.439999999999998 112.458 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.42 78.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 75.230000000000004 112.488 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -143.89 153.95 42.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 75.439999999999998 110.863 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -93.11 138.97 31.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 73.239999999999995 110.921 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 m -117.76 175.15 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 52.420000000000002 110.802 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -76.29 160.52 77.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.6 0.714 . . . . 50.119999999999997 110.881 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.409999999999997 112.311 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m120 57.52 32.89 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -142.07 132.11 24.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.851 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -97.74 168.27 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.129999999999995 110.971 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 m -95.98 124.25 39.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.883 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 131.7 70.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 44.549999999999997 111.127 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -83.39 124.67 30.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 64.230000000000004 110.929 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 75.540000000000006 110.862 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.634 0.73 . . . . 72.519999999999996 110.798 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 166.45 27.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 72.0 112.366 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -127.26 172.21 10.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 72.010000000000005 110.841 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.9 m -103.3 118.11 36.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.420000000000002 110.952 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 148.82 64.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.594 0.711 . . . . 71.219999999999999 110.812 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 149.99 67.96 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.626 2.217 . . . . 71.299999999999997 112.392 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 56' ' ' GLY . 26.8 mt -61.21 157.86 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 61.149999999999999 110.891 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 157.07 51.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 72.219999999999999 112.501 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -108.29 -173.47 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 73.439999999999998 110.878 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 36' ' ' ASN . 24.7 tp -71.62 148.29 46.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 70.230000000000004 110.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.538 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.0 m-20 55.02 35.4 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.209999999999994 110.879 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.32 159.53 56.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.61 0.719 . . . . 73.540000000000006 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 117.97 5.4 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 52.43 112.333 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -133.89 171.06 14.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 51.409999999999997 110.847 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -126.98 147.82 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.64 -63.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 73.329999999999998 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 154.14 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 63.049999999999997 110.897 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -169.64 0.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.675 2.25 . . . . 54.310000000000002 112.382 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -169.34 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 71.209999999999994 110.907 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -65.2 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.040000000000006 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -93.69 -25.66 17.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 64.129999999999995 110.895 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.25 5.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.777 -0.725 . . . . 63.509999999999998 112.431 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.452 HG21 ' HB2' ' A' ' 17' ' ' GLN . 5.6 mm -108.74 156.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 73.099999999999994 111.129 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.75 -176.73 2.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.962 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -79.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.5 110.805 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -123.32 -58.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 110.951 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -77.22 158.68 30.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 74.310000000000002 110.898 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.6 m -107.57 159.4 30.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 61.549999999999997 110.873 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 168.22 22.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 71.329999999999998 112.355 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.7 m -69.45 132.84 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 70.409999999999997 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.67 19.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.708 -0.758 . . . . 74.140000000000001 112.466 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.61 27.0 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 72.540000000000006 110.946 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.49 23.09 19.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 52.439999999999998 112.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.6 mt -109.77 177.04 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 72.430000000000007 110.908 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.34 122.36 7.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.409999999999997 110.878 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.12 111.8 0.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 73.140000000000001 110.871 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -131.25 136.56 48.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 111.121 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -65.99 127.23 31.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 74.430000000000007 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.79 -23.59 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 73.299999999999997 111.131 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.5 -167.46 12.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 62.549999999999997 112.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.1 pt-20 -119.09 159.69 44.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.692 0.758 . . . . 54.310000000000002 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.76 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 -1.796 . . . . 73.040000000000006 112.346 -0.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -131.25 43.58 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 62.020000000000003 110.835 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -66.5 89.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.41 136.38 33.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.519999999999996 110.886 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -135.35 145.99 47.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.936 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.29 136.66 55.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 74.439999999999998 110.882 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -144.99 126.04 14.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 63.240000000000002 110.878 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -51.85 116.92 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 74.329999999999998 110.953 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.71 155.67 38.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 75.319999999999993 110.928 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 51.100000000000001 110.864 -179.773 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.833 0.349 . . . . 63.109999999999999 111.118 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -132.05 110.06 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 73.510000000000005 111.152 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.13 137.97 52.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.88 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.22 18.58 69.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 72.439999999999998 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.09 -19.62 48.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.78 -0.724 . . . . 75.230000000000004 112.509 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -108.41 152.88 24.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.722 0.296 . . . . 75.439999999999998 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -80.73 144.19 32.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.239999999999995 110.974 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.81 159.84 24.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 52.420000000000002 110.894 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -56.6 160.99 4.78 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.526 0.679 . . . . 50.119999999999997 110.944 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 166.87 26.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.716 2.277 . . . . 75.409999999999997 112.332 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 59.23 33.96 22.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.91 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -141.97 123.8 15.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 72.299999999999997 110.901 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -88.78 168.12 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 110.897 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -88.62 120.38 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 62.119999999999997 110.979 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.64 141.04 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 44.549999999999997 111.12 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 122.84 47.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.230000000000004 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.540000000000006 110.916 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.6 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.687 0.756 . . . . 72.519999999999996 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 166.56 27.33 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 72.0 112.261 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -135.23 173.81 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.010000000000005 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 m -96.67 129.83 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 71.420000000000002 110.861 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.07 148.32 68.84 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.549 0.69 . . . . 71.219999999999999 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 155.69 65.4 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 71.299999999999997 112.338 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -63.68 162.07 13.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 61.149999999999999 110.913 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.68 150.21 41.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.741 . . . . 72.219999999999999 112.459 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -99.47 -174.29 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.439999999999998 110.957 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 ' H ' ' A' ' 36' ' ' ASN . 20.9 tp -71.14 144.01 50.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 70.230000000000004 110.924 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.546 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.2 m-20 57.38 26.86 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 110.869 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.04 159.55 31.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 73.540000000000006 110.863 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 119.27 6.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.646 2.231 . . . . 52.43 112.383 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -136.59 166.07 24.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 51.409999999999997 110.814 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -125.64 142.58 51.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 72.030000000000001 110.883 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -51.67 -63.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 111.078 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -138.52 157.11 72.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.693 0.759 . . . . 63.049999999999997 110.841 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 54.310000000000002 112.3 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -72.98 -169.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.209999999999994 110.858 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.63 -14.15 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.040000000000006 110.883 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -97.63 -28.34 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.129999999999995 110.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.07 32.12 4.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 63.509999999999998 112.527 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mt -125.26 148.84 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.844 0.355 . . . . 73.099999999999994 111.101 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -99.78 -176.26 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.219999999999999 110.908 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.13 -77.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 72.5 110.929 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -123.01 -59.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -74.88 162.42 28.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.9 m -113.36 158.73 37.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.542 0.686 . . . . 61.549999999999997 110.918 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 168.11 22.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.636 2.224 . . . . 71.329999999999998 112.34 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -67.74 125.64 26.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 70.409999999999997 110.911 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.52 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.54 15.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.733 . . . . 74.140000000000001 112.469 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.4 pt-20 -125.9 37.21 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 72.540000000000006 110.878 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.4 24.6 39.18 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 52.439999999999998 112.501 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.473 HD12 ' HG2' ' A' ' 57' ' ' GLU . 13.3 mt -110.37 174.85 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 72.430000000000007 110.848 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.5 118.77 6.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 64.409999999999997 110.791 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 110.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.140000000000001 110.862 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -130.7 140.99 50.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 111.117 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -67.83 119.68 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.855 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.85 -20.4 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 111.147 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.34 -157.47 7.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 62.549999999999997 112.464 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -144.1 159.73 51.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.717 . . . . 54.310000000000002 110.886 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.3 Cg_endo -69.7 -48.41 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.156 0 C-N-CA 122.69 -1.796 . . . . 73.040000000000006 112.372 -0.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -124.69 58.33 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 62.020000000000003 110.845 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -90.21 82.36 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.935 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.28 149.24 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 110.94 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -151.13 146.51 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.420000000000002 110.834 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.41 141.28 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.891 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -150.9 127.06 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 63.240000000000002 110.941 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -51.9 116.94 2.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.58 157.67 37.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 51.100000000000001 110.788 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 9' ' ' CYS . 6.8 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.976 0.417 . . . . 63.109999999999999 111.108 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -147.88 123.55 10.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 73.510000000000005 111.131 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.2 m -150.2 150.44 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.209999999999994 110.877 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.82 37.14 89.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 72.439999999999998 112.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.79 20.83 62.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 75.230000000000004 112.505 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -140.22 154.46 46.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 75.439999999999998 110.876 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -93.99 138.27 32.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.239999999999995 110.961 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB2' HG13 ' A' ' 2' ' ' VAL . 17.4 m -113.58 174.99 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 52.420000000000002 110.856 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -81.75 160.88 62.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 50.119999999999997 110.899 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.78 33.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.737 2.292 . . . . 75.409999999999997 112.322 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.04 25.26 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.92 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -142.05 119.99 12.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.811 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.96 168.0 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.0 m -88.2 133.25 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 62.119999999999997 110.959 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.53 124.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 44.549999999999997 111.121 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -82.61 125.65 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 64.230000000000004 110.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m120 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 110.921 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.701 0.762 . . . . 72.519999999999996 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 166.67 26.74 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.716 2.277 . . . . 72.0 112.398 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -127.03 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 110.85 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.8 m -103.45 111.73 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 110.886 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.51 148.64 42.24 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.603 0.716 . . . . 71.219999999999999 110.808 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.54 69.27 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.663 2.242 . . . . 71.299999999999997 112.344 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.603 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.0 mt -64.31 148.51 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 61.149999999999999 110.912 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.81 152.87 38.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.752 . . . . 72.219999999999999 112.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -103.94 -170.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 73.439999999999998 110.883 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.0 tp -73.03 142.1 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.912 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.6 m-20 59.65 34.64 22.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.851 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.62 49.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.651 0.739 . . . . 73.540000000000006 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 52.43 112.381 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.51 161.96 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 51.409999999999997 110.857 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.67 146.65 47.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 72.030000000000001 110.855 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.94 -64.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.164 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -138.29 156.98 73.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 63.049999999999997 110.907 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.632 2.222 . . . . 54.310000000000002 112.344 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.23 -169.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 71.209999999999994 110.959 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.48 -15.58 63.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 74.040000000000006 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -95.46 -28.32 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.129999999999995 110.89 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.03 32.06 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 63.509999999999998 112.502 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.3 mt -125.64 149.54 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 73.099999999999994 111.123 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -102.19 -176.09 3.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.918 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.71 -77.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 72.5 110.916 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -122.85 -59.46 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.946 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -75.93 160.9 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -112.79 160.07 32.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.649 0.738 . . . . 61.549999999999997 110.889 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 168.04 22.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.227 . . . . 71.329999999999998 112.423 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -68.87 126.31 29.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 70.409999999999997 110.887 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.9 19.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 74.140000000000001 112.481 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -127.85 27.48 5.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 72.540000000000006 110.887 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.55 19.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.729 -0.748 . . . . 52.439999999999998 112.498 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.5 mt -109.74 169.5 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 110.898 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.52 117.79 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 64.409999999999997 110.872 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.3 m -55.66 103.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 73.140000000000001 110.908 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -115.77 136.58 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.450000000000003 111.065 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -68.91 124.67 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.89 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG21 ' HG3' ' A' ' 71' ' ' ARG . 16.7 m -126.07 13.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.108 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.13 -167.52 33.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 62.549999999999997 112.513 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -127.48 159.58 64.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.6 0.714 . . . . 54.310000000000002 110.942 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.77 -48.23 0.28 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 73.040000000000006 112.355 -0.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.13 43.72 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 62.020000000000003 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -65.06 102.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 74.0 110.991 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 61' ' ' CYS . 5.7 mp -104.88 138.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 73.519999999999996 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.573 ' HG3' HG21 ' A' ' 64' ' ' VAL . 18.2 mmt85 -135.86 150.24 49.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.829 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.47 140.28 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.439999999999998 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -151.56 129.14 11.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 110.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.77 116.95 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 110.896 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -66.94 149.5 50.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.319999999999993 110.94 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 51.100000000000001 110.847 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.956 0.408 . . . . 63.109999999999999 111.096 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -128.73 115.58 18.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 73.510000000000005 111.136 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 m -137.48 125.51 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.209999999999994 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.44 17.76 79.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 72.439999999999998 112.477 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.25 -16.72 58.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 75.230000000000004 112.482 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.53 152.33 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 110.848 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -97.17 154.7 17.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 73.239999999999995 110.878 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.49 172.04 14.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 52.420000000000002 110.9 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -64.08 160.83 44.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.719 . . . . 50.119999999999997 110.898 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 175.75 7.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.236 . . . . 75.409999999999997 112.321 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 56.5 37.81 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.941 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.33 122.32 14.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 72.299999999999997 110.807 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -87.72 168.1 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 72.129999999999995 110.88 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -90.56 134.63 34.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 62.119999999999997 110.87 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.34 144.83 36.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 44.549999999999997 111.156 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -89.34 124.09 34.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 110.972 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.6 m120 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 75.540000000000006 110.905 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.716 0.77 . . . . 72.519999999999996 110.868 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 166.2 28.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.669 2.246 . . . . 72.0 112.339 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -136.11 174.05 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 72.010000000000005 110.832 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.57 130.29 46.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.420000000000002 110.924 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 149.4 53.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 71.219999999999999 110.861 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 144.67 54.66 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.26 . . . . 71.299999999999997 112.307 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -54.29 149.11 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.149999999999999 110.942 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 153.04 51.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 72.219999999999999 112.509 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -106.34 -172.33 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.439999999999998 110.875 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.4 tp -74.77 151.15 39.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 70.230000000000004 110.939 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 60.5 21.87 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.209999999999994 110.907 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.22 159.52 44.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.627 0.727 . . . . 73.540000000000006 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 145.93 58.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 52.43 112.361 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.9 p -153.96 167.3 30.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 51.409999999999997 110.881 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -126.54 145.43 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 72.030000000000001 110.897 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -53.13 -65.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 111.172 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -140.01 156.8 70.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.641 0.734 . . . . 63.049999999999997 110.927 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -170.5 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.238 . . . . 54.310000000000002 112.308 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.209999999999994 110.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.72 -16.58 64.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 74.040000000000006 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -96.36 -28.37 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 64.129999999999995 110.86 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 63.509999999999998 112.505 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.71 146.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 73.099999999999994 111.111 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -100.15 -176.3 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 74.219999999999999 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.51 -77.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.5 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -122.81 -58.85 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 74.409999999999997 110.985 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -76.31 167.74 21.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.908 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -117.8 160.19 39.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.548 0.689 . . . . 61.549999999999997 110.913 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 168.11 22.47 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 71.329999999999998 112.332 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 91.9 m -69.1 127.97 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.409999999999997 110.841 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.622 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.11 19.36 0.73 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.68 -0.772 . . . . 74.140000000000001 112.465 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.7 pt-20 -127.57 27.64 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 72.540000000000006 110.813 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.04 20.44 23.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 52.439999999999998 112.507 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.6 mt -109.34 177.48 4.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 72.430000000000007 110.939 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 122.18 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 64.409999999999997 110.861 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.09 108.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 73.140000000000001 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -123.92 148.45 46.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 111.173 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -82.47 122.75 28.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.909 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.94 13.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.299999999999997 111.082 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.05 -167.98 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 62.549999999999997 112.466 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -140.26 160.04 61.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 54.310000000000002 110.872 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.2 Cg_endo -69.68 -44.91 0.46 Allowed 'Cis proline' 0 C--N 1.341 0.151 0 C-N-CA 122.753 -1.769 . . . . 73.040000000000006 112.325 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -130.73 69.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 62.020000000000003 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -94.26 78.2 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.17 137.9 33.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.519999999999996 110.888 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -144.15 170.81 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.38 135.44 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -146.7 130.93 17.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.240000000000002 110.872 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.77 117.24 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.851 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.87 149.21 49.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.901 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 51.100000000000001 110.85 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.893 0.377 . . . . 63.109999999999999 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.4 m -136.47 109.17 7.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.510000000000005 111.159 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.3 m -136.97 137.58 39.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.897 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 39.96 97.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.701 -0.761 . . . . 72.439999999999998 112.446 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.98 29.07 64.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 75.230000000000004 112.442 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -144.94 139.59 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 75.439999999999998 110.831 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -89.64 148.58 23.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 110.939 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -139.09 170.4 16.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 52.420000000000002 110.881 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -60.35 161.07 14.66 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.544 0.687 . . . . 50.119999999999997 110.876 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 173.42 10.95 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.666 2.244 . . . . 75.409999999999997 112.334 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 58.19 37.58 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.21 122.54 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.299999999999997 110.86 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.55 168.1 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 110.861 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -89.82 129.89 36.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 62.119999999999997 110.828 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.1 152.64 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 44.549999999999997 111.165 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HG2' HG21 ' A' ' 48' ' ' ILE . 4.9 mm-40 -112.07 136.72 51.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 64.230000000000004 110.898 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 75.540000000000006 110.894 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.711 0.767 . . . . 72.519999999999996 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 166.46 27.48 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 72.0 112.389 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.0 mtp85 -140.24 173.98 10.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.010000000000005 110.859 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.26 129.97 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 71.420000000000002 110.858 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.12 149.64 54.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 71.219999999999999 110.838 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.29 62.35 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.655 2.237 . . . . 71.299999999999997 112.318 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 56' ' ' GLY . 36.2 mt -56.6 148.8 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 61.149999999999999 110.863 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.68 154.48 45.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 72.219999999999999 112.518 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -107.34 -174.42 2.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.856 0.36 . . . . 73.439999999999998 110.837 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.1 tp -70.7 145.47 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 70.230000000000004 110.9 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.7 m-20 58.37 38.33 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 110.946 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.03 159.74 68.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.585 0.707 . . . . 73.540000000000006 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 130.96 20.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.683 2.255 . . . . 52.43 112.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -144.38 170.44 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 51.409999999999997 110.894 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -129.53 147.78 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.030000000000001 110.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.32 -67.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.123 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -138.51 156.78 73.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 63.049999999999997 110.881 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 54.310000000000002 112.358 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -169.51 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 71.209999999999994 110.904 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -66.79 -16.54 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.885 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -97.49 -28.25 14.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 64.129999999999995 110.865 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.98 4.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 63.509999999999998 112.491 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.473 HG21 ' HG2' ' A' ' 17' ' ' GLN . 65.7 mt -119.7 146.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 73.099999999999994 111.153 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -103.1 -176.09 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.885 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.06 -77.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.5 110.868 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -123.02 -59.88 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.932 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -75.72 158.29 32.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 110.885 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.53 160.17 30.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 61.549999999999997 110.844 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 168.08 22.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.673 2.249 . . . . 71.329999999999998 112.432 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.58 128.77 37.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 70.409999999999997 110.86 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.99 20.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 74.140000000000001 112.495 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.8 28.26 5.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.923 0.392 . . . . 72.540000000000006 110.919 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.95 23.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 52.439999999999998 112.516 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -109.06 176.11 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 72.430000000000007 110.996 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.65 119.6 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 110.893 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.21 108.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 137.12 55.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -71.92 124.06 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.430000000000007 110.908 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.89 -20.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.299999999999997 111.154 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.05 -174.06 16.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 62.549999999999997 112.504 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -116.7 159.41 40.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.571 0.701 . . . . 54.310000000000002 110.837 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -48.25 0.28 Allowed 'Cis proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.708 -1.788 . . . . 73.040000000000006 112.403 -0.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -130.98 46.55 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 62.020000000000003 110.865 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -70.12 83.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 74.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.17 145.8 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.941 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -143.33 154.96 44.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.846 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.92 139.28 48.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.98 128.59 12.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 63.240000000000002 110.874 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.04 117.05 2.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.329999999999998 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.16 153.92 42.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 75.319999999999993 110.906 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 51.100000000000001 110.862 -179.809 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.936 0.398 . . . . 63.109999999999999 111.095 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 m -129.7 122.22 28.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 73.510000000000005 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 m -139.68 130.35 25.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 73.209999999999994 110.878 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.24 22.84 59.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.07 68.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.73 . . . . 75.230000000000004 112.455 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 139.05 31.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 75.439999999999998 110.866 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.12 142.97 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 73.239999999999995 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -139.45 174.63 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 52.420000000000002 110.905 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -72.41 160.73 82.01 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 50.119999999999997 110.877 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 177.77 5.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.626 2.217 . . . . 75.409999999999997 112.313 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 m120 62.81 27.09 15.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 75.25 110.955 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.0 m -142.03 117.41 10.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 72.299999999999997 110.855 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.19 168.26 16.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -91.57 131.0 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 62.119999999999997 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 28' ' ' ARG . 5.9 m -124.19 147.04 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 44.549999999999997 111.153 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.94 136.54 54.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 64.230000000000004 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 75.540000000000006 110.848 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.708 0.766 . . . . 72.519999999999996 110.851 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 165.64 30.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.75 2.3 . . . . 72.0 112.329 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 16' ' ' VAL . 8.1 tpt180 -130.51 163.39 27.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 72.010000000000005 110.86 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -90.72 121.04 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.934 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.56 148.57 50.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 71.219999999999999 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 154.8 67.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.725 2.283 . . . . 71.299999999999997 112.327 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.6 mt -65.35 158.18 27.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 61.149999999999999 110.928 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.32 158.59 50.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 72.219999999999999 112.511 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -110.37 -173.08 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 73.439999999999998 110.895 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 36' ' ' ASN . 32.3 tp -70.37 145.0 51.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 70.230000000000004 110.958 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 35' ' ' LEU . 90.2 m-20 57.24 39.45 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.209999999999994 110.869 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -127.16 159.45 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.68 0.752 . . . . 73.540000000000006 110.888 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' ND2' ' A' ' 37' ' ' ASN . 53.2 Cg_endo -69.8 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.767 2.311 . . . . 52.43 112.289 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -142.16 160.21 40.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 51.409999999999997 110.841 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.9 142.44 47.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 72.030000000000001 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.6 -60.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.15 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -139.03 157.08 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.702 0.763 . . . . 63.049999999999997 110.868 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -170.41 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.637 2.225 . . . . 54.310000000000002 112.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.209999999999994 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.92 -15.75 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 110.815 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -96.52 -28.44 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.11 32.14 4.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 63.509999999999998 112.554 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.3 mt -125.54 150.51 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.099999999999994 111.123 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -102.04 -176.1 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.219999999999999 110.868 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.54 -77.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 72.5 110.854 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -123.04 -58.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 110.981 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -75.2 169.72 17.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 24.0 m -119.17 158.35 48.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.621 0.724 . . . . 61.549999999999997 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 168.27 22.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.637 2.225 . . . . 71.329999999999998 112.355 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -64.69 125.18 23.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 70.409999999999997 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.94 17.88 1.08 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 74.140000000000001 112.479 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.8 pt-20 -127.07 28.99 5.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 72.540000000000006 110.831 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.67 22.52 23.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 52.439999999999998 112.454 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.2 mt -109.81 179.36 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 72.430000000000007 110.923 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.74 116.59 5.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 64.409999999999997 110.833 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 110.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 73.140000000000001 110.847 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -126.21 136.77 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 111.145 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -65.41 123.92 20.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.896 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 69' ' ' LYS . 31.4 m -116.76 -19.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.43 . . . . 73.299999999999997 111.096 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.91 -164.5 11.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 62.549999999999997 112.438 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -131.39 159.7 70.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.621 0.724 . . . . 54.310000000000002 110.918 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.4 Cg_endo -69.74 -48.37 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.146 0 C-N-CA 122.67 -1.804 . . . . 73.040000000000006 112.326 -0.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -126.21 47.91 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.020000000000003 110.903 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 64' ' ' VAL . 29.6 ttpt -79.61 77.99 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.54 152.55 25.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.519999999999996 110.936 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -145.61 145.53 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.88 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.63 136.11 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.851 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -143.76 125.04 14.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.240000000000002 110.912 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -51.8 116.93 2.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 110.86 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.91 156.97 38.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.319999999999993 110.929 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 51.100000000000001 110.876 -179.784 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.949 0.404 . . . . 63.109999999999999 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -137.32 110.48 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 73.510000000000005 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 m -125.94 130.99 52.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.824 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 20.89 63.82 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 72.439999999999998 112.471 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.31 -20.38 44.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.77 -0.728 . . . . 75.230000000000004 112.541 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -100.12 145.56 27.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 75.439999999999998 110.864 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.903 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.99 171.53 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 52.420000000000002 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -65.4 160.69 57.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.702 . . . . 50.119999999999997 110.893 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 174.97 8.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.244 . . . . 75.409999999999997 112.341 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m120 58.47 30.0 19.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.887 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 m -142.06 120.75 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.299999999999997 110.826 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.2 p -90.31 168.1 12.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 72.129999999999995 110.881 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 m -90.14 126.36 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.78 136.97 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 44.549999999999997 111.186 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -104.62 128.09 52.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 110.877 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.540000000000006 110.908 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.608 0.718 . . . . 72.519999999999996 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 165.64 30.28 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.704 2.269 . . . . 72.0 112.31 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -129.19 171.52 12.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 72.010000000000005 110.83 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.2 m -102.3 112.99 25.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 110.81 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 148.96 40.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 71.219999999999999 110.889 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 150.39 68.52 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 71.299999999999997 112.391 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.595 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.0 mt -59.0 147.99 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 61.149999999999999 110.932 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.9 156.7 36.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 72.219999999999999 112.503 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -108.32 -170.78 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 73.439999999999998 110.868 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 36' ' ' ASN . 27.9 tp -73.75 146.4 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 70.230000000000004 110.868 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.574 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 56.47 32.52 20.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.209999999999994 110.849 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.88 159.67 45.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 73.540000000000006 110.941 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.92 5.97 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 52.43 112.295 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -135.04 169.33 17.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 51.409999999999997 110.893 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -130.21 144.64 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.857 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -52.62 -63.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 73.329999999999998 111.113 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -138.98 156.75 72.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 63.049999999999997 110.863 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -169.99 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.752 2.301 . . . . 54.310000000000002 112.323 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -168.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 71.209999999999994 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.1 -24.14 67.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.040000000000006 110.812 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -89.94 -28.37 19.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.129999999999995 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.54 32.25 4.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 63.509999999999998 112.566 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.9 mt -120.66 150.73 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 73.099999999999994 111.088 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -104.18 -176.09 2.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.219999999999999 110.955 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.55 -76.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 72.5 110.864 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -122.66 -60.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.923 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -74.9 158.85 32.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 74.310000000000002 110.792 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.1 m -109.93 160.05 29.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 61.549999999999997 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 167.93 23.04 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.698 2.266 . . . . 71.329999999999998 112.293 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.73 124.74 24.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 70.409999999999997 110.883 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.04 17.61 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.140000000000001 112.478 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.82 27.44 6.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.540000000000006 110.951 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.46 21.58 24.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.646 -0.788 . . . . 52.439999999999998 112.523 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -107.8 170.94 7.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 72.430000000000007 110.841 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 110.935 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.23 109.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.140000000000001 110.909 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -127.75 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.129 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -66.87 127.97 34.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 74.430000000000007 110.941 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.31 13.21 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.299999999999997 111.11 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.56 -157.95 18.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 62.549999999999997 112.484 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -140.25 159.39 63.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 54.310000000000002 110.913 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.74 -41.75 0.86 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.664 -1.807 . . . . 73.040000000000006 112.351 -0.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.56 63.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 62.020000000000003 110.912 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -81.95 79.81 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -82.15 133.04 35.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.519999999999996 110.954 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.94 147.77 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.896 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.85 129.42 39.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.72 128.1 30.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 63.240000000000002 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 119.98 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.842 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -64.12 154.53 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 75.319999999999993 110.831 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 51.100000000000001 110.885 -179.814 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.879 0.371 . . . . 63.109999999999999 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -128.87 115.29 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.510000000000005 111.1 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -138.16 123.14 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.887 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 19.4 79.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.439999999999998 112.482 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.57 -13.96 64.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 75.230000000000004 112.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.95 139.31 31.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 75.439999999999998 110.906 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.1 138.1 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.79 171.91 12.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 52.420000000000002 110.907 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.35 160.74 30.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 50.119999999999997 110.815 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 177.8 5.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.668 2.245 . . . . 75.409999999999997 112.397 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.98 36.32 27.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 75.25 110.921 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m -141.95 124.51 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.299999999999997 110.889 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -87.78 168.2 13.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.129999999999995 110.866 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 m -90.72 128.01 36.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 62.119999999999997 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -120.59 166.49 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 44.549999999999997 111.09 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.613 ' HG2' HG21 ' A' ' 48' ' ' ILE . 1.1 mm-40 -117.93 137.63 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.230000000000004 110.93 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 110.856 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.679 0.752 . . . . 72.519999999999996 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 164.95 32.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 72.0 112.348 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -133.6 173.8 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.010000000000005 110.919 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.14 131.88 50.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.887 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 149.34 62.78 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.606 0.717 . . . . 71.219999999999999 110.806 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 145.7 57.65 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.654 2.236 . . . . 71.299999999999997 112.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD13 ' HA3' ' A' ' 56' ' ' GLY . 42.6 mt -54.14 149.42 9.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 61.149999999999999 110.873 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.6 157.06 52.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.732 . . . . 72.219999999999999 112.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -105.62 -169.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.324 . . . . 73.439999999999998 110.898 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 36' ' ' ASN . 25.4 tp -72.96 149.04 43.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 70.230000000000004 110.927 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.525 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.7 m-20 53.03 33.34 14.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 110.899 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.13 159.66 42.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.641 0.734 . . . . 73.540000000000006 110.842 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.81 5.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.68 2.254 . . . . 52.43 112.309 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.5 p -132.19 170.87 14.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 51.409999999999997 110.872 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -131.09 146.36 52.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.030000000000001 110.88 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' HG3' ' A' ' 42' ' ' GLU . 47.5 t -52.2 -66.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 73.329999999999998 111.155 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 41' ' ' VAL . 74.3 mt-10 -140.64 156.74 69.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 63.049999999999997 110.84 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -170.42 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 54.310000000000002 112.375 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -169.39 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 71.209999999999994 110.856 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.15 -16.03 64.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 74.040000000000006 110.908 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -98.38 -28.18 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 64.129999999999995 110.882 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 31.99 4.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 63.509999999999998 112.449 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.613 HG21 ' HG2' ' A' ' 17' ' ' GLN . 68.4 mt -119.08 145.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.387 . . . . 73.099999999999994 111.102 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -102.82 -176.19 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 74.219999999999999 110.879 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.82 -77.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 72.5 110.843 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -123.06 -59.39 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 74.409999999999997 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -76.23 159.23 30.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.310000000000002 110.888 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.8 m -112.02 160.06 31.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.605 0.717 . . . . 61.549999999999997 110.886 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.99 22.85 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.698 2.265 . . . . 71.329999999999998 112.334 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.22 124.17 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.409999999999997 110.848 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.98 17.83 1.07 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 74.140000000000001 112.48 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -126.6 29.21 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 72.540000000000006 110.91 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.74 26.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 52.439999999999998 112.446 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.3 mt -109.01 179.56 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 72.430000000000007 110.857 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 120.27 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 64.409999999999997 110.844 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -54.94 108.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 73.140000000000001 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -125.69 136.63 53.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 111.209 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.87 125.59 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.430000000000007 110.924 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' LYS . 27.9 m -116.68 -21.22 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 73.299999999999997 111.122 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.19 -162.26 9.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.688 -0.768 . . . . 62.549999999999997 112.486 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -130.09 159.69 68.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.57 0.7 . . . . 54.310000000000002 110.92 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.83 -48.48 0.27 Allowed 'Cis proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.676 -1.801 . . . . 73.040000000000006 112.291 0.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -127.29 46.55 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 62.020000000000003 110.82 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 64' ' ' VAL . 5.4 ttpm? -72.98 77.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.1 141.96 35.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 73.519999999999996 110.928 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -139.39 145.68 39.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.839 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.48 136.73 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.859 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.51 126.94 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.240000000000002 110.906 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.856 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.49 152.48 41.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.319999999999993 110.857 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 51.100000000000001 110.807 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.836 0.35 . . . . 63.109999999999999 111.165 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.6 m -137.28 113.7 10.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 111.221 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.8 m -139.48 157.1 46.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 73.209999999999994 110.855 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.81 16.51 51.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 72.439999999999998 112.491 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.18 -15.21 60.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 75.230000000000004 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.83 163.46 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 75.439999999999998 110.893 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -94.63 155.39 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 73.239999999999995 110.963 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -132.63 177.19 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.420000000000002 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -80.24 160.65 67.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.545 0.688 . . . . 50.119999999999997 110.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 168.33 21.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.67 2.246 . . . . 75.409999999999997 112.429 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 63.33 27.56 15.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.96 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.0 p -142.02 119.2 11.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.299999999999997 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -88.07 168.13 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 72.129999999999995 110.924 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 m -91.18 125.48 35.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 62.119999999999997 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.15 156.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 44.549999999999997 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.544 ' CG ' HG21 ' A' ' 48' ' ' ILE . 2.4 mm-40 -118.2 129.21 55.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.230000000000004 110.896 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 75.540000000000006 110.961 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.611 0.72 . . . . 72.519999999999996 110.821 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.0 32.51 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.699 2.266 . . . . 72.0 112.347 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -133.84 173.95 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.010000000000005 110.911 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.61 130.85 51.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 71.420000000000002 110.848 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 149.35 73.2 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.646 0.736 . . . . 71.219999999999999 110.871 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 146.75 61.38 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.725 2.283 . . . . 71.299999999999997 112.387 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.3 mt -55.09 149.85 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.946 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.81 151.89 36.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.688 . . . . 72.219999999999999 112.415 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -177.48 3.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 73.439999999999998 110.898 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 29.5 tp -69.73 143.22 53.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 70.230000000000004 110.863 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 70.6 m-20 60.53 39.45 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 73.209999999999994 110.904 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.04 159.46 72.56 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.586 0.708 . . . . 73.540000000000006 110.921 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 133.18 24.81 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 52.43 112.327 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 p -148.03 167.78 24.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 51.409999999999997 110.965 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -126.31 148.07 49.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.030000000000001 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -52.74 -64.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.329999999999998 111.127 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.15 156.74 64.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.647 0.736 . . . . 63.049999999999997 110.851 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.675 2.25 . . . . 54.310000000000002 112.303 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.58 -169.53 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.209999999999994 110.875 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.99 -16.78 64.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 74.040000000000006 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -97.36 -28.08 14.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 64.129999999999995 110.829 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 32.01 4.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.683 -0.77 . . . . 63.509999999999998 112.493 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.544 HG21 ' CG ' ' A' ' 17' ' ' GLN . 72.3 mt -117.98 145.6 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 73.099999999999994 111.192 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -104.49 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.219999999999999 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.58 -78.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 72.5 110.842 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.19 -58.32 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.935 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -77.42 169.06 18.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.901 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.8 m -117.77 160.67 37.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.563 0.696 . . . . 61.549999999999997 110.89 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.07 22.59 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.675 2.25 . . . . 71.329999999999998 112.334 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 89.0 m -70.67 126.01 28.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 70.409999999999997 110.852 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -152.24 18.58 0.81 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.76 . . . . 74.140000000000001 112.402 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.51 30.7 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.540000000000006 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.15 22.23 27.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 52.439999999999998 112.489 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.1 mt -108.77 176.42 5.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.365 . . . . 72.430000000000007 110.933 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.5 116.8 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 64.409999999999997 110.883 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 103.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 73.140000000000001 110.853 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -118.21 136.98 53.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.450000000000003 111.159 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -76.17 122.71 24.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.946 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 71' ' ' ARG . 18.9 m -116.73 -19.29 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 73.299999999999997 111.079 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.72 -159.82 9.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 62.549999999999997 112.518 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.5 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.1 pt-20 -139.78 159.47 64.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.691 0.758 . . . . 54.310000000000002 110.864 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.8 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 -1.802 . . . . 73.040000000000006 112.342 0.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.76 53.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.020000000000003 110.867 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -79.67 78.1 6.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.91 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.09 141.17 34.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 73.519999999999996 110.933 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG3' HG22 ' A' ' 64' ' ' VAL . 9.0 mtt180 -139.16 153.11 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 74.420000000000002 110.904 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.0 140.97 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.875 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -151.86 129.43 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 63.240000000000002 110.888 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.93 117.02 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.898 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -64.05 149.53 47.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 75.319999999999993 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 51.100000000000001 110.877 -179.828 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.893 0.377 . . . . 63.109999999999999 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.9 m -143.12 107.55 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 111.107 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.6 m -146.4 149.29 33.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 73.209999999999994 110.855 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.0 75.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 72.439999999999998 112.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.67 24.97 75.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 75.230000000000004 112.475 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -148.87 137.79 21.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 75.439999999999998 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -78.01 133.29 38.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 110.9 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.98 176.7 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 52.420000000000002 110.923 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -77.87 160.73 73.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.625 0.726 . . . . 50.119999999999997 110.85 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.88 15.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.755 2.304 . . . . 75.409999999999997 112.333 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 63.19 27.78 15.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 75.25 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.75 117.42 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.299999999999997 110.891 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 p -88.48 168.09 12.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.129999999999995 110.877 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 m -91.69 131.11 37.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 62.119999999999997 110.888 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.98 124.0 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 44.549999999999997 111.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -78.88 125.65 29.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 64.230000000000004 110.902 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m120 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 75.540000000000006 110.9 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.66 0.743 . . . . 72.519999999999996 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 166.48 27.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 72.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.53 171.36 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 72.010000000000005 110.884 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.9 m -107.57 107.37 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.23 149.25 43.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.561 0.696 . . . . 71.219999999999999 110.868 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 152.46 69.57 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 71.299999999999997 112.35 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.0 mt -62.16 149.43 41.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 61.149999999999999 110.882 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.57 149.68 39.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.219999999999999 112.476 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -172.82 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.754 0.311 . . . . 73.439999999999998 110.894 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 ' H ' ' A' ' 36' ' ' ASN . 38.0 tp -72.29 146.37 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 70.230000000000004 110.925 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' LEU . 71.8 m-20 58.31 35.51 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.861 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.67 159.74 68.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.68 0.752 . . . . 73.540000000000006 110.802 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 138.4 37.84 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.601 2.201 . . . . 52.43 112.357 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -147.6 170.77 16.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 51.409999999999997 110.918 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -129.22 146.04 51.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.030000000000001 110.88 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.76 -67.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.124 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -139.64 156.69 71.08 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.734 . . . . 63.049999999999997 110.923 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.719 2.279 . . . . 54.310000000000002 112.332 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 -169.47 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 71.209999999999994 110.955 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.69 -17.75 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.040000000000006 110.901 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -96.28 -28.35 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 64.129999999999995 110.926 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.28 31.95 4.47 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.668 -0.777 . . . . 63.509999999999998 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.16 146.95 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.099999999999994 111.127 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -101.93 -176.19 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.899 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -77.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 72.5 110.858 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -122.78 -59.55 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 74.409999999999997 110.942 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -76.95 156.02 32.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.896 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.3 m -106.74 160.41 26.39 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 61.549999999999997 110.797 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 167.92 23.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 71.329999999999998 112.275 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.7 m -72.92 125.62 28.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 70.409999999999997 110.831 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.83 17.62 0.84 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 74.140000000000001 112.482 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.68 31.47 5.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 72.540000000000006 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.25 21.65 31.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.741 . . . . 52.439999999999998 112.539 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -108.04 176.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.430000000000007 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -148.78 119.16 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.826 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.36 103.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.833 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.39 145.68 47.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 111.184 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -82.89 123.46 29.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 74.430000000000007 110.899 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 ' HE ' ' A' ' 71' ' ' ARG . 32.3 m -125.97 13.13 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.299999999999997 111.104 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -158.6 9.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 62.549999999999997 112.397 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.0 pt-20 -158.52 159.43 29.81 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.683 0.754 . . . . 54.310000000000002 110.809 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -43.09 0.65 Allowed 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 122.727 -1.781 . . . . 73.040000000000006 112.309 0.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -126.97 75.1 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 110.851 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -108.36 78.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 70' ' ' LEU . 5.1 tp -81.2 136.6 35.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 73.519999999999996 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.594 ' HE ' HG21 ' A' ' 64' ' ' VAL . 22.5 mtm180 -140.11 156.93 46.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 74.420000000000002 110.857 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.61 141.6 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 110.884 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.04 127.41 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.964 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -52.02 117.06 2.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.329999999999998 110.866 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.75 157.79 29.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 51.100000000000001 110.874 -179.771 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.915 0.388 . . . . 63.109999999999999 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.1 m -137.1 107.43 6.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 111.19 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -125.87 143.25 51.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 73.209999999999994 110.87 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.37 43.63 57.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 72.439999999999998 112.474 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.14 19.52 46.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 75.230000000000004 112.471 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -134.75 140.69 46.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 75.439999999999998 110.846 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.25 148.95 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.18 178.76 6.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 52.420000000000002 110.939 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -73.7 160.61 81.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.543 0.687 . . . . 50.119999999999997 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 172.92 11.76 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 75.409999999999997 112.369 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 63.11 26.74 15.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 75.25 110.94 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -142.08 118.26 10.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.299999999999997 110.888 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.95 168.24 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 72.129999999999995 110.852 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.0 m -93.11 133.64 36.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 62.119999999999997 110.873 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 49' ' ' TYR . 5.3 m -131.04 137.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 44.549999999999997 111.149 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.71 131.22 37.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 64.230000000000004 110.93 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 75.540000000000006 110.875 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.614 0.721 . . . . 72.519999999999996 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 164.86 33.04 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.65 2.233 . . . . 72.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -123.8 173.78 7.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.934 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 m -97.06 130.03 44.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 71.420000000000002 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.28 148.83 71.72 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.626 0.727 . . . . 71.219999999999999 110.839 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 155.11 66.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 71.299999999999997 112.279 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.601 HD13 ' HA3' ' A' ' 56' ' ' GLY . 24.6 mt -65.49 154.13 39.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 61.149999999999999 110.913 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.91 159.68 43.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 72.219999999999999 112.495 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -115.44 -176.25 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.9 tp -70.6 142.35 51.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 70.230000000000004 110.919 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.0 m-20 60.57 39.5 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 73.209999999999994 110.882 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 159.52 71.45 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.596 0.713 . . . . 73.540000000000006 110.937 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 129.03 16.89 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 52.43 112.396 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.1 p -147.44 167.79 23.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 51.409999999999997 110.893 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.04 150.54 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.909 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -55.9 -65.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.52 157.02 72.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.686 0.755 . . . . 63.049999999999997 110.893 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -170.13 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.645 2.23 . . . . 54.310000000000002 112.348 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.83 -169.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 71.209999999999994 110.908 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.93 -15.56 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.825 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -96.58 -28.21 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.16 4.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 63.509999999999998 112.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.9 mt -123.95 146.69 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 73.099999999999994 111.129 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.452 ' HB2' HG12 ' A' ' 16' ' ' VAL . 51.3 m-85 -101.53 -176.11 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.927 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -77.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 72.5 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -122.89 -58.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 74.409999999999997 110.958 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -77.15 161.36 28.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.922 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -111.55 159.98 31.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 61.549999999999997 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 168.11 22.55 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.71 2.273 . . . . 71.329999999999998 112.403 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.8 m -68.67 126.1 28.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 70.409999999999997 110.925 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.601 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.39 19.51 0.92 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 74.140000000000001 112.402 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -127.31 27.77 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 72.540000000000006 110.847 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.3 22.87 21.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 52.439999999999998 112.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.2 mt -109.65 175.13 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 72.430000000000007 110.979 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.66 116.8 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 64.409999999999997 110.912 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.09 105.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.927 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -119.8 137.13 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 111.17 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -71.63 123.98 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 74.430000000000007 110.988 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.47 -20.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 73.299999999999997 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.64 -156.82 7.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 62.549999999999997 112.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.8 pt-20 -140.6 159.63 62.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.696 0.76 . . . . 54.310000000000002 110.78 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.75 -48.37 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.206 0 C-N-CA 122.677 -1.801 . . . . 73.040000000000006 112.347 -0.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -125.38 50.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 62.020000000000003 110.915 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -77.93 77.96 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.77 148.85 28.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 73.519999999999996 110.892 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -145.9 152.75 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.873 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -70.76 137.59 49.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.439999999999998 110.883 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -147.38 127.86 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 118.8 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.899 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.1 156.35 28.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 75.319999999999993 110.892 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 51.100000000000001 110.867 -179.773 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.023 0.44 . . . . 63.109999999999999 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 m -142.63 115.45 8.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 73.510000000000005 111.082 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -132.49 132.62 42.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 110.903 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.77 66.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.781 -0.723 . . . . 72.439999999999998 112.478 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.83 -20.85 42.65 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 75.230000000000004 112.46 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -99.82 149.16 23.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 75.439999999999998 110.931 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -93.48 147.46 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 110.897 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.22 169.06 16.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 52.420000000000002 110.852 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -63.91 160.79 43.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.62 0.724 . . . . 50.119999999999997 110.896 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.73 176.44 6.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.75 2.3 . . . . 75.409999999999997 112.323 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 m120 62.6 25.27 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.25 110.857 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 72.299999999999997 110.844 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.05 168.13 13.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 72.129999999999995 110.925 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.89 134.78 34.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.119999999999997 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.73 135.26 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 44.549999999999997 111.203 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.7 123.3 39.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.230000000000004 110.956 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 75.540000000000006 110.886 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.625 0.726 . . . . 72.519999999999996 110.837 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 166.6 27.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.703 2.269 . . . . 72.0 112.312 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 161.48 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 110.865 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 m -95.69 109.05 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.420000000000002 110.939 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 148.99 39.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 71.219999999999999 110.887 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.17 64.79 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.669 2.246 . . . . 71.299999999999997 112.316 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.6 mt -56.65 150.35 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 61.149999999999999 110.858 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.39 148.44 51.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 72.219999999999999 112.476 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -171.73 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.321 . . . . 73.439999999999998 110.898 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 59' ' ' LEU . 42.4 tp -73.12 146.89 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 70.230000000000004 110.903 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.79 24.08 13.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 159.72 36.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.604 0.716 . . . . 73.540000000000006 110.856 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 125.75 12.54 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 52.43 112.323 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.54 164.61 29.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 51.409999999999997 110.857 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.84 156.12 43.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.030000000000001 110.857 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -61.12 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 73.329999999999998 111.136 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -140.61 156.9 69.02 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.637 0.732 . . . . 63.049999999999997 110.884 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 54.310000000000002 112.335 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.08 -169.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.209999999999994 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.34 -15.2 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.905 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.81 -28.31 14.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 64.129999999999995 110.937 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.13 32.14 4.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 63.509999999999998 112.456 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt -124.66 150.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 73.099999999999994 111.144 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.1 -176.2 3.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.77 -76.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 72.5 110.84 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -122.65 -59.54 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.949 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -75.9 160.04 30.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 74.310000000000002 110.87 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 m -111.48 160.29 29.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.653 0.74 . . . . 61.549999999999997 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 168.0 22.86 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.657 2.238 . . . . 71.329999999999998 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.92 126.35 29.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 70.409999999999997 110.88 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.2 18.27 0.92 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 74.140000000000001 112.478 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.0 pt-20 -127.27 26.47 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 72.540000000000006 110.944 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.01 22.82 16.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.726 -0.75 . . . . 52.439999999999998 112.475 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.2 mt -109.73 171.94 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.430000000000007 110.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 120.0 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.865 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.66 102.48 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.864 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -115.42 140.93 48.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.450000000000003 111.117 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.75 125.74 29.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 110.847 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.679 HG23 ' HD2' ' A' ' 69' ' ' LYS . 7.9 m -117.06 -21.24 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 111.112 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.6 -176.54 15.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 62.549999999999997 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -118.0 159.54 42.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.579 0.704 . . . . 54.310000000000002 110.897 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.78 -48.68 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.679 -1.8 . . . . 73.040000000000006 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.11 65.9 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 62.020000000000003 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.679 ' HD2' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -89.44 77.79 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.862 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.1 140.93 30.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 73.519999999999996 110.863 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -140.44 157.39 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.863 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.12 132.04 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.913 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -143.21 129.06 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 63.240000000000002 110.9 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -52.05 117.33 2.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 110.877 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.92 147.5 53.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.319999999999993 110.845 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 51.100000000000001 110.843 -179.818 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.946 0.403 . . . . 63.109999999999999 111.073 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -146.11 107.83 4.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.2 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -147.03 144.59 29.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 73.209999999999994 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.07 20.08 78.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.523 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.87 23.79 73.83 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.728 -0.749 . . . . 75.230000000000004 112.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -144.95 155.28 43.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 75.439999999999998 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -101.4 155.26 18.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.856 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.91 173.13 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 52.420000000000002 110.923 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -69.06 160.58 77.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.71 . . . . 50.119999999999997 110.849 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 175.11 8.51 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.603 2.202 . . . . 75.409999999999997 112.389 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 59.98 27.56 16.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 75.25 110.928 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 p -142.02 119.23 11.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.299999999999997 110.848 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -89.13 168.14 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.129999999999995 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -89.75 132.65 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 62.119999999999997 110.869 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.05 123.98 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 44.549999999999997 111.139 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.92 122.94 25.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.230000000000004 110.896 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 75.540000000000006 110.835 -179.912 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.712 0.768 . . . . 72.519999999999996 110.845 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.97 25.81 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.656 2.237 . . . . 72.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.66 174.01 10.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.010000000000005 110.877 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 120.42 40.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.420000000000002 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.64 149.02 47.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 71.219999999999999 110.839 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 149.71 67.25 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 71.299999999999997 112.337 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 56' ' ' GLY . 34.7 mt -59.34 148.67 31.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.149999999999999 110.894 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 155.42 34.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.819 -0.705 . . . . 72.219999999999999 112.448 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -108.72 -172.89 2.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 73.439999999999998 110.902 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 36' ' ' ASN . 23.6 tp -73.15 145.6 46.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.230000000000004 110.981 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 35' ' ' LEU . 77.5 m-20 58.27 38.68 26.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 73.209999999999994 110.836 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.41 159.59 69.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.688 0.756 . . . . 73.540000000000006 110.876 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 124.37 11.01 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.715 2.277 . . . . 52.43 112.33 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 p -136.31 168.26 19.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 51.409999999999997 110.798 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.16 144.39 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 72.030000000000001 110.947 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.94 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.329999999999998 111.07 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -140.01 156.8 70.28 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 63.049999999999997 110.935 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -169.87 0.36 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.638 2.225 . . . . 54.310000000000002 112.33 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -168.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 110.846 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.86 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 110.852 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -88.21 -28.44 21.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 110.826 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.86 32.07 4.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 63.509999999999998 112.514 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.46 147.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.353 . . . . 73.099999999999994 111.117 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -100.43 -175.99 3.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.219999999999999 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.21 -77.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.5 110.883 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -123.06 -58.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.409999999999997 110.9 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -77.06 168.65 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 110.852 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -116.1 160.34 35.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 61.549999999999997 110.946 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 168.13 22.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.659 2.24 . . . . 71.329999999999998 112.35 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 93.1 m -70.07 125.47 26.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 70.409999999999997 110.936 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.88 19.23 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 74.140000000000001 112.501 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -125.75 28.1 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 72.540000000000006 110.87 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.94 22.65 22.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.7 -0.762 . . . . 52.439999999999998 112.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.8 mt -108.64 177.4 4.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 72.430000000000007 110.875 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.41 118.6 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.409999999999997 110.809 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.1 m -55.41 106.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.901 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.59 136.88 54.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 111.178 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.43 126.1 29.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 110.889 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -125.03 13.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 111.101 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.87 -160.18 13.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 62.549999999999997 112.473 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -138.3 159.99 65.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.686 0.755 . . . . 54.310000000000002 110.858 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.84 -42.82 0.69 Allowed 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 122.631 -1.82 . . . . 73.040000000000006 112.288 0.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.42 49.47 2.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 62.020000000000003 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -70.55 97.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 74.0 110.88 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.88 136.87 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.93 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.63 ' HE ' HG21 ' A' ' 64' ' ' VAL . 26.4 mtm180 -139.64 150.14 44.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.828 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.72 138.57 55.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -147.01 127.17 13.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 63.240000000000002 110.926 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.39 117.02 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 110.898 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -67.17 155.03 39.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.319999999999993 110.907 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 51.100000000000001 110.854 -179.798 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.8 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.893 0.378 . . . . 63.109999999999999 111.124 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.9 m -137.49 111.15 8.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 73.510000000000005 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 m -130.61 129.16 42.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 110.965 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.58 39.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.439999999999998 112.442 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.04 20.58 64.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 75.230000000000004 112.516 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.07 143.86 46.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 75.439999999999998 110.875 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -90.88 136.44 33.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 110.882 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -124.41 169.11 12.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 52.420000000000002 110.868 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -63.83 160.6 44.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 50.119999999999997 110.964 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 175.95 7.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 75.409999999999997 112.3 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 61.05 28.51 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 p -142.06 122.81 14.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.842 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 p -89.97 168.14 12.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.476 . . . . 72.129999999999995 110.842 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.28 122.07 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 62.119999999999997 110.854 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -119.95 131.39 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 44.549999999999997 111.131 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.36 124.88 31.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 64.230000000000004 110.958 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.540000000000006 110.881 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.758 0.79 . . . . 72.519999999999996 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 166.56 27.17 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.739 2.293 . . . . 72.0 112.384 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -137.08 174.03 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.809 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.6 m -96.86 128.47 43.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 71.420000000000002 110.931 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 148.96 69.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 71.219999999999999 110.87 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 152.16 69.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.227 . . . . 71.299999999999997 112.409 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.578 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.6 mt -61.48 154.67 23.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 61.149999999999999 110.951 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.36 154.46 53.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 72.219999999999999 112.446 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.22 -171.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 73.439999999999998 110.926 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.1 tp -71.99 147.59 46.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 70.230000000000004 110.977 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.532 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 55.05 32.35 18.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 110.89 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.66 159.7 45.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.68 0.753 . . . . 73.540000000000006 110.827 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.701 2.267 . . . . 52.43 112.27 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 p -134.47 169.81 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.409999999999997 110.883 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -129.66 148.31 51.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 72.030000000000001 110.854 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.51 -63.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 73.329999999999998 111.098 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -141.7 154.31 65.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 63.049999999999997 110.899 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.641 2.227 . . . . 54.310000000000002 112.367 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -74.09 -169.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 71.209999999999994 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.2 -17.54 64.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 74.040000000000006 110.863 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -95.6 -28.39 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.06 4.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 63.509999999999998 112.528 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mt -119.1 148.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.812 0.339 . . . . 73.099999999999994 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -104.63 -175.95 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.899 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.7 -77.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 72.5 110.875 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.71 -60.06 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.93 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -75.53 158.52 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.310000000000002 110.82 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 m -109.41 159.7 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 61.549999999999997 110.869 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.08 22.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 71.329999999999998 112.355 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.3 128.49 36.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.409999999999997 110.842 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.12 17.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.679 -0.772 . . . . 74.140000000000001 112.488 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.7 pt-20 -127.66 27.14 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 72.540000000000006 110.876 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.93 19.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 52.439999999999998 112.548 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.407 HD12 ' HG2' ' A' ' 57' ' ' GLU . 9.5 mt -108.86 173.15 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.829 0.347 . . . . 72.430000000000007 110.887 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 120.88 8.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 64.409999999999997 110.817 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.24 111.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.140000000000001 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -128.7 136.75 51.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 111.167 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -68.0 125.75 27.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 74.430000000000007 110.891 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 13.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.092 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.92 -156.57 10.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 62.549999999999997 112.536 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -152.56 159.51 32.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 54.310000000000002 110.898 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.8 -48.14 0.28 Allowed 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 -1.803 . . . . 73.040000000000006 112.34 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -122.77 75.01 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 62.020000000000003 110.899 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.7 93.11 4.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 74.0 110.904 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.98 142.41 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 73.519999999999996 110.875 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -142.44 145.71 34.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.420000000000002 110.839 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.39 133.11 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.858 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -141.64 128.74 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 63.240000000000002 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -51.94 117.13 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.329999999999998 110.888 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.59 155.14 40.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.89 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 51.100000000000001 110.831 -179.734 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.882 0.372 . . . . 63.109999999999999 111.138 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -140.28 111.25 6.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 73.510000000000005 111.075 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.8 m -139.21 146.19 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 110.879 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.91 20.38 72.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 72.439999999999998 112.54 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.69 28.99 56.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 75.230000000000004 112.507 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -154.77 151.47 28.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.297 . . . . 75.439999999999998 110.89 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.53 136.24 33.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 73.239999999999995 110.942 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.88 156.54 24.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.61 160.91 3.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.592 0.71 . . . . 50.119999999999997 110.85 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 164.52 34.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 75.409999999999997 112.362 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 63.4 30.48 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 75.25 110.941 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -142.0 116.67 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 110.9 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.53 168.3 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 72.129999999999995 110.867 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.21 127.81 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 62.119999999999997 110.861 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 28' ' ' ARG . 6.3 m -118.77 135.02 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 44.549999999999997 111.064 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.412 ' HB2' HG21 ' A' ' 48' ' ' ILE . 6.7 tp-100 -92.0 126.57 37.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 64.230000000000004 110.943 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.540000000000006 110.904 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.693 0.759 . . . . 72.519999999999996 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.9 26.05 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.652 2.235 . . . . 72.0 112.335 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.476 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -134.0 161.63 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 110.876 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 m -90.18 117.85 29.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.868 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 148.72 46.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.528 0.68 . . . . 71.219999999999999 110.91 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 154.81 67.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.647 2.231 . . . . 71.299999999999997 112.373 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.611 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.5 mt -62.44 149.76 41.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 61.149999999999999 110.872 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.52 154.77 48.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 72.219999999999999 112.474 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -108.51 -173.37 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 73.439999999999998 110.892 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 59' ' ' LEU . 41.0 tp -73.36 147.09 44.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.893 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.91 22.54 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.209999999999994 110.892 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.59 159.58 36.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.581 0.705 . . . . 73.540000000000006 110.881 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 123.9 10.58 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.723 2.282 . . . . 52.43 112.339 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.2 p -136.91 170.34 16.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 51.409999999999997 110.936 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -133.93 146.81 50.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.030000000000001 110.927 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.89 -66.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -139.29 156.87 71.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.629 0.728 . . . . 63.049999999999997 110.888 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -169.62 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 54.310000000000002 112.304 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.89 -168.6 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.914 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.18 67.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 110.898 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -88.7 -28.31 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 64.129999999999995 110.905 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.76 32.01 4.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 63.509999999999998 112.515 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 17' ' ' GLN . 39.1 mt -120.39 149.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 73.099999999999994 111.159 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.34 -176.12 3.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 74.219999999999999 110.927 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.22 -77.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 72.5 110.814 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -123.0 -59.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.934 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -77.05 158.48 30.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.802 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.6 m -108.77 160.29 27.82 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.71 . . . . 61.549999999999997 110.922 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 168.03 22.75 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.716 2.277 . . . . 71.329999999999998 112.305 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.5 m -68.69 127.1 31.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 70.409999999999997 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.67 17.42 0.97 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 74.140000000000001 112.499 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.56 27.24 5.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 72.540000000000006 110.841 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.63 23.95 19.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 52.439999999999998 112.457 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.4 mt -108.74 171.43 7.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.430000000000007 110.9 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 127.72 17.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.409999999999997 110.81 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.92 106.23 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.140000000000001 110.881 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.24 144.47 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.182 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -81.4 123.75 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.873 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.18 -24.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 73.299999999999997 111.154 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.16 -161.64 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 62.549999999999997 112.51 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.7 pt-20 -127.97 159.44 66.66 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.699 0.762 . . . . 54.310000000000002 110.882 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.79 -42.2 0.79 Allowed 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.631 -1.82 . . . . 73.040000000000006 112.368 0.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.34 63.53 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 62.020000000000003 110.894 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 79.32 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.0 110.937 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.25 147.05 32.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.519999999999996 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -152.89 159.03 42.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -72.76 128.6 36.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.884 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.82 126.46 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 63.240000000000002 110.948 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.329999999999998 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -65.66 152.03 45.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 75.319999999999993 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 51.100000000000001 110.886 -179.873 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.921 0.391 . . . . 63.109999999999999 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -153.34 110.52 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.510000000000005 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 m -148.52 133.64 18.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.209999999999994 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.83 76.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 72.439999999999998 112.464 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.39 28.66 65.41 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.687 -0.768 . . . . 75.230000000000004 112.529 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.96 134.99 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.674 0.273 . . . . 75.439999999999998 110.953 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.51 152.01 21.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 73.239999999999995 110.919 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.48 171.14 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 52.420000000000002 110.877 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -63.28 160.76 38.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.589 0.709 . . . . 50.119999999999997 110.856 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.05 8.57 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.756 2.304 . . . . 75.409999999999997 112.328 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.18 38.44 26.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 75.25 110.828 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -141.32 123.55 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 72.299999999999997 110.907 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -88.92 168.16 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.129999999999995 110.948 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -88.32 134.44 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 62.119999999999997 110.882 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.35 130.53 65.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 44.549999999999997 111.113 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.87 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.230000000000004 110.917 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 75.540000000000006 110.875 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.655 0.74 . . . . 72.519999999999996 110.852 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 166.46 27.47 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.627 2.218 . . . . 72.0 112.327 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -138.14 173.99 11.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.010000000000005 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -99.24 130.18 45.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 71.420000000000002 110.932 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 149.71 56.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.702 . . . . 71.219999999999999 110.815 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 147.32 62.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 71.299999999999997 112.376 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 56' ' ' GLY . 27.7 mt -57.73 149.89 21.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.948 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.44 160.5 32.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 72.219999999999999 112.481 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -114.38 -171.87 2.0 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.439999999999998 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 36' ' ' ASN . 26.7 tp -73.18 144.57 46.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.879 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.595 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.8 m-20 58.19 37.09 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 73.209999999999994 110.932 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.95 159.72 65.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.638 0.732 . . . . 73.540000000000006 110.938 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 124.28 10.91 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.701 2.268 . . . . 52.43 112.344 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -135.0 165.43 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 51.409999999999997 110.926 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.17 145.54 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 72.030000000000001 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.86 -67.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 111.096 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -139.07 156.81 72.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.643 0.735 . . . . 63.049999999999997 110.877 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -169.73 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.264 . . . . 54.310000000000002 112.34 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -168.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.209999999999994 110.878 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.14 67.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.03 -28.42 21.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 64.129999999999995 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.72 32.15 4.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.509999999999998 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 mt -122.26 150.54 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.099999999999994 111.131 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.47 -176.02 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 110.976 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.75 -77.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.5 110.836 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -122.82 -59.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.71 159.95 30.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 74.310000000000002 110.861 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.8 m -111.54 160.13 30.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.561 0.696 . . . . 61.549999999999997 110.943 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.99 22.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.658 2.239 . . . . 71.329999999999998 112.373 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.5 m -70.23 124.54 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 70.409999999999997 110.916 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.63 19.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 74.140000000000001 112.494 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.76 28.45 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 72.540000000000006 110.903 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.19 22.73 24.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 52.439999999999998 112.523 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.34 172.39 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 72.430000000000007 110.923 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -144.81 118.32 9.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 64.409999999999997 110.852 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.43 102.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.140000000000001 110.838 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -118.55 147.55 43.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.450000000000003 111.149 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -88.96 124.84 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.430000000000007 110.927 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.55 13.17 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.299999999999997 111.136 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.36 -161.5 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 62.549999999999997 112.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.2 pt-20 -151.12 159.47 33.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.310000000000002 110.862 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.78 -48.39 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.748 -1.772 . . . . 73.040000000000006 112.331 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -123.82 72.53 1.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 62.020000000000003 110.832 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -99.9 78.15 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.68 141.69 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 73.519999999999996 110.887 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -149.75 160.67 43.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.59 140.34 41.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.957 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.76 127.3 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 63.240000000000002 110.911 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.01 120.35 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 110.833 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -64.39 150.31 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.319999999999993 110.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 51.100000000000001 110.878 -179.782 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.902 0.382 . . . . 52.32 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.46 142.21 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 63.109999999999999 111.127 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.5 m -136.02 109.59 7.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 111.121 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.8 m -127.54 143.89 51.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 110.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.88 43.11 70.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 72.439999999999998 112.489 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.99 24.51 58.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 75.230000000000004 112.49 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -145.09 136.26 24.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.694 0.283 . . . . 75.439999999999998 110.938 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.8 139.35 50.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 73.239999999999995 110.932 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.1 m -122.09 164.07 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 52.420000000000002 110.915 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -66.1 161.1 59.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.564 0.697 . . . . 50.119999999999997 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 167.49 24.3 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.68 2.253 . . . . 75.409999999999997 112.335 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 63.62 27.55 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.87 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -141.99 116.64 9.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.299999999999997 110.883 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.88 168.13 13.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 72.129999999999995 110.898 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 m -90.51 131.72 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 62.119999999999997 110.909 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.68 133.68 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 44.549999999999997 111.109 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -78.83 123.08 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.230000000000004 110.902 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.03 34.97 4.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 75.540000000000006 110.907 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -93.32 137.79 32.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 42.210000000000001 110.812 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.08 25.91 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 71.420000000000002 110.832 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 32.18 22.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 73.439999999999998 112.493 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -75.38 -24.36 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 74.540000000000006 110.915 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.98 -5.53 34.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 64.299999999999997 112.524 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -123.76 94.76 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.344 . . . . 75.430000000000007 110.915 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -52.36 103.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 51.329999999999998 110.846 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -126.41 84.91 61.18 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 72.519999999999996 110.861 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.03 28.93 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.697 2.265 . . . . 72.0 112.358 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -123.63 162.32 23.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.010000000000005 110.871 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.4 m -91.89 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 71.420000000000002 110.906 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 148.42 40.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.566 0.698 . . . . 71.219999999999999 110.888 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 152.18 69.24 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 71.299999999999997 112.375 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.614 HD13 ' HA3' ' A' ' 56' ' ' GLY . 22.5 mt -60.52 150.59 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 61.149999999999999 110.892 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.25 152.84 49.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.219999999999999 112.503 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -108.73 -172.96 2.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 73.439999999999998 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.6 tp -74.82 151.79 39.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 70.230000000000004 110.873 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.14 22.29 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.66 159.33 46.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 73.540000000000006 110.895 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 132.14 22.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 52.43 112.385 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.0 159.1 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 51.409999999999997 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -122.2 143.35 49.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 72.030000000000001 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -52.01 -65.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 111.129 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -137.66 156.99 74.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 63.049999999999997 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 54.310000000000002 112.343 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.41 -169.35 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 71.209999999999994 110.868 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -68.54 -14.89 63.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -95.61 -28.29 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.129999999999995 110.863 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 32.12 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 63.509999999999998 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.37 147.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 73.099999999999994 111.134 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -99.76 -175.95 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.911 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -77.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 72.5 110.819 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -123.01 -58.57 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 74.409999999999997 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -75.59 169.93 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.310000000000002 110.817 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.5 m -118.09 160.0 40.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 61.549999999999997 110.853 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 166.55 27.22 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 71.329999999999998 112.324 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.5 m -66.81 124.55 23.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 70.409999999999997 110.89 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -148.96 16.03 1.18 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 74.140000000000001 112.463 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.2 pt-20 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 72.540000000000006 110.892 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.01 23.57 29.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 52.439999999999998 112.509 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 74' ' ' GLU . 10.3 mt -109.9 176.07 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 72.430000000000007 110.942 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 119.77 5.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 64.409999999999997 110.866 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.99 108.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 110.858 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.51 137.8 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.138 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.34 120.87 18.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.886 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.69 -19.36 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 73.299999999999997 111.118 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.37 -157.25 7.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 62.549999999999997 112.503 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -138.0 159.55 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 54.310000000000002 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.8 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.663 -1.807 . . . . 73.040000000000006 112.339 0.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -130.12 49.7 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.020000000000003 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -72.93 78.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mp -79.73 129.25 34.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 73.519999999999996 110.905 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.26 157.78 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.43 129.23 36.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.439999999999998 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -140.64 124.3 17.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 63.240000000000002 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HG2' HD23 ' A' ' 59' ' ' LEU . 25.8 mm-40 -51.78 116.94 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 74.329999999999998 110.918 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.96 147.59 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.319999999999993 110.887 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 51.100000000000001 110.816 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.865 0.364 . . . . 52.32 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.58 135.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.109999999999999 111.125 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -128.96 109.99 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.510000000000005 111.167 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.59 142.86 50.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 73.209999999999994 110.872 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.98 41.55 59.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 72.439999999999998 112.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.14 20.18 57.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 75.230000000000004 112.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -135.75 140.45 44.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 75.439999999999998 110.932 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -84.01 135.41 34.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 73.239999999999995 110.95 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 m -123.65 167.7 13.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 52.420000000000002 110.825 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -67.78 160.67 72.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 50.119999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 174.55 9.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.718 2.279 . . . . 75.409999999999997 112.321 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 62.54 26.14 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.1 p -141.45 119.53 12.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.299999999999997 110.816 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.97 168.23 12.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 72.129999999999995 110.845 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.7 m -92.92 128.62 38.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 110.83 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -117.9 141.57 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.549999999999997 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.43 136.36 53.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 64.230000000000004 110.861 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -132.4 27.79 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.954 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -55.28 129.37 38.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 42.210000000000001 110.876 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -101.35 26.11 7.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 71.420000000000002 110.883 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 22.88 62.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 73.439999999999998 112.518 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.01 -25.8 43.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.365 . . . . 74.540000000000006 110.934 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.82 15.03 35.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.707 -0.758 . . . . 64.299999999999997 112.504 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -127.01 87.13 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.837 0.351 . . . . 75.430000000000007 110.885 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.86 94.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 51.329999999999998 110.868 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -122.28 85.02 46.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 72.519999999999996 110.89 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.8 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.764 2.31 . . . . 72.0 112.276 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -132.32 164.78 25.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.010000000000005 110.86 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -96.34 119.04 34.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 149.27 47.88 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 71.219999999999999 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 148.11 64.02 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.723 2.282 . . . . 71.299999999999997 112.379 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.618 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.3 mt -57.25 149.33 20.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 61.149999999999999 110.931 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.75 145.6 49.91 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 72.219999999999999 112.506 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -100.87 -172.83 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 73.439999999999998 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.94 151.12 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 70.230000000000004 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 m120 58.21 22.34 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.209999999999994 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.93 159.47 40.74 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 73.540000000000006 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 141.59 45.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 52.43 112.254 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -150.79 165.37 33.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 51.409999999999997 110.959 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 72.030000000000001 110.835 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.8 t -51.65 -61.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.139 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -142.27 156.74 64.19 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.678 0.751 . . . . 63.049999999999997 110.817 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -168.43 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.538 2.158 . . . . 54.310000000000002 112.381 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -169.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 71.209999999999994 110.895 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -65.98 -19.76 65.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 74.040000000000006 110.824 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -97.06 -28.24 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.129999999999995 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.33 3.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 63.509999999999998 112.463 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.25 155.99 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 73.099999999999994 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -112.91 -176.03 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.926 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.36 -78.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.782 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -122.94 -59.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.409999999999997 110.971 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -76.01 157.87 32.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.836 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.77 159.81 29.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 61.549999999999997 110.953 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.05 36.06 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 71.329999999999998 112.324 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.1 m -66.55 127.82 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 70.409999999999997 110.839 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.618 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.39 17.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 74.140000000000001 112.516 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.91 27.59 5.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 72.540000000000006 110.895 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.64 19.17 28.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.706 -0.759 . . . . 52.439999999999998 112.533 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -108.54 164.68 12.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 72.430000000000007 110.944 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -142.61 125.61 16.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 64.409999999999997 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -55.46 101.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.140000000000001 110.936 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -118.57 140.27 50.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 111.091 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -70.5 125.84 27.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.430000000000007 110.892 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.46 HG21 ' HG3' ' A' ' 71' ' ' ARG . 28.1 m -126.05 12.86 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.299999999999997 111.093 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.11 -165.49 30.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 62.549999999999997 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -142.5 159.83 56.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.310000000000002 110.856 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.1 Cg_endo -69.64 -48.74 0.26 Allowed 'Cis proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.721 -1.783 . . . . 73.040000000000006 112.369 -0.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -125.2 75.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 62.020000000000003 110.898 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -101.47 78.03 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 74.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.8 136.93 36.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 73.519999999999996 110.916 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' HG21 ' A' ' 64' ' ' VAL . 13.2 mmt180 -144.78 154.18 42.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 74.420000000000002 110.859 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.08 134.11 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.96 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -141.62 136.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -51.11 116.68 2.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.889 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 158.51 29.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 75.319999999999993 110.822 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 51.100000000000001 110.897 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.948 0.404 . . . . 52.32 110.865 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 13' ' ' SER . 57.3 t -70.07 134.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.109999999999999 111.117 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 8' ' ' GLN . 10.1 m -146.86 110.27 4.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 73.510000000000005 111.099 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.2 m -146.63 135.24 22.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.477 . . . . 73.209999999999994 110.886 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.78 73.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.764 . . . . 72.439999999999998 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.5 70.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 75.230000000000004 112.504 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 136.24 27.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.711 0.291 . . . . 75.439999999999998 110.903 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 3' ' ' THR . 10.7 mt-30 -93.36 142.81 26.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.239999999999995 110.913 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -130.97 169.61 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 52.420000000000002 110.897 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -57.41 160.73 6.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.582 0.705 . . . . 50.119999999999997 110.834 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 175.5 7.95 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.727 2.285 . . . . 75.409999999999997 112.354 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 58.63 37.34 25.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.47 . . . . 75.25 110.905 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 2' ' ' VAL . 58.4 m -140.96 127.57 20.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 72.299999999999997 110.866 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 p -90.36 168.11 12.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 72.129999999999995 110.839 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 m -90.49 126.58 35.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 62.119999999999997 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 m -122.46 155.19 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 44.549999999999997 111.124 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.13 131.73 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.230000000000004 110.902 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -110.37 -26.21 9.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 75.540000000000006 110.896 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -52.46 119.87 4.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 42.210000000000001 110.85 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -101.49 28.48 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 71.420000000000002 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.06 22.69 10.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.685 -0.769 . . . . 73.439999999999998 112.44 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.67 -25.96 64.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 74.540000000000006 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.98 -5.94 34.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 64.299999999999997 112.563 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -122.34 90.5 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 75.430000000000007 110.883 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -59.06 101.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 51.329999999999998 110.877 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.1 p -134.22 85.12 39.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.739 . . . . 72.519999999999996 110.795 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 165.96 29.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 72.0 112.307 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -131.57 170.19 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.010000000000005 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.9 130.26 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.420000000000002 110.855 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 149.52 58.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.587 0.708 . . . . 71.219999999999999 110.871 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.73 51.84 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.622 2.215 . . . . 71.299999999999997 112.379 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.4 mt -54.33 151.26 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 61.149999999999999 110.887 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.48 158.72 48.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 72.219999999999999 112.525 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -111.12 -175.08 2.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 73.439999999999998 110.943 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 36' ' ' ASN . 28.1 tp -70.09 144.19 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 70.230000000000004 110.916 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' H ' HD12 ' A' ' 35' ' ' LEU . 59.4 m-20 58.51 38.92 25.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.209999999999994 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 159.67 67.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.64 0.733 . . . . 73.540000000000006 110.866 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 123.39 10.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.629 2.219 . . . . 52.43 112.308 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 p -142.07 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 51.409999999999997 110.933 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -128.52 146.84 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 72.030000000000001 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -52.24 -64.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 111.118 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -139.78 157.05 70.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 63.049999999999997 110.831 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.06 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.759 2.306 . . . . 54.310000000000002 112.298 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.95 -169.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 110.892 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -67.88 -16.25 63.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.844 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.62 -28.42 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 64.129999999999995 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.39 32.07 4.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 63.509999999999998 112.432 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mt -122.04 148.5 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 73.099999999999994 111.158 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -104.9 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.918 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.35 -76.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 72.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -122.64 -59.65 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.409999999999997 110.905 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -75.33 163.57 27.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.804 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 m -115.13 159.61 37.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 61.549999999999997 110.935 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 168.28 22.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.22 . . . . 71.329999999999998 112.34 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.45 130.97 44.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.409999999999997 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.44 19.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 74.140000000000001 112.483 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -128.02 26.24 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 72.540000000000006 110.842 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.47 21.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 52.439999999999998 112.478 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.7 mt -108.4 175.67 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.430000000000007 110.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.1 116.26 7.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 64.409999999999997 110.797 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 106.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 73.140000000000001 110.887 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -119.24 139.43 51.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.450000000000003 111.115 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -68.75 122.28 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 110.872 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.7 HG21 ' HD3' ' A' ' 71' ' ' ARG . 30.1 m -116.79 -18.88 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.299999999999997 111.069 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.95 -157.45 7.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 62.549999999999997 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -144.17 159.6 51.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 54.310000000000002 110.917 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.79 -48.41 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 -1.79 . . . . 73.040000000000006 112.312 0.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -123.06 52.7 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 62.020000000000003 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -88.64 77.98 7.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.69 156.2 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 73.519999999999996 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.7 ' HD3' HG21 ' A' ' 64' ' ' VAL . 45.5 mtp180 -147.84 157.92 43.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.868 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.6 140.45 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.862 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -149.36 125.74 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 63.240000000000002 110.92 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -52.04 117.59 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 74.329999999999998 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -66.52 158.76 28.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.100000000000001 110.818 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.9 0.381 . . . . 52.32 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 13' ' ' SER . 84.5 t -75.61 133.9 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 63.109999999999999 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 8' ' ' GLN . 8.1 m -138.67 107.84 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 111.165 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 m -135.19 147.93 49.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.864 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.29 37.57 87.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 72.439999999999998 112.455 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.63 23.14 64.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 75.230000000000004 112.499 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -142.36 143.53 32.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 75.439999999999998 110.914 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 3' ' ' THR . 34.0 mt-30 -95.92 148.18 22.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 110.971 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.2 m -137.93 168.87 18.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 52.420000000000002 110.904 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -54.43 160.94 2.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 50.119999999999997 110.843 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.26 8.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.714 2.276 . . . . 75.409999999999997 112.308 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.17 39.07 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.905 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 2' ' ' VAL . 93.2 p -140.61 131.26 25.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 72.299999999999997 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -94.01 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 72.129999999999995 110.875 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 m -90.25 123.59 34.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 62.119999999999997 110.852 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.22 144.47 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 44.549999999999997 111.087 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -90.56 124.82 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 64.230000000000004 110.951 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -131.12 37.77 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.948 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.6 p -76.26 140.5 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 42.210000000000001 110.829 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -76.69 -23.06 53.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 110.898 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.99 34.73 4.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.704 -0.76 . . . . 73.439999999999998 112.505 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -107.11 25.19 11.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 74.540000000000006 110.986 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.28 -5.63 79.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.776 . . . . 64.299999999999997 112.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -118.94 101.16 7.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 75.430000000000007 110.883 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -80.28 123.07 27.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 51.329999999999998 110.807 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.6 t -134.93 85.02 36.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.731 0.777 . . . . 72.519999999999996 110.865 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 165.88 29.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.72 2.28 . . . . 72.0 112.342 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -134.48 173.91 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 72.010000000000005 110.872 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.45 130.95 46.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 149.39 59.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 71.219999999999999 110.912 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 146.28 59.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 71.299999999999997 112.328 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.9 mt -55.73 150.04 13.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 61.149999999999999 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.77 157.19 52.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 72.219999999999999 112.492 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -109.51 -171.69 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.899 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.7 tp -72.13 146.1 47.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.230000000000004 110.938 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.507 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.4 m-20 58.09 34.6 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.44 159.74 56.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.540000000000006 110.907 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 119.41 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 52.43 112.279 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -136.58 168.31 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.409999999999997 110.851 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -129.96 144.27 51.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 72.030000000000001 110.94 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.08 -63.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 111.127 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -138.98 156.99 72.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.695 0.759 . . . . 63.049999999999997 110.851 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.83 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 54.310000000000002 112.402 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.07 -169.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.209999999999994 110.878 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.47 -16.32 64.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 74.040000000000006 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -96.97 -28.34 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 64.129999999999995 110.947 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.17 31.99 4.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 63.509999999999998 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.9 149.64 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 73.099999999999994 111.111 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -104.13 -176.27 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 110.892 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -77.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 72.5 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -122.76 -59.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 74.409999999999997 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -74.77 161.09 29.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.795 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.1 159.9 31.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 61.549999999999997 110.949 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.07 22.55 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 71.329999999999998 112.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.57 129.93 41.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 70.409999999999997 110.906 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -154.67 19.41 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 74.140000000000001 112.476 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.5 pt-20 -127.34 25.83 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 72.540000000000006 110.892 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.0 22.8 16.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 52.439999999999998 112.466 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -108.84 178.47 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 72.430000000000007 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.33 114.39 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 64.409999999999997 110.882 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.3 106.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.875 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -119.14 139.26 52.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.450000000000003 111.105 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -69.27 123.4 21.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 110.905 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 m -116.45 -21.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 73.299999999999997 111.126 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.92 -164.55 10.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 62.549999999999997 112.468 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -133.34 160.14 69.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 54.310000000000002 110.906 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.73 -48.55 0.26 Allowed 'Cis proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.714 -1.786 . . . . 73.040000000000006 112.364 -0.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -125.53 50.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.020000000000003 110.932 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -83.99 77.92 9.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -86.8 154.46 20.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.519999999999996 110.915 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -146.31 149.7 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 110.883 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.1 137.52 56.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.439999999999998 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -146.84 126.29 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 63.240000000000002 110.92 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.03 117.43 2.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.87 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.06 158.11 32.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 51.100000000000001 110.867 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.991 0.424 . . . . 52.32 110.879 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.31 140.66 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 63.109999999999999 111.074 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 m -148.93 114.49 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.510000000000005 111.131 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.18 152.62 40.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.27 25.81 67.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 72.439999999999998 112.458 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.42 78.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 75.230000000000004 112.488 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -143.89 153.95 42.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 75.439999999999998 110.863 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -93.11 138.97 31.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 73.239999999999995 110.921 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 m -117.76 175.15 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 52.420000000000002 110.802 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -76.29 160.52 77.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.6 0.714 . . . . 50.119999999999997 110.881 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.409999999999997 112.311 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m120 57.52 32.89 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -142.07 132.11 24.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.851 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -97.74 168.27 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.129999999999995 110.971 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 m -95.98 124.25 39.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.883 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 131.7 70.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 44.549999999999997 111.127 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -83.39 124.67 30.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 64.230000000000004 110.929 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -135.33 47.31 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 75.540000000000006 110.862 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -64.15 163.12 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 42.210000000000001 110.885 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -117.54 25.52 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 71.420000000000002 110.82 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.79 50.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.768 -0.729 . . . . 73.439999999999998 112.401 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -94.56 -34.98 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.816 0.341 . . . . 74.540000000000006 110.905 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.53 15.03 16.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 64.299999999999997 112.428 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.28 102.81 7.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 75.430000000000007 110.844 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -52.7 107.32 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 51.329999999999998 110.895 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -129.37 84.97 60.49 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 72.519999999999996 110.798 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 166.45 27.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 72.0 112.366 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -127.26 172.21 10.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 72.010000000000005 110.841 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.9 m -103.3 118.11 36.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.420000000000002 110.952 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 148.82 64.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.594 0.711 . . . . 71.219999999999999 110.812 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 149.99 67.96 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.626 2.217 . . . . 71.299999999999997 112.392 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 56' ' ' GLY . 26.8 mt -61.21 157.86 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 61.149999999999999 110.891 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 157.07 51.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 72.219999999999999 112.501 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -108.29 -173.47 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 73.439999999999998 110.878 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 36' ' ' ASN . 24.7 tp -71.62 148.29 46.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 70.230000000000004 110.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.538 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.0 m-20 55.02 35.4 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.209999999999994 110.879 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.32 159.53 56.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.61 0.719 . . . . 73.540000000000006 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 117.97 5.4 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 52.43 112.333 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -133.89 171.06 14.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 51.409999999999997 110.847 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -126.98 147.82 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.64 -63.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 73.329999999999998 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 154.14 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 63.049999999999997 110.897 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -169.64 0.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.675 2.25 . . . . 54.310000000000002 112.382 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -169.34 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 71.209999999999994 110.907 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -65.2 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.040000000000006 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -93.69 -25.66 17.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 64.129999999999995 110.895 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.25 5.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.777 -0.725 . . . . 63.509999999999998 112.431 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.452 HG21 ' HB2' ' A' ' 17' ' ' GLN . 5.6 mm -108.74 156.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 73.099999999999994 111.129 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.75 -176.73 2.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.962 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -79.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.5 110.805 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -123.32 -58.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 110.951 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -77.22 158.68 30.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 74.310000000000002 110.898 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.6 m -107.57 159.4 30.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 61.549999999999997 110.873 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 168.22 22.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 71.329999999999998 112.355 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.7 m -69.45 132.84 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 70.409999999999997 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.67 19.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.708 -0.758 . . . . 74.140000000000001 112.466 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.61 27.0 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 72.540000000000006 110.946 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.49 23.09 19.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 52.439999999999998 112.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.6 mt -109.77 177.04 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 72.430000000000007 110.908 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.34 122.36 7.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.409999999999997 110.878 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.12 111.8 0.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 73.140000000000001 110.871 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -131.25 136.56 48.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 111.121 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -65.99 127.23 31.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 74.430000000000007 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.79 -23.59 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 73.299999999999997 111.131 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.5 -167.46 12.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 62.549999999999997 112.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.1 pt-20 -119.09 159.69 44.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.692 0.758 . . . . 54.310000000000002 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.76 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 -1.796 . . . . 73.040000000000006 112.346 -0.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -131.25 43.58 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 62.020000000000003 110.835 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -66.5 89.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.41 136.38 33.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.519999999999996 110.886 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -135.35 145.99 47.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.936 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.29 136.66 55.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 74.439999999999998 110.882 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -144.99 126.04 14.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 63.240000000000002 110.878 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -51.85 116.92 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 74.329999999999998 110.953 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.71 155.67 38.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 75.319999999999993 110.928 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 51.100000000000001 110.864 -179.773 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.929 0.395 . . . . 52.32 110.857 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.0 t -88.0 134.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 63.109999999999999 111.118 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -132.05 110.06 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 73.510000000000005 111.152 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.13 137.97 52.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.88 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.22 18.58 69.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 72.439999999999998 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.09 -19.62 48.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.78 -0.724 . . . . 75.230000000000004 112.509 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -108.41 152.88 24.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.722 0.296 . . . . 75.439999999999998 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -80.73 144.19 32.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.239999999999995 110.974 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.81 159.84 24.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 52.420000000000002 110.894 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -56.6 160.99 4.78 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.526 0.679 . . . . 50.119999999999997 110.944 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 166.87 26.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.716 2.277 . . . . 75.409999999999997 112.332 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 59.23 33.96 22.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.91 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -141.97 123.8 15.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 72.299999999999997 110.901 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -88.78 168.12 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 72.129999999999995 110.897 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -88.62 120.38 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 62.119999999999997 110.979 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.64 141.04 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 44.549999999999997 111.12 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 122.84 47.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.230000000000004 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -128.8 91.19 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.540000000000006 110.916 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -107.09 153.78 22.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 42.210000000000001 110.909 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -111.3 27.92 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.941 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 24.41 76.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.797 -0.716 . . . . 73.439999999999998 112.457 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -87.62 -28.12 22.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 74.540000000000006 110.95 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.14 32.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 64.299999999999997 112.436 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -120.1 90.6 3.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 75.430000000000007 110.937 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.47 102.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 51.329999999999998 110.843 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.6 p -129.77 85.07 59.19 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.687 0.756 . . . . 72.519999999999996 110.878 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 166.56 27.33 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 72.0 112.261 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -135.23 173.81 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.010000000000005 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 m -96.67 129.83 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 71.420000000000002 110.861 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.07 148.32 68.84 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.549 0.69 . . . . 71.219999999999999 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 155.69 65.4 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 71.299999999999997 112.338 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -63.68 162.07 13.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 61.149999999999999 110.913 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.68 150.21 41.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.741 . . . . 72.219999999999999 112.459 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -99.47 -174.29 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.439999999999998 110.957 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 ' H ' ' A' ' 36' ' ' ASN . 20.9 tp -71.14 144.01 50.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 70.230000000000004 110.924 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.546 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.2 m-20 57.38 26.86 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 110.869 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.04 159.55 31.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 73.540000000000006 110.863 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 119.27 6.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.646 2.231 . . . . 52.43 112.383 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -136.59 166.07 24.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 51.409999999999997 110.814 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -125.64 142.58 51.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 72.030000000000001 110.883 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -51.67 -63.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 111.078 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -138.52 157.11 72.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.693 0.759 . . . . 63.049999999999997 110.841 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 54.310000000000002 112.3 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -72.98 -169.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.209999999999994 110.858 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.63 -14.15 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.040000000000006 110.883 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -97.63 -28.34 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.129999999999995 110.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.07 32.12 4.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 63.509999999999998 112.527 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mt -125.26 148.84 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.844 0.355 . . . . 73.099999999999994 111.101 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -99.78 -176.26 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.219999999999999 110.908 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.13 -77.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 72.5 110.929 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -123.01 -59.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -74.88 162.42 28.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.9 m -113.36 158.73 37.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.542 0.686 . . . . 61.549999999999997 110.918 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 168.11 22.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.636 2.224 . . . . 71.329999999999998 112.34 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -67.74 125.64 26.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 70.409999999999997 110.911 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.54 15.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.733 . . . . 74.140000000000001 112.469 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.4 pt-20 -125.9 37.21 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 72.540000000000006 110.878 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.4 24.6 39.18 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 52.439999999999998 112.501 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.473 HD12 ' HG2' ' A' ' 57' ' ' GLU . 13.3 mt -110.37 174.85 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 72.430000000000007 110.848 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.5 118.77 6.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 64.409999999999997 110.791 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 110.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.140000000000001 110.862 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -130.7 140.99 50.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 111.117 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -67.83 119.68 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.855 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.85 -20.4 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 111.147 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.34 -157.47 7.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 62.549999999999997 112.464 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -144.1 159.73 51.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.717 . . . . 54.310000000000002 110.886 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.3 Cg_endo -69.7 -48.41 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.156 0 C-N-CA 122.69 -1.796 . . . . 73.040000000000006 112.372 -0.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -124.69 58.33 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 62.020000000000003 110.845 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -90.21 82.36 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.935 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.28 149.24 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 110.94 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -151.13 146.51 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.420000000000002 110.834 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.41 141.28 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.891 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -150.9 127.06 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 63.240000000000002 110.941 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -51.9 116.94 2.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.58 157.67 37.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 51.100000000000001 110.788 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.959 0.409 . . . . 52.32 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 9' ' ' CYS . 6.8 p -74.45 144.02 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.502 . . . . 63.109999999999999 111.108 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -147.88 123.55 10.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 73.510000000000005 111.131 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.2 m -150.2 150.44 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.209999999999994 110.877 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.82 37.14 89.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 72.439999999999998 112.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.79 20.83 62.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 75.230000000000004 112.505 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -140.22 154.46 46.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 75.439999999999998 110.876 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -93.99 138.27 32.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.239999999999995 110.961 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB2' HG13 ' A' ' 2' ' ' VAL . 17.4 m -113.58 174.99 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 52.420000000000002 110.856 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -81.75 160.88 62.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 50.119999999999997 110.899 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.78 33.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.737 2.292 . . . . 75.409999999999997 112.322 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.04 25.26 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.92 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -142.05 119.99 12.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.811 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.96 168.0 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.0 m -88.2 133.25 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 62.119999999999997 110.959 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.53 124.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 44.549999999999997 111.121 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -82.61 125.65 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 64.230000000000004 110.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -126.65 47.65 2.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 110.921 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 158.13 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 42.210000000000001 110.842 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -122.07 28.5 7.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.792 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 21.67 67.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.716 -0.754 . . . . 73.439999999999998 112.535 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -80.63 -29.47 36.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 74.540000000000006 110.93 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.08 15.07 27.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 64.299999999999997 112.428 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -124.29 103.21 8.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.311 . . . . 75.430000000000007 110.873 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.87 100.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 51.329999999999998 110.855 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.2 t -128.54 85.03 61.43 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.701 0.762 . . . . 72.519999999999996 110.875 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 166.67 26.74 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.716 2.277 . . . . 72.0 112.398 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -127.03 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 110.85 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.8 m -103.45 111.73 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 110.886 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.51 148.64 42.24 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.603 0.716 . . . . 71.219999999999999 110.808 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.54 69.27 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.663 2.242 . . . . 71.299999999999997 112.344 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.603 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.0 mt -64.31 148.51 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 61.149999999999999 110.912 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.81 152.87 38.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.752 . . . . 72.219999999999999 112.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -103.94 -170.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 73.439999999999998 110.883 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.0 tp -73.03 142.1 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 70.230000000000004 110.912 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.6 m-20 59.65 34.64 22.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.851 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.62 49.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.651 0.739 . . . . 73.540000000000006 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 52.43 112.381 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.51 161.96 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 51.409999999999997 110.857 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.67 146.65 47.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 72.030000000000001 110.855 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.94 -64.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.164 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -138.29 156.98 73.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 63.049999999999997 110.907 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.632 2.222 . . . . 54.310000000000002 112.344 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.23 -169.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 71.209999999999994 110.959 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.48 -15.58 63.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 74.040000000000006 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -95.46 -28.32 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.129999999999995 110.89 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.03 32.06 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 63.509999999999998 112.502 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.3 mt -125.64 149.54 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 73.099999999999994 111.123 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -102.19 -176.09 3.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.918 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.71 -77.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 72.5 110.916 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -122.85 -59.46 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.946 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -75.93 160.9 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -112.79 160.07 32.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.649 0.738 . . . . 61.549999999999997 110.889 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 168.04 22.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.227 . . . . 71.329999999999998 112.423 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -68.87 126.31 29.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 70.409999999999997 110.887 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.9 19.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 74.140000000000001 112.481 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -127.85 27.48 5.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 72.540000000000006 110.887 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.55 19.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.729 -0.748 . . . . 52.439999999999998 112.498 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.5 mt -109.74 169.5 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 110.898 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.52 117.79 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 64.409999999999997 110.872 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.3 m -55.66 103.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 73.140000000000001 110.908 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -115.77 136.58 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.450000000000003 111.065 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -68.91 124.67 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.89 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG21 ' HG3' ' A' ' 71' ' ' ARG . 16.7 m -126.07 13.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.108 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.13 -167.52 33.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 62.549999999999997 112.513 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -127.48 159.58 64.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.6 0.714 . . . . 54.310000000000002 110.942 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.77 -48.23 0.28 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 73.040000000000006 112.355 -0.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.13 43.72 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 62.020000000000003 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -65.06 102.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 74.0 110.991 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 61' ' ' CYS . 5.7 mp -104.88 138.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 73.519999999999996 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.573 ' HG3' HG21 ' A' ' 64' ' ' VAL . 18.2 mmt85 -135.86 150.24 49.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.829 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.47 140.28 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.439999999999998 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -151.56 129.14 11.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 110.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.77 116.95 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 110.896 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -66.94 149.5 50.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.319999999999993 110.94 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 51.100000000000001 110.847 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.949 0.404 . . . . 52.32 110.849 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.85 143.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 63.109999999999999 111.096 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -128.73 115.58 18.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 73.510000000000005 111.136 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 m -137.48 125.51 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.209999999999994 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.44 17.76 79.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 72.439999999999998 112.477 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.25 -16.72 58.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 75.230000000000004 112.482 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.53 152.33 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 75.439999999999998 110.848 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -97.17 154.7 17.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 73.239999999999995 110.878 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.49 172.04 14.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 52.420000000000002 110.9 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -64.08 160.83 44.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.719 . . . . 50.119999999999997 110.898 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 175.75 7.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.236 . . . . 75.409999999999997 112.321 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 56.5 37.81 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.941 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.33 122.32 14.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 72.299999999999997 110.807 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -87.72 168.1 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 72.129999999999995 110.88 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -90.56 134.63 34.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 62.119999999999997 110.87 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.34 144.83 36.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 44.549999999999997 111.156 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -89.34 124.09 34.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 110.972 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -120.47 86.38 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 75.540000000000006 110.905 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -139.75 125.55 19.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 42.210000000000001 110.927 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -103.38 28.47 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.420000000000002 110.857 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.39 26.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.811 -0.709 . . . . 73.439999999999998 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -79.4 -32.18 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.795 0.331 . . . . 74.540000000000006 110.904 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.33 -5.75 41.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 64.299999999999997 112.48 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -113.61 89.41 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 75.430000000000007 110.888 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.62 104.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 51.329999999999998 110.913 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -135.08 84.94 35.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.716 0.77 . . . . 72.519999999999996 110.868 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 166.2 28.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.669 2.246 . . . . 72.0 112.339 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -136.11 174.05 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 72.010000000000005 110.832 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.57 130.29 46.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.420000000000002 110.924 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 149.4 53.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 71.219999999999999 110.861 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 144.67 54.66 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.26 . . . . 71.299999999999997 112.307 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -54.29 149.11 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.149999999999999 110.942 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 153.04 51.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 72.219999999999999 112.509 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -106.34 -172.33 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.439999999999998 110.875 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.4 tp -74.77 151.15 39.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 70.230000000000004 110.939 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 60.5 21.87 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.209999999999994 110.907 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.22 159.52 44.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.627 0.727 . . . . 73.540000000000006 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 145.93 58.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 52.43 112.361 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.9 p -153.96 167.3 30.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 51.409999999999997 110.881 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -126.54 145.43 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 72.030000000000001 110.897 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -53.13 -65.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 111.172 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -140.01 156.8 70.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.641 0.734 . . . . 63.049999999999997 110.927 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -170.5 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.238 . . . . 54.310000000000002 112.308 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.209999999999994 110.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.72 -16.58 64.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 74.040000000000006 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -96.36 -28.37 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 64.129999999999995 110.86 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 63.509999999999998 112.505 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.71 146.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 73.099999999999994 111.111 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -100.15 -176.3 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 74.219999999999999 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.51 -77.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.5 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -122.81 -58.85 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 74.409999999999997 110.985 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -76.31 167.74 21.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.908 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -117.8 160.19 39.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.548 0.689 . . . . 61.549999999999997 110.913 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 168.11 22.47 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 71.329999999999998 112.332 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 91.9 m -69.1 127.97 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.409999999999997 110.841 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.622 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.11 19.36 0.73 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.68 -0.772 . . . . 74.140000000000001 112.465 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.7 pt-20 -127.57 27.64 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 72.540000000000006 110.813 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.04 20.44 23.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 52.439999999999998 112.507 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.6 mt -109.34 177.48 4.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 72.430000000000007 110.939 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 122.18 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 64.409999999999997 110.861 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.09 108.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 73.140000000000001 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -123.92 148.45 46.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 111.173 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -82.47 122.75 28.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.909 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.94 13.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.299999999999997 111.082 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.05 -167.98 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 62.549999999999997 112.466 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -140.26 160.04 61.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 54.310000000000002 110.872 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.2 Cg_endo -69.68 -44.91 0.46 Allowed 'Cis proline' 0 C--N 1.341 0.151 0 C-N-CA 122.753 -1.769 . . . . 73.040000000000006 112.325 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -130.73 69.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 62.020000000000003 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -94.26 78.2 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.17 137.9 33.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.519999999999996 110.888 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -144.15 170.81 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.38 135.44 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -146.7 130.93 17.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.240000000000002 110.872 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.77 117.24 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 110.851 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.87 149.21 49.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.901 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 51.100000000000001 110.85 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.901 0.381 . . . . 52.32 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.06 132.34 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 63.109999999999999 111.163 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.4 m -136.47 109.17 7.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.510000000000005 111.159 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.3 m -136.97 137.58 39.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.897 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 39.96 97.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.701 -0.761 . . . . 72.439999999999998 112.446 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.98 29.07 64.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 75.230000000000004 112.442 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -144.94 139.59 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 75.439999999999998 110.831 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -89.64 148.58 23.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 110.939 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -139.09 170.4 16.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 52.420000000000002 110.881 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -60.35 161.07 14.66 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.544 0.687 . . . . 50.119999999999997 110.876 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 173.42 10.95 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.666 2.244 . . . . 75.409999999999997 112.334 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 58.19 37.58 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.21 122.54 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.299999999999997 110.86 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.55 168.1 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 110.861 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -89.82 129.89 36.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 62.119999999999997 110.828 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.1 152.64 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 44.549999999999997 111.165 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HG2' HG21 ' A' ' 48' ' ' ILE . 4.9 mm-40 -112.07 136.72 51.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 64.230000000000004 110.898 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -150.31 114.38 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 75.540000000000006 110.894 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.25 162.43 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 42.210000000000001 110.83 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -104.28 -15.33 15.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 71.420000000000002 110.841 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.16 35.91 3.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.705 -0.76 . . . . 73.439999999999998 112.503 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.94 -20.54 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 74.540000000000006 110.925 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.23 15.0 15.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.704 -0.76 . . . . 64.299999999999997 112.492 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -118.18 99.47 6.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 75.430000000000007 110.896 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -76.78 113.79 14.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 51.329999999999998 110.85 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m -137.08 85.03 23.28 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.711 0.767 . . . . 72.519999999999996 110.875 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 166.46 27.48 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 72.0 112.389 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.0 mtp85 -140.24 173.98 10.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.010000000000005 110.859 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.26 129.97 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 71.420000000000002 110.858 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.12 149.64 54.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 71.219999999999999 110.838 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.29 62.35 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.655 2.237 . . . . 71.299999999999997 112.318 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 56' ' ' GLY . 36.2 mt -56.6 148.8 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 61.149999999999999 110.863 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.68 154.48 45.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 72.219999999999999 112.518 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -107.34 -174.42 2.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.856 0.36 . . . . 73.439999999999998 110.837 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.1 tp -70.7 145.47 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 70.230000000000004 110.9 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.7 m-20 58.37 38.33 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 110.946 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.03 159.74 68.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.585 0.707 . . . . 73.540000000000006 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 130.96 20.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.683 2.255 . . . . 52.43 112.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -144.38 170.44 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 51.409999999999997 110.894 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -129.53 147.78 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.030000000000001 110.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.32 -67.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.123 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -138.51 156.78 73.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 63.049999999999997 110.881 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 54.310000000000002 112.358 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -169.51 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 71.209999999999994 110.904 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -66.79 -16.54 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.885 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -97.49 -28.25 14.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 64.129999999999995 110.865 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.98 4.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 63.509999999999998 112.491 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.473 HG21 ' HG2' ' A' ' 17' ' ' GLN . 65.7 mt -119.7 146.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 73.099999999999994 111.153 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -103.1 -176.09 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.885 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.06 -77.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.5 110.868 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -123.02 -59.88 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.932 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -75.72 158.29 32.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 110.885 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.53 160.17 30.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 61.549999999999997 110.844 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 168.08 22.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.673 2.249 . . . . 71.329999999999998 112.432 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.58 128.77 37.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 70.409999999999997 110.86 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.99 20.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 74.140000000000001 112.495 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.8 28.26 5.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.923 0.392 . . . . 72.540000000000006 110.919 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.95 23.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 52.439999999999998 112.516 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -109.06 176.11 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 72.430000000000007 110.996 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.65 119.6 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 110.893 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.21 108.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 137.12 55.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -71.92 124.06 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.430000000000007 110.908 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.89 -20.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.299999999999997 111.154 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.05 -174.06 16.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 62.549999999999997 112.504 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -116.7 159.41 40.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.571 0.701 . . . . 54.310000000000002 110.837 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -48.25 0.28 Allowed 'Cis proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.708 -1.788 . . . . 73.040000000000006 112.403 -0.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -130.98 46.55 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 62.020000000000003 110.865 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -70.12 83.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 74.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.17 145.8 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.941 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -143.33 154.96 44.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.846 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.92 139.28 48.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.98 128.59 12.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 63.240000000000002 110.874 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.04 117.05 2.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.329999999999998 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.16 153.92 42.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 75.319999999999993 110.906 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 51.100000000000001 110.862 -179.809 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.902 0.382 . . . . 52.32 110.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.89 144.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 63.109999999999999 111.095 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 m -129.7 122.22 28.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 73.510000000000005 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 m -139.68 130.35 25.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 73.209999999999994 110.878 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.24 22.84 59.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.07 68.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.73 . . . . 75.230000000000004 112.455 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 139.05 31.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 75.439999999999998 110.866 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.12 142.97 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 73.239999999999995 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -139.45 174.63 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 52.420000000000002 110.905 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -72.41 160.73 82.01 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 50.119999999999997 110.877 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 177.77 5.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.626 2.217 . . . . 75.409999999999997 112.313 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 m120 62.81 27.09 15.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 75.25 110.955 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.0 m -142.03 117.41 10.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 72.299999999999997 110.855 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.19 168.26 16.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -91.57 131.0 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 62.119999999999997 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 28' ' ' ARG . 5.9 m -124.19 147.04 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 44.549999999999997 111.153 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.94 136.54 54.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 64.230000000000004 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.64 28.71 4.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 75.540000000000006 110.848 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 81.1 p -59.06 159.37 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 42.210000000000001 110.789 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -124.65 26.69 7.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 71.420000000000002 110.827 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.59 33.24 67.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 73.439999999999998 112.467 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -93.61 -24.41 17.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 74.540000000000006 110.832 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.02 15.02 15.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.796 -0.716 . . . . 64.299999999999997 112.447 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -127.06 96.48 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 75.430000000000007 110.867 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -79.21 95.69 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 51.329999999999998 110.899 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -123.02 85.0 50.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.708 0.766 . . . . 72.519999999999996 110.851 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 165.64 30.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.75 2.3 . . . . 72.0 112.329 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 16' ' ' VAL . 8.1 tpt180 -130.51 163.39 27.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 72.010000000000005 110.86 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -90.72 121.04 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.934 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.56 148.57 50.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 71.219999999999999 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 154.8 67.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.725 2.283 . . . . 71.299999999999997 112.327 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.6 mt -65.35 158.18 27.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 61.149999999999999 110.928 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.32 158.59 50.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 72.219999999999999 112.511 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -110.37 -173.08 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 73.439999999999998 110.895 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 36' ' ' ASN . 32.3 tp -70.37 145.0 51.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 70.230000000000004 110.958 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 35' ' ' LEU . 90.2 m-20 57.24 39.45 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.209999999999994 110.869 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' ND2' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -127.16 159.45 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.68 0.752 . . . . 73.540000000000006 110.888 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' ND2' ' A' ' 37' ' ' ASN . 53.2 Cg_endo -69.8 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.767 2.311 . . . . 52.43 112.289 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -142.16 160.21 40.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 51.409999999999997 110.841 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.9 142.44 47.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 72.030000000000001 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.6 -60.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.15 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -139.03 157.08 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.702 0.763 . . . . 63.049999999999997 110.868 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -170.41 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.637 2.225 . . . . 54.310000000000002 112.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.209999999999994 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.92 -15.75 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 110.815 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -96.52 -28.44 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.11 32.14 4.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 63.509999999999998 112.554 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.3 mt -125.54 150.51 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.099999999999994 111.123 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -102.04 -176.1 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.219999999999999 110.868 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.54 -77.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 72.5 110.854 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -123.04 -58.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 110.981 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -75.2 169.72 17.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 24.0 m -119.17 158.35 48.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.621 0.724 . . . . 61.549999999999997 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 168.27 22.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.637 2.225 . . . . 71.329999999999998 112.355 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -64.69 125.18 23.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 70.409999999999997 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.94 17.88 1.08 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 74.140000000000001 112.479 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.8 pt-20 -127.07 28.99 5.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 72.540000000000006 110.831 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.67 22.52 23.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 52.439999999999998 112.454 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.2 mt -109.81 179.36 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 72.430000000000007 110.923 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.74 116.59 5.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 64.409999999999997 110.833 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 110.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 73.140000000000001 110.847 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -126.21 136.77 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.450000000000003 111.145 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -65.41 123.92 20.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.896 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 69' ' ' LYS . 31.4 m -116.76 -19.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.43 . . . . 73.299999999999997 111.096 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.91 -164.5 11.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 62.549999999999997 112.438 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -131.39 159.7 70.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.621 0.724 . . . . 54.310000000000002 110.918 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.4 Cg_endo -69.74 -48.37 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.146 0 C-N-CA 122.67 -1.804 . . . . 73.040000000000006 112.326 -0.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -126.21 47.91 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.020000000000003 110.903 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 64' ' ' VAL . 29.6 ttpt -79.61 77.99 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.54 152.55 25.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.519999999999996 110.936 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -145.61 145.53 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.88 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.63 136.11 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.851 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -143.76 125.04 14.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.240000000000002 110.912 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -51.8 116.93 2.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 110.86 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.91 156.97 38.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.319999999999993 110.929 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 51.100000000000001 110.876 -179.784 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.94 0.4 . . . . 52.32 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.15 141.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 63.109999999999999 111.164 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -137.32 110.48 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 73.510000000000005 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 m -125.94 130.99 52.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.824 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 20.89 63.82 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 72.439999999999998 112.471 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.31 -20.38 44.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.77 -0.728 . . . . 75.230000000000004 112.541 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -100.12 145.56 27.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 75.439999999999998 110.864 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.903 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.99 171.53 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 52.420000000000002 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -65.4 160.69 57.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.702 . . . . 50.119999999999997 110.893 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 174.97 8.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.244 . . . . 75.409999999999997 112.341 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m120 58.47 30.0 19.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.887 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 m -142.06 120.75 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.299999999999997 110.826 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.2 p -90.31 168.1 12.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 72.129999999999995 110.881 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 m -90.14 126.36 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 62.119999999999997 110.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.78 136.97 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 44.549999999999997 111.186 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -104.62 128.09 52.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 64.230000000000004 110.877 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.68 32.11 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.540000000000006 110.908 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -68.36 152.13 45.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 42.210000000000001 110.837 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -124.99 26.16 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 71.420000000000002 110.844 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.18 30.0 35.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.771 . . . . 73.439999999999998 112.48 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -85.16 -28.67 25.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 74.540000000000006 110.861 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 9.44 35.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 64.299999999999997 112.507 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -127.01 88.74 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 75.430000000000007 110.96 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.8 94.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 51.329999999999998 110.86 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -118.32 84.95 24.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 72.519999999999996 110.935 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 165.64 30.28 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.704 2.269 . . . . 72.0 112.31 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -129.19 171.52 12.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 72.010000000000005 110.83 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.2 m -102.3 112.99 25.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 110.81 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 148.96 40.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 71.219999999999999 110.889 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 150.39 68.52 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 71.299999999999997 112.391 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.0 mt -59.0 147.99 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 61.149999999999999 110.932 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.9 156.7 36.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 72.219999999999999 112.503 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -108.32 -170.78 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 73.439999999999998 110.868 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 36' ' ' ASN . 27.9 tp -73.75 146.4 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 70.230000000000004 110.868 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.574 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 56.47 32.52 20.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.209999999999994 110.849 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.88 159.67 45.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 73.540000000000006 110.941 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.92 5.97 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 52.43 112.295 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -135.04 169.33 17.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 51.409999999999997 110.893 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -130.21 144.64 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.857 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -52.62 -63.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 73.329999999999998 111.113 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -138.98 156.75 72.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 63.049999999999997 110.863 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -169.99 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.752 2.301 . . . . 54.310000000000002 112.323 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -168.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 71.209999999999994 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.1 -24.14 67.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.040000000000006 110.812 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -89.94 -28.37 19.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.129999999999995 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.54 32.25 4.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 63.509999999999998 112.566 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.9 mt -120.66 150.73 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 73.099999999999994 111.088 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -104.18 -176.09 2.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.219999999999999 110.955 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.55 -76.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 72.5 110.864 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -122.66 -60.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.923 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -74.9 158.85 32.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 74.310000000000002 110.792 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.1 m -109.93 160.05 29.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 61.549999999999997 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 167.93 23.04 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.698 2.266 . . . . 71.329999999999998 112.293 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.73 124.74 24.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 70.409999999999997 110.883 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.04 17.61 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.140000000000001 112.478 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.82 27.44 6.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.540000000000006 110.951 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.46 21.58 24.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.646 -0.788 . . . . 52.439999999999998 112.523 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -107.8 170.94 7.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 72.430000000000007 110.841 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 110.935 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.23 109.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.140000000000001 110.909 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -127.75 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.129 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -66.87 127.97 34.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 74.430000000000007 110.941 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.31 13.21 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.299999999999997 111.11 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.56 -157.95 18.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 62.549999999999997 112.484 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -140.25 159.39 63.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 54.310000000000002 110.913 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.74 -41.75 0.86 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.664 -1.807 . . . . 73.040000000000006 112.351 -0.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.56 63.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 62.020000000000003 110.912 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -81.95 79.81 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -82.15 133.04 35.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.519999999999996 110.954 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.94 147.77 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.896 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.85 129.42 39.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.72 128.1 30.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 63.240000000000002 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 119.98 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.842 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -64.12 154.53 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 75.319999999999993 110.831 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 51.100000000000001 110.885 -179.814 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.9 0.381 . . . . 52.32 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -71.26 143.13 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 63.109999999999999 111.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -128.87 115.29 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.510000000000005 111.1 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -138.16 123.14 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.887 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 19.4 79.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.439999999999998 112.482 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.57 -13.96 64.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 75.230000000000004 112.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.95 139.31 31.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 75.439999999999998 110.906 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.1 138.1 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.79 171.91 12.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 52.420000000000002 110.907 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.35 160.74 30.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 50.119999999999997 110.815 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 177.8 5.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.668 2.245 . . . . 75.409999999999997 112.397 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.98 36.32 27.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 75.25 110.921 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m -141.95 124.51 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.299999999999997 110.889 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -87.78 168.2 13.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.129999999999995 110.866 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 m -90.72 128.01 36.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 62.119999999999997 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -120.59 166.49 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 44.549999999999997 111.09 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.613 ' HG2' HG21 ' A' ' 48' ' ' ILE . 1.1 mm-40 -117.93 137.63 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.230000000000004 110.93 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.74 29.78 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 110.856 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.8 p -63.15 144.61 56.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 42.210000000000001 110.862 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -127.05 26.07 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 71.420000000000002 110.828 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.77 60.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 73.439999999999998 112.483 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -88.9 -25.96 21.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 74.540000000000006 110.905 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.99 -6.21 34.78 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.743 -0.742 . . . . 64.299999999999997 112.505 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -124.73 92.66 3.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 75.430000000000007 110.892 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.57 117.86 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 51.329999999999998 110.856 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 p -137.16 85.0 23.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.679 0.752 . . . . 72.519999999999996 110.893 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 164.95 32.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 72.0 112.348 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -133.6 173.8 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.010000000000005 110.919 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.14 131.88 50.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.887 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 149.34 62.78 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.606 0.717 . . . . 71.219999999999999 110.806 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 145.7 57.65 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.654 2.236 . . . . 71.299999999999997 112.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD13 ' HA3' ' A' ' 56' ' ' GLY . 42.6 mt -54.14 149.42 9.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 61.149999999999999 110.873 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.6 157.06 52.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.732 . . . . 72.219999999999999 112.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -105.62 -169.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.324 . . . . 73.439999999999998 110.898 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 36' ' ' ASN . 25.4 tp -72.96 149.04 43.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 70.230000000000004 110.927 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.525 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.7 m-20 53.03 33.34 14.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 110.899 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.13 159.66 42.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.641 0.734 . . . . 73.540000000000006 110.842 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.81 5.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.68 2.254 . . . . 52.43 112.309 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.5 p -132.19 170.87 14.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 51.409999999999997 110.872 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -131.09 146.36 52.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.030000000000001 110.88 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' HG3' ' A' ' 42' ' ' GLU . 47.5 t -52.2 -66.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 73.329999999999998 111.155 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 41' ' ' VAL . 74.3 mt-10 -140.64 156.74 69.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 63.049999999999997 110.84 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -170.42 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 54.310000000000002 112.375 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -169.39 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 71.209999999999994 110.856 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.15 -16.03 64.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 74.040000000000006 110.908 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -98.38 -28.18 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 64.129999999999995 110.882 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 31.99 4.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 63.509999999999998 112.449 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.613 HG21 ' HG2' ' A' ' 17' ' ' GLN . 68.4 mt -119.08 145.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.387 . . . . 73.099999999999994 111.102 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -102.82 -176.19 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 74.219999999999999 110.879 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.82 -77.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 72.5 110.843 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -123.06 -59.39 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 74.409999999999997 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -76.23 159.23 30.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.310000000000002 110.888 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.8 m -112.02 160.06 31.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.605 0.717 . . . . 61.549999999999997 110.886 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.99 22.85 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.698 2.265 . . . . 71.329999999999998 112.334 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.22 124.17 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.409999999999997 110.848 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.98 17.83 1.07 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 74.140000000000001 112.48 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -126.6 29.21 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 72.540000000000006 110.91 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.74 26.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 52.439999999999998 112.446 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.3 mt -109.01 179.56 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 72.430000000000007 110.857 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 120.27 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 64.409999999999997 110.844 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -54.94 108.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 73.140000000000001 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -125.69 136.63 53.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 111.209 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.87 125.59 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.430000000000007 110.924 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' LYS . 27.9 m -116.68 -21.22 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 73.299999999999997 111.122 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.19 -162.26 9.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.688 -0.768 . . . . 62.549999999999997 112.486 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -130.09 159.69 68.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.57 0.7 . . . . 54.310000000000002 110.92 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.83 -48.48 0.27 Allowed 'Cis proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.676 -1.801 . . . . 73.040000000000006 112.291 0.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -127.29 46.55 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 62.020000000000003 110.82 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 64' ' ' VAL . 5.4 ttpm? -72.98 77.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.1 141.96 35.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 73.519999999999996 110.928 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -139.39 145.68 39.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.839 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.48 136.73 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.859 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.51 126.94 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.240000000000002 110.906 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.856 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.49 152.48 41.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.319999999999993 110.857 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 51.100000000000001 110.807 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.941 0.4 . . . . 52.32 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.2 130.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 63.109999999999999 111.165 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.6 m -137.28 113.7 10.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 111.221 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.8 m -139.48 157.1 46.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 73.209999999999994 110.855 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.81 16.51 51.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 72.439999999999998 112.491 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.18 -15.21 60.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 75.230000000000004 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.83 163.46 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 75.439999999999998 110.893 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -94.63 155.39 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 73.239999999999995 110.963 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -132.63 177.19 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.420000000000002 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -80.24 160.65 67.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.545 0.688 . . . . 50.119999999999997 110.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 168.33 21.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.67 2.246 . . . . 75.409999999999997 112.429 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 63.33 27.56 15.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.96 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.0 p -142.02 119.2 11.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.299999999999997 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -88.07 168.13 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 72.129999999999995 110.924 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 m -91.18 125.48 35.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 62.119999999999997 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.15 156.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 44.549999999999997 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.544 ' CG ' HG21 ' A' ' 48' ' ' ILE . 2.4 mm-40 -118.2 129.21 55.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.230000000000004 110.896 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.57 95.97 2.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 75.540000000000006 110.961 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 163.25 16.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 42.210000000000001 110.845 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -98.63 26.35 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 71.420000000000002 110.85 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.9 22.59 72.22 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 73.439999999999998 112.49 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -79.98 -27.94 39.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 74.540000000000006 110.884 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.5 15.02 18.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 64.299999999999997 112.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -118.76 93.75 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 75.430000000000007 110.914 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.58 108.57 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 51.329999999999998 110.879 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.9 m -135.84 85.01 30.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.611 0.72 . . . . 72.519999999999996 110.821 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.0 32.51 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.699 2.266 . . . . 72.0 112.347 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -133.84 173.95 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.010000000000005 110.911 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.61 130.85 51.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 71.420000000000002 110.848 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 149.35 73.2 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.646 0.736 . . . . 71.219999999999999 110.871 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 146.75 61.38 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.725 2.283 . . . . 71.299999999999997 112.387 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.3 mt -55.09 149.85 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.946 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.81 151.89 36.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.688 . . . . 72.219999999999999 112.415 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -177.48 3.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 73.439999999999998 110.898 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 29.5 tp -69.73 143.22 53.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 70.230000000000004 110.863 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 70.6 m-20 60.53 39.45 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 73.209999999999994 110.904 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.04 159.46 72.56 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.586 0.708 . . . . 73.540000000000006 110.921 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 133.18 24.81 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 52.43 112.327 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 p -148.03 167.78 24.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 51.409999999999997 110.965 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -126.31 148.07 49.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.030000000000001 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -52.74 -64.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.329999999999998 111.127 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.15 156.74 64.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.647 0.736 . . . . 63.049999999999997 110.851 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.675 2.25 . . . . 54.310000000000002 112.303 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.58 -169.53 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.209999999999994 110.875 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.99 -16.78 64.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 74.040000000000006 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -97.36 -28.08 14.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 64.129999999999995 110.829 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 32.01 4.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.683 -0.77 . . . . 63.509999999999998 112.493 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.544 HG21 ' CG ' ' A' ' 17' ' ' GLN . 72.3 mt -117.98 145.6 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 73.099999999999994 111.192 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -104.49 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.219999999999999 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.58 -78.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 72.5 110.842 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.19 -58.32 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.935 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -77.42 169.06 18.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.901 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.8 m -117.77 160.67 37.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.563 0.696 . . . . 61.549999999999997 110.89 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.07 22.59 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.675 2.25 . . . . 71.329999999999998 112.334 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 89.0 m -70.67 126.01 28.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 70.409999999999997 110.852 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -152.24 18.58 0.81 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.76 . . . . 74.140000000000001 112.402 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.51 30.7 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.540000000000006 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.15 22.23 27.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 52.439999999999998 112.489 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.1 mt -108.77 176.42 5.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.365 . . . . 72.430000000000007 110.933 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.5 116.8 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 64.409999999999997 110.883 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 103.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 73.140000000000001 110.853 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -118.21 136.98 53.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.450000000000003 111.159 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -76.17 122.71 24.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.946 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 71' ' ' ARG . 18.9 m -116.73 -19.29 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 73.299999999999997 111.079 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.72 -159.82 9.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 62.549999999999997 112.518 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.5 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.1 pt-20 -139.78 159.47 64.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.691 0.758 . . . . 54.310000000000002 110.864 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.8 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 -1.802 . . . . 73.040000000000006 112.342 0.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.76 53.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.020000000000003 110.867 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -79.67 78.1 6.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.91 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.09 141.17 34.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 73.519999999999996 110.933 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG3' HG22 ' A' ' 64' ' ' VAL . 9.0 mtt180 -139.16 153.11 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 74.420000000000002 110.904 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.0 140.97 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.439999999999998 110.875 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -151.86 129.43 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 63.240000000000002 110.888 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.93 117.02 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.898 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -64.05 149.53 47.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 75.319999999999993 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 51.100000000000001 110.877 -179.828 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.953 0.406 . . . . 52.32 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.98 139.42 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 63.109999999999999 111.123 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.9 m -143.12 107.55 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 111.107 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.6 m -146.4 149.29 33.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 73.209999999999994 110.855 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.0 75.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 72.439999999999998 112.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.67 24.97 75.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 75.230000000000004 112.475 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -148.87 137.79 21.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 75.439999999999998 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -78.01 133.29 38.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 110.9 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.98 176.7 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 52.420000000000002 110.923 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -77.87 160.73 73.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.625 0.726 . . . . 50.119999999999997 110.85 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.88 15.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.755 2.304 . . . . 75.409999999999997 112.333 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 63.19 27.78 15.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 75.25 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.75 117.42 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.299999999999997 110.891 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 p -88.48 168.09 12.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.129999999999995 110.877 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 m -91.69 131.11 37.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 62.119999999999997 110.888 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.98 124.0 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 44.549999999999997 111.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -78.88 125.65 29.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 64.230000000000004 110.902 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -126.02 26.44 6.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 75.540000000000006 110.9 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -68.59 158.6 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 42.210000000000001 110.852 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -111.36 27.38 9.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 71.420000000000002 110.881 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.93 26.47 71.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.79 -0.719 . . . . 73.439999999999998 112.447 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -82.66 -25.49 33.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 74.540000000000006 110.907 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.95 15.11 15.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.837 -0.697 . . . . 64.299999999999997 112.428 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -121.49 102.45 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 75.430000000000007 110.908 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -69.11 100.02 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 51.329999999999998 110.842 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.5 p -130.95 84.91 56.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 72.519999999999996 110.848 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 166.48 27.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 72.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.53 171.36 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 72.010000000000005 110.884 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.9 m -107.57 107.37 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.23 149.25 43.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.561 0.696 . . . . 71.219999999999999 110.868 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 152.46 69.57 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 71.299999999999997 112.35 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.0 mt -62.16 149.43 41.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 61.149999999999999 110.882 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.57 149.68 39.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.219999999999999 112.476 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -172.82 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.754 0.311 . . . . 73.439999999999998 110.894 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 ' H ' ' A' ' 36' ' ' ASN . 38.0 tp -72.29 146.37 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 70.230000000000004 110.925 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' LEU . 71.8 m-20 58.31 35.51 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.861 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.67 159.74 68.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.68 0.752 . . . . 73.540000000000006 110.802 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 138.4 37.84 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.601 2.201 . . . . 52.43 112.357 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -147.6 170.77 16.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 51.409999999999997 110.918 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -129.22 146.04 51.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.030000000000001 110.88 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.76 -67.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.124 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -139.64 156.69 71.08 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.734 . . . . 63.049999999999997 110.923 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.719 2.279 . . . . 54.310000000000002 112.332 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 -169.47 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 71.209999999999994 110.955 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.69 -17.75 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.040000000000006 110.901 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -96.28 -28.35 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 64.129999999999995 110.926 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.28 31.95 4.47 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.668 -0.777 . . . . 63.509999999999998 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.16 146.95 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.099999999999994 111.127 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -101.93 -176.19 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.899 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -77.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 72.5 110.858 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -122.78 -59.55 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 74.409999999999997 110.942 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -76.95 156.02 32.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.896 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.3 m -106.74 160.41 26.39 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 61.549999999999997 110.797 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 167.92 23.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 71.329999999999998 112.275 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.7 m -72.92 125.62 28.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 70.409999999999997 110.831 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.83 17.62 0.84 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 74.140000000000001 112.482 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.68 31.47 5.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 72.540000000000006 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.25 21.65 31.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.741 . . . . 52.439999999999998 112.539 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -108.04 176.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.430000000000007 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -148.78 119.16 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.826 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.36 103.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.833 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.39 145.68 47.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 111.184 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -82.89 123.46 29.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 74.430000000000007 110.899 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 ' HE ' ' A' ' 71' ' ' ARG . 32.3 m -125.97 13.13 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.299999999999997 111.104 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -158.6 9.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 62.549999999999997 112.397 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.0 pt-20 -158.52 159.43 29.81 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.683 0.754 . . . . 54.310000000000002 110.809 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -43.09 0.65 Allowed 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 122.727 -1.781 . . . . 73.040000000000006 112.309 0.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -126.97 75.1 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 110.851 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -108.36 78.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 70' ' ' LEU . 5.1 tp -81.2 136.6 35.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 73.519999999999996 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.594 ' HE ' HG21 ' A' ' 64' ' ' VAL . 22.5 mtm180 -140.11 156.93 46.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 74.420000000000002 110.857 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.61 141.6 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 110.884 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.04 127.41 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.964 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -52.02 117.06 2.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.329999999999998 110.866 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.75 157.79 29.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 51.100000000000001 110.874 -179.771 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.896 0.379 . . . . 52.32 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.36 140.31 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 63.109999999999999 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.1 m -137.1 107.43 6.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 111.19 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -125.87 143.25 51.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 73.209999999999994 110.87 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.37 43.63 57.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 72.439999999999998 112.474 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.14 19.52 46.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 75.230000000000004 112.471 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -134.75 140.69 46.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 75.439999999999998 110.846 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.25 148.95 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.18 178.76 6.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 52.420000000000002 110.939 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -73.7 160.61 81.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.543 0.687 . . . . 50.119999999999997 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 172.92 11.76 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 75.409999999999997 112.369 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 63.11 26.74 15.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 75.25 110.94 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -142.08 118.26 10.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.299999999999997 110.888 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.95 168.24 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 72.129999999999995 110.852 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.0 m -93.11 133.64 36.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 62.119999999999997 110.873 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 49' ' ' TYR . 5.3 m -131.04 137.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 44.549999999999997 111.149 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.71 131.22 37.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 64.230000000000004 110.93 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -129.06 51.96 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 75.540000000000006 110.875 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 t -82.4 136.4 34.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 42.210000000000001 110.805 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -101.64 26.04 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 71.420000000000002 110.861 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.94 24.45 64.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.544 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -84.67 -28.77 26.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 74.540000000000006 110.911 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.96 23.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.687 -0.768 . . . . 64.299999999999997 112.574 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.97 94.68 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 75.430000000000007 110.893 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.28 94.94 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 51.329999999999998 110.849 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.3 p -131.87 84.89 52.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 72.519999999999996 110.863 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 164.86 33.04 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.65 2.233 . . . . 72.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -123.8 173.78 7.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.934 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 m -97.06 130.03 44.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 71.420000000000002 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.28 148.83 71.72 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.626 0.727 . . . . 71.219999999999999 110.839 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 155.11 66.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 71.299999999999997 112.279 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.601 HD13 ' HA3' ' A' ' 56' ' ' GLY . 24.6 mt -65.49 154.13 39.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 61.149999999999999 110.913 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.91 159.68 43.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 72.219999999999999 112.495 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -115.44 -176.25 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.9 tp -70.6 142.35 51.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 70.230000000000004 110.919 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.0 m-20 60.57 39.5 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 73.209999999999994 110.882 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 159.52 71.45 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.596 0.713 . . . . 73.540000000000006 110.937 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 129.03 16.89 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 52.43 112.396 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.1 p -147.44 167.79 23.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 51.409999999999997 110.893 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.04 150.54 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.909 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -55.9 -65.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.52 157.02 72.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.686 0.755 . . . . 63.049999999999997 110.893 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -170.13 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.645 2.23 . . . . 54.310000000000002 112.348 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.83 -169.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 71.209999999999994 110.908 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.93 -15.56 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.825 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -96.58 -28.21 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.16 4.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 63.509999999999998 112.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.9 mt -123.95 146.69 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 73.099999999999994 111.129 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.452 ' HB2' HG12 ' A' ' 16' ' ' VAL . 51.3 m-85 -101.53 -176.11 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.927 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -77.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 72.5 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -122.89 -58.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 74.409999999999997 110.958 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -77.15 161.36 28.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.922 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -111.55 159.98 31.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 61.549999999999997 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 168.11 22.55 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.71 2.273 . . . . 71.329999999999998 112.403 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.8 m -68.67 126.1 28.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 70.409999999999997 110.925 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.601 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.39 19.51 0.92 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 74.140000000000001 112.402 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -127.31 27.77 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 72.540000000000006 110.847 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.3 22.87 21.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 52.439999999999998 112.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.2 mt -109.65 175.13 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 72.430000000000007 110.979 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.66 116.8 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 64.409999999999997 110.912 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.09 105.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.927 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -119.8 137.13 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 111.17 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -71.63 123.98 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 74.430000000000007 110.988 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.47 -20.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 73.299999999999997 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.64 -156.82 7.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 62.549999999999997 112.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.8 pt-20 -140.6 159.63 62.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.696 0.76 . . . . 54.310000000000002 110.78 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.75 -48.37 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.206 0 C-N-CA 122.677 -1.801 . . . . 73.040000000000006 112.347 -0.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -125.38 50.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 62.020000000000003 110.915 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -77.93 77.96 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.77 148.85 28.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 73.519999999999996 110.892 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -145.9 152.75 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.873 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -70.76 137.59 49.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.439999999999998 110.883 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -147.38 127.86 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 118.8 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.899 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.1 156.35 28.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 75.319999999999993 110.892 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 51.100000000000001 110.867 -179.773 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.913 0.387 . . . . 52.32 110.854 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.85 143.33 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 63.109999999999999 111.034 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 m -142.63 115.45 8.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 73.510000000000005 111.082 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -132.49 132.62 42.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 110.903 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.77 66.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.781 -0.723 . . . . 72.439999999999998 112.478 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.83 -20.85 42.65 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 75.230000000000004 112.46 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -99.82 149.16 23.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 75.439999999999998 110.931 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -93.48 147.46 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 73.239999999999995 110.897 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.22 169.06 16.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 52.420000000000002 110.852 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -63.91 160.79 43.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.62 0.724 . . . . 50.119999999999997 110.896 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.73 176.44 6.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.75 2.3 . . . . 75.409999999999997 112.323 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 m120 62.6 25.27 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.25 110.857 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 72.299999999999997 110.844 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.05 168.13 13.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 72.129999999999995 110.925 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.89 134.78 34.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.119999999999997 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.73 135.26 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 44.549999999999997 111.203 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.7 123.3 39.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.230000000000004 110.956 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -129.59 42.72 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 75.540000000000006 110.886 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -71.33 154.62 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 42.210000000000001 110.846 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -109.19 26.44 10.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 71.420000000000002 110.875 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.4 27.16 66.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 73.439999999999998 112.452 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.2 -31.08 23.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 74.540000000000006 110.846 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.81 15.09 15.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 64.299999999999997 112.473 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -119.87 98.95 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 75.430000000000007 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.07 94.5 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 51.329999999999998 110.902 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 t -126.91 84.92 62.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 72.519999999999996 110.837 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 166.6 27.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.703 2.269 . . . . 72.0 112.312 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 161.48 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 110.865 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 m -95.69 109.05 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.420000000000002 110.939 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 148.99 39.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 71.219999999999999 110.887 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.17 64.79 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.669 2.246 . . . . 71.299999999999997 112.316 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.6 mt -56.65 150.35 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 61.149999999999999 110.858 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.39 148.44 51.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 72.219999999999999 112.476 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -171.73 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.321 . . . . 73.439999999999998 110.898 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 59' ' ' LEU . 42.4 tp -73.12 146.89 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 70.230000000000004 110.903 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m120 59.79 24.08 13.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 159.72 36.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.604 0.716 . . . . 73.540000000000006 110.856 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 125.75 12.54 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 52.43 112.323 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.54 164.61 29.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 51.409999999999997 110.857 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.84 156.12 43.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.030000000000001 110.857 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -61.12 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 73.329999999999998 111.136 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -140.61 156.9 69.02 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.637 0.732 . . . . 63.049999999999997 110.884 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 54.310000000000002 112.335 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.08 -169.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.209999999999994 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.34 -15.2 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.905 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.81 -28.31 14.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 64.129999999999995 110.937 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.13 32.14 4.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 63.509999999999998 112.456 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt -124.66 150.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 73.099999999999994 111.144 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.1 -176.2 3.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.77 -76.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 72.5 110.84 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -122.65 -59.54 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.949 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -75.9 160.04 30.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 74.310000000000002 110.87 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 m -111.48 160.29 29.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.653 0.74 . . . . 61.549999999999997 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 168.0 22.86 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.657 2.238 . . . . 71.329999999999998 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.92 126.35 29.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 70.409999999999997 110.88 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.2 18.27 0.92 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 74.140000000000001 112.478 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.0 pt-20 -127.27 26.47 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 72.540000000000006 110.944 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.01 22.82 16.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.726 -0.75 . . . . 52.439999999999998 112.475 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.2 mt -109.73 171.94 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.430000000000007 110.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 120.0 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.865 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.66 102.48 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.864 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -115.42 140.93 48.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.450000000000003 111.117 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.75 125.74 29.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 110.847 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.679 HG23 ' HD2' ' A' ' 69' ' ' LYS . 7.9 m -117.06 -21.24 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 111.112 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.6 -176.54 15.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 62.549999999999997 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -118.0 159.54 42.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.579 0.704 . . . . 54.310000000000002 110.897 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.78 -48.68 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.679 -1.8 . . . . 73.040000000000006 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.11 65.9 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 62.020000000000003 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.679 ' HD2' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -89.44 77.79 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.862 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.1 140.93 30.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 73.519999999999996 110.863 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -140.44 157.39 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.863 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.12 132.04 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.913 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -143.21 129.06 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 63.240000000000002 110.9 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -52.05 117.33 2.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 110.877 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.92 147.5 53.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.319999999999993 110.845 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 51.100000000000001 110.843 -179.818 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.852 0.358 . . . . 52.32 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.3 136.02 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.123 -0.49 . . . . 63.109999999999999 111.073 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -146.11 107.83 4.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.2 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -147.03 144.59 29.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 73.209999999999994 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.07 20.08 78.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 72.439999999999998 112.523 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.87 23.79 73.83 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.728 -0.749 . . . . 75.230000000000004 112.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -144.95 155.28 43.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 75.439999999999998 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -101.4 155.26 18.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.856 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.91 173.13 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 52.420000000000002 110.923 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -69.06 160.58 77.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.71 . . . . 50.119999999999997 110.849 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 175.11 8.51 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.603 2.202 . . . . 75.409999999999997 112.389 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 59.98 27.56 16.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 75.25 110.928 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 p -142.02 119.23 11.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.299999999999997 110.848 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -89.13 168.14 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.129999999999995 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -89.75 132.65 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 62.119999999999997 110.869 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.05 123.98 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 44.549999999999997 111.139 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.92 122.94 25.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.230000000000004 110.896 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -130.01 84.81 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 75.540000000000006 110.835 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -96.83 164.97 12.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 42.210000000000001 110.867 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -127.66 26.01 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 71.420000000000002 110.817 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.19 27.28 66.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 73.439999999999998 112.465 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -91.9 -36.0 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.305 . . . . 74.540000000000006 110.866 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.6 15.02 16.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 64.299999999999997 112.528 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -125.32 95.25 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 75.430000000000007 110.836 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -54.44 107.25 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 51.329999999999998 110.857 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -133.68 84.98 43.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.712 0.768 . . . . 72.519999999999996 110.845 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.97 25.81 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.656 2.237 . . . . 72.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.66 174.01 10.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.010000000000005 110.877 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 120.42 40.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.420000000000002 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.64 149.02 47.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 71.219999999999999 110.839 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 149.71 67.25 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 71.299999999999997 112.337 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 56' ' ' GLY . 34.7 mt -59.34 148.67 31.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.149999999999999 110.894 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 155.42 34.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.819 -0.705 . . . . 72.219999999999999 112.448 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -108.72 -172.89 2.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 73.439999999999998 110.902 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 36' ' ' ASN . 23.6 tp -73.15 145.6 46.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.230000000000004 110.981 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 35' ' ' LEU . 77.5 m-20 58.27 38.68 26.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 73.209999999999994 110.836 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.41 159.59 69.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.688 0.756 . . . . 73.540000000000006 110.876 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 124.37 11.01 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.715 2.277 . . . . 52.43 112.33 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 p -136.31 168.26 19.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 51.409999999999997 110.798 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.16 144.39 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 72.030000000000001 110.947 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.94 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.329999999999998 111.07 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -140.01 156.8 70.28 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 63.049999999999997 110.935 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -169.87 0.36 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.638 2.225 . . . . 54.310000000000002 112.33 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -168.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 110.846 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.86 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 110.852 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -88.21 -28.44 21.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 110.826 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.86 32.07 4.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 63.509999999999998 112.514 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.46 147.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.353 . . . . 73.099999999999994 111.117 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -100.43 -175.99 3.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.219999999999999 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.21 -77.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.5 110.883 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -123.06 -58.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.409999999999997 110.9 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -77.06 168.65 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 110.852 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -116.1 160.34 35.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 61.549999999999997 110.946 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 168.13 22.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.659 2.24 . . . . 71.329999999999998 112.35 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 93.1 m -70.07 125.47 26.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 70.409999999999997 110.936 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.88 19.23 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 74.140000000000001 112.501 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -125.75 28.1 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 72.540000000000006 110.87 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.94 22.65 22.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.7 -0.762 . . . . 52.439999999999998 112.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.8 mt -108.64 177.4 4.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 72.430000000000007 110.875 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.41 118.6 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.409999999999997 110.809 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.1 m -55.41 106.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.901 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.59 136.88 54.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 111.178 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.43 126.1 29.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 110.889 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -125.03 13.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 73.299999999999997 111.101 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.87 -160.18 13.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 62.549999999999997 112.473 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -138.3 159.99 65.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.686 0.755 . . . . 54.310000000000002 110.858 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.84 -42.82 0.69 Allowed 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 122.631 -1.82 . . . . 73.040000000000006 112.288 0.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.42 49.47 2.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 62.020000000000003 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -70.55 97.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 74.0 110.88 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.88 136.87 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.93 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.63 ' HE ' HG21 ' A' ' 64' ' ' VAL . 26.4 mtm180 -139.64 150.14 44.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.828 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.72 138.57 55.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -147.01 127.17 13.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 63.240000000000002 110.926 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.39 117.02 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 110.898 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -67.17 155.03 39.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.319999999999993 110.907 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 51.100000000000001 110.854 -179.798 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.859 0.361 . . . . 52.32 110.917 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.8 t -81.31 142.62 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 63.109999999999999 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.9 m -137.49 111.15 8.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 73.510000000000005 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 m -130.61 129.16 42.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 110.965 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.58 39.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.439999999999998 112.442 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.04 20.58 64.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 75.230000000000004 112.516 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.07 143.86 46.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 75.439999999999998 110.875 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -90.88 136.44 33.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 110.882 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -124.41 169.11 12.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 52.420000000000002 110.868 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -63.83 160.6 44.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 50.119999999999997 110.964 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 175.95 7.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 75.409999999999997 112.3 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 61.05 28.51 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 p -142.06 122.81 14.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.842 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 p -89.97 168.14 12.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.476 . . . . 72.129999999999995 110.842 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.28 122.07 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 62.119999999999997 110.854 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -119.95 131.39 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 44.549999999999997 111.131 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.36 124.88 31.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 64.230000000000004 110.958 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -150.09 107.54 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.540000000000006 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 m -117.11 169.75 9.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 42.210000000000001 110.819 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -102.96 27.02 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 71.420000000000002 110.929 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.1 20.14 70.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 73.439999999999998 112.497 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.86 -26.62 34.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 74.540000000000006 110.916 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.0 15.0 15.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.85 -0.691 . . . . 64.299999999999997 112.521 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -125.94 102.62 7.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 75.430000000000007 110.902 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.61 103.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 51.329999999999998 110.896 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.7 t -124.88 84.95 57.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.758 0.79 . . . . 72.519999999999996 110.9 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 166.56 27.17 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.739 2.293 . . . . 72.0 112.384 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -137.08 174.03 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.809 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.6 m -96.86 128.47 43.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 71.420000000000002 110.931 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 148.96 69.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 71.219999999999999 110.87 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 152.16 69.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.227 . . . . 71.299999999999997 112.409 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.578 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.6 mt -61.48 154.67 23.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 61.149999999999999 110.951 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.36 154.46 53.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 72.219999999999999 112.446 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.22 -171.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 73.439999999999998 110.926 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.1 tp -71.99 147.59 46.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 70.230000000000004 110.977 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.532 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 55.05 32.35 18.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 110.89 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.66 159.7 45.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.68 0.753 . . . . 73.540000000000006 110.827 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.701 2.267 . . . . 52.43 112.27 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 p -134.47 169.81 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.409999999999997 110.883 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -129.66 148.31 51.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 72.030000000000001 110.854 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.51 -63.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 73.329999999999998 111.098 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -141.7 154.31 65.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 63.049999999999997 110.899 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.641 2.227 . . . . 54.310000000000002 112.367 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -74.09 -169.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 71.209999999999994 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.2 -17.54 64.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 74.040000000000006 110.863 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -95.6 -28.39 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.06 4.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 63.509999999999998 112.528 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mt -119.1 148.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.812 0.339 . . . . 73.099999999999994 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -104.63 -175.95 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.899 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.7 -77.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 72.5 110.875 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.71 -60.06 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.93 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -75.53 158.52 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.310000000000002 110.82 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 m -109.41 159.7 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 61.549999999999997 110.869 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.08 22.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 71.329999999999998 112.355 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.3 128.49 36.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.409999999999997 110.842 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.12 17.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.679 -0.772 . . . . 74.140000000000001 112.488 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.7 pt-20 -127.66 27.14 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 72.540000000000006 110.876 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.93 19.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 52.439999999999998 112.548 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.407 HD12 ' HG2' ' A' ' 57' ' ' GLU . 9.5 mt -108.86 173.15 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.829 0.347 . . . . 72.430000000000007 110.887 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 120.88 8.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 64.409999999999997 110.817 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.24 111.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.140000000000001 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -128.7 136.75 51.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 74.450000000000003 111.167 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -68.0 125.75 27.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 74.430000000000007 110.891 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 13.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 73.299999999999997 111.092 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.92 -156.57 10.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 62.549999999999997 112.536 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -152.56 159.51 32.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 54.310000000000002 110.898 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.8 -48.14 0.28 Allowed 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 -1.803 . . . . 73.040000000000006 112.34 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -122.77 75.01 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 62.020000000000003 110.899 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.7 93.11 4.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 74.0 110.904 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.98 142.41 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 73.519999999999996 110.875 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -142.44 145.71 34.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.420000000000002 110.839 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.39 133.11 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.858 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -141.64 128.74 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 63.240000000000002 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -51.94 117.13 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.329999999999998 110.888 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.59 155.14 40.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 75.319999999999993 110.89 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 51.100000000000001 110.831 -179.734 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.927 0.394 . . . . 52.32 110.859 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.97 131.28 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 63.109999999999999 111.138 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -140.28 111.25 6.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 73.510000000000005 111.075 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.8 m -139.21 146.19 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 110.879 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.91 20.38 72.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 72.439999999999998 112.54 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.69 28.99 56.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 75.230000000000004 112.507 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -154.77 151.47 28.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.297 . . . . 75.439999999999998 110.89 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.53 136.24 33.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 73.239999999999995 110.942 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.88 156.54 24.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.61 160.91 3.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.592 0.71 . . . . 50.119999999999997 110.85 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 164.52 34.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 75.409999999999997 112.362 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 63.4 30.48 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 75.25 110.941 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -142.0 116.67 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 110.9 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.53 168.3 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 72.129999999999995 110.867 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.21 127.81 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 62.119999999999997 110.861 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 28' ' ' ARG . 6.3 m -118.77 135.02 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 44.549999999999997 111.064 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' HB2' HG21 ' A' ' 48' ' ' ILE . 6.7 tp-100 -92.0 126.57 37.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 64.230000000000004 110.943 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -154.01 107.37 2.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.540000000000006 110.904 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 p -116.18 172.6 7.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 42.210000000000001 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -114.62 26.97 9.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 110.902 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.45 75.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.769 -0.729 . . . . 73.439999999999998 112.459 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -88.18 -30.75 19.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 74.540000000000006 110.89 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.05 15.17 20.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.776 -0.726 . . . . 64.299999999999997 112.467 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.51 103.12 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.306 . . . . 75.430000000000007 110.904 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.27 109.01 0.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 51.329999999999998 110.858 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -131.59 84.98 53.71 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.759 . . . . 72.519999999999996 110.848 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.9 26.05 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.652 2.235 . . . . 72.0 112.335 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.476 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -134.0 161.63 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 110.876 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 m -90.18 117.85 29.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.868 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 148.72 46.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.528 0.68 . . . . 71.219999999999999 110.91 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 154.81 67.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.647 2.231 . . . . 71.299999999999997 112.373 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.611 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.5 mt -62.44 149.76 41.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 61.149999999999999 110.872 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.52 154.77 48.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 72.219999999999999 112.474 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -108.51 -173.37 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 73.439999999999998 110.892 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 59' ' ' LEU . 41.0 tp -73.36 147.09 44.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.893 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.91 22.54 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.209999999999994 110.892 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.59 159.58 36.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.581 0.705 . . . . 73.540000000000006 110.881 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 123.9 10.58 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.723 2.282 . . . . 52.43 112.339 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.2 p -136.91 170.34 16.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 51.409999999999997 110.936 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -133.93 146.81 50.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.030000000000001 110.927 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.89 -66.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -139.29 156.87 71.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.629 0.728 . . . . 63.049999999999997 110.888 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -169.62 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 54.310000000000002 112.304 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.89 -168.6 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.914 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.18 67.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 110.898 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -88.7 -28.31 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 64.129999999999995 110.905 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.76 32.01 4.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 63.509999999999998 112.515 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 17' ' ' GLN . 39.1 mt -120.39 149.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 73.099999999999994 111.159 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.34 -176.12 3.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 74.219999999999999 110.927 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.22 -77.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 72.5 110.814 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -123.0 -59.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.934 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -77.05 158.48 30.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.802 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.6 m -108.77 160.29 27.82 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.71 . . . . 61.549999999999997 110.922 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 168.03 22.75 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.716 2.277 . . . . 71.329999999999998 112.305 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.5 m -68.69 127.1 31.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 70.409999999999997 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.67 17.42 0.97 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 74.140000000000001 112.499 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.56 27.24 5.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 72.540000000000006 110.841 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.63 23.95 19.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 52.439999999999998 112.457 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.4 mt -108.74 171.43 7.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.430000000000007 110.9 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 127.72 17.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.409999999999997 110.81 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.92 106.23 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.140000000000001 110.881 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.24 144.47 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.182 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -81.4 123.75 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.873 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.18 -24.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 73.299999999999997 111.154 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.16 -161.64 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 62.549999999999997 112.51 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.7 pt-20 -127.97 159.44 66.66 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.699 0.762 . . . . 54.310000000000002 110.882 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.79 -42.2 0.79 Allowed 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.631 -1.82 . . . . 73.040000000000006 112.368 0.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.34 63.53 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 62.020000000000003 110.894 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 79.32 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.0 110.937 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.25 147.05 32.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.519999999999996 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -152.89 159.03 42.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -72.76 128.6 36.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 110.884 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.82 126.46 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 63.240000000000002 110.948 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.329999999999998 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -65.66 152.03 45.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 75.319999999999993 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 51.100000000000001 110.886 -179.873 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.842 0.353 . . . . 52.32 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.29 144.49 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 63.109999999999999 111.09 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -153.34 110.52 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.510000000000005 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 m -148.52 133.64 18.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.209999999999994 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.83 76.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 72.439999999999998 112.464 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.39 28.66 65.41 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.687 -0.768 . . . . 75.230000000000004 112.529 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.96 134.99 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.674 0.273 . . . . 75.439999999999998 110.953 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.51 152.01 21.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 73.239999999999995 110.919 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.48 171.14 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 52.420000000000002 110.877 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -63.28 160.76 38.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.589 0.709 . . . . 50.119999999999997 110.856 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.05 8.57 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.756 2.304 . . . . 75.409999999999997 112.328 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.18 38.44 26.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 75.25 110.828 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -141.32 123.55 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 72.299999999999997 110.907 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -88.92 168.16 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.129999999999995 110.948 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -88.32 134.44 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 62.119999999999997 110.882 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.35 130.53 65.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 44.549999999999997 111.113 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.87 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.230000000000004 110.917 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.7 120.13 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 75.540000000000006 110.875 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 179.88 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 42.210000000000001 110.853 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -126.35 28.8 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 71.420000000000002 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.97 65.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 73.439999999999998 112.415 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -92.05 -31.02 15.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 74.540000000000006 110.888 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.03 -5.38 34.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 64.299999999999997 112.458 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -117.19 93.0 4.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 75.430000000000007 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.06 117.9 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 51.329999999999998 110.931 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -135.19 84.94 34.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.74 . . . . 72.519999999999996 110.852 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 166.46 27.47 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.627 2.218 . . . . 72.0 112.327 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -138.14 173.99 11.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.010000000000005 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -99.24 130.18 45.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 71.420000000000002 110.932 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 149.71 56.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.702 . . . . 71.219999999999999 110.815 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 147.32 62.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 71.299999999999997 112.376 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 56' ' ' GLY . 27.7 mt -57.73 149.89 21.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 61.149999999999999 110.948 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.44 160.5 32.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 72.219999999999999 112.481 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -114.38 -171.87 2.0 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.439999999999998 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 36' ' ' ASN . 26.7 tp -73.18 144.57 46.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.879 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.595 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.8 m-20 58.19 37.09 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 73.209999999999994 110.932 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.95 159.72 65.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.638 0.732 . . . . 73.540000000000006 110.938 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 124.28 10.91 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.701 2.268 . . . . 52.43 112.344 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -135.0 165.43 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 51.409999999999997 110.926 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.17 145.54 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 72.030000000000001 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.86 -67.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 111.096 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -139.07 156.81 72.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.643 0.735 . . . . 63.049999999999997 110.877 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -169.73 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.264 . . . . 54.310000000000002 112.34 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -168.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.209999999999994 110.878 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.14 67.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.040000000000006 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.03 -28.42 21.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 64.129999999999995 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.72 32.15 4.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.509999999999998 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 mt -122.26 150.54 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.099999999999994 111.131 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.47 -176.02 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 110.976 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.75 -77.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.5 110.836 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -122.82 -59.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.71 159.95 30.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 74.310000000000002 110.861 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.8 m -111.54 160.13 30.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.561 0.696 . . . . 61.549999999999997 110.943 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.99 22.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.658 2.239 . . . . 71.329999999999998 112.373 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.5 m -70.23 124.54 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 70.409999999999997 110.916 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.63 19.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 74.140000000000001 112.494 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.76 28.45 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 72.540000000000006 110.903 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.19 22.73 24.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 52.439999999999998 112.523 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.34 172.39 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 72.430000000000007 110.923 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -144.81 118.32 9.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 64.409999999999997 110.852 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.43 102.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.140000000000001 110.838 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -118.55 147.55 43.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.450000000000003 111.149 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -88.96 124.84 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.430000000000007 110.927 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.55 13.17 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.299999999999997 111.136 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.36 -161.5 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 62.549999999999997 112.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.2 pt-20 -151.12 159.47 33.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.310000000000002 110.862 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.78 -48.39 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.748 -1.772 . . . . 73.040000000000006 112.331 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -123.82 72.53 1.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 62.020000000000003 110.832 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -99.9 78.15 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.68 141.69 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 73.519999999999996 110.887 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -149.75 160.67 43.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.420000000000002 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.59 140.34 41.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.957 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.76 127.3 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 63.240000000000002 110.911 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.01 120.35 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 110.833 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -64.39 150.31 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.319999999999993 110.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 51.100000000000001 110.878 -179.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.878 0.37 . . . . 63.11 111.127 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.5 m -136.02 109.59 7.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.121 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.8 m -127.54 143.89 51.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.88 43.11 70.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.99 24.51 58.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.49 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -145.09 136.26 24.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.694 0.283 . . . . 75.44 110.938 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.8 139.35 50.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 73.24 110.932 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.1 m -122.09 164.07 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 52.42 110.915 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -66.1 161.1 59.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.564 0.697 . . . . 50.12 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 167.49 24.3 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.68 2.253 . . . . 75.41 112.335 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 63.62 27.55 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.87 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -141.99 116.64 9.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.883 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.88 168.13 13.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.898 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 m -90.51 131.72 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 62.12 110.909 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.68 133.68 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 44.55 111.109 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -78.83 123.08 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.902 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.907 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.688 0.756 . . . . 72.52 110.861 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.03 28.93 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.697 2.265 . . . . 72.0 112.358 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -123.63 162.32 23.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.871 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.4 m -91.89 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.906 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 148.42 40.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.566 0.698 . . . . 71.22 110.888 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 152.18 69.24 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 71.3 112.375 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.614 HD13 ' HA3' ' A' ' 56' ' ' GLY . 22.5 mt -60.52 150.59 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 61.15 110.892 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.25 152.84 49.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.503 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -108.73 -172.96 2.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 73.44 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.6 tp -74.82 151.79 39.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.873 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.14 22.29 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.21 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.66 159.33 46.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 73.54 110.895 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 132.14 22.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 52.43 112.385 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.0 159.1 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 51.41 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -122.2 143.35 49.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 72.03 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -52.01 -65.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.33 111.129 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -137.66 156.99 74.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 63.05 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 54.31 112.343 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.41 -169.35 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 71.21 110.868 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -68.54 -14.89 63.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -95.61 -28.29 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.13 110.863 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 32.12 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.37 147.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 73.1 111.134 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -99.76 -175.95 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.911 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -77.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 72.5 110.819 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -123.01 -58.57 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -75.59 169.93 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.817 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.5 m -118.09 160.0 40.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 61.55 110.853 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 166.55 27.22 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 71.33 112.324 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.5 m -66.81 124.55 23.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.89 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -148.96 16.03 1.18 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 74.14 112.463 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.2 pt-20 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 72.54 110.892 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.01 23.57 29.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 52.44 112.509 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 74' ' ' GLU . 10.3 mt -109.9 176.07 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 72.43 110.942 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 119.77 5.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 64.41 110.866 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.99 108.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.858 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.51 137.8 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.138 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.34 120.87 18.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.886 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.69 -19.36 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 73.3 111.118 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.37 -157.25 7.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 62.55 112.503 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -138.0 159.55 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 54.31 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.8 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.663 -1.807 . . . . 73.04 112.339 0.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -130.12 49.7 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -72.93 78.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mp -79.73 129.25 34.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 73.52 110.905 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.26 157.78 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.43 129.23 36.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -140.64 124.3 17.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 63.24 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HG2' HD23 ' A' ' 59' ' ' LEU . 25.8 mm-40 -51.78 116.94 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.918 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.96 147.59 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.32 110.887 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 51.1 110.816 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.876 0.37 . . . . 63.11 111.125 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -128.96 109.99 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.51 111.167 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.59 142.86 50.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.872 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.98 41.55 59.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 72.44 112.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.14 20.18 57.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 75.23 112.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -135.75 140.45 44.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 75.44 110.932 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -84.01 135.41 34.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 73.24 110.95 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 m -123.65 167.7 13.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 52.42 110.825 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -67.78 160.67 72.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 50.12 110.879 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 174.55 9.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.718 2.279 . . . . 75.41 112.321 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 62.54 26.14 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.1 p -141.45 119.53 12.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.3 110.816 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.97 168.23 12.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 72.13 110.845 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.7 m -92.92 128.62 38.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.12 110.83 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -117.9 141.57 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.55 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.43 136.36 53.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.861 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.954 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.618 0.723 . . . . 72.52 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.8 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.764 2.31 . . . . 72.0 112.276 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -132.32 164.78 25.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.01 110.86 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -96.34 119.04 34.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 149.27 47.88 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 71.22 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 148.11 64.02 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.723 2.282 . . . . 71.3 112.379 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.618 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.3 mt -57.25 149.33 20.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 61.15 110.931 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.75 145.6 49.91 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 72.22 112.506 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -100.87 -172.83 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 73.44 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.94 151.12 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 70.23 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 m120 58.21 22.34 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.93 159.47 40.74 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 73.54 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 141.59 45.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 52.43 112.254 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -150.79 165.37 33.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 51.41 110.959 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 72.03 110.835 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.8 t -51.65 -61.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 73.33 111.139 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -142.27 156.74 64.19 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.678 0.751 . . . . 63.05 110.817 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -168.43 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.538 2.158 . . . . 54.31 112.381 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -169.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 71.21 110.895 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -65.98 -19.76 65.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 74.04 110.824 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -97.06 -28.24 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.13 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.33 3.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 63.51 112.463 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.25 155.99 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 73.1 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -112.91 -176.03 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.926 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.36 -78.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.782 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -122.94 -59.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.971 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -76.01 157.87 32.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.836 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.77 159.81 29.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 61.55 110.953 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.05 36.06 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 71.33 112.324 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.1 m -66.55 127.82 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.839 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.618 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.39 17.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 74.14 112.516 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.91 27.59 5.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 72.54 110.895 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.64 19.17 28.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.533 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -108.54 164.68 12.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 72.43 110.944 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -142.61 125.61 16.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 64.41 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -55.46 101.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.936 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -118.57 140.27 50.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.45 111.091 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -70.5 125.84 27.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.43 110.892 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.46 HG21 ' HG3' ' A' ' 71' ' ' ARG . 28.1 m -126.05 12.86 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.3 111.093 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.11 -165.49 30.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 62.55 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -142.5 159.83 56.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.31 110.856 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.1 Cg_endo -69.64 -48.74 0.26 Allowed 'Cis proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.721 -1.783 . . . . 73.04 112.369 -0.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -125.2 75.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.898 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -101.47 78.03 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 74.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.8 136.93 36.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.916 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' HG21 ' A' ' 64' ' ' VAL . 13.2 mmt180 -144.78 154.18 42.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 74.42 110.859 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.08 134.11 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.96 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -141.62 136.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -51.11 116.68 2.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.889 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 158.51 29.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.822 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 51.1 110.897 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 13' ' ' SER . 57.3 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.94 0.4 . . . . 63.11 111.117 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 8' ' ' GLN . 10.1 m -146.86 110.27 4.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 73.51 111.099 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.2 m -146.63 135.24 22.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.477 . . . . 73.21 110.886 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.78 73.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.764 . . . . 72.44 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.5 70.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.504 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 136.24 27.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.711 0.291 . . . . 75.44 110.903 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 3' ' ' THR . 10.7 mt-30 -93.36 142.81 26.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.913 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -130.97 169.61 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 52.42 110.897 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -57.41 160.73 6.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.582 0.705 . . . . 50.12 110.834 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 175.5 7.95 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.727 2.285 . . . . 75.41 112.354 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 58.63 37.34 25.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.47 . . . . 75.25 110.905 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 2' ' ' VAL . 58.4 m -140.96 127.57 20.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 72.3 110.866 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 p -90.36 168.11 12.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.839 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 m -90.49 126.58 35.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 62.12 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 m -122.46 155.19 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 44.55 111.124 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.13 131.73 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.23 110.902 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 75.54 110.896 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.1 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.653 0.739 . . . . 72.52 110.795 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 165.96 29.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 72.0 112.307 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -131.57 170.19 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.01 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.9 130.26 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.42 110.855 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 149.52 58.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.587 0.708 . . . . 71.22 110.871 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.73 51.84 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.622 2.215 . . . . 71.3 112.379 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.4 mt -54.33 151.26 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 61.15 110.887 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.48 158.72 48.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.525 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -111.12 -175.08 2.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 73.44 110.943 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 36' ' ' ASN . 28.1 tp -70.09 144.19 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 70.23 110.916 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.596 ' H ' HD12 ' A' ' 35' ' ' LEU . 59.4 m-20 58.51 38.92 25.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.21 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 159.67 67.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.64 0.733 . . . . 73.54 110.866 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 123.39 10.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.629 2.219 . . . . 52.43 112.308 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 p -142.07 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 51.41 110.933 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -128.52 146.84 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -52.24 -64.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.118 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -139.78 157.05 70.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 63.05 110.831 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.06 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.759 2.306 . . . . 54.31 112.298 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.95 -169.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.892 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -67.88 -16.25 63.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.844 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.62 -28.42 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.39 32.07 4.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 63.51 112.432 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mt -122.04 148.5 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 73.1 111.158 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -104.9 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.918 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.35 -76.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 72.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -122.64 -59.65 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.905 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -75.33 163.57 27.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.804 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 m -115.13 159.61 37.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 61.55 110.935 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 168.28 22.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.22 . . . . 71.33 112.34 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.45 130.97 44.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.44 19.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 74.14 112.483 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -128.02 26.24 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 72.54 110.842 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.47 21.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 52.44 112.478 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.7 mt -108.4 175.67 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.43 110.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.1 116.26 7.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 64.41 110.797 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 106.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 73.14 110.887 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -119.24 139.43 51.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.45 111.115 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -68.75 122.28 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.872 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.7 HG21 ' HD3' ' A' ' 71' ' ' ARG . 30.1 m -116.79 -18.88 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.3 111.069 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.95 -157.45 7.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 62.55 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -144.17 159.6 51.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 54.31 110.917 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.79 -48.41 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 -1.79 . . . . 73.04 112.312 0.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -123.06 52.7 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 62.02 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -88.64 77.98 7.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.69 156.2 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.7 ' HD3' HG21 ' A' ' 64' ' ' VAL . 45.5 mtp180 -147.84 157.92 43.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 74.42 110.868 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.6 140.45 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -149.36 125.74 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 63.24 110.92 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -52.04 117.59 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -66.52 158.76 28.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.1 110.818 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 13' ' ' SER . 84.5 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.937 0.398 . . . . 63.11 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 8' ' ' GLN . 8.1 m -138.67 107.84 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 73.51 111.165 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 m -135.19 147.93 49.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.864 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.29 37.57 87.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 72.44 112.455 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.63 23.14 64.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 75.23 112.499 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -142.36 143.53 32.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 75.44 110.914 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 3' ' ' THR . 34.0 mt-30 -95.92 148.18 22.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.971 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.2 m -137.93 168.87 18.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 52.42 110.904 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -54.43 160.94 2.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 50.12 110.843 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.26 8.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.714 2.276 . . . . 75.41 112.308 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.17 39.07 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.905 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 2' ' ' VAL . 93.2 p -140.61 131.26 25.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 72.3 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -94.01 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 72.13 110.875 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 m -90.25 123.59 34.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 62.12 110.852 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.22 144.47 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 44.55 111.087 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -90.56 124.82 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 64.23 110.951 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 m120 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.948 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.731 0.777 . . . . 72.52 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 165.88 29.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.72 2.28 . . . . 72.0 112.342 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -134.48 173.91 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 72.01 110.872 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.45 130.95 46.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 149.39 59.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 71.22 110.912 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 146.28 59.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 71.3 112.328 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.9 mt -55.73 150.04 13.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 61.15 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.77 157.19 52.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 72.22 112.492 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -109.51 -171.69 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.858 0.361 . . . . 73.44 110.899 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.7 tp -72.13 146.1 47.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.938 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.507 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.4 m-20 58.09 34.6 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.44 159.74 56.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.54 110.907 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 119.41 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 52.43 112.279 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -136.58 168.31 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.41 110.851 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -129.96 144.27 51.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 72.03 110.94 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.08 -63.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -138.98 156.99 72.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.695 0.759 . . . . 63.05 110.851 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.83 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 54.31 112.402 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.07 -169.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.21 110.878 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.47 -16.32 64.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -96.97 -28.34 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.947 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.17 31.99 4.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.9 149.64 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 73.1 111.111 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -104.13 -176.27 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.892 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -77.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 72.5 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -122.76 -59.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 74.41 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -74.77 161.09 29.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.795 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.1 159.9 31.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 61.55 110.949 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.07 22.55 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 71.33 112.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.57 129.93 41.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 70.41 110.906 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -154.67 19.41 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 74.14 112.476 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.5 pt-20 -127.34 25.83 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 72.54 110.892 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.0 22.8 16.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 52.44 112.466 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -108.84 178.47 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 72.43 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.33 114.39 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.882 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.3 106.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.875 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -119.14 139.26 52.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.45 111.105 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -69.27 123.4 21.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 m -116.45 -21.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 73.3 111.126 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.92 -164.55 10.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 62.55 112.468 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -133.34 160.14 69.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 54.31 110.906 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.73 -48.55 0.26 Allowed 'Cis proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.714 -1.786 . . . . 73.04 112.364 -0.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -125.53 50.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.02 110.932 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -83.99 77.92 9.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -86.8 154.46 20.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.915 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -146.31 149.7 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.883 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.1 137.52 56.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.44 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -146.84 126.29 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.92 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.03 117.43 2.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.87 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.06 158.11 32.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 51.1 110.867 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.9 0.381 . . . . 63.11 111.074 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 m -148.93 114.49 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.51 111.131 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.18 152.62 40.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.27 25.81 67.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 72.44 112.458 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.42 78.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 75.23 112.488 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -143.89 153.95 42.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 75.44 110.863 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -93.11 138.97 31.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 73.24 110.921 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 m -117.76 175.15 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 52.42 110.802 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -76.29 160.52 77.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.6 0.714 . . . . 50.12 110.881 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.41 112.311 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.52 32.89 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -142.07 132.11 24.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 72.3 110.851 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -97.74 168.27 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 m -95.98 124.25 39.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 62.12 110.883 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 131.7 70.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 44.55 111.127 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -83.39 124.67 30.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 64.23 110.929 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 75.54 110.862 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.634 0.73 . . . . 72.52 110.798 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 166.45 27.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 72.0 112.366 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -127.26 172.21 10.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 72.01 110.841 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.9 m -103.3 118.11 36.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.952 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 148.82 64.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.594 0.711 . . . . 71.22 110.812 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 149.99 67.96 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.626 2.217 . . . . 71.3 112.392 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 56' ' ' GLY . 26.8 mt -61.21 157.86 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.891 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 157.07 51.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 72.22 112.501 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -108.29 -173.47 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 73.44 110.878 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 36' ' ' ASN . 24.7 tp -71.62 148.29 46.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 70.23 110.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.538 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.0 m-20 55.02 35.4 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.879 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.32 159.53 56.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.61 0.719 . . . . 73.54 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 117.97 5.4 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 52.43 112.333 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -133.89 171.06 14.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 51.41 110.847 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -126.98 147.82 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.03 110.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.64 -63.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 73.33 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 154.14 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 63.05 110.897 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -169.64 0.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.675 2.25 . . . . 54.31 112.382 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.66 -169.34 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 71.21 110.907 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -65.2 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -93.69 -25.66 17.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 64.13 110.895 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.25 5.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.431 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.452 HG21 ' HB2' ' A' ' 17' ' ' GLN . 5.6 mm -108.74 156.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 73.1 111.129 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.75 -176.73 2.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.962 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -79.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.5 110.805 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -123.32 -58.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.41 110.951 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -77.22 158.68 30.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.898 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.6 m -107.57 159.4 30.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 61.55 110.873 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 168.22 22.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 71.33 112.355 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.7 m -69.45 132.84 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 70.41 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.67 19.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.708 -0.758 . . . . 74.14 112.466 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.61 27.0 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 72.54 110.946 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.49 23.09 19.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 52.44 112.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.6 mt -109.77 177.04 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 72.43 110.908 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.34 122.36 7.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.41 110.878 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.12 111.8 0.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 73.14 110.871 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -131.25 136.56 48.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 74.45 111.121 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -65.99 127.23 31.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.79 -23.59 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 73.3 111.131 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.5 -167.46 12.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 62.55 112.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.1 pt-20 -119.09 159.69 44.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.692 0.758 . . . . 54.31 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.76 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 -1.796 . . . . 73.04 112.346 -0.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -131.25 43.58 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 62.02 110.835 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -66.5 89.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.41 136.38 33.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.886 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -135.35 145.99 47.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.936 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.29 136.66 55.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 74.44 110.882 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -144.99 126.04 14.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 63.24 110.878 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -51.85 116.92 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.953 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.71 155.67 38.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 75.32 110.928 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 51.1 110.864 -179.773 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.833 0.349 . . . . 63.11 111.118 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -132.05 110.06 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 73.51 111.152 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.13 137.97 52.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.88 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.22 18.58 69.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.09 -19.62 48.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.509 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -108.41 152.88 24.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.722 0.296 . . . . 75.44 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -80.73 144.19 32.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.974 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.81 159.84 24.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 52.42 110.894 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -56.6 160.99 4.78 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.526 0.679 . . . . 50.12 110.944 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 166.87 26.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.716 2.277 . . . . 75.41 112.332 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 59.23 33.96 22.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.91 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -141.97 123.8 15.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 72.3 110.901 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -88.78 168.12 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 72.13 110.897 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -88.62 120.38 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 62.12 110.979 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.64 141.04 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 44.55 111.12 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 122.84 47.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.23 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.54 110.916 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.6 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.687 0.756 . . . . 72.52 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 166.56 27.33 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 72.0 112.261 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -135.23 173.81 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.01 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 m -96.67 129.83 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.861 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.07 148.32 68.84 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.549 0.69 . . . . 71.22 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 155.69 65.4 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 71.3 112.338 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -63.68 162.07 13.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 61.15 110.913 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.68 150.21 41.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.741 . . . . 72.22 112.459 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -99.47 -174.29 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.44 110.957 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 ' H ' ' A' ' 36' ' ' ASN . 20.9 tp -71.14 144.01 50.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.924 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.546 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.2 m-20 57.38 26.86 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.869 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.04 159.55 31.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 73.54 110.863 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 119.27 6.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.646 2.231 . . . . 52.43 112.383 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -136.59 166.07 24.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 51.41 110.814 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -125.64 142.58 51.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 72.03 110.883 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -51.67 -63.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.33 111.078 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -138.52 157.11 72.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.693 0.759 . . . . 63.05 110.841 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 54.31 112.3 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -72.98 -169.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.21 110.858 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.63 -14.15 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.04 110.883 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -97.63 -28.34 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.13 110.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.07 32.12 4.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 63.51 112.527 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mt -125.26 148.84 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.844 0.355 . . . . 73.1 111.101 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -99.78 -176.26 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.908 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.13 -77.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 72.5 110.929 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.01 -59.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -74.88 162.42 28.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.9 m -113.36 158.73 37.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.542 0.686 . . . . 61.55 110.918 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 168.11 22.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.636 2.224 . . . . 71.33 112.34 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -67.74 125.64 26.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.911 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.52 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.54 15.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.733 . . . . 74.14 112.469 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.4 pt-20 -125.9 37.21 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 72.54 110.878 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.4 24.6 39.18 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 52.44 112.501 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.473 HD12 ' HG2' ' A' ' 57' ' ' GLU . 13.3 mt -110.37 174.85 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 72.43 110.848 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.5 118.77 6.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 64.41 110.791 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 110.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.14 110.862 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -130.7 140.99 50.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.117 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -67.83 119.68 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.855 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.85 -20.4 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.147 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.34 -157.47 7.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 62.55 112.464 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -144.1 159.73 51.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.717 . . . . 54.31 110.886 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.3 Cg_endo -69.7 -48.41 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.156 0 C-N-CA 122.69 -1.796 . . . . 73.04 112.372 -0.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -124.69 58.33 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 62.02 110.845 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -90.21 82.36 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.935 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.28 149.24 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.94 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -151.13 146.51 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.42 110.834 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.41 141.28 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.891 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -150.9 127.06 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 63.24 110.941 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -51.9 116.94 2.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.58 157.67 37.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 51.1 110.788 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 9' ' ' CYS . 6.8 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.976 0.417 . . . . 63.11 111.108 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -147.88 123.55 10.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 73.51 111.131 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.2 m -150.2 150.44 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.877 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.82 37.14 89.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.79 20.83 62.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 75.23 112.505 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -140.22 154.46 46.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 75.44 110.876 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -93.99 138.27 32.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.24 110.961 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB2' HG13 ' A' ' 2' ' ' VAL . 17.4 m -113.58 174.99 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 52.42 110.856 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -81.75 160.88 62.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 50.12 110.899 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.78 33.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.737 2.292 . . . . 75.41 112.322 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.04 25.26 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.92 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -142.05 119.99 12.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.3 110.811 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.96 168.0 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.0 m -88.2 133.25 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 62.12 110.959 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.53 124.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 44.55 111.121 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -82.61 125.65 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 64.23 110.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m120 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.921 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.701 0.762 . . . . 72.52 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 166.67 26.74 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.716 2.277 . . . . 72.0 112.398 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -127.03 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.01 110.85 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.8 m -103.45 111.73 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.886 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.51 148.64 42.24 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.603 0.716 . . . . 71.22 110.808 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.54 69.27 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.663 2.242 . . . . 71.3 112.344 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.603 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.0 mt -64.31 148.51 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 61.15 110.912 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.81 152.87 38.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.752 . . . . 72.22 112.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -103.94 -170.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 73.44 110.883 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.0 tp -73.03 142.1 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.912 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.6 m-20 59.65 34.64 22.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.851 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.62 49.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.651 0.739 . . . . 73.54 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 52.43 112.381 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.51 161.96 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 51.41 110.857 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.67 146.65 47.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 72.03 110.855 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.94 -64.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.164 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -138.29 156.98 73.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 63.05 110.907 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.632 2.222 . . . . 54.31 112.344 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.23 -169.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 71.21 110.959 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.48 -15.58 63.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -95.46 -28.32 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.13 110.89 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.03 32.06 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.502 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.3 mt -125.64 149.54 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 73.1 111.123 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -102.19 -176.09 3.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.71 -77.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 72.5 110.916 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -122.85 -59.46 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.946 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -75.93 160.9 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -112.79 160.07 32.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.649 0.738 . . . . 61.55 110.889 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 168.04 22.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.227 . . . . 71.33 112.423 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -68.87 126.31 29.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 70.41 110.887 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.9 19.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 74.14 112.481 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -127.85 27.48 5.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 72.54 110.887 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.55 19.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.729 -0.748 . . . . 52.44 112.498 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.5 mt -109.74 169.5 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 72.43 110.898 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.52 117.79 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 64.41 110.872 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.3 m -55.66 103.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.908 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -115.77 136.58 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.45 111.065 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -68.91 124.67 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.89 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG21 ' HG3' ' A' ' 71' ' ' ARG . 16.7 m -126.07 13.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.108 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.13 -167.52 33.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 62.55 112.513 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -127.48 159.58 64.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.6 0.714 . . . . 54.31 110.942 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.77 -48.23 0.28 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 73.04 112.355 -0.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.13 43.72 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 62.02 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -65.06 102.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 74.0 110.991 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 61' ' ' CYS . 5.7 mp -104.88 138.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 73.52 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.573 ' HG3' HG21 ' A' ' 64' ' ' VAL . 18.2 mmt85 -135.86 150.24 49.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.42 110.829 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.47 140.28 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.44 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -151.56 129.14 11.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 63.24 110.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.77 116.95 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.896 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -66.94 149.5 50.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.94 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 51.1 110.847 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.956 0.408 . . . . 63.11 111.096 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -128.73 115.58 18.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 73.51 111.136 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 m -137.48 125.51 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.44 17.76 79.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 72.44 112.477 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.25 -16.72 58.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 75.23 112.482 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.53 152.33 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 75.44 110.848 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -97.17 154.7 17.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.878 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.49 172.04 14.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 52.42 110.9 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -64.08 160.83 44.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.719 . . . . 50.12 110.898 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 175.75 7.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.236 . . . . 75.41 112.321 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 56.5 37.81 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.941 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.33 122.32 14.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 72.3 110.807 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -87.72 168.1 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.88 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -90.56 134.63 34.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 62.12 110.87 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.34 144.83 36.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 44.55 111.156 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -89.34 124.09 34.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.972 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.6 m120 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.905 -179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.716 0.77 . . . . 72.52 110.868 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 166.2 28.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.669 2.246 . . . . 72.0 112.339 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -136.11 174.05 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 72.01 110.832 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.57 130.29 46.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.924 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 149.4 53.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 71.22 110.861 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 144.67 54.66 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.26 . . . . 71.3 112.307 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -54.29 149.11 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.15 110.942 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 153.04 51.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 72.22 112.509 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -106.34 -172.33 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.44 110.875 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.4 tp -74.77 151.15 39.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 70.23 110.939 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 60.5 21.87 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.22 159.52 44.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.627 0.727 . . . . 73.54 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 145.93 58.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 52.43 112.361 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.9 p -153.96 167.3 30.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 51.41 110.881 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -126.54 145.43 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 72.03 110.897 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -53.13 -65.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.33 111.172 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -140.01 156.8 70.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.641 0.734 . . . . 63.05 110.927 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -170.5 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.238 . . . . 54.31 112.308 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.21 110.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.72 -16.58 64.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 74.04 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -96.36 -28.37 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.86 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 63.51 112.505 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.71 146.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 73.1 111.111 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -100.15 -176.3 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.51 -77.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.5 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -122.81 -58.85 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 74.41 110.985 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -76.31 167.74 21.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.908 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -117.8 160.19 39.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.548 0.689 . . . . 61.55 110.913 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 168.11 22.47 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 71.33 112.332 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 91.9 m -69.1 127.97 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.841 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.622 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.11 19.36 0.73 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.68 -0.772 . . . . 74.14 112.465 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.7 pt-20 -127.57 27.64 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 72.54 110.813 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.04 20.44 23.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 52.44 112.507 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.6 mt -109.34 177.48 4.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 72.43 110.939 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 122.18 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 64.41 110.861 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.09 108.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -123.92 148.45 46.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.45 111.173 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -82.47 122.75 28.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.909 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.94 13.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.3 111.082 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.05 -167.98 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 62.55 112.466 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -140.26 160.04 61.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 54.31 110.872 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.2 Cg_endo -69.68 -44.91 0.46 Allowed 'Cis proline' 0 C--N 1.341 0.151 0 C-N-CA 122.753 -1.769 . . . . 73.04 112.325 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -130.73 69.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 62.02 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -94.26 78.2 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.17 137.9 33.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.52 110.888 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -144.15 170.81 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.38 135.44 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -146.7 130.93 17.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.24 110.872 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.77 117.24 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.851 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.87 149.21 49.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.901 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 51.1 110.85 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.893 0.377 . . . . 63.11 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.4 m -136.47 109.17 7.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.51 111.159 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.3 m -136.97 137.58 39.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.897 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 39.96 97.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.701 -0.761 . . . . 72.44 112.446 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.98 29.07 64.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.442 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -144.94 139.59 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 75.44 110.831 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -89.64 148.58 23.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.939 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -139.09 170.4 16.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 52.42 110.881 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -60.35 161.07 14.66 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.544 0.687 . . . . 50.12 110.876 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 173.42 10.95 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.666 2.244 . . . . 75.41 112.334 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 58.19 37.58 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.21 122.54 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.86 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.55 168.1 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.861 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -89.82 129.89 36.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 62.12 110.828 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.1 152.64 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 44.55 111.165 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HG2' HG21 ' A' ' 48' ' ' ILE . 4.9 mm-40 -112.07 136.72 51.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 64.23 110.898 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 75.54 110.894 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.711 0.767 . . . . 72.52 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 166.46 27.48 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 72.0 112.389 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.0 mtp85 -140.24 173.98 10.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.859 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.26 129.97 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 71.42 110.858 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.12 149.64 54.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 71.22 110.838 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.29 62.35 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.655 2.237 . . . . 71.3 112.318 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 56' ' ' GLY . 36.2 mt -56.6 148.8 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 61.15 110.863 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.68 154.48 45.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 72.22 112.518 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -107.34 -174.42 2.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.856 0.36 . . . . 73.44 110.837 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.1 tp -70.7 145.47 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 70.23 110.9 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.7 m-20 58.37 38.33 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.946 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.03 159.74 68.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.585 0.707 . . . . 73.54 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 130.96 20.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.683 2.255 . . . . 52.43 112.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -144.38 170.44 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 51.41 110.894 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -129.53 147.78 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.03 110.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.32 -67.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 73.33 111.123 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -138.51 156.78 73.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 63.05 110.881 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 54.31 112.358 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -169.51 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.904 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -66.79 -16.54 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.885 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -97.49 -28.25 14.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 64.13 110.865 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.98 4.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 63.51 112.491 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.473 HG21 ' HG2' ' A' ' 17' ' ' GLN . 65.7 mt -119.7 146.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 73.1 111.153 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -103.1 -176.09 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.885 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.06 -77.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.5 110.868 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -123.02 -59.88 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.932 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -75.72 158.29 32.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.885 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.53 160.17 30.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 61.55 110.844 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 168.08 22.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.673 2.249 . . . . 71.33 112.432 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.58 128.77 37.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 70.41 110.86 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.99 20.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 74.14 112.495 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.8 28.26 5.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.923 0.392 . . . . 72.54 110.919 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.95 23.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 52.44 112.516 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -109.06 176.11 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 72.43 110.996 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.65 119.6 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.41 110.893 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.21 108.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 137.12 55.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 74.45 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -71.92 124.06 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.908 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.89 -20.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.3 111.154 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.05 -174.06 16.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 62.55 112.504 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -116.7 159.41 40.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.571 0.701 . . . . 54.31 110.837 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -48.25 0.28 Allowed 'Cis proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.708 -1.788 . . . . 73.04 112.403 -0.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -130.98 46.55 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 62.02 110.865 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -70.12 83.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 74.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.17 145.8 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.941 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -143.33 154.96 44.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.846 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.92 139.28 48.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.98 128.59 12.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 63.24 110.874 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.04 117.05 2.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.16 153.92 42.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.906 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 51.1 110.862 -179.809 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.936 0.398 . . . . 63.11 111.095 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 m -129.7 122.22 28.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 73.51 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 m -139.68 130.35 25.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.878 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.24 22.84 59.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.07 68.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.73 . . . . 75.23 112.455 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 139.05 31.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 75.44 110.866 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.12 142.97 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 73.24 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -139.45 174.63 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 52.42 110.905 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -72.41 160.73 82.01 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 50.12 110.877 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 177.77 5.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.626 2.217 . . . . 75.41 112.313 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 62.81 27.09 15.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 75.25 110.955 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.0 m -142.03 117.41 10.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 72.3 110.855 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.19 168.26 16.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -91.57 131.0 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 62.12 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 28' ' ' ARG . 5.9 m -124.19 147.04 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 44.55 111.153 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.94 136.54 54.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 64.23 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.848 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 121.708 0.766 . . . . 72.52 110.851 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 165.64 30.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.75 2.3 . . . . 72.0 112.329 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 16' ' ' VAL . 8.1 tpt180 -130.51 163.39 27.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.86 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -90.72 121.04 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.934 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.56 148.57 50.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 71.22 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 154.8 67.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.725 2.283 . . . . 71.3 112.327 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.6 mt -65.35 158.18 27.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 61.15 110.928 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.32 158.59 50.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 72.22 112.511 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -110.37 -173.08 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 73.44 110.895 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 36' ' ' ASN . 32.3 tp -70.37 145.0 51.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.958 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 35' ' ' LEU . 90.2 m-20 57.24 39.45 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.21 110.869 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 159.45 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.68 0.752 . . . . 73.54 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.767 2.311 . . . . 52.43 112.289 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -142.16 160.21 40.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 51.41 110.841 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.9 142.44 47.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 72.03 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.6 -60.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.15 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -139.03 157.08 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.702 0.763 . . . . 63.05 110.868 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -170.41 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.637 2.225 . . . . 54.31 112.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.21 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.92 -15.75 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.815 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -96.52 -28.44 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 64.13 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.11 32.14 4.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 63.51 112.554 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.3 mt -125.54 150.51 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.1 111.123 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -102.04 -176.1 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.868 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.54 -77.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 72.5 110.854 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -123.04 -58.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.981 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -75.2 169.72 17.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 24.0 m -119.17 158.35 48.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.621 0.724 . . . . 61.55 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 168.27 22.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.637 2.225 . . . . 71.33 112.355 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -64.69 125.18 23.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 70.41 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.94 17.88 1.08 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 74.14 112.479 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.8 pt-20 -127.07 28.99 5.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 72.54 110.831 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.67 22.52 23.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 52.44 112.454 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.2 mt -109.81 179.36 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 72.43 110.923 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.74 116.59 5.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 64.41 110.833 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 110.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 73.14 110.847 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -126.21 136.77 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.145 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -65.41 123.92 20.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.896 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 69' ' ' LYS . 31.4 m -116.76 -19.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.43 . . . . 73.3 111.096 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.91 -164.5 11.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 62.55 112.438 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -131.39 159.7 70.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.621 0.724 . . . . 54.31 110.918 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.4 Cg_endo -69.74 -48.37 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.146 0 C-N-CA 122.67 -1.804 . . . . 73.04 112.326 -0.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -126.21 47.91 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.02 110.903 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 64' ' ' VAL . 29.6 ttpt -79.61 77.99 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.54 152.55 25.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.936 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -145.61 145.53 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.88 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.63 136.11 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.44 110.851 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -143.76 125.04 14.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.24 110.912 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -51.8 116.93 2.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.86 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.91 156.97 38.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.929 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 51.1 110.876 -179.784 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.949 0.404 . . . . 63.11 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -137.32 110.48 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 73.51 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 m -125.94 130.99 52.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.824 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 20.89 63.82 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 72.44 112.471 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.31 -20.38 44.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.77 -0.728 . . . . 75.23 112.541 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -100.12 145.56 27.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 75.44 110.864 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.903 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.99 171.53 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 52.42 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -65.4 160.69 57.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.702 . . . . 50.12 110.893 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 174.97 8.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.244 . . . . 75.41 112.341 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 58.47 30.0 19.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.887 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 m -142.06 120.75 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.3 110.826 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.2 p -90.31 168.1 12.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.881 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 m -90.14 126.36 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 62.12 110.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.78 136.97 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 44.55 111.186 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -104.62 128.09 52.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 64.23 110.877 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.54 110.908 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.608 0.718 . . . . 72.52 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 165.64 30.28 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.704 2.269 . . . . 72.0 112.31 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -129.19 171.52 12.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 72.01 110.83 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.2 m -102.3 112.99 25.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.81 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 148.96 40.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 71.22 110.889 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 150.39 68.52 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 71.3 112.391 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.595 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.0 mt -59.0 147.99 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 61.15 110.932 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.9 156.7 36.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 72.22 112.503 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -108.32 -170.78 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 73.44 110.868 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 36' ' ' ASN . 27.9 tp -73.75 146.4 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 70.23 110.868 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.574 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 56.47 32.52 20.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.849 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.88 159.67 45.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 73.54 110.941 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.92 5.97 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 52.43 112.295 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -135.04 169.33 17.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 51.41 110.893 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -130.21 144.64 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 72.03 110.857 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -52.62 -63.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.113 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -138.98 156.75 72.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 63.05 110.863 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -169.99 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.752 2.301 . . . . 54.31 112.323 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -168.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 71.21 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.1 -24.14 67.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.812 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -89.94 -28.37 19.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.13 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.54 32.25 4.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 63.51 112.566 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.9 mt -120.66 150.73 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 73.1 111.088 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -104.18 -176.09 2.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.22 110.955 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.55 -76.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 72.5 110.864 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -122.66 -60.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 74.41 110.923 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -74.9 158.85 32.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 74.31 110.792 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.1 m -109.93 160.05 29.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 61.55 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 167.93 23.04 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.698 2.266 . . . . 71.33 112.293 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.73 124.74 24.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 70.41 110.883 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.04 17.61 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.14 112.478 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.82 27.44 6.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.54 110.951 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.46 21.58 24.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.646 -0.788 . . . . 52.44 112.523 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -107.8 170.94 7.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 72.43 110.841 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 64.41 110.935 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.23 109.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.14 110.909 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -127.75 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.45 111.129 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -66.87 127.97 34.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.941 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.31 13.21 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.3 111.11 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.56 -157.95 18.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 62.55 112.484 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -140.25 159.39 63.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 54.31 110.913 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.74 -41.75 0.86 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.664 -1.807 . . . . 73.04 112.351 -0.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.56 63.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.912 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -81.95 79.81 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -82.15 133.04 35.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.954 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.94 147.77 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 74.42 110.896 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.85 129.42 39.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.72 128.1 30.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 63.24 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 119.98 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.842 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -64.12 154.53 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 75.32 110.831 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 51.1 110.885 -179.814 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.879 0.371 . . . . 63.11 111.084 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -128.87 115.29 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.51 111.1 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -138.16 123.14 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.887 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 19.4 79.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.44 112.482 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.57 -13.96 64.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 75.23 112.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.95 139.31 31.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 75.44 110.906 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.1 138.1 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.79 171.91 12.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 52.42 110.907 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.35 160.74 30.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 50.12 110.815 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 177.8 5.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.668 2.245 . . . . 75.41 112.397 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.98 36.32 27.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 75.25 110.921 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m -141.95 124.51 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.3 110.889 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -87.78 168.2 13.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.866 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 m -90.72 128.01 36.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 62.12 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -120.59 166.49 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 44.55 111.09 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.613 ' HG2' HG21 ' A' ' 48' ' ' ILE . 1.1 mm-40 -117.93 137.63 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.23 110.93 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.856 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.679 0.752 . . . . 72.52 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 164.95 32.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 72.0 112.348 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -133.6 173.8 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.01 110.919 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.14 131.88 50.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 149.34 62.78 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.606 0.717 . . . . 71.22 110.806 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 145.7 57.65 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.654 2.236 . . . . 71.3 112.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD13 ' HA3' ' A' ' 56' ' ' GLY . 42.6 mt -54.14 149.42 9.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 61.15 110.873 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.6 157.06 52.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.732 . . . . 72.22 112.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -105.62 -169.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.324 . . . . 73.44 110.898 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 36' ' ' ASN . 25.4 tp -72.96 149.04 43.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 70.23 110.927 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.525 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.7 m-20 53.03 33.34 14.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.899 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.13 159.66 42.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.641 0.734 . . . . 73.54 110.842 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.81 5.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.68 2.254 . . . . 52.43 112.309 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.5 p -132.19 170.87 14.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 51.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -131.09 146.36 52.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.03 110.88 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' HG3' ' A' ' 42' ' ' GLU . 47.5 t -52.2 -66.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 73.33 111.155 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 41' ' ' VAL . 74.3 mt-10 -140.64 156.74 69.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 63.05 110.84 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -170.42 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 54.31 112.375 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -169.39 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.856 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.15 -16.03 64.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 74.04 110.908 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -98.38 -28.18 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.882 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 31.99 4.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 63.51 112.449 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.613 HG21 ' HG2' ' A' ' 17' ' ' GLN . 68.4 mt -119.08 145.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.387 . . . . 73.1 111.102 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -102.82 -176.19 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 74.22 110.879 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.82 -77.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 72.5 110.843 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -123.06 -59.39 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 74.41 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -76.23 159.23 30.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.888 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.8 m -112.02 160.06 31.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.605 0.717 . . . . 61.55 110.886 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.99 22.85 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.698 2.265 . . . . 71.33 112.334 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.22 124.17 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.41 110.848 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.98 17.83 1.07 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.48 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -126.6 29.21 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 72.54 110.91 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.74 26.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 52.44 112.446 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.3 mt -109.01 179.56 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 72.43 110.857 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 120.27 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 64.41 110.844 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -54.94 108.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 73.14 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -125.69 136.63 53.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.45 111.209 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.87 125.59 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.924 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' LYS . 27.9 m -116.68 -21.22 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 73.3 111.122 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.19 -162.26 9.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.688 -0.768 . . . . 62.55 112.486 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -130.09 159.69 68.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.57 0.7 . . . . 54.31 110.92 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.83 -48.48 0.27 Allowed 'Cis proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.676 -1.801 . . . . 73.04 112.291 0.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -127.29 46.55 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 62.02 110.82 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 64' ' ' VAL . 5.4 ttpm? -72.98 77.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.1 141.96 35.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 73.52 110.928 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -139.39 145.68 39.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.839 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.48 136.73 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.859 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.51 126.94 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.24 110.906 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.856 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.49 152.48 41.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.32 110.857 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 51.1 110.807 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.836 0.35 . . . . 63.11 111.165 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.6 m -137.28 113.7 10.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.221 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.8 m -139.48 157.1 46.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.855 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.81 16.51 51.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 72.44 112.491 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.18 -15.21 60.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 75.23 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.83 163.46 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 75.44 110.893 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -94.63 155.39 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 73.24 110.963 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -132.63 177.19 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.42 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -80.24 160.65 67.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.545 0.688 . . . . 50.12 110.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 168.33 21.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.67 2.246 . . . . 75.41 112.429 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 63.33 27.56 15.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.96 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.0 p -142.02 119.2 11.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.3 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -88.07 168.13 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 72.13 110.924 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 m -91.18 125.48 35.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 62.12 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.15 156.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 44.55 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.544 ' CG ' HG21 ' A' ' 48' ' ' ILE . 2.4 mm-40 -118.2 129.21 55.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.23 110.896 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.961 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 121.611 0.72 . . . . 72.52 110.821 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.0 32.51 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.699 2.266 . . . . 72.0 112.347 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -133.84 173.95 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.01 110.911 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.61 130.85 51.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 71.42 110.848 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 149.35 73.2 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.646 0.736 . . . . 71.22 110.871 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 146.75 61.38 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.725 2.283 . . . . 71.3 112.387 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.3 mt -55.09 149.85 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 61.15 110.946 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.81 151.89 36.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.688 . . . . 72.22 112.415 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -177.48 3.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 73.44 110.898 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 29.5 tp -69.73 143.22 53.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 70.23 110.863 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 70.6 m-20 60.53 39.45 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 73.21 110.904 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.04 159.46 72.56 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.586 0.708 . . . . 73.54 110.921 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 133.18 24.81 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 52.43 112.327 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 p -148.03 167.78 24.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 51.41 110.965 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -126.31 148.07 49.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.03 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -52.74 -64.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.15 156.74 64.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.647 0.736 . . . . 63.05 110.851 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.675 2.25 . . . . 54.31 112.303 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.58 -169.53 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.875 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.99 -16.78 64.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -97.36 -28.08 14.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.829 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 32.01 4.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.683 -0.77 . . . . 63.51 112.493 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.544 HG21 ' CG ' ' A' ' 17' ' ' GLN . 72.3 mt -117.98 145.6 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 73.1 111.192 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -104.49 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.58 -78.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 72.5 110.842 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.19 -58.32 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.935 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -77.42 169.06 18.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.901 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.8 m -117.77 160.67 37.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.563 0.696 . . . . 61.55 110.89 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.07 22.59 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.675 2.25 . . . . 71.33 112.334 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 89.0 m -70.67 126.01 28.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 70.41 110.852 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -152.24 18.58 0.81 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.76 . . . . 74.14 112.402 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.51 30.7 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.54 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.15 22.23 27.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.489 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.1 mt -108.77 176.42 5.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.365 . . . . 72.43 110.933 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.5 116.8 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 64.41 110.883 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 103.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.853 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -118.21 136.98 53.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.45 111.159 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -76.17 122.71 24.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.946 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 71' ' ' ARG . 18.9 m -116.73 -19.29 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 73.3 111.079 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.72 -159.82 9.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 62.55 112.518 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.5 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.1 pt-20 -139.78 159.47 64.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.691 0.758 . . . . 54.31 110.864 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.8 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 -1.802 . . . . 73.04 112.342 0.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.76 53.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.02 110.867 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -79.67 78.1 6.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.91 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.09 141.17 34.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 73.52 110.933 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG3' HG22 ' A' ' 64' ' ' VAL . 9.0 mtt180 -139.16 153.11 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 74.42 110.904 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.0 140.97 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.875 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -151.86 129.43 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 63.24 110.888 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.93 117.02 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -64.05 149.53 47.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 51.1 110.877 -179.828 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.893 0.377 . . . . 63.11 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.9 m -143.12 107.55 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.51 111.107 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.6 m -146.4 149.29 33.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.855 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.0 75.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 72.44 112.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.67 24.97 75.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 75.23 112.475 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -148.87 137.79 21.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 75.44 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -78.01 133.29 38.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.9 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.98 176.7 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 52.42 110.923 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -77.87 160.73 73.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.625 0.726 . . . . 50.12 110.85 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.88 15.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.755 2.304 . . . . 75.41 112.333 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 63.19 27.78 15.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 75.25 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.75 117.42 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.3 110.891 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 p -88.48 168.09 12.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.877 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 m -91.69 131.11 37.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 62.12 110.888 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.98 124.0 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 44.55 111.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -78.88 125.65 29.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 64.23 110.902 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m120 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 75.54 110.9 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.5 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.66 0.743 . . . . 72.52 110.848 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 166.48 27.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 72.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.53 171.36 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 72.01 110.884 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.9 m -107.57 107.37 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.23 149.25 43.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.561 0.696 . . . . 71.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 152.46 69.57 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 71.3 112.35 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.0 mt -62.16 149.43 41.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 61.15 110.882 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.57 149.68 39.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.22 112.476 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -172.82 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.754 0.311 . . . . 73.44 110.894 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 ' H ' ' A' ' 36' ' ' ASN . 38.0 tp -72.29 146.37 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 70.23 110.925 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' LEU . 71.8 m-20 58.31 35.51 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.861 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.67 159.74 68.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.68 0.752 . . . . 73.54 110.802 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 138.4 37.84 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.601 2.201 . . . . 52.43 112.357 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -147.6 170.77 16.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 51.41 110.918 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -129.22 146.04 51.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.03 110.88 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.76 -67.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 73.33 111.124 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -139.64 156.69 71.08 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.734 . . . . 63.05 110.923 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.719 2.279 . . . . 54.31 112.332 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 -169.47 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.955 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.69 -17.75 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.04 110.901 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -96.28 -28.35 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 64.13 110.926 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.28 31.95 4.47 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.668 -0.777 . . . . 63.51 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.16 146.95 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.1 111.127 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -101.93 -176.19 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 74.22 110.899 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -77.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 72.5 110.858 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -122.78 -59.55 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.942 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -76.95 156.02 32.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.896 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.3 m -106.74 160.41 26.39 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 61.55 110.797 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 167.92 23.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 71.33 112.275 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.7 m -72.92 125.62 28.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 70.41 110.831 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.83 17.62 0.84 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 74.14 112.482 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.68 31.47 5.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 72.54 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.25 21.65 31.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.741 . . . . 52.44 112.539 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -108.04 176.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -148.78 119.16 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 64.41 110.826 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.36 103.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.833 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.39 145.68 47.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.184 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -82.89 123.46 29.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 74.43 110.899 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 ' HE ' ' A' ' 71' ' ' ARG . 32.3 m -125.97 13.13 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.3 111.104 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -158.6 9.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 62.55 112.397 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.0 pt-20 -158.52 159.43 29.81 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.683 0.754 . . . . 54.31 110.809 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -43.09 0.65 Allowed 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 122.727 -1.781 . . . . 73.04 112.309 0.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -126.97 75.1 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 62.02 110.851 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -108.36 78.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 70' ' ' LEU . 5.1 tp -81.2 136.6 35.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 73.52 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.594 ' HE ' HG21 ' A' ' 64' ' ' VAL . 22.5 mtm180 -140.11 156.93 46.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.857 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.61 141.6 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.44 110.884 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.04 127.41 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.964 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -52.02 117.06 2.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.866 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.75 157.79 29.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 51.1 110.874 -179.771 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.915 0.388 . . . . 63.11 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.1 m -137.1 107.43 6.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 73.51 111.19 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -125.87 143.25 51.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 73.21 110.87 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.37 43.63 57.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.474 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.14 19.52 46.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.471 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -134.75 140.69 46.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 75.44 110.846 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.25 148.95 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.18 178.76 6.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 52.42 110.939 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -73.7 160.61 81.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.543 0.687 . . . . 50.12 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 172.92 11.76 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 75.41 112.369 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 63.11 26.74 15.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 75.25 110.94 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -142.08 118.26 10.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.3 110.888 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.95 168.24 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 72.13 110.852 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.0 m -93.11 133.64 36.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 62.12 110.873 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 49' ' ' TYR . 5.3 m -131.04 137.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 44.55 111.149 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -92.71 131.22 37.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 64.23 110.93 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.875 -179.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.614 0.721 . . . . 72.52 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 164.86 33.04 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.65 2.233 . . . . 72.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -123.8 173.78 7.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.01 110.934 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 m -97.06 130.03 44.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 71.42 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.28 148.83 71.72 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.626 0.727 . . . . 71.22 110.839 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 155.11 66.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 71.3 112.279 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.601 HD13 ' HA3' ' A' ' 56' ' ' GLY . 24.6 mt -65.49 154.13 39.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 61.15 110.913 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.91 159.68 43.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 72.22 112.495 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -115.44 -176.25 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 73.44 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.9 tp -70.6 142.35 51.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 70.23 110.919 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.0 m-20 60.57 39.5 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 73.21 110.882 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 159.52 71.45 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.596 0.713 . . . . 73.54 110.937 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 129.03 16.89 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 52.43 112.396 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.1 p -147.44 167.79 23.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 51.41 110.893 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.04 150.54 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 72.03 110.909 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -55.9 -65.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.52 157.02 72.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.686 0.755 . . . . 63.05 110.893 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -170.13 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.645 2.23 . . . . 54.31 112.348 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.83 -169.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 71.21 110.908 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.93 -15.56 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.825 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -96.58 -28.21 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 64.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.16 4.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 63.51 112.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.9 mt -123.95 146.69 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 73.1 111.129 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.452 ' HB2' HG12 ' A' ' 16' ' ' VAL . 51.3 m-85 -101.53 -176.11 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 74.22 110.927 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -77.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 72.5 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -122.89 -58.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 74.41 110.958 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -77.15 161.36 28.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.922 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -111.55 159.98 31.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 61.55 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 168.11 22.55 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.71 2.273 . . . . 71.33 112.403 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.8 m -68.67 126.1 28.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 70.41 110.925 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.601 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.39 19.51 0.92 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 74.14 112.402 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -127.31 27.77 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 72.54 110.847 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.3 22.87 21.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 52.44 112.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.2 mt -109.65 175.13 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 72.43 110.979 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.66 116.8 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 64.41 110.912 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.09 105.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.927 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -119.8 137.13 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.17 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -71.63 123.98 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.988 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.47 -20.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 73.3 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.64 -156.82 7.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 62.55 112.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.8 pt-20 -140.6 159.63 62.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.696 0.76 . . . . 54.31 110.78 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.75 -48.37 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.206 0 C-N-CA 122.677 -1.801 . . . . 73.04 112.347 -0.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -125.38 50.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 62.02 110.915 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -77.93 77.96 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.77 148.85 28.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 73.52 110.892 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -145.9 152.75 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.873 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -70.76 137.59 49.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.883 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -147.38 127.86 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 118.8 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.899 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.1 156.35 28.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.892 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 51.1 110.867 -179.773 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.023 0.44 . . . . 63.11 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 m -142.63 115.45 8.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 73.51 111.082 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -132.49 132.62 42.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.21 110.903 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.77 66.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.781 -0.723 . . . . 72.44 112.478 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.83 -20.85 42.65 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.46 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -99.82 149.16 23.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 75.44 110.931 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -93.48 147.46 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.897 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.22 169.06 16.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 52.42 110.852 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -63.91 160.79 43.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.62 0.724 . . . . 50.12 110.896 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.73 176.44 6.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.75 2.3 . . . . 75.41 112.323 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 62.6 25.27 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.25 110.857 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.844 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.05 168.13 13.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 72.13 110.925 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.89 134.78 34.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.12 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.73 135.26 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 44.55 111.203 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.7 123.3 39.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.23 110.956 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 75.54 110.886 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.625 0.726 . . . . 72.52 110.837 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 166.6 27.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.703 2.269 . . . . 72.0 112.312 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 161.48 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.865 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 m -95.69 109.05 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.939 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 148.99 39.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 71.22 110.887 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.17 64.79 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.669 2.246 . . . . 71.3 112.316 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.6 mt -56.65 150.35 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 61.15 110.858 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.39 148.44 51.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 72.22 112.476 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -171.73 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.321 . . . . 73.44 110.898 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 59' ' ' LEU . 42.4 tp -73.12 146.89 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.903 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.79 24.08 13.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 159.72 36.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.604 0.716 . . . . 73.54 110.856 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 125.75 12.54 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 52.43 112.323 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.54 164.61 29.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 51.41 110.857 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.84 156.12 43.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.857 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -61.12 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.136 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -140.61 156.9 69.02 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.637 0.732 . . . . 63.05 110.884 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 54.31 112.335 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.08 -169.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.21 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.34 -15.2 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.905 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.81 -28.31 14.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.937 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.13 32.14 4.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 63.51 112.456 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt -124.66 150.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 73.1 111.144 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.1 -176.2 3.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.77 -76.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 72.5 110.84 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -122.65 -59.54 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.949 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -75.9 160.04 30.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 74.31 110.87 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 m -111.48 160.29 29.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.653 0.74 . . . . 61.55 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 168.0 22.86 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.657 2.238 . . . . 71.33 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.92 126.35 29.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 70.41 110.88 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.2 18.27 0.92 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 74.14 112.478 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.0 pt-20 -127.27 26.47 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 72.54 110.944 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.01 22.82 16.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.726 -0.75 . . . . 52.44 112.475 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.2 mt -109.73 171.94 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.43 110.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 120.0 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.865 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.66 102.48 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.864 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -115.42 140.93 48.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.45 111.117 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.75 125.74 29.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.847 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.679 HG23 ' HD2' ' A' ' 69' ' ' LYS . 7.9 m -117.06 -21.24 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.112 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.6 -176.54 15.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 62.55 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -118.0 159.54 42.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.579 0.704 . . . . 54.31 110.897 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.78 -48.68 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.679 -1.8 . . . . 73.04 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -131.11 65.9 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 62.02 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.679 ' HD2' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -89.44 77.79 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.862 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.1 140.93 30.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 73.52 110.863 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -140.44 157.39 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.863 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.12 132.04 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.913 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -143.21 129.06 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.9 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -52.05 117.33 2.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.877 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.92 147.5 53.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.32 110.845 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 51.1 110.843 -179.818 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.946 0.403 . . . . 63.11 111.073 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -146.11 107.83 4.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 73.51 111.2 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -147.03 144.59 29.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 73.21 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.07 20.08 78.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.523 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.87 23.79 73.83 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.728 -0.749 . . . . 75.23 112.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -144.95 155.28 43.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 75.44 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -101.4 155.26 18.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.856 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.91 173.13 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 52.42 110.923 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -69.06 160.58 77.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.71 . . . . 50.12 110.849 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 175.11 8.51 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.603 2.202 . . . . 75.41 112.389 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 59.98 27.56 16.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 75.25 110.928 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 p -142.02 119.23 11.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.3 110.848 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -89.13 168.14 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.13 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -89.75 132.65 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 62.12 110.869 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.05 123.98 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 44.55 111.139 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.92 122.94 25.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.23 110.896 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.835 -179.912 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.712 0.768 . . . . 72.52 110.845 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.97 25.81 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.656 2.237 . . . . 72.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.66 174.01 10.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.01 110.877 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 120.42 40.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.42 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.64 149.02 47.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 71.22 110.839 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 149.71 67.25 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 71.3 112.337 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 56' ' ' GLY . 34.7 mt -59.34 148.67 31.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.894 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 155.42 34.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.819 -0.705 . . . . 72.22 112.448 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -108.72 -172.89 2.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 73.44 110.902 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 36' ' ' ASN . 23.6 tp -73.15 145.6 46.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.23 110.981 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 35' ' ' LEU . 77.5 m-20 58.27 38.68 26.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 73.21 110.836 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.41 159.59 69.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.688 0.756 . . . . 73.54 110.876 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 124.37 11.01 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.715 2.277 . . . . 52.43 112.33 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 p -136.31 168.26 19.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 51.41 110.798 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.16 144.39 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 72.03 110.947 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.94 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.33 111.07 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -140.01 156.8 70.28 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 63.05 110.935 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -169.87 0.36 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.638 2.225 . . . . 54.31 112.33 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -168.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.846 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.86 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.852 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -88.21 -28.44 21.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 64.13 110.826 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.86 32.07 4.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 63.51 112.514 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.46 147.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.353 . . . . 73.1 111.117 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -100.43 -175.99 3.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.21 -77.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.5 110.883 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -123.06 -58.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.41 110.9 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -77.06 168.65 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.852 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -116.1 160.34 35.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 61.55 110.946 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 168.13 22.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.659 2.24 . . . . 71.33 112.35 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 93.1 m -70.07 125.47 26.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.936 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.88 19.23 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 74.14 112.501 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -125.75 28.1 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 72.54 110.87 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.94 22.65 22.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.7 -0.762 . . . . 52.44 112.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.8 mt -108.64 177.4 4.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 72.43 110.875 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.41 118.6 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.41 110.809 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.1 m -55.41 106.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.901 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.59 136.88 54.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 74.45 111.178 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.43 126.1 29.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.889 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -125.03 13.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 73.3 111.101 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.87 -160.18 13.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 62.55 112.473 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -138.3 159.99 65.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.686 0.755 . . . . 54.31 110.858 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.84 -42.82 0.69 Allowed 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.288 0.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.42 49.47 2.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 62.02 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -70.55 97.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 74.0 110.88 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.88 136.87 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.93 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.63 ' HE ' HG21 ' A' ' 64' ' ' VAL . 26.4 mtm180 -139.64 150.14 44.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.828 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.72 138.57 55.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -147.01 127.17 13.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.926 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.39 117.02 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -67.17 155.03 39.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.907 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 51.1 110.854 -179.798 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.8 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.893 0.378 . . . . 63.11 111.124 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.9 m -137.49 111.15 8.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 73.51 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 m -130.61 129.16 42.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.965 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.58 39.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.44 112.442 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.04 20.58 64.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.516 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.07 143.86 46.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 75.44 110.875 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -90.88 136.44 33.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.882 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -124.41 169.11 12.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 52.42 110.868 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -63.83 160.6 44.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 50.12 110.964 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 175.95 7.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 75.41 112.3 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 61.05 28.51 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 p -142.06 122.81 14.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.3 110.842 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 p -89.97 168.14 12.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.842 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.28 122.07 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 62.12 110.854 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -119.95 131.39 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 44.55 111.131 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.36 124.88 31.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 64.23 110.958 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.54 110.881 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.758 0.79 . . . . 72.52 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 166.56 27.17 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.739 2.293 . . . . 72.0 112.384 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -137.08 174.03 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.809 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.6 m -96.86 128.47 43.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.931 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 148.96 69.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 71.22 110.87 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 152.16 69.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.227 . . . . 71.3 112.409 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.578 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.6 mt -61.48 154.67 23.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 61.15 110.951 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.36 154.46 53.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 72.22 112.446 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.22 -171.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 73.44 110.926 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.1 tp -71.99 147.59 46.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 70.23 110.977 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.532 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 55.05 32.35 18.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.21 110.89 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.66 159.7 45.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.68 0.753 . . . . 73.54 110.827 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.701 2.267 . . . . 52.43 112.27 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 p -134.47 169.81 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.41 110.883 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -129.66 148.31 51.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 72.03 110.854 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.51 -63.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 73.33 111.098 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -141.7 154.31 65.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 63.05 110.899 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.641 2.227 . . . . 54.31 112.367 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -74.09 -169.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 71.21 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.2 -17.54 64.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.863 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -95.6 -28.39 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.06 4.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 63.51 112.528 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mt -119.1 148.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.812 0.339 . . . . 73.1 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -104.63 -175.95 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.899 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.7 -77.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 72.5 110.875 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.71 -60.06 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.93 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -75.53 158.52 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.31 110.82 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 m -109.41 159.7 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 61.55 110.869 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.08 22.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 71.33 112.355 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.3 128.49 36.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.842 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.12 17.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.679 -0.772 . . . . 74.14 112.488 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.7 pt-20 -127.66 27.14 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 72.54 110.876 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.93 19.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 52.44 112.548 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.407 HD12 ' HG2' ' A' ' 57' ' ' GLU . 9.5 mt -108.86 173.15 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.829 0.347 . . . . 72.43 110.887 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 120.88 8.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 64.41 110.817 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.24 111.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.14 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -128.7 136.75 51.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 74.45 111.167 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -68.0 125.75 27.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 74.43 110.891 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 13.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.092 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.92 -156.57 10.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 62.55 112.536 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -152.56 159.51 32.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 54.31 110.898 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.8 -48.14 0.28 Allowed 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 -1.803 . . . . 73.04 112.34 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -122.77 75.01 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 62.02 110.899 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.7 93.11 4.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 74.0 110.904 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.98 142.41 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 73.52 110.875 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -142.44 145.71 34.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.839 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.39 133.11 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.858 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -141.64 128.74 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 63.24 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -51.94 117.13 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.888 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.59 155.14 40.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 75.32 110.89 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 51.1 110.831 -179.734 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.882 0.372 . . . . 63.11 111.138 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -140.28 111.25 6.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 73.51 111.075 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.8 m -139.21 146.19 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.879 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.91 20.38 72.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 72.44 112.54 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.69 28.99 56.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 75.23 112.507 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -154.77 151.47 28.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.297 . . . . 75.44 110.89 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.53 136.24 33.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 73.24 110.942 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.88 156.54 24.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 52.42 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.61 160.91 3.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.592 0.71 . . . . 50.12 110.85 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 164.52 34.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 75.41 112.362 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 63.4 30.48 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 75.25 110.941 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -142.0 116.67 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 72.3 110.9 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.53 168.3 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 72.13 110.867 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.21 127.81 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 62.12 110.861 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 28' ' ' ARG . 6.3 m -118.77 135.02 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 44.55 111.064 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.412 ' HB2' HG21 ' A' ' 48' ' ' ILE . 6.7 tp-100 -92.0 126.57 37.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 64.23 110.943 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.54 110.904 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.693 0.759 . . . . 72.52 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.9 26.05 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.652 2.235 . . . . 72.0 112.335 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.476 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -134.0 161.63 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.876 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 m -90.18 117.85 29.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.868 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 148.72 46.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.528 0.68 . . . . 71.22 110.91 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 154.81 67.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.647 2.231 . . . . 71.3 112.373 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.611 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.5 mt -62.44 149.76 41.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 61.15 110.872 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.52 154.77 48.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 72.22 112.474 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -108.51 -173.37 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 73.44 110.892 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 59' ' ' LEU . 41.0 tp -73.36 147.09 44.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.893 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.91 22.54 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.892 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.59 159.58 36.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.581 0.705 . . . . 73.54 110.881 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 123.9 10.58 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.723 2.282 . . . . 52.43 112.339 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.2 p -136.91 170.34 16.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 51.41 110.936 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -133.93 146.81 50.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.03 110.927 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.89 -66.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -139.29 156.87 71.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.629 0.728 . . . . 63.05 110.888 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -169.62 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 54.31 112.304 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.89 -168.6 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.21 110.914 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.18 67.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -88.7 -28.31 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 64.13 110.905 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.76 32.01 4.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 63.51 112.515 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 17' ' ' GLN . 39.1 mt -120.39 149.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 73.1 111.159 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.34 -176.12 3.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 74.22 110.927 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.22 -77.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 72.5 110.814 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -123.0 -59.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.934 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -77.05 158.48 30.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.802 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.6 m -108.77 160.29 27.82 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.71 . . . . 61.55 110.922 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 168.03 22.75 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.716 2.277 . . . . 71.33 112.305 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.5 m -68.69 127.1 31.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 70.41 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.67 17.42 0.97 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 74.14 112.499 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.56 27.24 5.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 72.54 110.841 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.63 23.95 19.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.457 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.4 mt -108.74 171.43 7.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.9 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 127.72 17.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.41 110.81 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.92 106.23 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.881 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.24 144.47 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.182 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -81.4 123.75 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.873 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.18 -24.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 73.3 111.154 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.16 -161.64 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 62.55 112.51 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.7 pt-20 -127.97 159.44 66.66 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.699 0.762 . . . . 54.31 110.882 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.79 -42.2 0.79 Allowed 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.368 0.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.34 63.53 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.894 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 79.32 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.0 110.937 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.25 147.05 32.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -152.89 159.03 42.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -72.76 128.6 36.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.884 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.82 126.46 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.948 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.33 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -65.66 152.03 45.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 51.1 110.886 -179.873 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.921 0.391 . . . . 63.11 111.09 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -153.34 110.52 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.51 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 m -148.52 133.64 18.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.21 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.83 76.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 72.44 112.464 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.39 28.66 65.41 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.687 -0.768 . . . . 75.23 112.529 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.96 134.99 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.674 0.273 . . . . 75.44 110.953 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.51 152.01 21.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.919 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.48 171.14 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 52.42 110.877 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -63.28 160.76 38.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.589 0.709 . . . . 50.12 110.856 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.05 8.57 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.756 2.304 . . . . 75.41 112.328 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.18 38.44 26.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 75.25 110.828 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -141.32 123.55 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 72.3 110.907 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -88.92 168.16 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.948 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -88.32 134.44 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 62.12 110.882 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.35 130.53 65.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 44.55 111.113 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.87 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.917 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.875 -179.903 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.655 0.74 . . . . 72.52 110.852 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 166.46 27.47 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.627 2.218 . . . . 72.0 112.327 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -138.14 173.99 11.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.01 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -99.24 130.18 45.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.932 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 149.71 56.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.702 . . . . 71.22 110.815 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 147.32 62.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 71.3 112.376 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 56' ' ' GLY . 27.7 mt -57.73 149.89 21.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 61.15 110.948 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.44 160.5 32.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 72.22 112.481 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -114.38 -171.87 2.0 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.44 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 36' ' ' ASN . 26.7 tp -73.18 144.57 46.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.879 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.595 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.8 m-20 58.19 37.09 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.932 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.95 159.72 65.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.638 0.732 . . . . 73.54 110.938 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 124.28 10.91 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.701 2.268 . . . . 52.43 112.344 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -135.0 165.43 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 51.41 110.926 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.17 145.54 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 72.03 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.86 -67.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.33 111.096 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -139.07 156.81 72.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.643 0.735 . . . . 63.05 110.877 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -169.73 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.264 . . . . 54.31 112.34 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -168.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.21 110.878 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.14 67.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.04 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.03 -28.42 21.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 64.13 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.72 32.15 4.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.51 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 mt -122.26 150.54 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.1 111.131 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.47 -176.02 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.976 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.75 -77.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.5 110.836 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -122.82 -59.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.71 159.95 30.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 74.31 110.861 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.8 m -111.54 160.13 30.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.561 0.696 . . . . 61.55 110.943 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.99 22.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.658 2.239 . . . . 71.33 112.373 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.5 m -70.23 124.54 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 70.41 110.916 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.63 19.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.494 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.76 28.45 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 72.54 110.903 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.19 22.73 24.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 52.44 112.523 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.34 172.39 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 72.43 110.923 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -144.81 118.32 9.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 64.41 110.852 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.43 102.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.838 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -118.55 147.55 43.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.45 111.149 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -88.96 124.84 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.927 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.55 13.17 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.3 111.136 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.36 -161.5 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 62.55 112.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.2 pt-20 -151.12 159.47 33.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.31 110.862 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.78 -48.39 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.748 -1.772 . . . . 73.04 112.331 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -123.82 72.53 1.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 62.02 110.832 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -99.9 78.15 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.68 141.69 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 73.52 110.887 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -149.75 160.67 43.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.59 140.34 41.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.957 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.76 127.3 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.911 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.01 120.35 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.833 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -64.39 150.31 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 51.1 110.878 -179.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.902 0.382 . . . . 52.32 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.46 142.21 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 63.11 111.127 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.5 m -136.02 109.59 7.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.121 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.8 m -127.54 143.89 51.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 73.21 110.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.88 43.11 70.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.99 24.51 58.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.49 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -145.09 136.26 24.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.694 0.283 . . . . 75.44 110.938 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.8 139.35 50.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 73.24 110.932 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.1 m -122.09 164.07 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 52.42 110.915 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -66.1 161.1 59.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.564 0.697 . . . . 50.12 110.885 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 167.49 24.3 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.68 2.253 . . . . 75.41 112.335 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 63.62 27.55 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.87 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -141.99 116.64 9.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 72.3 110.883 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.88 168.13 13.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.898 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 m -90.51 131.72 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 62.12 110.909 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.68 133.68 64.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 44.55 111.109 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -78.83 123.08 26.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.902 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -125.03 34.97 4.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.907 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -93.32 137.79 32.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 42.21 110.812 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.08 25.91 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 71.42 110.832 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 32.18 22.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.712 -0.756 . . . . 73.44 112.493 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -75.38 -24.36 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.852 0.358 . . . . 74.54 110.915 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.98 -5.53 34.39 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 64.3 112.524 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -123.76 94.76 4.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.344 . . . . 75.43 110.915 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -52.36 103.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 51.33 110.846 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -126.41 84.91 61.18 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 72.52 110.861 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.03 28.93 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.697 2.265 . . . . 72.0 112.358 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -123.63 162.32 23.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.01 110.871 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.4 m -91.89 112.86 24.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 71.42 110.906 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 148.42 40.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.566 0.698 . . . . 71.22 110.888 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 152.18 69.24 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 71.3 112.375 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.614 HD13 ' HA3' ' A' ' 56' ' ' GLY . 22.5 mt -60.52 150.59 30.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 61.15 110.892 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.25 152.84 49.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 72.22 112.503 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -108.73 -172.96 2.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.842 0.353 . . . . 73.44 110.91 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.6 tp -74.82 151.79 39.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.873 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 59.14 22.29 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.21 110.889 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.66 159.33 46.7 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 73.54 110.895 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 132.14 22.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.694 2.263 . . . . 52.43 112.385 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.0 159.1 43.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 51.41 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -122.2 143.35 49.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 72.03 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.9 t -52.01 -65.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.33 111.129 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -137.66 156.99 74.42 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.64 0.733 . . . . 63.05 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -170.04 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.66 2.24 . . . . 54.31 112.343 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.41 -169.35 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 71.21 110.868 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -68.54 -14.89 63.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.04 110.88 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -95.61 -28.29 14.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.13 110.863 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.44 32.12 4.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 mt -126.37 147.71 31.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.793 0.33 . . . . 73.1 111.134 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -99.76 -175.95 3.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.911 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -77.61 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 72.5 110.819 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -123.01 -58.57 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 -75.59 169.93 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.817 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.5 m -118.09 160.0 40.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.651 0.739 . . . . 61.55 110.853 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 166.55 27.22 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 71.33 112.324 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.5 m -66.81 124.55 23.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 70.41 110.89 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -148.96 16.03 1.18 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.687 -0.768 . . . . 74.14 112.463 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.403 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.2 pt-20 -125.42 32.62 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 72.54 110.892 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 91.01 23.57 29.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 52.44 112.509 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 74' ' ' GLU . 10.3 mt -109.9 176.07 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 72.43 110.942 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 119.77 5.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 64.41 110.866 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.99 108.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.858 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.51 137.8 54.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.138 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.34 120.87 18.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.43 110.886 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.69 -19.36 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 73.3 111.118 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.37 -157.25 7.23 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 62.55 112.503 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -138.0 159.55 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 54.31 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.8 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.663 -1.807 . . . . 73.04 112.339 0.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -130.12 49.7 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -72.93 78.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.0 110.926 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 mp -79.73 129.25 34.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 73.52 110.905 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -127.26 157.78 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.905 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.43 129.23 36.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.44 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -140.64 124.3 17.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 63.24 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HG2' HD23 ' A' ' 59' ' ' LEU . 25.8 mm-40 -51.78 116.94 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.918 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.96 147.59 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.32 110.887 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 51.1 110.816 -179.776 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.865 0.364 . . . . 52.32 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.0 t -82.58 135.17 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.11 111.125 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -128.96 109.99 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.51 111.167 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.59 142.86 50.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.872 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.98 41.55 59.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 72.44 112.513 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.14 20.18 57.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.747 -0.74 . . . . 75.23 112.477 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -135.75 140.45 44.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.745 0.307 . . . . 75.44 110.932 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -84.01 135.41 34.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 73.24 110.95 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 m -123.65 167.7 13.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 52.42 110.825 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -67.78 160.67 72.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.537 0.684 . . . . 50.12 110.879 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 174.55 9.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.718 2.279 . . . . 75.41 112.321 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 62.54 26.14 15.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.1 p -141.45 119.53 12.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 72.3 110.816 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.97 168.23 12.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 72.13 110.845 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.7 m -92.92 128.62 38.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 62.12 110.83 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -117.9 141.57 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 44.55 111.119 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.43 136.36 53.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.861 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -132.4 27.79 4.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.954 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -55.28 129.37 38.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 42.21 110.876 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -101.35 26.11 7.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 71.42 110.883 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.15 22.88 62.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 73.44 112.518 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.01 -25.8 43.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.365 . . . . 74.54 110.934 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.82 15.03 35.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.707 -0.758 . . . . 64.3 112.504 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -127.01 87.13 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.837 0.351 . . . . 75.43 110.885 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -62.86 94.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 51.33 110.868 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.6 t -122.28 85.02 46.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.618 0.723 . . . . 72.52 110.89 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.8 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.764 2.31 . . . . 72.0 112.276 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.1 ttm-85 -132.32 164.78 25.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 72.01 110.86 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -96.34 119.04 34.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.9 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 149.27 47.88 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 71.22 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 148.11 64.02 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.723 2.282 . . . . 71.3 112.379 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.618 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.3 mt -57.25 149.33 20.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 61.15 110.931 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.75 145.6 49.91 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.765 -0.731 . . . . 72.22 112.506 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -100.87 -172.83 2.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 73.44 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.5 tp -72.94 151.12 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 70.23 110.906 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 m120 58.21 22.34 9.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.93 159.47 40.74 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.546 0.689 . . . . 73.54 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.87 141.59 45.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 52.43 112.254 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -150.79 165.37 33.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 51.41 110.959 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -125.22 143.19 51.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 72.03 110.835 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.8 t -51.65 -61.0 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 73.33 111.139 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -142.27 156.74 64.19 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.678 0.751 . . . . 63.05 110.817 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -168.43 0.27 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.538 2.158 . . . . 54.31 112.381 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.77 -169.56 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 71.21 110.895 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -65.98 -19.76 65.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 74.04 110.824 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -97.06 -28.24 14.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 64.13 110.858 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.33 3.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 63.51 112.463 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.25 155.99 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 73.1 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -112.91 -176.03 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.926 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.36 -78.21 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.782 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -122.94 -59.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.971 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -76.01 157.87 32.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.836 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.2 m -108.77 159.81 29.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 61.55 110.953 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 164.05 36.06 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.689 2.26 . . . . 71.33 112.324 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.1 m -66.55 127.82 33.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.839 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.618 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.39 17.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.752 -0.737 . . . . 74.14 112.516 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.91 27.59 5.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.846 0.355 . . . . 72.54 110.895 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.64 19.17 28.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.533 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -108.54 164.68 12.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 72.43 110.944 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 t -142.61 125.61 16.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 64.41 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -55.46 101.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.14 110.936 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -118.57 140.27 50.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 74.45 111.091 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -70.5 125.84 27.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 74.43 110.892 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.46 HG21 ' HG3' ' A' ' 71' ' ' ARG . 28.1 m -126.05 12.86 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 73.3 111.093 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.11 -165.49 30.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.768 -0.729 . . . . 62.55 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -142.5 159.83 56.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.31 110.856 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.1 Cg_endo -69.64 -48.74 0.26 Allowed 'Cis proline' 0 N--CA 1.466 -0.14 0 C-N-CA 122.721 -1.783 . . . . 73.04 112.369 -0.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -125.2 75.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 62.02 110.898 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -101.47 78.03 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 74.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.8 136.93 36.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.916 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HG3' HG21 ' A' ' 64' ' ' VAL . 13.2 mmt180 -144.78 154.18 42.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 74.42 110.859 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.08 134.11 41.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.96 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -141.62 136.8 31.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 63.24 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -51.11 116.68 2.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 74.33 110.889 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -78.05 158.51 29.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 75.32 110.822 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 51.1 110.897 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.948 0.404 . . . . 52.32 110.865 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 13' ' ' SER . 57.3 t -70.07 134.18 30.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 63.11 111.117 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 8' ' ' GLN . 10.1 m -146.86 110.27 4.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 73.51 111.099 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.2 m -146.63 135.24 22.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.477 . . . . 73.21 110.886 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.78 73.55 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.764 . . . . 72.44 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.5 70.71 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 75.23 112.504 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 136.24 27.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.711 0.291 . . . . 75.44 110.903 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 3' ' ' THR . 10.7 mt-30 -93.36 142.81 26.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.24 110.913 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -130.97 169.61 15.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 52.42 110.897 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -57.41 160.73 6.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.582 0.705 . . . . 50.12 110.834 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.67 175.5 7.95 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.727 2.285 . . . . 75.41 112.354 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 58.63 37.34 25.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.47 . . . . 75.25 110.905 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 2' ' ' VAL . 58.4 m -140.96 127.57 20.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 72.3 110.866 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.0 p -90.36 168.11 12.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 72.13 110.839 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 m -90.49 126.58 35.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 62.12 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 m -122.46 155.19 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 44.55 111.124 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -108.13 131.73 54.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.23 110.902 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -110.37 -26.21 9.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 75.54 110.896 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -52.46 119.87 4.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 42.21 110.85 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -101.49 28.48 5.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 71.42 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.06 22.69 10.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.685 -0.769 . . . . 73.44 112.44 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.67 -25.96 64.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 74.54 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.98 -5.94 34.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 64.3 112.563 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -122.34 90.5 3.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.798 0.332 . . . . 75.43 110.883 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -59.06 101.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 51.33 110.877 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.1 p -134.22 85.12 39.86 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.739 . . . . 72.52 110.795 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 165.96 29.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.693 2.262 . . . . 72.0 112.307 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -131.57 170.19 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.01 110.867 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -99.9 130.26 46.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.42 110.855 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.54 149.52 58.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.587 0.708 . . . . 71.22 110.871 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 143.73 51.84 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.622 2.215 . . . . 71.3 112.379 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.4 mt -54.33 151.26 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 61.15 110.887 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.48 158.72 48.77 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.525 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -111.12 -175.08 2.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.339 . . . . 73.44 110.943 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 36' ' ' ASN . 28.1 tp -70.09 144.19 52.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 70.23 110.916 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' H ' HD12 ' A' ' 35' ' ' LEU . 59.4 m-20 58.51 38.92 25.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.21 110.951 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 159.67 67.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.64 0.733 . . . . 73.54 110.866 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 123.39 10.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.629 2.219 . . . . 52.43 112.308 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 p -142.07 168.98 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 51.41 110.933 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -128.52 146.84 50.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -52.24 -64.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.118 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -139.78 157.05 70.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 63.05 110.831 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -170.06 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.759 2.306 . . . . 54.31 112.298 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.95 -169.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.892 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -67.88 -16.25 63.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.844 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -96.62 -28.42 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.39 32.07 4.71 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 63.51 112.432 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mt -122.04 148.5 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 73.1 111.158 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -104.9 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.918 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.35 -76.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 72.5 110.828 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -122.64 -59.65 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.905 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -75.33 163.57 27.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 74.31 110.804 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 m -115.13 159.61 37.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 61.55 110.935 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 168.28 22.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.22 . . . . 71.33 112.34 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.45 130.97 44.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.44 19.83 0.53 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 74.14 112.483 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -128.02 26.24 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 72.54 110.842 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.47 21.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 52.44 112.478 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.7 mt -108.4 175.67 5.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.43 110.904 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.1 116.26 7.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 64.41 110.797 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.02 106.19 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.066 -0.515 . . . . 73.14 110.887 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -119.24 139.43 51.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 74.45 111.115 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -68.75 122.28 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.872 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.7 HG21 ' HD3' ' A' ' 71' ' ' ARG . 30.1 m -116.79 -18.88 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 73.3 111.069 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.95 -157.45 7.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 62.55 112.482 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.0 OUTLIER -144.17 159.6 51.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 54.31 110.917 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.79 -48.41 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 -1.79 . . . . 73.04 112.312 0.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -123.06 52.7 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 62.02 110.875 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -88.64 77.98 7.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 74.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.69 156.2 19.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.936 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.7 ' HD3' HG21 ' A' ' 64' ' ' VAL . 45.5 mtp180 -147.84 157.92 43.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 74.42 110.868 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.6 140.45 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.862 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -149.36 125.74 10.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 63.24 110.92 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -52.04 117.59 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 74.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -66.52 158.76 28.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.1 110.818 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.9 0.381 . . . . 52.32 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 13' ' ' SER . 84.5 t -75.61 133.9 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 63.11 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 8' ' ' GLN . 8.1 m -138.67 107.84 6.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 73.51 111.165 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.0 m -135.19 147.93 49.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.864 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.29 37.57 87.59 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 72.44 112.455 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.63 23.14 64.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 75.23 112.499 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -142.36 143.53 32.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.724 0.297 . . . . 75.44 110.914 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 3' ' ' THR . 34.0 mt-30 -95.92 148.18 22.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.971 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.2 m -137.93 168.87 18.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 52.42 110.904 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -54.43 160.94 2.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.597 0.713 . . . . 50.12 110.843 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 175.26 8.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.714 2.276 . . . . 75.41 112.308 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 58.17 39.07 26.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.905 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 2' ' ' VAL . 93.2 p -140.61 131.26 25.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 72.3 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.7 p -94.01 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.125 -0.489 . . . . 72.13 110.875 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 m -90.25 123.59 34.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 62.12 110.852 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -120.22 144.47 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 44.55 111.087 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -90.56 124.82 35.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 64.23 110.951 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -131.12 37.77 3.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 75.54 110.948 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.6 p -76.26 140.5 41.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 42.21 110.829 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -76.69 -23.06 53.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 71.42 110.898 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.99 34.73 4.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.704 -0.76 . . . . 73.44 112.505 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -107.11 25.19 11.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.844 0.354 . . . . 74.54 110.986 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.28 -5.63 79.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.776 . . . . 64.3 112.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -118.94 101.16 7.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 75.43 110.883 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -80.28 123.07 27.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 51.33 110.807 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.6 t -134.93 85.02 36.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.731 0.777 . . . . 72.52 110.865 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 165.88 29.54 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.72 2.28 . . . . 72.0 112.342 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttt180 -134.48 173.91 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 72.01 110.872 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.45 130.95 46.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.854 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.98 149.39 59.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 71.22 110.912 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 146.28 59.8 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.694 2.263 . . . . 71.3 112.328 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.597 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.9 mt -55.73 150.04 13.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 61.15 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.77 157.19 52.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 72.22 112.492 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -109.51 -171.69 1.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.858 0.361 . . . . 73.44 110.899 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.7 tp -72.13 146.1 47.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 70.23 110.938 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.507 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.4 m-20 58.09 34.6 24.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.911 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.44 159.74 56.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.733 . . . . 73.54 110.907 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 119.41 6.35 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.711 2.274 . . . . 52.43 112.279 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -136.58 168.31 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 51.41 110.851 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -129.96 144.27 51.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 72.03 110.94 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.08 -63.85 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -138.98 156.99 72.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.695 0.759 . . . . 63.05 110.851 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.83 -170.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.652 2.235 . . . . 54.31 112.402 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.07 -169.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 71.21 110.878 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.47 -16.32 64.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -96.97 -28.34 14.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.947 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.17 31.99 4.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.75 . . . . 63.51 112.492 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.7 mt -121.9 149.64 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 73.1 111.111 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -104.13 -176.27 3.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.892 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -77.17 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.097 -0.501 . . . . 72.5 110.854 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -122.76 -59.96 1.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 74.41 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -74.77 161.09 29.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.795 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.7 m -112.1 159.9 31.99 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 61.55 110.949 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.07 22.55 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.737 2.291 . . . . 71.33 112.383 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.57 129.93 41.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 70.41 110.906 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.597 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -154.67 19.41 0.59 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.73 . . . . 74.14 112.476 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.5 pt-20 -127.34 25.83 6.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 72.54 110.892 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.0 22.8 16.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 52.44 112.466 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -108.84 178.47 4.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 72.43 110.966 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.33 114.39 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 64.41 110.882 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.3 106.11 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.875 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 t -119.14 139.26 52.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 74.45 111.105 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 tttt -69.27 123.4 21.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.0 m -116.45 -21.33 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 73.3 111.126 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.92 -164.55 10.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 62.55 112.468 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -133.34 160.14 69.81 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 54.31 110.906 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.73 -48.55 0.26 Allowed 'Cis proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.714 -1.786 . . . . 73.04 112.364 -0.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -125.53 50.54 1.8 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 62.02 110.932 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -83.99 77.92 9.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 74.0 111.002 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 mp -86.8 154.46 20.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.52 110.915 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -146.31 149.7 34.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.883 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.1 137.52 56.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 74.44 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -146.84 126.29 13.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.92 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.03 117.43 2.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.87 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -76.06 158.11 32.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.829 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 51.1 110.867 -179.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.991 0.424 . . . . 52.32 110.879 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 p -70.31 140.66 18.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.082 -0.508 . . . . 63.11 111.074 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 m -148.93 114.49 5.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 73.51 111.131 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.8 m -145.18 152.62 40.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.83 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.27 25.81 67.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.699 -0.762 . . . . 72.44 112.458 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.42 78.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 75.23 112.488 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -143.89 153.95 42.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.761 0.315 . . . . 75.44 110.863 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -93.11 138.97 31.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 73.24 110.921 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 m -117.76 175.15 5.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 52.42 110.802 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -76.29 160.52 77.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.6 0.714 . . . . 50.12 110.881 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.41 112.311 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 57.52 32.89 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.2 m -142.07 132.11 24.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 72.3 110.851 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -97.74 168.27 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 m -95.98 124.25 39.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 62.12 110.883 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.74 131.7 70.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 44.55 111.127 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -83.39 124.67 30.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 64.23 110.929 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -135.33 47.31 2.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 75.54 110.862 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 p -64.15 163.12 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 42.21 110.885 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -117.54 25.52 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.82 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.36 32.79 50.6 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.768 -0.729 . . . . 73.44 112.401 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -94.56 -34.98 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.816 0.341 . . . . 74.54 110.905 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.53 15.03 16.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 64.3 112.428 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.28 102.81 7.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 75.43 110.844 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -52.7 107.32 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 51.33 110.895 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -129.37 84.97 60.49 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 72.52 110.798 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 166.45 27.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.64 2.226 . . . . 72.0 112.366 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -127.26 172.21 10.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 72.01 110.841 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.9 m -103.3 118.11 36.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.952 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.21 148.82 64.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.594 0.711 . . . . 71.22 110.812 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 149.99 67.96 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.626 2.217 . . . . 71.3 112.392 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HA3' ' A' ' 56' ' ' GLY . 26.8 mt -61.21 157.86 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 61.15 110.891 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 157.07 51.78 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.75 . . . . 72.22 112.501 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -108.29 -173.47 2.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 73.44 110.878 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 36' ' ' ASN . 24.7 tp -71.62 148.29 46.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 70.23 110.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.538 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.0 m-20 55.02 35.4 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.879 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.32 159.53 56.87 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.61 0.719 . . . . 73.54 110.899 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 117.97 5.4 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.627 2.218 . . . . 52.43 112.333 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.8 p -133.89 171.06 14.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 51.41 110.847 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -126.98 147.82 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 72.03 110.858 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.64 -63.86 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 73.33 111.064 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.06 154.14 64.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.597 0.713 . . . . 63.05 110.897 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -169.64 0.34 Allowed 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.675 2.25 . . . . 54.31 112.382 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.66 -169.34 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 71.21 110.907 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -65.2 -22.47 66.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.878 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -93.69 -25.66 17.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 64.13 110.895 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 29.25 5.77 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.431 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.452 HG21 ' HB2' ' A' ' 17' ' ' GLN . 5.6 mm -108.74 156.27 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 73.1 111.129 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.75 -176.73 2.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 74.22 110.962 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -79.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.5 110.805 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -123.32 -58.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 74.41 110.951 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -77.22 158.68 30.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 74.31 110.898 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.6 m -107.57 159.4 30.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.658 0.742 . . . . 61.55 110.873 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 168.22 22.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.279 . . . . 71.33 112.355 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.7 m -69.45 132.84 46.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 70.41 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -155.67 19.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.708 -0.758 . . . . 74.14 112.466 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.61 27.0 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.918 0.39 . . . . 72.54 110.946 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.49 23.09 19.96 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 52.44 112.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.6 mt -109.77 177.04 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 72.43 110.908 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.34 122.36 7.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.41 110.878 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.12 111.8 0.93 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 73.14 110.871 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -131.25 136.56 48.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 74.45 111.121 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -65.99 127.23 31.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 74.43 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.7 m -116.79 -23.59 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.41 . . . . 73.3 111.131 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.5 -167.46 12.86 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.747 . . . . 62.55 112.483 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.1 pt-20 -119.09 159.69 44.01 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.692 0.758 . . . . 54.31 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.76 -48.49 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.689 -1.796 . . . . 73.04 112.346 -0.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -131.25 43.58 3.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 62.02 110.835 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 tttp -66.5 89.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 74.0 110.935 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.41 136.38 33.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.52 110.886 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -135.35 145.99 47.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.936 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.29 136.66 55.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.251 -0.431 . . . . 74.44 110.882 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -144.99 126.04 14.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 63.24 110.878 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -51.85 116.92 2.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.953 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -67.71 155.67 38.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 75.32 110.928 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 51.1 110.864 -179.773 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.929 0.395 . . . . 52.32 110.857 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 66.0 t -88.0 134.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 63.11 111.118 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -132.05 110.06 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 73.51 111.152 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -128.13 137.97 52.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.21 110.88 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.22 18.58 69.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 72.44 112.455 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.09 -19.62 48.19 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.78 -0.724 . . . . 75.23 112.509 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -108.41 152.88 24.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.722 0.296 . . . . 75.44 110.879 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -80.73 144.19 32.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.974 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -120.81 159.84 24.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 52.42 110.894 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -56.6 160.99 4.78 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.526 0.679 . . . . 50.12 110.944 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 166.87 26.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.716 2.277 . . . . 75.41 112.332 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 59.23 33.96 22.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.91 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 t -141.97 123.8 15.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 72.3 110.901 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -88.78 168.12 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 72.13 110.897 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -88.62 120.38 29.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 62.12 110.979 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.64 141.04 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 44.55 111.12 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.7 122.84 47.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 64.23 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -128.8 91.19 3.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.54 110.916 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 p -107.09 153.78 22.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 42.21 110.909 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -111.3 27.92 9.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.941 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 24.41 76.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.797 -0.716 . . . . 73.44 112.457 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -87.62 -28.12 22.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 74.54 110.95 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.14 32.46 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 64.3 112.436 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -120.1 90.6 3.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 75.43 110.937 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.47 102.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 51.33 110.843 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.6 p -129.77 85.07 59.19 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.687 0.756 . . . . 72.52 110.878 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 166.56 27.33 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 72.0 112.261 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -135.23 173.81 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 72.01 110.918 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 m -96.67 129.83 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.861 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.07 148.32 68.84 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.549 0.69 . . . . 71.22 110.904 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 155.69 65.4 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 71.3 112.338 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -63.68 162.07 13.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 61.15 110.913 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.68 150.21 41.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.745 -0.741 . . . . 72.22 112.459 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -99.47 -174.29 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.44 110.957 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD12 ' H ' ' A' ' 36' ' ' ASN . 20.9 tp -71.14 144.01 50.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.924 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.546 ' H ' HD12 ' A' ' 35' ' ' LEU . 57.2 m-20 57.38 26.86 13.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.869 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.04 159.55 31.47 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 73.54 110.863 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 119.27 6.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.646 2.231 . . . . 52.43 112.383 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -136.59 166.07 24.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 51.41 110.814 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -125.64 142.58 51.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 72.03 110.883 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -51.67 -63.09 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 73.33 111.078 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -138.52 157.11 72.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.693 0.759 . . . . 63.05 110.841 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.685 2.256 . . . . 54.31 112.3 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -72.98 -169.34 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 71.21 110.858 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.63 -14.15 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.04 110.883 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -97.63 -28.34 13.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.13 110.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.07 32.12 4.16 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.711 -0.757 . . . . 63.51 112.527 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mt -125.26 148.84 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.844 0.355 . . . . 73.1 111.101 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -99.78 -176.26 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.22 110.908 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.13 -77.48 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 72.5 110.929 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -123.01 -59.52 1.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -74.88 162.42 28.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.9 m -113.36 158.73 37.57 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.542 0.686 . . . . 61.55 110.918 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 168.11 22.64 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.636 2.224 . . . . 71.33 112.34 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -67.74 125.64 26.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 70.41 110.911 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.54 15.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.733 . . . . 74.14 112.469 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.4 pt-20 -125.9 37.21 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 72.54 110.878 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.4 24.6 39.18 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 52.44 112.501 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.473 HD12 ' HG2' ' A' ' 57' ' ' GLU . 13.3 mt -110.37 174.85 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 72.43 110.848 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.5 118.77 6.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 64.41 110.791 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.92 110.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.14 110.862 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -130.7 140.99 50.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.117 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -67.83 119.68 12.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.43 110.855 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.85 -20.4 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.147 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.34 -157.47 7.78 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.725 -0.75 . . . . 62.55 112.464 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.513 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -144.1 159.73 51.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.717 . . . . 54.31 110.886 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.3 Cg_endo -69.7 -48.41 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.156 0 C-N-CA 122.69 -1.796 . . . . 73.04 112.372 -0.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -124.69 58.33 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 62.02 110.845 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -90.21 82.36 6.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.935 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -75.28 149.24 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.94 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -151.13 146.51 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 74.42 110.834 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.6 m -66.41 141.28 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.891 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -150.9 127.06 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 63.24 110.941 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -51.9 116.94 2.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.58 157.67 37.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 75.32 110.888 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 51.1 110.788 -179.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.959 0.409 . . . . 52.32 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 9' ' ' CYS . 6.8 p -74.45 144.02 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.502 . . . . 63.11 111.108 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -147.88 123.55 10.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 73.51 111.131 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.2 m -150.2 150.44 31.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.21 110.877 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.82 37.14 89.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.464 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.79 20.83 62.45 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 75.23 112.505 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -140.22 154.46 46.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.714 0.292 . . . . 75.44 110.876 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -93.99 138.27 32.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.24 110.961 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HB2' HG13 ' A' ' 2' ' ' VAL . 17.4 m -113.58 174.99 5.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 52.42 110.856 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -81.75 160.88 62.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.545 0.688 . . . . 50.12 110.899 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.78 33.22 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.737 2.292 . . . . 75.41 112.322 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 60.04 25.26 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.92 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -142.05 119.99 12.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 72.3 110.811 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.96 168.0 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.0 m -88.2 133.25 34.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 62.12 110.959 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.53 124.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 44.55 111.121 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -82.61 125.65 31.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 64.23 110.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -126.65 47.65 2.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.921 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.6 t -77.43 158.13 30.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 42.21 110.842 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -122.07 28.5 7.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 71.42 110.792 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 21.67 67.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.716 -0.754 . . . . 73.44 112.535 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -80.63 -29.47 36.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 74.54 110.93 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.08 15.07 27.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 64.3 112.428 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 mtmt -124.29 103.21 8.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.311 . . . . 75.43 110.873 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.87 100.75 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 51.33 110.855 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.2 t -128.54 85.03 61.43 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.701 0.762 . . . . 72.52 110.875 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 166.67 26.74 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.716 2.277 . . . . 72.0 112.398 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -127.03 173.03 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.01 110.85 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.8 m -103.45 111.73 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.886 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.51 148.64 42.24 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.603 0.716 . . . . 71.22 110.808 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 152.54 69.27 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.663 2.242 . . . . 71.3 112.344 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.603 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.0 mt -64.31 148.51 50.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 61.15 110.912 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.81 152.87 38.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.722 -0.752 . . . . 72.22 112.495 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -103.94 -170.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 73.44 110.883 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.0 tp -73.03 142.1 47.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 70.23 110.912 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.6 m-20 59.65 34.64 22.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.851 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.62 49.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.651 0.739 . . . . 73.54 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 52.43 112.381 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.51 161.96 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 51.41 110.857 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.67 146.65 47.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 72.03 110.855 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -53.94 -64.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.164 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -138.29 156.98 73.41 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.627 0.727 . . . . 63.05 110.907 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.632 2.222 . . . . 54.31 112.344 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -72.23 -169.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 71.21 110.959 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -68.48 -15.58 63.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -95.46 -28.32 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 64.13 110.89 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.03 32.06 4.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 63.51 112.502 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 31.3 mt -125.64 149.54 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.837 0.351 . . . . 73.1 111.123 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -102.19 -176.09 3.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.71 -77.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 72.5 110.916 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -122.85 -59.46 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.946 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -75.93 160.9 29.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.831 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -112.79 160.07 32.06 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.649 0.738 . . . . 61.55 110.889 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 168.04 22.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.227 . . . . 71.33 112.423 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -68.87 126.31 29.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 70.41 110.887 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.9 19.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 74.14 112.481 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -127.85 27.48 5.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 72.54 110.887 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.55 19.34 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.729 -0.748 . . . . 52.44 112.498 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.5 mt -109.74 169.5 8.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 72.43 110.898 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.52 117.79 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 64.41 110.872 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' HD23 ' A' ' 70' ' ' LEU . 1.3 m -55.66 103.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.908 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.0 t -115.77 136.58 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.45 111.065 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -68.91 124.67 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.89 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG21 ' HG3' ' A' ' 71' ' ' ARG . 16.7 m -126.07 13.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.108 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -174.13 -167.52 33.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 62.55 112.513 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.9 OUTLIER -127.48 159.58 64.93 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.6 0.714 . . . . 54.31 110.942 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.77 -48.23 0.28 Allowed 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 -1.815 . . . . 73.04 112.355 -0.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -127.13 43.72 3.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 62.02 110.953 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.7 OUTLIER -65.06 102.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 74.0 110.991 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 61' ' ' CYS . 5.7 mp -104.88 138.71 40.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 73.52 110.939 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.573 ' HG3' HG21 ' A' ' 64' ' ' VAL . 18.2 mmt85 -135.86 150.24 49.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.42 110.829 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -70.47 140.28 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.44 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -151.56 129.14 11.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 63.24 110.89 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.77 116.95 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.896 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -66.94 149.5 50.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 75.32 110.94 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 51.1 110.847 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.949 0.404 . . . . 52.32 110.849 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -78.85 143.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.12 -0.491 . . . . 63.11 111.096 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.8 m -128.73 115.58 18.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 73.51 111.136 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 m -137.48 125.51 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 73.21 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.44 17.76 79.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 72.44 112.477 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.25 -16.72 58.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 75.23 112.482 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.53 152.33 19.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.775 0.321 . . . . 75.44 110.848 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -97.17 154.7 17.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.878 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.49 172.04 14.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 52.42 110.9 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -64.08 160.83 44.81 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.611 0.719 . . . . 50.12 110.898 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 175.75 7.69 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.236 . . . . 75.41 112.321 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 56.5 37.81 29.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.25 110.941 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.33 122.32 14.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.119 -0.491 . . . . 72.3 110.807 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -87.72 168.1 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.88 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -90.56 134.63 34.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 62.12 110.87 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.34 144.83 36.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.083 -0.508 . . . . 44.55 111.156 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -89.34 124.09 34.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.972 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -120.47 86.38 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.905 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -139.75 125.55 19.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 42.21 110.927 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -103.38 28.47 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.857 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.96 28.39 26.06 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.811 -0.709 . . . . 73.44 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -79.4 -32.18 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.795 0.331 . . . . 74.54 110.904 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.33 -5.75 41.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.762 -0.732 . . . . 64.3 112.48 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -113.61 89.41 3.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 75.43 110.888 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -56.62 104.29 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 51.33 110.913 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -135.08 84.94 35.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.716 0.77 . . . . 72.52 110.868 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 166.2 28.44 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.669 2.246 . . . . 72.0 112.339 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -136.11 174.05 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 72.01 110.832 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 p -100.57 130.29 46.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.924 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.9 149.4 53.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 71.22 110.861 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 144.67 54.66 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.26 . . . . 71.3 112.307 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.622 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.2 mt -54.29 149.11 10.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 61.15 110.942 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.62 153.04 51.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 72.22 112.509 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -106.34 -172.33 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.44 110.875 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 59' ' ' LEU . 47.4 tp -74.77 151.15 39.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 70.23 110.939 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 60.5 21.87 11.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.907 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -119.22 159.52 44.94 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.627 0.727 . . . . 73.54 110.891 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 145.93 58.84 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.693 2.262 . . . . 52.43 112.361 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.9 p -153.96 167.3 30.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 51.41 110.881 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -126.54 145.43 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 72.03 110.897 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.0 t -53.13 -65.35 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.33 111.172 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -140.01 156.8 70.27 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.641 0.734 . . . . 63.05 110.927 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -170.5 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.238 . . . . 54.31 112.308 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.21 110.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.72 -16.58 64.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 74.04 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -96.36 -28.37 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 64.13 110.86 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 32.08 4.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 63.51 112.505 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.71 146.71 27.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 73.1 111.111 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -100.15 -176.3 3.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.949 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.51 -77.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.5 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -122.81 -58.85 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 74.41 110.985 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -76.31 167.74 21.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.908 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -117.8 160.19 39.52 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.548 0.689 . . . . 61.55 110.913 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 168.11 22.47 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 71.33 112.332 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 91.9 m -69.1 127.97 35.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 70.41 110.841 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.622 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.11 19.36 0.73 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.68 -0.772 . . . . 74.14 112.465 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.7 pt-20 -127.57 27.64 5.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 72.54 110.813 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.04 20.44 23.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.72 -0.752 . . . . 52.44 112.507 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 35' ' ' LEU . 6.6 mt -109.34 177.48 4.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.832 0.348 . . . . 72.43 110.939 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.68 122.18 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 64.41 110.861 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.09 108.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -123.92 148.45 46.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 74.45 111.173 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -82.47 122.75 28.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.909 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.94 13.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 73.3 111.082 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.05 -167.98 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.706 -0.759 . . . . 62.55 112.466 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -140.26 160.04 61.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 54.31 110.872 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.2 Cg_endo -69.68 -44.91 0.46 Allowed 'Cis proline' 0 C--N 1.341 0.151 0 C-N-CA 122.753 -1.769 . . . . 73.04 112.325 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -130.73 69.4 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 62.02 110.852 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -94.26 78.2 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.17 137.9 33.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.52 110.888 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -144.15 170.81 15.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.38 135.44 34.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.886 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -146.7 130.93 17.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 63.24 110.872 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.77 117.24 2.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.851 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -64.87 149.21 49.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.901 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 51.1 110.85 -179.765 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.901 0.381 . . . . 52.32 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.06 132.34 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 63.11 111.163 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.4 m -136.47 109.17 7.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.51 111.159 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.3 m -136.97 137.58 39.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.897 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.51 39.96 97.27 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.701 -0.761 . . . . 72.44 112.446 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.98 29.07 64.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.442 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -144.94 139.59 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 75.44 110.831 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -89.64 148.58 23.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.939 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -139.09 170.4 16.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 52.42 110.881 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -60.35 161.07 14.66 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.544 0.687 . . . . 50.12 110.876 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 173.42 10.95 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.666 2.244 . . . . 75.41 112.334 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 58.19 37.58 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.21 122.54 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.3 110.86 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.55 168.1 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.861 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -89.82 129.89 36.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 62.12 110.828 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.1 152.64 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.091 -0.504 . . . . 44.55 111.165 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' HG2' HG21 ' A' ' 48' ' ' ILE . 4.9 mm-40 -112.07 136.72 51.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 64.23 110.898 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -150.31 114.38 5.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 75.54 110.894 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.25 162.43 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 42.21 110.83 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -104.28 -15.33 15.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.841 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.16 35.91 3.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.705 -0.76 . . . . 73.44 112.503 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.94 -20.54 13.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.855 0.36 . . . . 74.54 110.925 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.23 15.0 15.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.704 -0.76 . . . . 64.3 112.492 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -118.18 99.47 6.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.754 0.311 . . . . 75.43 110.896 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -76.78 113.79 14.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 51.33 110.85 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 m -137.08 85.03 23.28 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.711 0.767 . . . . 72.52 110.875 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 166.46 27.48 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.698 2.265 . . . . 72.0 112.389 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.0 mtp85 -140.24 173.98 10.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 72.01 110.859 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.6 p -100.26 129.97 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 71.42 110.858 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.12 149.64 54.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.638 0.732 . . . . 71.22 110.838 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.29 62.35 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.655 2.237 . . . . 71.3 112.318 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD13 ' HA3' ' A' ' 56' ' ' GLY . 36.2 mt -56.6 148.8 18.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 61.15 110.863 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.68 154.48 45.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 72.22 112.518 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -107.34 -174.42 2.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.856 0.36 . . . . 73.44 110.837 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD12 ' H ' ' A' ' 36' ' ' ASN . 21.1 tp -70.7 145.47 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 70.23 110.9 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.7 m-20 58.37 38.33 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.21 110.946 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.03 159.74 68.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.585 0.707 . . . . 73.54 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 130.96 20.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.683 2.255 . . . . 52.43 112.367 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -144.38 170.44 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 51.41 110.894 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -129.53 147.78 51.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.03 110.833 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -54.32 -67.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 73.33 111.123 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -138.51 156.78 73.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 63.05 110.881 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -170.59 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.664 2.243 . . . . 54.31 112.358 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.14 -169.51 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 71.21 110.904 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -66.79 -16.54 64.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.885 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -97.49 -28.25 14.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 64.13 110.865 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.98 4.86 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 63.51 112.491 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.473 HG21 ' HG2' ' A' ' 17' ' ' GLN . 65.7 mt -119.7 146.12 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 73.1 111.153 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -103.1 -176.09 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.885 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.06 -77.39 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 72.5 110.868 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -123.02 -59.88 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.932 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -75.72 158.29 32.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.885 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.53 160.17 30.42 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 61.55 110.844 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 168.08 22.52 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.673 2.249 . . . . 71.33 112.432 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 97.4 m -70.58 128.77 37.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 70.41 110.86 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.615 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -153.99 20.01 0.66 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 74.14 112.495 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.8 28.26 5.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.923 0.392 . . . . 72.54 110.919 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.95 23.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 52.44 112.516 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.7 mt -109.06 176.11 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 72.43 110.996 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.65 119.6 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.41 110.893 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.21 108.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 137.12 55.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 74.45 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -71.92 124.06 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 74.43 110.908 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.89 -20.6 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 73.3 111.154 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.05 -174.06 16.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 62.55 112.504 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -116.7 159.41 40.57 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.571 0.701 . . . . 54.31 110.837 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -48.25 0.28 Allowed 'Cis proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.708 -1.788 . . . . 73.04 112.403 -0.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -130.98 46.55 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 62.02 110.865 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -70.12 83.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 74.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.17 145.8 27.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.941 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -143.33 154.96 44.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.846 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -71.92 139.28 48.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.98 128.59 12.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.486 . . . . 63.24 110.874 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -52.04 117.05 2.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.914 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -69.16 153.92 42.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 75.32 110.906 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 51.1 110.862 -179.809 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.902 0.382 . . . . 52.32 110.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.89 144.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 63.11 111.095 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 m -129.7 122.22 28.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 73.51 111.141 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 m -139.68 130.35 25.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 73.21 110.878 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.24 22.84 59.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.489 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.07 68.08 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.766 -0.73 . . . . 75.23 112.455 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.29 139.05 31.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 75.44 110.866 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -96.12 142.97 27.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 73.24 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -139.45 174.63 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 52.42 110.905 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -72.41 160.73 82.01 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.623 0.725 . . . . 50.12 110.877 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 177.77 5.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.626 2.217 . . . . 75.41 112.313 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 62.81 27.09 15.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 75.25 110.955 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.0 m -142.03 117.41 10.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 72.3 110.855 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.19 168.26 16.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.2 m -91.57 131.0 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 62.12 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 28' ' ' ARG . 5.9 m -124.19 147.04 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 44.55 111.153 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.94 136.54 54.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 64.23 110.924 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.64 28.71 4.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.848 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 81.1 p -59.06 159.37 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 42.21 110.789 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -124.65 26.69 7.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 71.42 110.827 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.59 33.24 67.31 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 73.44 112.467 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -93.61 -24.41 17.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 74.54 110.832 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.02 15.02 15.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.796 -0.716 . . . . 64.3 112.447 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -127.06 96.48 4.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 75.43 110.867 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -79.21 95.69 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 51.33 110.899 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.5 p -123.02 85.0 50.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.708 0.766 . . . . 72.52 110.851 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 165.64 30.3 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.75 2.3 . . . . 72.0 112.329 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 16' ' ' VAL . 8.1 tpt180 -130.51 163.39 27.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 72.01 110.86 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.6 m -90.72 121.04 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.934 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.56 148.57 50.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 71.22 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 154.8 67.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.725 2.283 . . . . 71.3 112.327 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 56' ' ' GLY . 29.6 mt -65.35 158.18 27.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 61.15 110.928 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.32 158.59 50.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 72.22 112.511 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -110.37 -173.08 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 73.44 110.895 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.582 HD12 ' H ' ' A' ' 36' ' ' ASN . 32.3 tp -70.37 145.0 51.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 70.23 110.958 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.582 ' H ' HD12 ' A' ' 35' ' ' LEU . 90.2 m-20 57.24 39.45 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.21 110.869 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.16 159.45 64.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.68 0.752 . . . . 73.54 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 121.31 7.99 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.767 2.311 . . . . 52.43 112.289 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -142.16 160.21 40.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 51.41 110.841 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.9 142.44 47.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 72.03 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.7 t -51.6 -60.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.15 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -139.03 157.08 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.702 0.763 . . . . 63.05 110.868 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -170.41 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.637 2.225 . . . . 54.31 112.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.27 -169.48 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.21 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -66.92 -15.75 63.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.815 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -96.52 -28.44 14.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 64.13 110.902 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.11 32.14 4.45 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 63.51 112.554 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.3 mt -125.54 150.51 30.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.1 111.123 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -102.04 -176.1 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.868 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.54 -77.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 72.5 110.854 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -123.04 -58.52 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.981 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -75.2 169.72 17.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 24.0 m -119.17 158.35 48.58 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.621 0.724 . . . . 61.55 110.883 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 168.27 22.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.637 2.225 . . . . 71.33 112.355 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -64.69 125.18 23.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 70.41 110.838 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.94 17.88 1.08 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 74.14 112.479 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.8 pt-20 -127.07 28.99 5.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 72.54 110.831 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.67 22.52 23.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 52.44 112.454 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 57' ' ' GLU . 8.2 mt -109.81 179.36 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 72.43 110.923 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.74 116.59 5.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 64.41 110.833 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 110.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 73.14 110.847 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -126.21 136.77 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.45 111.145 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -65.41 123.92 20.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.896 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 69' ' ' LYS . 31.4 m -116.76 -19.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.43 . . . . 73.3 111.096 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.91 -164.5 11.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 62.55 112.438 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -131.39 159.7 70.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.621 0.724 . . . . 54.31 110.918 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.4 Cg_endo -69.74 -48.37 0.27 Allowed 'Cis proline' 0 C--O 1.231 0.146 0 C-N-CA 122.67 -1.804 . . . . 73.04 112.326 -0.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -126.21 47.91 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 62.02 110.903 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 64' ' ' VAL . 29.6 ttpt -79.61 77.99 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 74.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.54 152.55 25.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.936 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 -145.61 145.53 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.88 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.63 136.11 55.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.44 110.851 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -143.76 125.04 14.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 63.24 110.912 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -51.8 116.93 2.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.86 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.91 156.97 38.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.929 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 51.1 110.876 -179.784 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.94 0.4 . . . . 52.32 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.15 141.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 63.11 111.164 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -137.32 110.48 7.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 73.51 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.3 m -125.94 130.99 52.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.824 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.38 20.89 63.82 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 72.44 112.471 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.31 -20.38 44.08 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.77 -0.728 . . . . 75.23 112.541 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -100.12 145.56 27.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 75.44 110.864 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.903 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.99 171.53 13.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 52.42 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -65.4 160.69 57.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.702 . . . . 50.12 110.893 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 174.97 8.67 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.244 . . . . 75.41 112.341 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 58.47 30.0 19.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.887 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 m -142.06 120.75 12.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.3 110.826 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.2 p -90.31 168.1 12.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.881 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 m -90.14 126.36 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 62.12 110.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.78 136.97 56.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 44.55 111.186 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -104.62 128.09 52.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 64.23 110.877 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.68 32.11 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.54 110.908 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.2 t -68.36 152.13 45.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 42.21 110.837 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -124.99 26.16 7.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 71.42 110.844 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.18 30.0 35.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.682 -0.771 . . . . 73.44 112.48 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -85.16 -28.67 25.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 74.54 110.861 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.5 9.44 35.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 64.3 112.507 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -127.01 88.74 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.758 0.314 . . . . 75.43 110.96 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.8 94.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 51.33 110.86 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -118.32 84.95 24.15 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.608 0.718 . . . . 72.52 110.935 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 165.64 30.28 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.704 2.269 . . . . 72.0 112.31 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -129.19 171.52 12.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.435 . . . . 72.01 110.83 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.2 m -102.3 112.99 25.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.81 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.59 148.96 40.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.607 0.718 . . . . 71.22 110.889 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 150.39 68.52 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 71.3 112.391 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.595 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.0 mt -59.0 147.99 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 61.15 110.932 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.9 156.7 36.21 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 72.22 112.503 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -108.32 -170.78 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 73.44 110.868 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 36' ' ' ASN . 27.9 tp -73.75 146.4 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 70.23 110.868 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.574 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 56.47 32.52 20.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.849 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.88 159.67 45.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 73.54 110.941 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.92 5.97 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.697 2.265 . . . . 52.43 112.295 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 p -135.04 169.33 17.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 51.41 110.893 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -130.21 144.64 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 72.03 110.857 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.9 t -52.62 -63.95 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 73.33 111.113 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -138.98 156.75 72.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 63.05 110.863 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -169.99 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.752 2.301 . . . . 54.31 112.323 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -168.32 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 71.21 110.843 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.1 -24.14 67.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 74.04 110.812 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -89.94 -28.37 19.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.13 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.54 32.25 4.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 63.51 112.566 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.9 mt -120.66 150.73 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 73.1 111.088 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -104.18 -176.09 2.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.22 110.955 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.55 -76.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 72.5 110.864 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -122.66 -60.06 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 74.41 110.923 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -74.9 158.85 32.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 74.31 110.792 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.1 m -109.93 160.05 29.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 61.55 110.963 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.78 167.93 23.04 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.698 2.266 . . . . 71.33 112.293 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.73 124.74 24.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 70.41 110.883 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.595 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.04 17.61 1.06 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.779 -0.724 . . . . 74.14 112.478 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.82 27.44 6.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.887 0.375 . . . . 72.54 110.951 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.46 21.58 24.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.646 -0.788 . . . . 52.44 112.523 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -107.8 170.94 7.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 72.43 110.841 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.6 119.42 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 64.41 110.935 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.4 m -55.23 109.95 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 73.14 110.909 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -127.75 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 74.45 111.129 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -66.87 127.97 34.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.941 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.31 13.21 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.3 111.11 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -176.56 -157.95 18.88 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 62.55 112.484 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.3 pt-20 -140.25 159.39 63.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 54.31 110.913 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 54.0 Cg_endo -69.74 -41.75 0.86 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.664 -1.807 . . . . 73.04 112.351 -0.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -134.56 63.79 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.912 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -81.95 79.81 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 tp -82.15 133.04 35.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.954 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.94 147.77 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 74.42 110.896 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.85 129.42 39.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.91 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.72 128.1 30.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 63.24 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 119.98 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.842 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -64.12 154.53 34.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 75.32 110.831 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 51.1 110.885 -179.814 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.9 0.381 . . . . 52.32 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -71.26 143.13 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 63.11 111.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 m -128.87 115.29 17.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.51 111.1 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -138.16 123.14 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.887 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.59 19.4 79.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.44 112.482 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.57 -13.96 64.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 75.23 112.414 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.95 139.31 31.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 75.44 110.906 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.1 138.1 35.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.926 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -131.79 171.91 12.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 52.42 110.907 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -62.35 160.74 30.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.61 0.719 . . . . 50.12 110.815 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 177.8 5.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.668 2.245 . . . . 75.41 112.397 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.98 36.32 27.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 75.25 110.921 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.7 m -141.95 124.51 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.3 110.889 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -87.78 168.2 13.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.13 110.866 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 m -90.72 128.01 36.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 62.12 110.885 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -120.59 166.49 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 44.55 111.09 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.613 ' HG2' HG21 ' A' ' 48' ' ' ILE . 1.1 mm-40 -117.93 137.63 52.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 64.23 110.93 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.74 29.78 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 75.54 110.856 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.8 p -63.15 144.61 56.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 42.21 110.862 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -127.05 26.07 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 71.42 110.828 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.77 60.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.705 -0.76 . . . . 73.44 112.483 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -88.9 -25.96 21.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.771 0.32 . . . . 74.54 110.905 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.99 -6.21 34.78 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.743 -0.742 . . . . 64.3 112.505 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -124.73 92.66 3.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.785 0.326 . . . . 75.43 110.892 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -58.57 117.86 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 51.33 110.856 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.3 p -137.16 85.0 23.07 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.679 0.752 . . . . 72.52 110.893 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 164.95 32.62 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.659 2.239 . . . . 72.0 112.348 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -133.6 173.8 11.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 72.01 110.919 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.3 p -104.14 131.88 50.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 149.34 62.78 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.606 0.717 . . . . 71.22 110.806 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 145.7 57.65 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.654 2.236 . . . . 71.3 112.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD13 ' HA3' ' A' ' 56' ' ' GLY . 42.6 mt -54.14 149.42 9.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 61.15 110.873 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.6 157.06 52.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.732 . . . . 72.22 112.453 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -105.62 -169.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.324 . . . . 73.44 110.898 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 36' ' ' ASN . 25.4 tp -72.96 149.04 43.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.18 -0.464 . . . . 70.23 110.927 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.525 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.7 m-20 53.03 33.34 14.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.899 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.13 159.66 42.28 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.641 0.734 . . . . 73.54 110.842 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 117.81 5.3 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.68 2.254 . . . . 52.43 112.309 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.5 p -132.19 170.87 14.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 51.41 110.872 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -131.09 146.36 52.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.03 110.88 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' HG3' ' A' ' 42' ' ' GLU . 47.5 t -52.2 -66.21 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 73.33 111.155 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 41' ' ' VAL . 74.3 mt-10 -140.64 156.74 69.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.656 0.741 . . . . 63.05 110.84 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -170.42 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 54.31 112.375 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -169.39 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.856 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.15 -16.03 64.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 74.04 110.908 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -98.38 -28.18 13.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.882 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 31.99 4.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 63.51 112.449 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.613 HG21 ' HG2' ' A' ' 17' ' ' GLN . 68.4 mt -119.08 145.48 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.912 0.387 . . . . 73.1 111.102 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -102.82 -176.19 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 74.22 110.879 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.82 -77.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 72.5 110.843 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -123.06 -59.39 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 74.41 110.873 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -76.23 159.23 30.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.31 110.888 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.8 m -112.02 160.06 31.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.605 0.717 . . . . 61.55 110.886 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 167.99 22.85 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.698 2.265 . . . . 71.33 112.334 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.3 m -68.22 124.17 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 70.41 110.848 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -149.98 17.83 1.07 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.48 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HG2' HD12 ' A' ' 59' ' ' LEU . 11.3 pt-20 -126.6 29.21 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 72.54 110.91 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.56 20.74 26.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 52.44 112.446 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.408 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.3 mt -109.01 179.56 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.874 0.368 . . . . 72.43 110.857 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 120.27 5.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 64.41 110.844 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -54.94 108.1 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 73.14 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -125.69 136.63 53.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.45 111.209 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.87 125.59 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.924 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' LYS . 27.9 m -116.68 -21.22 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 73.3 111.122 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.19 -162.26 9.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.688 -0.768 . . . . 62.55 112.486 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.7 OUTLIER -130.09 159.69 68.99 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.57 0.7 . . . . 54.31 110.92 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.83 -48.48 0.27 Allowed 'Cis proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.676 -1.801 . . . . 73.04 112.291 0.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -127.29 46.55 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 62.02 110.82 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 64' ' ' VAL . 5.4 ttpm? -72.98 77.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 74.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.1 141.96 35.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 73.52 110.928 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -139.39 145.68 39.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.839 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -67.48 136.73 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.859 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -145.51 126.94 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 63.24 110.906 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.856 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.49 152.48 41.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.32 110.857 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 51.1 110.807 -179.721 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.941 0.4 . . . . 52.32 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.2 130.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 63.11 111.165 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 84.6 m -137.28 113.7 10.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.51 111.221 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.8 m -139.48 157.1 46.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 73.21 110.855 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.81 16.51 51.92 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.782 -0.723 . . . . 72.44 112.491 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.18 -15.21 60.24 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.729 . . . . 75.23 112.495 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.83 163.46 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 75.44 110.893 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -94.63 155.39 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.444 . . . . 73.24 110.963 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.0 m -132.63 177.19 7.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.42 110.858 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -80.24 160.65 67.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.545 0.688 . . . . 50.12 110.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 168.33 21.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.67 2.246 . . . . 75.41 112.429 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 63.33 27.56 15.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.96 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.0 p -142.02 119.2 11.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 72.3 110.866 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.6 p -88.07 168.13 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 72.13 110.924 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 m -91.18 125.48 35.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 62.12 110.906 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.4 m -115.15 156.25 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 44.55 111.108 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.544 ' CG ' HG21 ' A' ' 48' ' ' ILE . 2.4 mm-40 -118.2 129.21 55.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.23 110.896 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -152.57 95.97 2.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.961 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 163.25 16.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 42.21 110.845 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -98.63 26.35 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 71.42 110.85 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.9 22.59 72.22 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 73.44 112.49 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 mmmt -79.98 -27.94 39.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.791 0.329 . . . . 74.54 110.884 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 106.5 15.02 18.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.792 -0.718 . . . . 64.3 112.517 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -118.76 93.75 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 75.43 110.914 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -57.58 108.57 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 51.33 110.879 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.9 m -135.84 85.01 30.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.611 0.72 . . . . 72.52 110.821 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.0 32.51 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.699 2.266 . . . . 72.0 112.347 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -133.84 173.95 10.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 72.01 110.911 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.61 130.85 51.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 71.42 110.848 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 149.35 73.2 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.646 0.736 . . . . 71.22 110.871 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 146.75 61.38 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.725 2.283 . . . . 71.3 112.387 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.3 mt -55.09 149.85 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 61.15 110.946 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.81 151.89 36.57 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.854 -0.688 . . . . 72.22 112.415 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.23 -177.48 3.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.839 0.352 . . . . 73.44 110.898 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 36' ' ' ASN . 29.5 tp -69.73 143.22 53.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 70.23 110.863 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' H ' HD12 ' A' ' 35' ' ' LEU . 70.6 m-20 60.53 39.45 18.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 73.21 110.904 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.04 159.46 72.56 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.586 0.708 . . . . 73.54 110.921 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 133.18 24.81 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 52.43 112.327 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 p -148.03 167.78 24.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 51.41 110.965 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -126.31 148.07 49.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 72.03 110.94 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -52.74 -64.42 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 73.33 111.127 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -142.15 156.74 64.57 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.647 0.736 . . . . 63.05 110.851 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.675 2.25 . . . . 54.31 112.303 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -74.58 -169.53 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.21 110.875 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.99 -16.78 64.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -97.36 -28.08 14.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 64.13 110.829 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.31 32.01 4.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.683 -0.77 . . . . 63.51 112.493 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.544 HG21 ' CG ' ' A' ' 17' ' ' GLN . 72.3 mt -117.98 145.6 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 73.1 111.192 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -104.49 -176.19 3.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.959 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.58 -78.01 0.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.073 -0.512 . . . . 72.5 110.842 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.19 -58.32 1.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.935 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -77.42 169.06 18.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.901 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.8 m -117.77 160.67 37.57 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.563 0.696 . . . . 61.55 110.89 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 168.07 22.59 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.675 2.25 . . . . 71.33 112.334 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 89.0 m -70.67 126.01 28.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 70.41 110.852 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -152.24 18.58 0.81 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.76 . . . . 74.14 112.402 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.51 30.7 5.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.905 0.383 . . . . 72.54 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.15 22.23 27.99 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 52.44 112.489 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.1 mt -108.77 176.42 5.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.868 0.365 . . . . 72.43 110.933 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.5 116.8 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 64.41 110.883 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 103.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.853 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 t -118.21 136.98 53.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.45 111.159 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -76.17 122.71 24.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.946 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' A' ' 71' ' ' ARG . 18.9 m -116.73 -19.29 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 73.3 111.079 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.72 -159.82 9.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.79 -0.719 . . . . 62.55 112.518 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.5 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.1 pt-20 -139.78 159.47 64.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.691 0.758 . . . . 54.31 110.864 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.8 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 -1.802 . . . . 73.04 112.342 0.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.76 53.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.02 110.867 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -79.67 78.1 6.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.91 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.09 141.17 34.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 73.52 110.933 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.412 ' HG3' HG22 ' A' ' 64' ' ' VAL . 9.0 mtt180 -139.16 153.11 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 74.42 110.904 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -71.0 140.97 50.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.44 110.875 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -151.86 129.43 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 63.24 110.888 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -51.93 117.02 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -64.05 149.53 47.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 75.32 110.892 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.143 -0.48 . . . . 51.1 110.877 -179.828 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.953 0.406 . . . . 52.32 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.98 139.42 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 63.11 111.123 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.9 m -143.12 107.55 4.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.51 111.107 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.6 m -146.4 149.29 33.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 73.21 110.855 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.0 75.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 72.44 112.474 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.67 24.97 75.2 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.71 -0.757 . . . . 75.23 112.475 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -148.87 137.79 21.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 75.44 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -78.01 133.29 38.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.9 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.98 176.7 5.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 52.42 110.923 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -77.87 160.73 73.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.625 0.726 . . . . 50.12 110.85 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.88 15.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.755 2.304 . . . . 75.41 112.333 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 63.19 27.78 15.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 75.25 110.886 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.75 117.42 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 72.3 110.891 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.9 p -88.48 168.09 12.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.877 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 m -91.69 131.11 37.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 62.12 110.888 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.98 124.0 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 44.55 111.142 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -78.88 125.65 29.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 64.23 110.902 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -126.02 26.44 6.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 75.54 110.9 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -68.59 158.6 33.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 42.21 110.852 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -111.36 27.38 9.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.51 . . . . 71.42 110.881 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.93 26.47 71.06 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.79 -0.719 . . . . 73.44 112.447 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -82.66 -25.49 33.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 74.54 110.907 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.95 15.11 15.37 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.837 -0.697 . . . . 64.3 112.428 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -121.49 102.45 8.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 75.43 110.908 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -69.11 100.02 1.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 51.33 110.842 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.5 p -130.95 84.91 56.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 72.52 110.848 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 166.48 27.36 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.684 2.256 . . . . 72.0 112.381 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.53 171.36 8.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 72.01 110.884 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.9 m -107.57 107.37 18.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.893 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.23 149.25 43.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.561 0.696 . . . . 71.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 152.46 69.57 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 71.3 112.35 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.0 mt -62.16 149.43 41.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 61.15 110.882 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.57 149.68 39.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 72.22 112.476 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -172.82 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.754 0.311 . . . . 73.44 110.894 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.545 HD12 ' H ' ' A' ' 36' ' ' ASN . 38.0 tp -72.29 146.37 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 70.23 110.925 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.545 ' H ' HD12 ' A' ' 35' ' ' LEU . 71.8 m-20 58.31 35.51 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.21 110.861 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.67 159.74 68.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.68 0.752 . . . . 73.54 110.802 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 138.4 37.84 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.601 2.201 . . . . 52.43 112.357 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.6 p -147.6 170.77 16.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.271 -0.422 . . . . 51.41 110.918 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -129.22 146.04 51.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 72.03 110.88 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.76 -67.78 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 73.33 111.124 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -139.64 156.69 71.08 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.64 0.734 . . . . 63.05 110.923 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.6 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.719 2.279 . . . . 54.31 112.332 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.51 -169.47 1.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.955 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.69 -17.75 64.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.04 110.901 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -96.28 -28.35 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 64.13 110.926 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.28 31.95 4.47 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.668 -0.777 . . . . 63.51 112.477 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.16 146.95 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.1 111.127 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -101.93 -176.19 3.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 74.22 110.899 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.12 -77.08 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.049 -0.523 . . . . 72.5 110.858 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -122.78 -59.55 1.59 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.942 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -76.95 156.02 32.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.896 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.3 m -106.74 160.41 26.39 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 61.55 110.797 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 167.92 23.06 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 71.33 112.275 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 85.7 m -72.92 125.62 28.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 70.41 110.831 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.83 17.62 0.84 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 74.14 112.482 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.68 31.47 5.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 72.54 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.25 21.65 31.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.745 -0.741 . . . . 52.44 112.539 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mt -108.04 176.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.901 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -148.78 119.16 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 64.41 110.826 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.36 103.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.833 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.39 145.68 47.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.45 111.184 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -82.89 123.46 29.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 74.43 110.899 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 ' HE ' ' A' ' 71' ' ' ARG . 32.3 m -125.97 13.13 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 73.3 111.104 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.59 -158.6 9.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.683 -0.77 . . . . 62.55 112.397 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.0 pt-20 -158.52 159.43 29.81 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.683 0.754 . . . . 54.31 110.809 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.77 -43.09 0.65 Allowed 'Cis proline' 0 C--N 1.342 0.216 0 C-N-CA 122.727 -1.781 . . . . 73.04 112.309 0.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 t30 -126.97 75.1 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 62.02 110.851 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -108.36 78.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.095 -0.502 . . . . 74.0 110.898 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 70' ' ' LEU . 5.1 tp -81.2 136.6 35.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.287 -0.415 . . . . 73.52 110.875 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.594 ' HE ' HG21 ' A' ' 64' ' ' VAL . 22.5 mtm180 -140.11 156.93 46.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 74.42 110.857 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.61 141.6 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 74.44 110.884 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.04 127.41 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 63.24 110.964 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -52.02 117.06 2.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.866 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -65.75 157.79 29.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.844 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 51.1 110.874 -179.771 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.896 0.379 . . . . 52.32 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.36 140.31 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 63.11 111.143 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.1 m -137.1 107.43 6.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 73.51 111.19 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.2 m -125.87 143.25 51.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 73.21 110.87 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.37 43.63 57.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 72.44 112.474 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.14 19.52 46.1 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.784 -0.722 . . . . 75.23 112.471 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -134.75 140.69 46.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.781 0.324 . . . . 75.44 110.846 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.25 148.95 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.18 178.76 6.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 52.42 110.939 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -73.7 160.61 81.7 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.543 0.687 . . . . 50.12 110.91 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 172.92 11.76 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 75.41 112.369 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 63.11 26.74 15.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.284 -0.417 . . . . 75.25 110.94 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 p -142.08 118.26 10.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.3 110.888 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -86.95 168.24 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 72.13 110.852 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.0 m -93.11 133.64 36.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 62.12 110.873 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 49' ' ' TYR . 5.3 m -131.04 137.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 44.55 111.149 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -92.71 131.22 37.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 64.23 110.93 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -129.06 51.96 2.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 75.54 110.875 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.1 t -82.4 136.4 34.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 42.21 110.805 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -101.64 26.04 7.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 71.42 110.861 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.94 24.45 64.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.544 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -84.67 -28.77 26.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 74.54 110.911 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.68 14.96 23.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.687 -0.768 . . . . 64.3 112.574 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.97 94.68 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 75.43 110.893 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.28 94.94 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 51.33 110.849 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.3 p -131.87 84.89 52.71 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.614 0.721 . . . . 72.52 110.863 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 164.86 33.04 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.65 2.233 . . . . 72.0 112.314 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -123.8 173.78 7.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 72.01 110.934 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 m -97.06 130.03 44.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 71.42 110.885 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.28 148.83 71.72 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.626 0.727 . . . . 71.22 110.839 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 155.11 66.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.731 2.287 . . . . 71.3 112.279 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.601 HD13 ' HA3' ' A' ' 56' ' ' GLY . 24.6 mt -65.49 154.13 39.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 61.15 110.913 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.91 159.68 43.01 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.729 . . . . 72.22 112.495 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -115.44 -176.25 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 73.44 110.923 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.9 tp -70.6 142.35 51.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 70.23 110.919 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' H ' HD12 ' A' ' 35' ' ' LEU . 68.0 m-20 60.57 39.5 17.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 73.21 110.882 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.55 159.52 71.45 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.596 0.713 . . . . 73.54 110.937 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 129.03 16.89 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.647 2.231 . . . . 52.43 112.396 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.1 p -147.44 167.79 23.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 51.41 110.893 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -127.04 150.54 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 72.03 110.909 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -55.9 -65.02 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -138.52 157.02 72.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.686 0.755 . . . . 63.05 110.893 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -170.13 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.645 2.23 . . . . 54.31 112.348 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -73.83 -169.29 0.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.435 . . . . 71.21 110.908 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -67.93 -15.56 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.825 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -96.58 -28.21 14.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 64.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.16 4.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.76 -0.733 . . . . 63.51 112.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.9 mt -123.95 146.69 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.851 0.358 . . . . 73.1 111.129 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.452 ' HB2' HG12 ' A' ' 16' ' ' VAL . 51.3 m-85 -101.53 -176.11 3.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 74.22 110.927 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.44 -77.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 72.5 110.873 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -122.89 -58.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 74.41 110.958 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -77.15 161.36 28.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.922 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.4 m -111.55 159.98 31.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 61.55 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 168.11 22.55 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.71 2.273 . . . . 71.33 112.403 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.8 m -68.67 126.1 28.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 70.41 110.925 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.601 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.39 19.51 0.92 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 74.14 112.402 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -127.31 27.77 5.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 72.54 110.847 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.3 22.87 21.07 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.671 -0.776 . . . . 52.44 112.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.2 mt -109.65 175.13 5.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 72.43 110.979 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.66 116.8 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 64.41 110.912 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.09 105.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.927 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -119.8 137.13 54.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.17 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -71.63 123.98 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.988 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.47 -20.32 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 73.3 111.133 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.64 -156.82 7.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 62.55 112.504 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.8 pt-20 -140.6 159.63 62.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.696 0.76 . . . . 54.31 110.78 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.7 Cg_endo -69.75 -48.37 0.27 Allowed 'Cis proline' 0 C--N 1.342 0.206 0 C-N-CA 122.677 -1.801 . . . . 73.04 112.347 -0.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -125.38 50.33 1.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 62.02 110.915 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 tttt -77.93 77.96 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 74.0 110.848 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.77 148.85 28.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 73.52 110.892 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -145.9 152.75 39.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.873 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -70.76 137.59 49.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.883 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -147.38 127.86 14.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.905 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.04 118.8 3.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 74.33 110.899 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.1 156.35 28.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 75.32 110.892 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 51.1 110.867 -179.773 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.913 0.387 . . . . 52.32 110.854 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.1 t -80.85 143.33 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 63.11 111.034 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 m -142.63 115.45 8.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 73.51 111.082 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.4 m -132.49 132.62 42.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.21 110.903 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.76 20.77 66.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.781 -0.723 . . . . 72.44 112.478 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.83 -20.85 42.65 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.46 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -99.82 149.16 23.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 75.44 110.931 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -93.48 147.46 22.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.897 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.22 169.06 16.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 52.42 110.852 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -63.91 160.79 43.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.62 0.724 . . . . 50.12 110.896 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.73 176.44 6.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.75 2.3 . . . . 75.41 112.323 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 62.6 25.27 15.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.25 110.857 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.6 p -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.844 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.0 p -88.05 168.13 13.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 72.13 110.925 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 m -90.89 134.78 34.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.12 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.73 135.26 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 44.55 111.203 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -95.7 123.3 39.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 64.23 110.956 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -129.59 42.72 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 75.54 110.886 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 p -71.33 154.62 41.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 42.21 110.846 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -109.19 26.44 10.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 71.42 110.875 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.4 27.16 66.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 73.44 112.452 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.2 -31.08 23.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 74.54 110.846 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.81 15.09 15.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 64.3 112.473 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -119.87 98.95 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.755 0.312 . . . . 75.43 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.07 94.5 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 51.33 110.902 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 t -126.91 84.92 62.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 72.52 110.837 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 166.6 27.06 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.703 2.269 . . . . 72.0 112.312 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 161.48 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.865 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 m -95.69 109.05 21.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 71.42 110.939 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 148.99 39.4 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.593 0.711 . . . . 71.22 110.887 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.17 64.79 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.669 2.246 . . . . 71.3 112.316 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.598 HD13 ' HA3' ' A' ' 56' ' ' GLY . 40.6 mt -56.65 150.35 15.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 61.15 110.858 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.39 148.44 51.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 72.22 112.476 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -171.73 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.773 0.321 . . . . 73.44 110.898 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 59' ' ' LEU . 42.4 tp -73.12 146.89 45.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 70.23 110.903 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.79 24.08 13.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.7 159.72 36.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.604 0.716 . . . . 73.54 110.856 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 125.75 12.54 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.271 . . . . 52.43 112.323 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.7 p -143.54 164.61 29.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 51.41 110.857 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.84 156.12 43.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.03 110.857 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.68 -61.12 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.136 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -140.61 156.9 69.02 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.637 0.732 . . . . 63.05 110.884 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.13 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 54.31 112.335 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.08 -169.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.21 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.34 -15.2 63.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.04 110.905 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.81 -28.31 14.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.937 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.13 32.14 4.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 63.51 112.456 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.6 mt -124.66 150.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 73.1 111.144 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.1 -176.2 3.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.892 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.77 -76.96 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 72.5 110.84 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -122.65 -59.54 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.949 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -75.9 160.04 30.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 74.31 110.87 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.0 m -111.48 160.29 29.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.653 0.74 . . . . 61.55 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 168.0 22.86 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.657 2.238 . . . . 71.33 112.324 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.9 m -69.92 126.35 29.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 70.41 110.88 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.598 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.2 18.27 0.92 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.766 -0.731 . . . . 74.14 112.478 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 59' ' ' LEU . 12.0 pt-20 -127.27 26.47 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 72.54 110.944 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.01 22.82 16.49 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.726 -0.75 . . . . 52.44 112.475 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.455 HD12 ' HG2' ' A' ' 57' ' ' GLU . 7.2 mt -109.73 171.94 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.43 110.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 t -143.63 120.0 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.865 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.66 102.48 0.12 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.864 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -115.42 140.93 48.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.45 111.117 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -77.75 125.74 29.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.847 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.679 HG23 ' HD2' ' A' ' 69' ' ' LYS . 7.9 m -117.06 -21.24 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.112 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.6 -176.54 15.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 62.55 112.476 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -118.0 159.54 42.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.579 0.704 . . . . 54.31 110.897 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.78 -48.68 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.156 0 C-N-CA 122.679 -1.8 . . . . 73.04 112.304 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -131.11 65.9 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 62.02 110.844 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.679 ' HD2' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -89.44 77.79 7.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 74.0 110.862 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.3 mp -85.1 140.93 30.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 73.52 110.863 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -140.44 157.39 45.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.863 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -72.12 132.04 43.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.913 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -143.21 129.06 19.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.9 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -52.05 117.33 2.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.877 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.92 147.5 53.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 75.32 110.845 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 51.1 110.843 -179.818 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.852 0.358 . . . . 52.32 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.3 136.02 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.123 -0.49 . . . . 63.11 111.073 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -146.11 107.83 4.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 73.51 111.2 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -147.03 144.59 29.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 73.21 110.899 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.07 20.08 78.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 72.44 112.523 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.87 23.79 73.83 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.728 -0.749 . . . . 75.23 112.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -144.95 155.28 43.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.711 0.291 . . . . 75.44 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -101.4 155.26 18.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.856 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -140.91 173.13 11.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 52.42 110.923 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -69.06 160.58 77.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.71 . . . . 50.12 110.849 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 175.11 8.51 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.603 2.202 . . . . 75.41 112.389 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 59.98 27.56 16.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 75.25 110.928 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 p -142.02 119.23 11.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.3 110.848 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -89.13 168.14 12.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.13 110.9 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 m -89.75 132.65 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 62.12 110.869 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -131.05 123.98 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 44.55 111.139 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.92 122.94 25.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 64.23 110.896 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -130.01 84.81 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 75.54 110.835 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -96.83 164.97 12.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 42.21 110.867 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -127.66 26.01 5.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 71.42 110.817 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.19 27.28 66.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 73.44 112.465 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -91.9 -36.0 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.742 0.305 . . . . 74.54 110.866 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.6 15.02 16.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.728 -0.749 . . . . 64.3 112.528 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.3 mtpt -125.32 95.25 4.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 75.43 110.836 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -54.44 107.25 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 51.33 110.857 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -133.68 84.98 43.33 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.712 0.768 . . . . 72.52 110.845 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 166.97 25.81 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.656 2.237 . . . . 72.0 112.434 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.66 174.01 10.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.01 110.877 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 120.42 40.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 71.42 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.64 149.02 47.31 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 71.22 110.839 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 149.71 67.25 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.654 2.236 . . . . 71.3 112.337 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 56' ' ' GLY . 34.7 mt -59.34 148.67 31.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 61.15 110.894 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 155.42 34.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.819 -0.705 . . . . 72.22 112.448 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -108.72 -172.89 2.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 73.44 110.902 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 36' ' ' ASN . 23.6 tp -73.15 145.6 46.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.23 110.981 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 35' ' ' LEU . 77.5 m-20 58.27 38.68 26.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 73.21 110.836 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.41 159.59 69.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.688 0.756 . . . . 73.54 110.876 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 124.37 11.01 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.715 2.277 . . . . 52.43 112.33 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 p -136.31 168.26 19.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 51.41 110.798 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -127.16 144.39 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 72.03 110.947 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -52.94 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.33 111.07 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -140.01 156.8 70.28 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.577 0.703 . . . . 63.05 110.935 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -169.87 0.36 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.638 2.225 . . . . 54.31 112.33 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.74 -168.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.21 110.846 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.86 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.852 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -88.21 -28.44 21.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 64.13 110.826 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.86 32.07 4.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 63.51 112.514 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.46 147.18 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.842 0.353 . . . . 73.1 111.117 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -100.43 -175.99 3.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.928 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.21 -77.77 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.5 110.883 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -123.06 -58.04 1.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 74.41 110.9 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -77.06 168.65 19.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.31 110.852 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.1 m -116.1 160.34 35.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 61.55 110.946 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 168.13 22.43 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.659 2.24 . . . . 71.33 112.35 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 93.1 m -70.07 125.47 26.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 70.41 110.936 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.88 19.23 0.86 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 74.14 112.501 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -125.75 28.1 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 72.54 110.87 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.94 22.65 22.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.7 -0.762 . . . . 52.44 112.457 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.8 mt -108.64 177.4 4.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 72.43 110.875 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.41 118.6 6.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.41 110.809 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.1 m -55.41 106.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.901 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -123.59 136.88 54.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 74.45 111.178 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.43 126.1 29.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 74.43 110.889 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG21 ' HE ' ' A' ' 71' ' ' ARG . 35.0 m -125.03 13.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 73.3 111.101 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.87 -160.18 13.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 62.55 112.473 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.508 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 0.6 OUTLIER -138.3 159.99 65.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.686 0.755 . . . . 54.31 110.858 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.9 Cg_endo -69.84 -42.82 0.69 Allowed 'Cis proline' 0 C--N 1.342 0.227 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.288 0.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -131.42 49.47 2.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 62.02 110.891 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.6 OUTLIER -70.55 97.96 1.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 74.0 110.88 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.88 136.87 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.93 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.63 ' HE ' HG21 ' A' ' 64' ' ' VAL . 26.4 mtm180 -139.64 150.14 44.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.828 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.72 138.57 55.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.896 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -147.01 127.17 13.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 63.24 110.926 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -52.39 117.02 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.898 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -67.17 155.03 39.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 75.32 110.907 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 51.1 110.854 -179.798 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.4 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.859 0.361 . . . . 52.32 110.917 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.8 t -81.31 142.62 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 63.11 111.124 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.9 m -137.49 111.15 8.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 73.51 111.151 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 m -130.61 129.16 42.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 73.21 110.965 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.58 39.35 95.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.44 112.442 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.04 20.58 64.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 75.23 112.516 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -135.07 143.86 46.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.307 . . . . 75.44 110.875 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -90.88 136.44 33.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.882 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -124.41 169.11 12.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 52.42 110.868 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -63.83 160.6 44.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.524 0.678 . . . . 50.12 110.964 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 175.95 7.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 75.41 112.3 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 61.05 28.51 18.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.25 110.881 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.0 p -142.06 122.81 14.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.3 110.842 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 p -89.97 168.14 12.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.842 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.1 m -91.28 122.07 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 62.12 110.854 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -119.95 131.39 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 44.55 111.131 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.36 124.88 31.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 64.23 110.958 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -150.09 107.54 3.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.54 110.881 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 m -117.11 169.75 9.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 42.21 110.819 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -102.96 27.02 7.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 71.42 110.929 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.1 20.14 70.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.713 -0.756 . . . . 73.44 112.497 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.86 -26.62 34.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 74.54 110.916 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.0 15.0 15.51 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.85 -0.691 . . . . 64.3 112.521 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -125.94 102.62 7.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 75.43 110.902 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.61 103.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 51.33 110.896 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.7 t -124.88 84.95 57.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.758 0.79 . . . . 72.52 110.9 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 166.56 27.17 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.739 2.293 . . . . 72.0 112.384 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -137.08 174.03 11.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.809 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.6 m -96.86 128.47 43.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 71.42 110.931 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.21 148.96 69.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 71.22 110.87 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 152.16 69.28 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.641 2.227 . . . . 71.3 112.409 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.578 HD13 ' HA3' ' A' ' 56' ' ' GLY . 31.6 mt -61.48 154.67 23.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 61.15 110.951 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.36 154.46 53.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 72.22 112.446 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -108.22 -171.9 1.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 73.44 110.926 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 36' ' ' ASN . 30.1 tp -71.99 147.59 46.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 70.23 110.977 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.532 ' H ' HD12 ' A' ' 35' ' ' LEU . 79.9 m-20 55.05 32.35 18.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.21 110.89 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.66 159.7 45.21 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.68 0.753 . . . . 73.54 110.827 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.701 2.267 . . . . 52.43 112.27 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 p -134.47 169.81 16.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 51.41 110.883 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -129.66 148.31 51.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 72.03 110.854 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.51 -63.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 73.33 111.098 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -141.7 154.31 65.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 63.05 110.899 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -170.47 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.641 2.227 . . . . 54.31 112.367 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -74.09 -169.29 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 71.21 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.2 -17.54 64.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.863 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -95.6 -28.39 14.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 64.13 110.876 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.06 4.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 63.51 112.528 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.5 mt -119.1 148.43 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.812 0.339 . . . . 73.1 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -104.63 -175.95 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 74.22 110.899 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.7 -77.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 72.5 110.875 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.71 -60.06 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.93 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -75.53 158.52 32.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.175 -0.466 . . . . 74.31 110.82 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 8.0 m -109.41 159.7 30.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.633 0.73 . . . . 61.55 110.869 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.08 22.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 71.33 112.355 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.3 128.49 36.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.842 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -151.12 17.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.679 -0.772 . . . . 74.14 112.488 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' HD12 ' A' ' 59' ' ' LEU . 10.7 pt-20 -127.66 27.14 5.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 72.54 110.876 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.93 19.5 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 52.44 112.548 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.407 HD12 ' HG2' ' A' ' 57' ' ' GLU . 9.5 mt -108.86 173.15 6.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.829 0.347 . . . . 72.43 110.887 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 120.88 8.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 64.41 110.817 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.24 111.54 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.494 . . . . 73.14 110.911 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -128.7 136.75 51.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 74.45 111.167 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -68.0 125.75 27.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 74.43 110.891 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 13.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 73.3 111.092 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.92 -156.57 10.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 62.55 112.536 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.506 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 2.7 pt-20 -152.56 159.51 32.46 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.634 0.73 . . . . 54.31 110.898 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.5 Cg_endo -69.8 -48.14 0.28 Allowed 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 122.674 -1.803 . . . . 73.04 112.34 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -122.77 75.01 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 62.02 110.899 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.7 93.11 4.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 74.0 110.904 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -95.98 142.41 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 73.52 110.875 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -142.44 145.71 34.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.839 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.39 133.11 48.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.44 110.858 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -141.64 128.74 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 63.24 110.919 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -51.94 117.13 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.888 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.59 155.14 40.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 75.32 110.89 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.6 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 51.1 110.831 -179.734 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.927 0.394 . . . . 52.32 110.859 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 56.9 t -86.97 131.28 35.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 63.11 111.138 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.6 m -140.28 111.25 6.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 73.51 111.075 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.8 m -139.21 146.19 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 73.21 110.879 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.91 20.38 72.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 72.44 112.54 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.69 28.99 56.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 75.23 112.507 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -154.77 151.47 28.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.297 . . . . 75.44 110.89 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -92.53 136.24 33.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.429 . . . . 73.24 110.942 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.7 m -114.88 156.54 24.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 52.42 110.891 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.61 160.91 3.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.592 0.71 . . . . 50.12 110.85 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 164.52 34.13 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 75.41 112.362 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 63.4 30.48 15.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 75.25 110.941 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -142.0 116.67 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 72.3 110.9 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.53 168.3 13.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 72.13 110.867 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.21 127.81 37.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 62.12 110.861 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 28' ' ' ARG . 6.3 m -118.77 135.02 60.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 44.55 111.064 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.412 ' HB2' HG21 ' A' ' 48' ' ' ILE . 6.7 tp-100 -92.0 126.57 37.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 64.23 110.943 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -154.01 107.37 2.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.54 110.904 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 p -116.18 172.6 7.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 42.21 110.905 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -114.62 26.97 9.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 71.42 110.902 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.45 75.45 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.769 -0.729 . . . . 73.44 112.459 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -88.18 -30.75 19.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 74.54 110.89 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.05 15.17 20.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.776 -0.726 . . . . 64.3 112.467 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.51 103.12 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.306 . . . . 75.43 110.904 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.27 109.01 0.68 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 51.33 110.858 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 t -131.59 84.98 53.71 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.693 0.759 . . . . 72.52 110.848 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 166.9 26.05 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.652 2.235 . . . . 72.0 112.335 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.476 ' O ' HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -134.0 161.63 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 72.01 110.876 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.2 m -90.18 117.85 29.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.868 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 148.72 46.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.528 0.68 . . . . 71.22 110.91 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 154.81 67.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.647 2.231 . . . . 71.3 112.373 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.611 HD13 ' HA3' ' A' ' 56' ' ' GLY . 33.5 mt -62.44 149.76 41.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 61.15 110.872 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.52 154.77 48.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 72.22 112.474 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -108.51 -173.37 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 73.44 110.892 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 59' ' ' LEU . 41.0 tp -73.36 147.09 44.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.893 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.91 22.54 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.892 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.59 159.58 36.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.581 0.705 . . . . 73.54 110.881 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 123.9 10.58 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.723 2.282 . . . . 52.43 112.339 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.2 p -136.91 170.34 16.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 51.41 110.936 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -133.93 146.81 50.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 72.03 110.927 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.89 -66.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -139.29 156.87 71.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.629 0.728 . . . . 63.05 110.888 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -169.62 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 54.31 112.304 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.89 -168.6 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 71.21 110.914 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.18 67.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -88.7 -28.31 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 64.13 110.905 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.76 32.01 4.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 63.51 112.515 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 17' ' ' GLN . 39.1 mt -120.39 149.03 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.343 . . . . 73.1 111.159 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -103.34 -176.12 3.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 74.22 110.927 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.22 -77.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 72.5 110.814 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -123.0 -59.22 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.934 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -77.05 158.48 30.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.802 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.6 m -108.77 160.29 27.82 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.592 0.71 . . . . 61.55 110.922 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 168.03 22.75 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.716 2.277 . . . . 71.33 112.305 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 74.5 m -68.69 127.1 31.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 70.41 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.611 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.67 17.42 0.97 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.78 -0.724 . . . . 74.14 112.499 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.56 27.24 5.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 72.54 110.841 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.63 23.95 19.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.457 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 35' ' ' LEU . 9.4 mt -108.74 171.43 7.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 72.43 110.9 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.75 127.72 17.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 64.41 110.81 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.92 106.23 1.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.881 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 t -121.24 144.47 48.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.182 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -81.4 123.75 28.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.873 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.18 -24.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 73.3 111.154 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.16 -161.64 9.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 62.55 112.51 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 1.7 pt-20 -127.97 159.44 66.66 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.699 0.762 . . . . 54.31 110.882 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.6 Cg_endo -69.79 -42.2 0.79 Allowed 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.631 -1.82 . . . . 73.04 112.368 0.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.34 63.53 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 62.02 110.894 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 79.32 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 74.0 110.937 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -79.25 147.05 32.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.896 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -152.89 159.03 42.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.908 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -72.76 128.6 36.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.884 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.82 126.46 21.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 63.24 110.948 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.83 117.35 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 74.33 110.867 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -65.66 152.03 45.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 75.32 110.885 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 51.1 110.886 -179.873 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.842 0.353 . . . . 52.32 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.29 144.49 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 63.11 111.09 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 m -153.34 110.52 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 73.51 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 m -148.52 133.64 18.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 73.21 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.25 19.83 76.19 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.725 -0.75 . . . . 72.44 112.464 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.39 28.66 65.41 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.687 -0.768 . . . . 75.23 112.529 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.96 134.99 28.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.674 0.273 . . . . 75.44 110.953 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.51 152.01 21.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.919 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.48 171.14 15.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 52.42 110.877 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -63.28 160.76 38.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.589 0.709 . . . . 50.12 110.856 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 175.05 8.57 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.756 2.304 . . . . 75.41 112.328 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 58.18 38.44 26.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 75.25 110.828 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.8 p -141.32 123.55 15.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 72.3 110.907 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -88.92 168.16 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.948 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -88.32 134.44 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 62.12 110.882 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.35 130.53 65.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 44.55 111.113 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.06 122.87 38.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.917 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -149.7 120.13 7.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 75.54 110.875 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.45 179.88 4.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 42.21 110.853 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -126.35 28.8 5.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 71.42 110.841 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.94 35.97 65.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 73.44 112.415 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -92.05 -31.02 15.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 74.54 110.888 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.03 -5.38 34.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 64.3 112.458 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -117.19 93.0 4.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.738 0.304 . . . . 75.43 110.885 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.06 117.9 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 51.33 110.931 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -135.19 84.94 34.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.655 0.74 . . . . 72.52 110.852 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 166.46 27.47 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.627 2.218 . . . . 72.0 112.327 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.7 ttt85 -138.14 173.99 11.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 72.01 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.8 p -99.24 130.18 45.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.932 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 149.71 56.16 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.702 . . . . 71.22 110.815 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 147.32 62.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 71.3 112.376 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 56' ' ' GLY . 27.7 mt -57.73 149.89 21.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 61.15 110.948 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.44 160.5 32.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.756 -0.735 . . . . 72.22 112.481 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -114.38 -171.87 2.0 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.44 110.866 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 36' ' ' ASN . 26.7 tp -73.18 144.57 46.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 70.23 110.879 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.595 ' H ' HD12 ' A' ' 35' ' ' LEU . 63.8 m-20 58.19 37.09 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 73.21 110.932 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.95 159.72 65.12 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.638 0.732 . . . . 73.54 110.938 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 124.28 10.91 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.701 2.268 . . . . 52.43 112.344 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 17.9 p -135.0 165.43 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 51.41 110.926 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -125.17 145.54 49.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 72.03 110.838 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -54.86 -67.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.33 111.096 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -139.07 156.81 72.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.643 0.735 . . . . 63.05 110.877 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -169.73 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.697 2.264 . . . . 54.31 112.34 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -168.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.21 110.878 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.3 -24.14 67.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.04 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -88.03 -28.42 21.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 64.13 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.72 32.15 4.57 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 63.51 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 mt -122.26 150.54 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 73.1 111.131 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -102.47 -176.02 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 74.22 110.976 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.75 -77.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 72.5 110.836 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -122.82 -59.64 1.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.893 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -75.71 159.95 30.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 74.31 110.861 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.8 m -111.54 160.13 30.58 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.561 0.696 . . . . 61.55 110.943 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.99 22.84 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.658 2.239 . . . . 71.33 112.373 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 88.5 m -70.23 124.54 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 70.41 110.916 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -150.63 19.99 1.02 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.74 -0.743 . . . . 74.14 112.494 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -126.76 28.45 5.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.853 0.359 . . . . 72.54 110.903 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.19 22.73 24.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 52.44 112.523 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.3 mt -108.34 172.39 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 72.43 110.923 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -144.81 118.32 9.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 64.41 110.852 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -55.43 102.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.838 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -118.55 147.55 43.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.45 111.149 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -88.96 124.84 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.927 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.55 13.17 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.3 111.136 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.36 -161.5 11.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.768 -0.729 . . . . 62.55 112.505 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HA ' ' C ' ' A' ' 67' ' ' PRO . 3.2 pt-20 -151.12 159.47 33.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 54.31 110.862 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 66' ' ' GLU . 53.2 Cg_endo -69.78 -48.39 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.748 -1.772 . . . . 73.04 112.331 0.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -123.82 72.53 1.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 62.02 110.832 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -99.9 78.15 2.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 74.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tp -84.68 141.69 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 73.52 110.887 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -149.75 160.67 43.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.59 140.34 41.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.957 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.76 127.3 12.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.911 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.01 120.35 5.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.833 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -64.39 150.31 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.829 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 51.1 110.878 -179.782 . . . . . . . . 0 0 . 1 stop_ save_